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II.  Abstract 
 
The aim of this project was to investigate the causes of spinal neural tube defects 
(NTDs), using the curly tail (ct/ct) mouse as a model system. The ct mutant allele 
corresponds to a hypomorphic allele of grainyhead-like-3 (Grhl3) gene. A two-
dimensional protein gel electrophoresis (2-DE) based approach was used to compare the 
proteome profile of ct/ct embryos with a genetically matched wild-type strain at the 
stage of spinal neural tube closure. This analysis revealed a series of proteins whose 
abundance or 2-DE gel migration are abnormal in ct/ct embryos. Detailed follow-up 
analysis was performed on one protein, lamin B1. Differential migration of lamin B1 on 
ct/ct compared with wild-type 2-DE gels was found to result from a sequence change in 
Lmnb1, resulting in the deletion of a glutamic acid (E) in a region of 9 glutamic acids in 
the wild-type protein. Lamin B1 in ct/ct therefore only has 8 glutamic acids in this part 
of the protein. Further analysis showed that the lamin B1 variants functionally differ. 
Genetic crosses were performed to generate sub-strains of ct/ct mice carrying different 
combinations of the Grhl3 mutation and lamin B1 variants. These studies support the 
hypothesis that Lmnb1 can modify the risk of NTDs in the ct/ct strain. Finally, while 
ct/ct NTDs result from diminished Grhl3 expression, the effects of Grhl3 over-
expression were also investigated by intercrossing curly tail Grhl3-transgenic mice 
(ct/ctTgGrhl3). High levels of Grhl3 expression were found to cause NTDs at high 
frequency, indicating that Grhl3 regulation is an important requirement for neural tube 
closure. Morphological and gene expression analysis in Grhl3 over-expressing 
transgenic embryos suggest that the cellular mechanism underlying NTDs differs from 
that in the ct/ct hypomorphic mutant. 
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Chapter 1 
 
 
General Introduction  
 25
1.0  Introduction 
 
1.1 Mouse development and neural tube closure 
The development of the mouse embryo involves a dynamic series of events during 
embryonic stages prior to the foetal stage. Later, 14-15 days after implantation, the 
development of the foetus mostly involves growth of the organs until birth, around 19-
20 days after conception. The mammalian neural tube is derived from the embryonic 
ectoderm. Closure of the neural folds proceeds from embryonic days (E) 8.0 to 10.5 
resulting in generation of the closed neural tube, the precursor of the entire central 
nervous system (Copp et al., 2003).  
 
During early embryogenesis, the three germ layers (mesoderm, endoderm, and 
ectoderm) are formed during gastrulation stage. A midline region of the ectoderm on the 
dorsal surface of the embryo is induced to become a layer of neuroectodermal cells, the 
neural plate (Figure 1.1). Subsequently the lateral edges of the neural plate elevate, 
fold, adhere to each other and fuse in the midline to form a tube that develops into the 
brain and upper spinal cord (Copp et al., 2003; Greene and Copp, 2009b). This process 
is known as primary neurulation. In contrast, in the lower spinal cord the neural tube 
develops by the process of secondary neurulation, which involves elongation and 
cavitation of a condensed mass of cells derived from the tail bud (Greene and Copp, 
2004).  
 
Neural tube closure is initiated separately and sequentially at three discrete initiation 
sites at (1) the cervical/hindbrain boundary, (2) the midbrain/forebrain boundary, and 
(3) the rostral limit of the forebrain (Figure 1.2 A). Closure spreads bidirectionally from 
initiation sites 1 and 2 and caudally from Closure 3. Thus, from Closure 1 (upper spinal 
level) fusion progresses rostrally into the brain and caudally down the spine, gradually 
closing the open regions, termed neuropores, with closure being completed at locations 
sited in the forebrain, hindbrain, and upper sacral region. The timing of neural tube 
closure varies among mouse strains, but cranial closure is generally complete at E9.5 
and the last part of the neural tube to close in the spinal region is the posterior neuropore 
(PNP) at E10.5 (Greene and Copp, 2004).  
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Conversion of the initially flat neural plate requires a complex sequence of shaping and 
bending events that ultimately results in apposition of the tips of the neural folds to form 
a closed neural tube (Greene and Copp, 2004). For example, the narrowing of the neural 
plate during its formation is predicted to be due to apicobasal elongation of cells. In 
addition, the embryo elongates within the rostrocaudal axis due to cellular convergent 
extension movements in combination with growth of the caudal region of the embryo, 
which continues throughout the period of neural tube closure. 
 
Bending of the lateral edges of the neural plate produces folds that fuse in the midline to 
form the neural tube, and differs between the cranial and spinal regions. At the cranial 
level, the elevating neural folds acquire a biconvex appearance in the midbrain where 
the tips of the folds face away from the midline. Subsequently and abruptly the folds 
assume a biconcave shape, and the tips approach each other in the midline allowing 
fusion to occur (Greene and Copp, 2009a). The mechanism underlying this complex 
bending pattern is not fully understood but there is evidence for the importance of 
expansion of the cranial mesenchyme, which underlies the neural folds, and components 
of the actin cytoskeleton. Some of these mechanisms will be discussed further in this 
chapter. In contrast, at the spinal level there is not a phase of biconvex neural folds, but 
three modes (closure morphologies) which vary in number and location depending on 
the embryo stage (Shum and Copp, 1996). An initial closure point (Mode 1) is 
characterised by the presence of a single bend in the midline above the notochord, the 
median hinge point (MHP; Fig. 1.A-B). The neural folds are straight at the site of 
Closure 1 and subsequently at the level of the posterior neuropore (PNP) at somite 
stages 6 to 15. From somite stages 16 to 23, when the PNP is at a more caudal level, the 
neural folds exhibit additional bending sites (dorsolateral hinge points, DLHP; Fig. 
1.C), and the neural tube has a diamond shaped lumen (Mode 2). Mode 3 occurs from 
somite stage 24, the PNP is characterised by the absence of a defined median hinge 
point but the persistence of DLHP such that the lumen of the closed neural tube is 
circular. 
 
In summary, the process of neural tube closure involves a series of morphological 
events resulting in the conversion of the flat neural plate into the neural tube. The 
processes that are required for closure include convergent extension cell movements, 
expansion of the cranial mesenchyme, contraction of actin microfilaments, regulated 
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bending of the neural plate, and adhesion of the tips of the neural folds (Greene and 
Copp, 2009a). These cellular and molecular mechanisms which were acquired mainly 
from studies in animal models will be further discussed in section 1.4.1, with major 
focus in the mouse.  
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F e 1.1 Diagrammaticigur  representations and hematoxylin-eosin stained 
tube closure in the mouse. (A) The neural plate (NP), 
which overlies the notochord (N), is a sheet of epithelial cells of ectodermal (E) 
trula-stage embryo. Along the ventral 
 the neural folds. Scale bars: 0.1 mm. 
transverse sections showing the main morphogenetic movements during the 
process of spinal neural 
origin on the dorsal surface of the gas
midline of the neuroepithelium, the median hinge point (MHP) forms a bend 
around which the plate bends. (B) Elevation of the neural folds (NF) results in 
formation of the groove (neural groove). (C) In the mid-lower spine, caudal to 
somite 15, secondary hinge points are formed in the dorsolateral (DLHP) part of 
the neural folds, facilitating convergence of the tips of the neural folds. (D-E) The 
tips of the neural folds meet and fuse at the dorsal midline and tissue remodelling 
separates the newly formed neural tube (NT) from the surface ectoderm (SE). (F-
I) Transverse sections through the PNP region of embryos of increasing somite 
stages show the events of spinal neural tube closure. These include formation of 
the MHP and elevation of the NF (F), the formation of DLHP (G), apposition of 
the tips of the NF (H) and the closed NT (I). Other abbreviations: FP, floor plate; 
Hg, hindgut; N, notochord. Arrowheads in G indicate DLHP. Arrow in F 
indicates the point of adhesion at the tips of
 29
1.2 Neural tube defects  
Abnormalities in the process of neurulation can prevent closure, resulting in neural tube 
defects (Copp et al., 2003).  
 
1.2.1 Neural tube defects in the mouse  
Failure of initiation of Closure 1 (hindbrain-cervical boundary) results in 
craniorachischisis. In this condition most of the brain (from the midbrain) and the entire 
spinal cord remains open, while Closures 2 and 3 usually occur normally. Failure of 
closure in the cranial region results in exencephaly (Closure 2, Fig. 1.2 C), with 
persistent open neural folds, which progresses to anencephaly, characterized by 
degeneration of the exposed brain tissue and lack of formation of the skull vault. 
Anencephaly is also observed in individuals with craniorachischisis as observed in 
Figure 1.2 B. Failure of Closure 3 results in a type of exencephaly referred to as a split 
face phenotype, in which the forebrain remains open. Failure of closure in the lower 
spine causes spina bifida (Fig. 1.2 D). In mice, spina bifida is usually accompanied by 
tail flexion defects, such as curled tail, as a secondary manifestation (Fig. 1.2 B-D). 
NTDs at different axial levels can occur in isolation or in combination (e.g., spina bifida 
may occur with exencephaly; Fig. 1.2 C-D).  
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Figure 1.2 Neural tube closure and NTDs. (A) Location of the sites where 
closure was previously initiated, and the subsequent progression of closure are 
indicated on an E10.5 embryo, near the final stage of neural tube closure. Closure 
spreads bidirectionally (red arrows) between the three initiation sites (1, 2 and 3, 
white) and caudally (red arrows), resulting in shortening of the neuropores (NP), 
and culminating with the closure of the posterior NP (PNP). Diagram adapted 
from (Copp et al., 2003). NTDs (B-D) arise if closure fails. (B) Newborn Loop-
tail mutant with craniorachischisis in which Closure 1 failed to occur. The whole 
spine remains open (black arrows), and the brain does not form (black 
arrowhead). (C-D) E15.5 curly tail foetus with exencephaly (red double-headed 
arrow) and spina bifida (red arrow) where Closure 2 and PNP closure failed to 
occur, respectively. Green arrow indicates curled tail. Scale bars: A, 0.5 mm; B-D, 
1.0 mm. 
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1.2.2         Neural tube defects in humans 
Similar to neural tube closure in the mouse embryo, closure in human embryos is also a 
discontinuous process characterized by multiple closure sites (Greene and Copp, 
2009a). The bending of the neural plate begins at around 17-18 days post-fertilization 
(dpf). Closure 1 occurs more rostrally than in the mouse, at around 22 dpf, while a 
corresponding event to closure 2 does not seem to occur, or if it does may be at a more 
anterior position than in the mouse. Closure 3 seems to occur in the same site as in the 
mouse (anterior forebrain). Completion of neural tube closure occurs at the level of the 
posterior neuropore, at 26-28 dpf, followed by secondary neurulation which forms the 
neural tube in the low sacral and coccygeal regions. Disturbances in the process of 
rimary neural tube closure in the developing embryo, result in open NTDs, as 
uring early pregnancy (Moretti et al., 2005) and maternal hyperglycemia, 
iabetes or obesity (Detrait et al., 2005; Loeken, 2005; Dheen et al., 2009).  
p
described in the mouse. Both craniorachischisis and anencephaly are lethal 
malformations. Individuals with spina bifida usually survive birth but are likely to 
require lifelong medical interventions for severe disabilities including loss of sensation 
and/or paralysis of the legs, hydrocephalus, spinal curvature, limb deformities and renal 
tract infections. 
 
In humans, NTDs are common birth defects, occurring in approximately 0.5-2.0 per 
1,000 pregnancies (Greene et al., 2009b). These defects have a multifactorial basis with 
genetic and environmental factors contributing to risk (Copp et al., 1990). 
Epidemiologic studies have indicated a range of environmental factors which appear to 
contribute to susceptibility to NTDs in humans, and may summate with predisposing 
genetic factors. Environmental risk factors include nutritional status (e.g. sub-optimal 
folate availability or insufficient vitamin B12 levels) and teratogenic agents (e.g., excess 
vitamin A or anti-epileptic drugs such as valproic acid). Other factors include 
hyperthermia d
d
 
To date, while a few possible ‘risk’ polymorphisms have been described, no genetic 
defects have been identified as a major cause of human NTDs. This suggests one or 
more of the following possibilities: that a major NTD has yet to be identified, that some 
cases involve rare, unique mutations or that cases typically arise from a combination of 
two or more risk factors (Greene and Copp, 2005; Greene et al., 2009b). In most NTDs 
a Mendelian pattern of inheritance has not been reported. However, there is an enhanced 
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recurrence risk among siblings of affected individuals, and a higher frequency in twins 
than in singletons. These patterns fit a model in which the majority of NTDs are 
sporadic with multifactorial polygenic or oligogenic inheritance (Detrait et al., 2005; 
Harris and Juriloff, 2007). One example of a mouse model which seems to fit within the 
additive, multifactorial genetics of human NTDs is the SELH/Bc strain, in which there 
appears to be a contribution of several critical genes which have an approximately 
equal, additive, and interchangeable effect on NTD risk (Juriloff et al., 2001). Another 
example is the curly tail (ct) mutant strain, where the presence of the ct mutation 
appears to be essential for NTDs, but with variable penetrance affected by at least three 
modifier” loci (Harris and Juriloff, 2007; Neumann et al., 1994). 
romic (Harris, 2001). Syndromic cases in humans, which make 
p less than 10% of all NTDs, are often associated with chromosomal anomalies 
at make up folate metabolism and polymorphisms in a number of these enzymes have 
“
 
Identification of the genes that are associated with risk of human NTDs has proven to be 
a difficult task. In humans, identification of familial cases of NTDs with a significant 
number of affected members, have proven difficult to ascertain. Other than spina bifida 
most types of NTDs are lethal (craniorachischisis and anencephaly), such that 
subsequent generations will not be present. A drawback of direct extrapolation of 
candidate genes from the mouse is that many of the mouse mutants with NTDs have 
multiple developmental defects (syndromic), which is not reflected in humans in which 
most cases are non-synd
u
(Greene et al., 2009b). The search for candidate genes has largely focussed on candidate 
genes related to: i) folate metabolism, since folic acid supplementation is known to 
reduce the incidence of NTDs (Wald et al., 1991) and sub-optimal folate status is a risk 
factor for NTDs (Kirke et al., 1993); ii) mouse models of NTDs of which there are more 
than 200 (Harris and Juriloff, 2010) positional candidates from linkage analysis (Boyles 
et al., 2005).  
 
Folate metabolism involves the activation and transfer of one carbon units which are 
used in a variety of anabolic and catabolic reactions, that are essential for a number of 
cellular processes including nucleotide synthesis and methylation reactions (Beaudin 
and Stover, 2007). A number of enzymes catalyse the interlinked network of reactions 
th
been analysed for possible association with risk of NTDs. The most well studied 
enzyme is 5,10-methylenetetrahydrofolate reductase (MTHFR) and the C677T 
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polymorphism in MTHFR has been associated with increased risk in some, although not 
all, populations (Boyles et al., 2005; Greene et al., 2009b). It is hypothesised that some 
NTDs result from an underlying defect of folate metabolism in the fetus. This idea was 
supported by biochemical analysis of folate metabolism in primary fibroblastic cell lines 
derived from fetuses affected with NTDs, which showed abnormalities in folate cycling 
in a proportion of cases (Dunlevy et al., 2007). These defects were proposed to be 
enetically determined but did not correlate to genotype for any of the commonly 
tudied polymorphisms in folate-related genes, including 5,10-
R). 
ibar et al., 2007; Kibar et al., 2009) and VANGL2 (Kibar et al., 
010)  have been identified in patients with open and closed forms of spina bifida. 
n NTDs.   
g
s
methylenetetrahydrofolate reductase (MTHF
 
Some genes whose mutation is known to cause NTDs in mice have been screened in 
human cases. In mice, mutations in the Pax3 gene result in NTDs in homozygous 
mutants such as splotch (reviewed by Greene et al., 2009). In humans, mutations in 
PAX3 are found in Waardenburg syndromes types I and III cases, and spina bifida has 
occasionally been reported in these syndromes (Carezani-Gavin et al., 1992; Chatkupt 
and Johnson, 1993). These observations suggest that PAX3 mutations can cause NTDs 
in humans (Greene et al., 2009a). However, neither mutation screens (by sequencing) 
nor association studies have suggested that PAX3 is a major risk factor for spina bifida  
(Greene et al., 2009a).  
 
Mutation of Vangl2, which encodes a member of planar cell polarity signalling 
pathway, causes craniorachischisis in loop-tail mutant mice (Murdoch et al., 2001). 
Vangl1 mutant mice do not develop NTDs, but a possible role in neural tube closure 
was indicated by the observation of craniorachischisis in Vangl1/2 compound 
heterozygous mutants (Torban et al., 2008). Several nucleotide variants and a 
heterozygous 7 base pair intronic duplication were found in VANGL1 and VANGL2 
genes in a collection comprising craniorachischisis, spina bifida, and anencephaly, but 
none were unique to NTDs cases (Doudney et al., 2005). Subsequently, missense 
variants in VANGL1 (K
2
These studies suggest variants in VANGL genes may contribute to some huma
 
Genome wide linkage screens may be a powerful method to find risk conferring genes. 
The drawback of this approach is the lack of families with multiple affected individuals 
 34
and access to sufficient numbers of parent-child triads (Boyles et al., 2005). However, 
one linkage study has revealed two candidate regions for human NTDs, on 
chromosomes 7 and 10. The region on chromosome 10 included three possible 
candidates genes, FGFR2, GFRA1 and PAX2 (Rampersaud et al., 2005). Given the 
likely heterogeneity of the genetics of NTDs, very large sample sets will be required for 
a genome wide association study using sporadic NTD cases. 
 
 
1.3  Prevention of neural tube defects  
tudies in the 1980s by Smithells and colleagues suggested that etiology of NTDs in the 
omen who have 
ad a previous affected pregnancy. Considering the folic acid groups together, there was 
n approximately 70% reduction in frequency of NTDs (Wald et al., 1991). In another 
was 90% lower frequency of NTDs in the treatment group compared to placebo 
umber of transcription 
ctors, signalling molecules, and the coordination of several biological processes 
including cell proliferation, migration and differentiation. This complexity is reflected 
S
human population was influenced by maternal diet, social class, maternal age, and 
smoking (Schorah, 2009). Subsequent studies and small scale non-randomised clinical 
trials suggested that maternal folate status may influence risk of NTDs. Formal 
randomised clinical trials showed that maternal folic acid supplementation prior to and 
during early pregnancy can prevent the first occurrence and recurrence of NTDs (Wald 
et al., 1991; Czeizel and Dudás, 1992). The recurrence trial analysed the effect of folic 
acid (4 mg/day) with or without multivitamins, on NTD recurrence in w
h
a
study the effect of folic acid (0.8 mg per day) on first occurrence was analysed and there 
controls, although this was not statistically significant (Czeizel and Dudás, 1992). These 
studies raised questions such as what should be the optimal dose of folic acid and 
whether folic acid should be taken with other vitamins (Czeizel, 2009). Mandatory 
fortification of food with folic acid was introduced in the USA in 1999, with a 
subsequent reduction in NTD frequency estimated at around 26% (Mersereau et al., 
2004). However, a subset of NTDs, estimated at 30-50% appear to be resistant to 
prevention by folic acid (Mersereau et al., 2004), and alternative methods of prevention 
are therefore needed.  
 
1.4 The mouse as a model system for the study of neural tube defects 
The normal development of the neural tube is mediated by a n
fa
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in the analysis of the distinct mouse mutants in which NTDs form part of the mutant 
phenotype. Over 240 mouse genetic mutants exhibit NTDs and may provide useful tools 
for studying the developmental mechanisms underlying neural tube closure as well as 
the complex etiology of these diseases in humans (Greene and Copp, 2005; Harris and 
Juriloff, 2007; Harris and Juriloff, 2010). The occurrence of NTDs in mutants for a 
range of different genes suggests that neural tube closure depends on a variety of 
cellular functions and has also shown that the mechanisms acting at differing axial 
levels may be distinct in some cases, for example in the brain as opposed to spinal cord 
(Copp et al., 2003).  
 
The main problem in the many of the mouse mutants appears to be failure of elevation 
of the neural folds, in the cranial region resulting in exencephaly, and/or the posterior 
neuropore, resulting in spina bifida. Among the total number of mutants, around 70% 
develop exencephaly alone, 5% exhibit only spina bifida and approximately 20% 
evelop both conditions. In many mouse models, females seem to have a higher rate of 
equirements for neural 
be closure (Copp and Greene, 2010). Most of the genes whose mutation causes NTDs 
d
exencephaly compared to males, as is observed in human NTDs. The basis to this sex 
bias is unknown (Harris and Juriloff, 2010; Harris and Juriloff, 2007).  
 
 
1.4.1 Cellular and genetic requirements for neural tube closure from studies in 
mice 
Mouse models provide useful systems in which to analyse the r
tu
are reported to be expressed either in the neuroepithelium or adjacent tissues, suggesting 
that the causative cellular defect may be intrinsic or extrinsic to the neural folds (Harris 
and Juriloff, 2007). Mutation of genes of the planar-cell-polarity (PCP) pathway, such 
as Vangl2 and Celsr1 causes failure of Closure 1. This is due to a deficiency of 
convergent extension cell movements that are necessary for narrowing and lengthening 
of the neural plate (Ybot-Gonzalez et al., 2007b).  Therefore, embryos carrying 
mutations in planar cell polarity genes exhibit widely spaced neural folds, abnormally 
short and a wide body axis resulting in association with the severe NTD, 
craniorachischisis (Copp et al., 2003; Copp and Greene, 2010).  
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Evaluation of mouse mutants suggest that neural tube closure, particularly in the cranial 
region, depends on regulation of the balance between cell proliferation, apoptosis and 
neuronal differentiation within the neural folds (Greene and Copp, 2009a). For example, 
cranial NTDs occur in association with premature neuronal differentiation in Hes1 and 
Hes1/Hes3 mutant embryos (Ishibashi et al., 1995; Hirata et al., 2001). Excess apoptosis 
has been proposed to be the cause of cranial NTDs in several mutant strains including 
e Cited2 knock-out (Martinez-Barbera et al., 2002). Apoptosis occurs in a 
mbryo culture by 
agents such as cytochalasin D causes exencephaly (Ybot-Gonzalez and Copp, 1999), 
lthough spinal neurulation is apparently unaffected. Loss of function of cytoskeletal 
in ed proteins (e.g. cofilin) or proteins that 
lds. Experimental manipulation of chick and mouse embryos 
uggest the MHP is induced by signals from the notochord (Greene and Copp, 2004), 
th
characteristic pattern during neural tube closure (Massa et al., 2009) and reduced levels 
of apoptosis are observed with cranial NTDs, for example in Apaf-1 or caspase 3/9 
mutant embryos (Massa et al., 2009). However, it appears unlikely that diminished 
apoptosis is directly causative  as direct inhibition of apoptosis shows that it is not 
required for neural tube closure (Massa et al., 2009). It is thought that NTDs in 
apoptosis-deficient embryos may result from other cellular defects, such as an 
associated miss-regulation of proliferation.   
 
Another requirement for normal closure of the cranial neural tube is normal function of 
the actin cytoskeleton. Disruption of the actin cytoskeleton in e
re
a
prote s, such as shroom, cytoskeleton associat
regulate cytoskeletal function (e.g. MARCKS), can each result in cranial NTDs (Harris 
and Juriloff, 2007; Copp and Greene, 2010; Massa et al., 2009).  
 
In the spinal region, bending of the neuroepithelium at the median hinge point (MHP) 
and the dorsolateral hinge points (DLHPs) is regulated by mutually antagonistic signals 
external to the neural fo
s
while formation of DLHPs depends on signals from the surface ectoderm, since 
unilateral removal of the surface ectoderm results in loss of dorsolateral bending of the 
subjacent neural fold  (Ybot-Gonzalez et al., 2002). However, the neural tube can close 
in the absence of MHP as shown by the absence of NTDs in mouse embryos in which 
the floor plate did not form. One example is the sonic hedgehog (Shh) mouse mutant, in 
which the floor plate of the neural tube does not form owing to loss of Shh signal from 
the notochord (Copp and Greene, 2010; Echelard et al., 1993).  
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A cellular mechanism suggested to account for bending of the neuroepithelium at the 
hinge points is the predominance of cells that are wedge-shaped, with a wider basal 
(nonluminal) pole (Greene and Copp, 2004). Possible explanations for cell wedging 
include localised apical constriction of neuroepithelial cells and cell cycle-dependent 
variations in the apicobasal position of nuclei within the pseudostratified 
neuroepithelium (Copp et al., 2003, Greene and Copp, 2009a).  
 
Finally, once the tips of the neural folds achieve apposition at the dorsal midline, fusion 
entification of mouse models of NTDs in which folic acid has a protective effect 
rovides models for investigation of the mechanism by which NTDs are prevented. 
reatment of splotch (Sp2H) embryos with folic acid in vivo, by maternal intraperitoneal 
jection, (10 mg/kg body weight) or in embryo culture (200 µg/ml) reduces the 
equency of NTDs in homozygous mutant embryos by up to 65% (Fleming and Copp, 
998). Folate-deficiency has also been induced in mouse embryos by maintaining 
females on folate-deficient diets prior to mating. In wild-type mice folate deficiency 
must occur at the contact points in order to complete neural tube formation. Subsequent 
to adhesion and fusion, the neural fold apices remodel to create two continuous 
epithelial layers: the surface ectoderm and the neuroepithelium itself.  The mechanism 
of adhesion and fusion is not well known, however, failure of adhesion would be 
expected to result in NTDs, and the mouse embryos lacking ephrin-A5 (cell surface Eph 
ligand) and EphA7 receptor (potential ligand of EphA5) exhibit exencephaly (Greene 
and Copp, 2004; Holmberg et al., 2000). Recent studies, in which Ephrin A-EphA 
interactions were disrupted in cultured mouse embryos suggest that these molecules are 
also required for closure in the spinal region (bdul-Aziz et al., 2009). 
 
 
1.5 Prevention of NTDs in mouse models 
Studies in humans showed that folic acid supplements can prevent NTDs, although the 
mechanism is not clear. Conversely, sub-optimal maternal folate levels or vitamin B12 
or elevated levels of homocysteine are risk factors (Wald et al., 1991; Kirke et al., 1993; 
Molloy et al., 2009).  Some of the mouse models for NTDs have been tested for 
response to folic acid as well as other agents such as methionine and inositol (examples 
are listed in Table 1.1). 
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c h 
However, folate deficiency can increa y o n s ) 
and curly tail mutants (Burren et al., 2008; Burren et al., 2010), demonstrating gene-
e  in s between folate sta and genetic pre sposition to NTDs. In 
t  t te content of the em o appeared to lace a strict t on 
developmental  it was hyp ed that NTDs e caused by i ibition 
of proliferation in the neural folds. 
 
Mutants that ar to folic acid include axial def xd) and curly tail, in 
which the incidence of spina bifida is not reduced among embryos which mothers 
r folinic amin (Greene and Copp, 2005). Methionine has been 
tested as for its possible protective effect owing as elevated homocysteine or diminished 
itamin B12, both risk factors for NTDs, could indicate reduced conversion of 
ho m 
of e 
cy n 
un f 
ho tion cycle. Moreover, in the mouse 
late deficiency causes reduced activity of the methylation cycle (Burren et al., 2008), 
hile direct inhibition of the methylation cycle causes cranial NTDs (Dunlevy et al., 
2006b). While methionine has no protective effect in curly tail (Van Straaten and Copp, 
frequency of spina bifida in axial defects mutants 
following maternal m
em o 
em
(Sp ing and Copp, 1998) and in non-
utant CD1 embryos (Dunlevy et al., 2006a). 
auses growt retardation but not NTDs  (Burgoon et al., 2002; Burren et al., 2008). 
se the frequenc f exencephaly i plotch (Sp2H
nvironment teraction tus di
hese models he fola bry  p limi
progression and othesis  ar nh
  
e not responsive ects (A
eceived  acid or B12 vit
v
mocysteine to methionine (Beaudin and Stover, 2009). Folic acid (the synthetic for
the vitamin) is converted to the bioactive form, tetrahydrofolate, to enter the folat
cle. Inside the cell, folate molecules function as acceptor and donors of one-carbo
its, in pathways required for pyrimidine and purine synthesis and the remethylation o
mocysteine to methionine required for the methyla
fo
w
2001), there was a 40% reduction in 
ethionine supplementation (70 mg/kg intraperitoneal injection) at 
bryonic days 8.0 and 9.0 (Essien, 1992). In other cases, addition of methionine t
bryo culture medium actually caused cranial NTDs, including splotch heterozygotes 
2H) which do not normally develop defects (Flem
m
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Mutant or 
strain 
Type of NTD Folic/folinic acid 
response (%) 
Methionine Inositol 
response (%) response 
(%) 
Cart1 null Exenc 85 - - 
Cited2 null Exenc 80 - - 
Sp2H SB +/or exenc 40-65 - - 
Axd SB None 50 - 
Efna5 null Exenc None - - 
Ct SB (occasional 
exenc) 
None None 70-85 
Grhl3-/- SB (occasional 
exenc 
None - None 
 
Table 1.1 Prevention of NTDs in mouse models. Examples of mouse mutants in 
which maternal agents have been tested in the prevention of NTDs. The vitamin 
response is given as percentage (%) of prevention (Adapted from (Greene and 
Copp, 2005; Harris and Juriloff, 2007; Harris, 2009). Abbreviations: Exc, 
exencephaly; SB, spina bifida; -, no information. 
 
 
 40
 
 
Figure 1.3 Diagram of folate one–carbon metabolism. Folate metabolism 
(black) is required for de novo synthesis of purines (dark-red) and thymidylate 
(Pyrimidine metabolism, purple) and for the remethylation of homocysteine to 
methionine (Methylation cycle, blue). 
 
1.6
Th o 
La l 
cro d 
Co
tha  
de n 
de
Initial observations suggested that the defects in these mice were probably caused by a 
recessive gene, whose effect on neural tube closure is affected by the genetic 
 
  The curly tail mouse model 
e curly tail (ct) mutation arose spontaneously in the GFF inbred strain at the Glax
boratories in 1950, and has been maintained by homozygous matings of an initia
ss between an affected ct/ct female and CBA/Gr inbred male (Van Straaten an
pp, 2001). The ct mutation has incomplete penetrance and variable expressivity such 
t homozygous curly tail embryos (ct/ct) develop: normally (40%), whereas 60%
velop NTDs comprising exencephaly (3-5%), spina bifida (14-15%) and tail flexio
fects (50%; Fig. 1.4; (Van Straaten and Copp, 2001).  
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background. This was shown in linkage studies to map the ct mutation, in which curly 
tail mice were crossed with several inbred strains. On some backgrounds the frequency 
of NTDs was similar to the original curly tail strain (e.g., 18.5% in C57BL/6), while 
other genetic backgrounds resulted in lower frequency (2.2% in DBA/2; (Neumann et 
al., 1994).  Therefore, penetrance of the ct trait is influenced by the genetic background, 
such that modifier genes act to increase or ameliorate the defects. Modifier genes have 
been mapped to chromosomes 3, 5 and 17 (Neumann et al., 1994; Letts et al., 1995), but 
the identity and function of these genes is unknown. These linkage studies also showed 
that rather than a recessive mutation, ct should be considered semi-dominant since 
abnormal tails were detected in a small proportion of mice heterozygous at the ct locus 
(Neumann et al., 1994; Beier et al., 1995).   
nts (see Section 1.6.1). 
 
The existence of modifier genes provided evidence of multifactorial inheritance in curly 
tail as in humans. A number of other characteristics of the curly tail mouse mutant 
resemble the defects in human cases of spina bifida, and curly tail has been considered 
to be a good model to investigate the human defects. Similarities between curly tail and 
human NTDs include the location of the spina bifida lesion at the lumbosacral level 
(Manning et al., 2000) the presence of elevated alpha-fetoprotein in the amniotic fluid 
(Van Straaten and Copp, 2001; Van Straaten and Copp, 2001), and the excess of 
females compared to males among exencephalic embryos (Embury et al., 1979; Seller, 
1987; Brook et al., 1994). In addition, the penetrance of defects can be influenced by 
environmental factors such as temperature and exogenous age
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Figure 1.4 Phenotypes observed among homozygous curly tail (ct/ct) embryos. 
t tail (ST), as observed in around 40% of curly tail embryos which 
ppear to develop normally. (B) Tail flexion defects such as bent tail (BT) occur 
 
(A) Straigh
a
in 50% of homozygotes. (C) Spina bifida (SB) accompanied by tail flexion defect 
(curled tail, CT) in 14-15% of the embryos. (D) Occasionally (~3-5%), embryos 
develop exencephaly (Ex) which can be in isolation or accompanied by a tail 
flexion defect and/or SB. (E-F) Higher magnifications of the caudal region of 
embryos with SB and CT (E) or CT alone (F). Scale bars: 1.0 mm. 
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Th in 
clo n 
de e 
dis  PNP length at E10.5 
(Copp, 1985a). The PNP size can be denoted as category 1/2, small neuropores (SPNP), 
hich correlate with normal development in the majority of embryos; category 3 , 
ed in embryos that develop 
ion (Copp et al., 
88a; Copp et al., 1988b). This growth imbalance causes pronounced ventral curvature 
e developmental origin of spinal NTDs in curly tail embryos is a failure or delay 
sure of the posterior neuropore (PNP), progressing to spina bifida and tail flexio
fects respectively (Copp, 1985a). Moreover, embryos developing spinal NTDs can b
tinguished from their littermates on the basis of the enlarged
w
moderately enlarged neuropores (MPNP), are observ
normally in 30% of cases, the remainder develop tail defects, and few develop spina 
bifida; category 4/5 refers to enlarged neuropores (LPNP), which predicts around 
normal development in 10% of embryos high likelihood of spina bifida and tail defects, 
or tail defects alone. 
 
Among curly tail embryos, those with enlarged PNP (category 4/5; also denominated 
affected) have an abnormally low proliferation rate in the hindgut endoderm and 
notochord compared to embryos with small PNPs (category 1/2, closing normally) 
whereas the neuroepithelium maintains a normal rate of cell divis
19
of the caudal region which inhibits closure of the PNP (Fig. 1.5; (Brook et al., 1991; 
Peeters et al., 1996). The increased axial curvature and delayed closure of the PNP in 
curly tail embryos can be recognised from somite stage 25-27, while in those embryos 
where PNP closure does occur this is complete by the 30-31 somite stage (Copp et al., 
1982; Copp, 1985a; Brook et al., 1991; Peeters et al., 1998).  
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Figure 1.5 Cellular mechanism underlying delay of PNP closure in curly tail 
embryos. (A) Curly tail embryo at 25 somites stage. (B) Section through the 
posterior neuropore (PNP, dashed line in A). In embryos with enlarged PNP there 
is reduced cell proliferation in the hindgut endoderm (Hg) and in the notochord 
(N), compared to embryos with small PNP sizes, whereas proliferation in the 
neuroepithelium (neural folds, NF) does not differ with PNP size. (C-D) This cell 
proliferation defect causes an imbalance between the ventral and the dorsal 
tissues, resulting in increased ventral curvature (yellow arrow), which 
mechanically opposes apposition of the NF, inhibiting neural tube closure at the 
level of the PNP. (D-F) In embryos with a small PNP (SPNP) closure occurs 
to secondary neurulation (which starts at around the time of posterior neuropore 
normally. Embryos with moderately enlarged PNP (MPNP) are more likely to 
have a delay in closure, and to develop tail flexion defects. In embryos with large 
PNP (LPNP) closure is prone to fail resulting in spina bifida (SB) and a curled tail 
(yellow arrowhead, F) as observed at E11.5 (Copp et al., 1988a; Copp, 1985a; 
Brook et al., 1991; Peeters et al., 1996). Images used in this figure were generated 
in the course of this project. 
 
Although it has been established that delay of the posterior neuropore closure causes tail 
flexion defects in curly tail embryos, the mechanism by which the tail bends or curls 
remains unclear. It has been suggested that there is an abnormal transition from primary 
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closure), subsequent to delayed closure of the PNP (Copp et al., 1982).  Figure 1.6 
shows sections at the transition between primary and secondary neurulation. 
 
                      
 
Figure 1.6 Haematoxylin-eosin stained transverse sections of mouse embryos 
at the level of the tail bud. Sections are arranged caudally to rostrally for two 
embryos (A-B and C-E).  A condensation of mesodermal cells (arrowhead in A) 
is observed that will canalise to form the secondary neural tube in a section (A) 
caudal to the level of the closed primary neural tube (B). (C-E) In an embryo with 
33 somites in which the posterior neuropore failed to close, a condensation of 
cells is visible in the   tail bud (Tb, C tral levels (D-E) a central 
 
1.6.1  
everal environmental factors have been found to affect the penetrance of spinal NTDs 
curly tail embryos. These include teratogens such as anti-mitotics, hyperthermia, and 
). At more ros
lumen forms in this condensation which will form the secondary neural tube (2ry 
NT in D), with a circular lumen as observed in (E). Abbreviations: Hg, hindgut; 
N, notochord; NF, neural folds; SE, surface ectoderm. Scale bars: 0.1 mm. Images 
used in this figure were generated in the course of this project. 
 
Environmental factors and NTDs in curly tail 
S
in 
levels of nutrients such as inositol and folate (Cockroft et al., 1992; Van Straaten and 
Copp, 2001; Burren et al., 2010). The interaction of the ct mutation with environmental 
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factors has been useful both in understanding the underlying developmental defects and 
in identification of possible preventive agents. For example, growth retardation of 
embryos by exposure to hyperthermia, corrected the growth imbalance between dorsal 
and ventral tissues and normalised PNP closure (Peeters et al., 1996), supporting the 
idea that the proliferation imbalance plays a causative role in NTDs.  
  
Retinoic acid (an active metabolite of vitamin A, and a known teratogen) has been 
hown to play a role in neural tube closure (Seller et al., 1979). Normal expression of 
ible effect of folic acid or other one carbon 
etabolites on the frequency of NTDs in curly tail. Folate one-carbon metabolism is 
s of other strains (Burgoon et al., 2002; Burren et al., 2008). In addition, some 
vidence suggests the possible presence of disturbed folate one-carbon metabolism in 
the curly tail strains, particularly involving the methylation cycle. Adult curly tail mice 
exhibit higher levels of homocysteine and s-adenosylhomocysteine ratio of s-
s
retinoic acid receptor-β (RAR-β) is normally expressed in the hindgut, but was found to 
be down-regulated in affected curly tail embryos, while RAR-γ was down-regulated in 
the PNP and tail bud (Chen et al., 1995). Supporting a possible role for abnormal RAR 
function in spinal NTDs, administration of low doses of retinoic acid to pregnant curly 
tail females (E10, before posterior neuropore closure), increased the expression of 
RAR-β in the hindgut, and reduced the frequency of spina bifida (Chen et al., 1994). 
Therefore, it has been suggested that RAR-β plays a role in the causation of the hindgut 
proliferation defect in curly tail (Chen et al., 1995).   
 
Several studies have examined the poss
m
summarised in Figure 1.3 (Section 1.5)  
 
Folic acid has been found to reduce the frequency of NTDs in some mouse models such 
as splotch (Sp2H), while methionine has been found to be protective in others such as the 
axial defects (Axd) mutant (Essien, 1992). However, neither folic acid nor methionine 
have been found to reduce the incidence of NTDs in curly tail (Van Straaten and Copp, 
2001; Van Straaten et al., 1995). However, dietary folate deficiency has been found 
increase the frequency of cranial NTDs in both curly tail and a genetically matched 
wild-type strain (Burren et al., 2010). These findings suggest the presence of one or 
more loci in the curly tail genetic background that give susceptibility to folate 
deficiency-related NTDs, as NTDs are not induced by folate deficiency in wild-type 
embryo
e
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adenosylmethionine to s-adenosylhomocysteine (SAM/SAH) in the liver than C57Bl/6 
mice, suggesting a possible sub-optimal methylation potential (Tran et al., 2002). This 
could be relevant to the development of NTDs as inhibition of the methylation cycle has 
been found to cause cranial NTDs (Dunlevy et al., 2006a). In contrast, folate deficiency 
was found to result in an increase in the SAM/SAH ratio in curly tail embryos unlike 
other strains where folate deficiency causes diminished SAM/SAH ratio (de Castro et 
al., 2010). Therefore it appears that reduced methylation is an unlikely cause of cranial 
NTDs in curly tail particularly as there is no apparent increase in the frequency of 
NTDs in homozygous ct/ct embryos that are also null for 5,10-
methylenetetrahydrofolate reductase (Mthfr) and have very low SAM/SAH ratio (de 
Castro et al., 2010). 
 
The lack of protective effect of folic acid has led to the use of curly tail as a possible 
model for folic acid-resistant NTDs (Greene and Copp, 2005). In contrast to folic acid 
and methionine, administration of inositol during mouse pregnancy or in whole embryo 
culture normalises closure of the PNP and reduces the incidence of spina bifida (Fig. 
1.7; (Greene and Copp, 1997; Cogram et al., 2002). Inositol is thought to act by 
increasing flux through the inositol/lipid cycle, which stimulates protein kinase C 
activity), in the underlying hindgut endoderm and corrects the proliferation defect, 
which normalises neural tube closure (Greene and Copp, 1997; Cogram et al., 2004). 
phosphorylate other proteins altering their function in a cell-type specific 
ma ner. The PKCβI and PKCγ isoforms were found to be specifically required for the 
pre C 
ha
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he preventive effect of inositol in mice encouraged the view that a clinical trial in 
umans would be worthwhile to test whether inositol may be a useful adjunct therapy to 
folic acid, for preventing folate-resistant NTDs cases. Studies in Italy reported the first 
cases of use of periconceptional inositol in patients with a history of NTDs despite use 
PKC acts to 
n
vention of NTDs (Cogram et al., 2004) but the critical downstream targets of PK
ve not yet been identified in treated ct/ct embryos. 
erestingly, loss of phosphatidylinositol-4-phosphate 5 kinase (PIP5Kiγ; (Wang et al
07), or reduced levels of inositol 1,3,4-triphosphate 5/6-kinase (IPTK1; (Wilson et al.
09; Majerus et al., 2010), two enzymes in the inositol pathway result in cranial an
inal NTDs.    
T
h
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of folic acid. No NTDs occurred in 6 pregnancies and while this is not a statistically 
significant finding no deleterious effects of inositol usage during pregnancy were 
reported (Cavalli and Copp, 2002; Cavalli et al., 2008). A randomised clinical trial, 
Prevention of Neural Tube Defects by Inositol (PONTI) study, is now being carried out 
to test whether a combined treatment with inositol and folate is more effective than folic 
acid alone for prevention of NTDs in women with a high recurrence risk, having a 
history of at least one affected pregnancy.  
 
    
 
Figure 1.7 Diagrams of the proposed mechanism underlying rescue of NTDs 
in curly tail mice by inositol. Mechanism by which inositol rescues spinal NTDs 
in ct/ct embryos. Exogenous inositol is incorporated into the inositol-lipid cycle, 
and through downstream signals, PKC isoforms are activated. Subsequent 
phosphorylation of specific substrates results in the correction of the proliferation 
defect in the hindgut, and normalises posterior neuropore (PNP) closure. The 
downstream targets of PKC (?) are not yet known.    
 
 
1.6.2 Curly tail genetics – ct is a hypomorphic allele of Grhl3 
The ct genetic defect was mapped to chromosome 4 by linkage studies using 
microsatellite markers (Neumann et al., 1994; Beier et al., 1995), to a region containing 
grainyhead-like-3 (Grhl3, also known as Get-1), which encodes a transcription factor 
(Ting et al., 2003a; Kudryavtseva et al., 2003). Gene targeting studies have shown that 
Grhl3 is essential for neural tube closure. Grhl3 knockout mice (Grhl3-/-) develop NTDs 
with 100% penetrance and do not survive (Ting et al., 2003a; Yu et al., 2006e). NTDs 
comprise thoracolumbosacral spina bifida (100% penetrance) and curled tail, and 
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exencephaly (2-14% depending on the study). Heterozygous (Grhl3+/-) mice were 
indistinguishable from their wild-type littermates. 
 
 A proliferation assay suggested that there may be reduced proliferation in ventral 
AC) containing the complete Grhl3 gene 
nd 120 kb of upstream sequence, encompassing the putative ct mutation, was used to 
tissues of Grhl3-/- compared with Grhl3+/+ embryos. No coding mutation in Grhl3 was 
identified in curly tail leading to the suggestion that ct could be a hypomorphic allele of 
Grhl3, with reduced expression (Ting et al., 2003a). Subsequently it was demonstrated 
that Grhl3 is indeed expressed in the hindgut endoderm at E10.5, the tissue in which the 
causative cellular defect is present, and that expression levels are reduce in ct/ct 
compared with matched wild-type embryos at the stage of PNP closure (Gustavsson et 
al., 2007). This expression deficit was proposed to be due to a putative regulatory 
mutation 21,350 base pairs upstream of the starting site, characterised by a single 
nucleotide substitution C/T (C-21350T). 
 
To test the hypothesis that reduced expression of Grhl3 causes spina bifida in ct/ct 
embryos, a rescue experiment was performed to reinstate Grhl3 expression in curly tail 
embryos. A bacterial artificial chromosome (B
a
generate a curly tail transgenic line carrying the BAC (summarised in Fig. 1.8). 
Transgenic, ct/ctTgGrhl3, mice were crossed to ct/ct mice to generate offspring, among 
which all embryos that carried the BAC developed normally without spina bifida or tail 
flexion defects, whereas ct/ct littermates showed the usual phenotypes. Grhl3 transgenic 
embryos showed up-regulation in the expression of Grhl3 and the apparent rescue of the 
spinal defects normally observed in ct/ct embryos supported the idea that reduced 
expression of Grhl3 is the cause of spina bifida in ct/ct embryos (Gustavsson et al., 
2007). 
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Figure 1.8 Diagram of generation of the Grhl3-BAC transgenic mouse. (A) 
The linearised BAC contained 31.7 kb full-length Grhl3 gene (2.8 kb transcript 
length), plus 120 kb upstream of the initiation site (including the region of the 
single nucleotide substitution) and a short region of pTARBAC vector. (B) After 
linearization and purification of the BAC, the DNA was injected into the 
pronucleus of fertilised curly tail oocytes which were transferred to surrogate 
CD1 mothers. (C) Transgenic litters were generated from a founder transgenic 
mouse, ct/ctTgGrhl3.  
 
 
 51
1.6.3 Genetic interaction of curly tail and grainyhead like-3 mutant strains with 
other strains 
The effect of combination of ct or Grhl3 null alleles with mutation of other genes has 
been tested in several studies. Homozygous splotch (Sp2H) mutant embryos develop 
spina bifida in 85-100% of embryos owing to a mutation in Pax3 (Greene et al., 2009a). 
ouble heterozygous (ct/+;Sp/+) exhibited tail flexion defect in 10% of the cases, while 
 spina bifida with high frequency (85%) compared to a low frequency (10%) in 
/+;ct/ct embryos in this cross (Stiefel and Meuli, 2007); AJ Copp, Personal 
ommunication). Heterozygous (Lp/+) mice exhibit tail defects (looped tail) and 
occasional low sacral spina bifida due to delayed posterior neuropore closure (similar to 
curly tail and splotch mutants), but are generally viable (Copp et al., 1994). Thus, the 
Lp allele modifies the risk of spinal NTDs in curly tail. Loop-tail (Lp) mice carry a 
mutation in Vangl2, a gene whose product is necessary for convergent extension of the 
neural plate during neural tube closure, and Lp/Lp homozygous embryos develop 
craniorachischisis with 100% penetrance (Copp et al., 2003; Greene et al., 1998). 
However, more recently, another study showed an interaction between Lp and Grhl3 by 
interbreeding Vangl2+/- (Lp/+) mice with Grhl3+/- (Caddy et al., 2010). Both the 
individual heterozygotes normally complete neural tube closure but 67% of the 
compound heterozygotes (Vangl2+/-;Grhl3+/-) exhibited spina bifida resembling that 
observed in Grhl3 null embryos By comparison, none of the Vangl2+/+;Grhl3+/- 
embryos exhibited NTDs while 87% of Vangl2+/-;Grhl3+/+ embryos developed a looped 
tail alone and 13% exhibited spina bifida, perhaps like Lp/+ embryos. The authors 
therefore suggested that Grhl3 functions like Vangl2 to regulate the planar cell polarity 
signalling pathway. However, unlike core members of the planar cell polarity pathway 
D
mice heterozygous for curly tail or splotch rarely develop NTDs defects. In addition, 
backcrossing double heterozygotes to curly tail mice generated ct/ct;Sp/+ which 
showed almost 100% penetrance of spina bifida and curled tail (Estibeiro et al., 1993). 
There was no apparent increase in the ventral curvature of the caudal region of ct/ct 
embryos when the Pax3 mutant allele was present, suggesting that the downstream 
effects of the ct and Sp2H mutations are different but summate to risk of increase spinal 
NTDs. 
 
Matings between homozygous curly tail mice with doubly heterozygous looptail/ct 
mice (Lp/+; ct/+) allowed generation of embryos with a Lp/+;ct/ct genotype that 
develop
+
C
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Grhl3 is not necessary for Closure 1 (Rifat et al., 2010), and is a transcription factor 
rather than a component of a signalling pathway. Therefore, this connection requires 
further investigation.    
 
Null embryos for another member of the Grhl family, Grh2, develop fully penetrant 
cranial NTDs characterised by ‘split-face’ malformation (failure of Closure 3), and die 
at E11.5 with the posterior neuropore still open, indicating that spina bifida would occur 
os survived (Rifat et al., 2010). A small proportion of Grhl +/-;Grhl3+/- 
developed mid- and hindbrain exencephaly (failure of Closure 2), similar to cranial 
NT d 
tho  
pe g 
tha  
ex t 
Gr s 
be e 
cra
ilure of closure of the neural tube at all cranial levels. To 
Lmo4+/- mice were crossed to Grhl3+/- mice, and double 
 
if embry 2
Ds defects in Grhl3-/- mutants. Embryos with a Grhl2+/-;Grhl3-/- genotype exhibite
raco-lumbosacral spina bifida and mid- hindbrain exencephaly with 100%
netrance. Both phenotypes resemble those observed in Grhl3-/- mutants suggestin
t Grhl3 is not necessary for closure of the rostral forebrain. Grhl2-/-;Grhl3+/- embryos
hibited split-face and fully penetrant thoraco-lumbosacral spina bifida. Double mutan
hl2-/-;Grhl3-/- embryos had a very severe phenotype in which closure did not progres
yond the site of Closure 1 such that the neural folds remained open throughout th
nial and spinal regions (Rifat et al., 2010).  
 
One of the genes known to interact with Grhl3 was originally identified on the basis of 
interaction, in a yeast two hybrid screen, with the LIM-only protein 4, Lmo4 
(Kudryavtseva et al., 2003). Lmo4 expression colocalises with Grhl3 in the cells of the 
surface ectoderm, and it is also expressed in dividing neuroepithelial cells within the 
ventricular zone along the entire rostro-caudal axis of the nervous system 
(Kudryavtseva et al., 2003). Lmo4-/- null mice, generated by gene targeting, die at birth 
and show abnormal neural tube closure (Lee et al., 2005). Interestingly, Lmo4 mutants 
exhibit exencephaly due to fa
generate double knockouts, 
knockout embryos exhibited exencephaly in 100% of cases, showing that these two 
genes not only interact biochemically but also genetically  (Yu et al., 2006e).  
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1.6.4 Functions of grainyhead-like transcription factors 
Grhl3 belongs to the Grh/CP2 family of proteins (Fig. 1.9). Mammalian GRH-like 
members are involved in transcription regulation, can bind DNA and other proteins, and 
as well as neural tube closure, have been functionally implicated in biological processes 
such as epidermis development (Wilanowski et al., 2002; Ting et al., 2005; 
Kudryavtseva et al., 2003), and wound healing (Ting et al., 2005). Grhl1, Grhl2 and 
Grhl3 have all been found to be expressed in epithelial tissues in developing mouse 
embryos (Wilanowski et al., 2002; Ting et al., 2003a; Kudryavtseva et al., 2003).   
 
 
 
Figure 1.9 Grainyhead-like family members. Sequence alignment of the 
Drosophila (dCP2, dGrainyhead) and mammalian Grainyhead-like/CP2 genes 
suggested they share a common ancestor and can be divided into two phylogenetic 
groups. The mammalian GRHL genes, GRHL1 (previously known as mammalian 
GRH), GRHL2 (Brother of Mammalian GRH) and GRHL3 (Sister of Mammalian 
GRH) are homologous to their Drosophila counterpart, dGrainyhead. 
Phylogenetic tree adapted from Wilanowski et al. (2002).  
rior to cloning of the mammalian homologues studies on grainyhead (grh; also known 
s Neurogenic element binding transcription factor, NTF-1/Elf-1), had been performed 
 Drosophila melanogaster. Grainyhead was first identified in vitro as a protein (GRH) 
at could bind to and activate transcription from the Dopa decarboxylase (Ddc) 
romoter (Bray et al., 1988; Dynlacht et al., 1989). GRH is required for expression of 
dc in epidermal cells but it does not influence neuronal expression of Ddc (Bray and 
afatos, 1991b).  The importance of grh during Drosophila development is shown by 
e fact that mutations in this gene result in an embryonic lethal phenotype. Mutant 
mbryos have flimsy cuticles, grainy discontinuous head skeletons, and patchy tracheal 
bes (Bray and Kafatos, 1991b).  
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Grainyhead is a maternal gene, for which the mRNA is synthesized during oogenesis 
nd deposited in the developing oocyte until translated (Huang et al., 1995). Later on, 
euroblasts switch on Grh expression and maintain it through many subsequent 
ivisions, and this appears to be important for specification of the regionalised patterns 
f neurogenesis that are characteristic of post-embryonic stages. For example, in the 
orax, Grh prolongs neural proliferation by maintaining neuroblasts in a mitotically 
ctive state. In contrast, in the abdomen, Grh terminates neural proliferation by 
regulating the competence of neuroblas  to undergo apoptosis in response to 
Abdominal-A (AbdA, Hox gene) expression (Cenci and Gould, 2005). Thus, Grh is 
linked to the Hox-mediated axial patterning system in Drosophila, and can have pro-
proliferative or anti-proliferative functions in different tissues. 
 
The three mammalian grainyhead-like genes share a high degree of sequence identity in 
the DNA-binding, protein dimerization and activation domains (Wilanowski et al., 
2002; Ting et al., 2005; Ting et al., 2003b). Protein interaction studies demonstrated that 
GRHL3 can homodimerize, as well as het erize with GRHL1 and GRHL2, but 
not with the CP2-like members (Ting et 003b). In addition, the transactivation 
domain of Grhl3 located between  296 is inhibited when combined 
with N-terminal or C-terminal sequences. These data suggest that Grhl3 contains 
repression domains in the N- and C-termini and this is consistent with strong repression 
observed in reporter assays using the C-terminus alone. Therefore, it is thought likely 
that Grhl3 can act as a tra ssor (Kudryavtseva et al., 
2003). 
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Figure 1.10 Diagram of the mouse Grhl3 gene and protein. The Grhl3 gene 
(Accession No ENSMUST00000105855) spans 31.7 kb and includes 16 exons 
and 15 introns, encoding a transcript length of 2.8 kb and a protein of 603 amino 
acids. The protein has two major functional domains, a DNA binding 
transcriptional activation domain at the N-terminal and a dimerisation domain 
which mediates protein-protein interactions at the C-terminus. These domains are 
critical for Grhl3 function as a transcription factor.  There is 90% identity between 
avtseva et al., 2003; Yu et al., 2009). The expression in skin appears essential for 
rmation of the epidermal barrier (Ting et al., 2005; Yu et al., 2006e). It is notable that 
 
arly stages of development, Grhl1-null mice show a delay in coat growth, and at later 
i anchoring of the hair shaft in the follicle. 
hese mice also develop palmoplantar keratoderma (Wilanowski et al., 2008). While 
the predicted human and murine GRHL3 proteins (Ting et al., 2003b).  
 
The three mammalian Grhl genes have restricted expression patterns during mouse 
development (Auden et al., 2006) Similar to Drosophila where grainyhead plays an 
important role in embryonic cuticle formation, Grhl3 is expressed in surface epidermis 
as well as epithelial cells of the gastrointestinal, genitourinary and respiratory tracts 
(Kudry
fo
homologous genes in Drospohila and mammals are required for the integrity of the 
surface structure even though the Drosophila cuticle and mammalian skin are 
structurally quite dissimilar.  
 
During mouse development, E14.5-E15.5, Grhl1 is predominantly expressed in the 
epidermis/skin, while Grhl2 expression is also observed in the skin, and in several 
internal organs, including lung, oesophagus and kidney (Wilanowski et al., 2002). At
e
stages m ce exhibit hair loss as a result of poor 
T
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ge n 
NT re 
res s 
(P e 
Dr t 
iso al., 2005; Ting et 
l., 2003b) although whether these have any functional role is yet to be determined. 
owever, there is no evidence of alternative splicing of Grhl3 in the mouse (Gustavsson 
s thesis focus on mouse models in which 
bnormal expression of Grhl3 results in development of NTDs. First, a proteomic 
 
 
 
 
 
ne targeting of Grhl2 in mice results in NTDs (Rifat et al., 2010), a link to huma
Ds has not yet been reported. However, mutations in the human GRHL2 gene a
ponsible for autosomal dominant type 28 non-syndromic sensorineural deafnes
eters et al., 2002). GRHL3 has not yet been linked to a human disease. Lik
osophila grainyhead (dgrh), the human GRHL genes produce several distinc
forms through alternative splicing (Wilanowski et al., 2002; Ting et 
a
H
et al., 2008).  
 
In summary, the Drosophila GRH gene is involved in several important biological 
processes including regulation of cell cycle, cell growth, and development (Wilanowski 
et al., 2002).  In the mouse Grhl3 is essential for neural tube closure (Ting et al., 2003a; 
Gustavsson et al., 2007). Studies in thi
a
analysis was performed to identify proteins that are differentially expressed of 
neurulation-stage curly tail and wild-type embryos (Chapter 3). One such protein, 
lamin B1, was investigated in detail and variation in sequence was found to modify the 
susceptibility to NTDs (Chapter 4). Finally, the consequences of over-expression of 
Grhl3 were investigated and it was found that both excess and diminished expression of 
Grhl3 are sufficient to cause NTDs (Chapter 5).  
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Chapter 2 
 
 
Materials and Methods 
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2.1  Embryo collection 
 
2.1.1  Experimental groups  
Curly tail (ct/ct) stock was previously derived from crosses between an affected ct/ct 
female (GFF inbred strain) and a CBA/Gr male (Van Straaten and Copp, 2001). The 
colony is kept as a random bred and all individuals are considered to have ct/ct 
genotype. A congenic strain was previously generated by successive backcrosses to ct/ct 
(four generations) following an initial cross between ct/ct and mice of the SWR inbred 
strain, with genotyping of microsatellite markers to maintain SWR sequence at the ct 
locus . These genetically matched wild-type (+ct/+ct) mice are thus wild-type at the ct 
locus, while the genetic background is predicted to be 93.75% curly tail. These mice are 
maintained as a homozygous colony. The third strain used in this project is the Grhl3-
transgenic curly tail, Tg(Grhl3)1Ndeg (Transgene Accession ID is MGI:3794067, 
referred to throughout this thesis as ct/ctTgGrhl3), in which spinal neural tube closure 
occurs normally. 
 
Male mice were housed individually once they had reached sexual maturity. Female 
mice were housed in small cages (capacity for 5 adult mice) and female breeding stocks 
were housed in larger ones with maximum capacity for ten adult mice. Standard pelleted 
food and water were freely available. Mouse rooms were maintained at 22˚C, with a 
relative humidity of 52% and a controlled diurnal cycle of 12 hours light and 12 hours 
dark.  
Mice were u
by tim
copulation plug was designated em
project focuses on neural tube closure and m
neuropore (PNP), e
type em
accord 9 and 30-31 ( ).  
 
sed for experimental matings from six weeks of age.  Litters were generated 
ed matings in which mice were paired overnight and the day of finding a 
bryonic day 0.5 (E0.5). Owing to the fact that this 
ore precisely the closure of the posterior 
mbryos were mostly collected at E10.5. PNP closure occurs in wild-
bryos at around the 30-31 somite stage and embryos were therefore subdivided 
ing to the number of somites: 26-27, 28-2 Figure 2.1
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Mou evel d stages of posteri ore closure. (A) 
ents duri evelo f the mouse until bir yonic day E8.0, 
closure of the n l tub s the neural folds levate (B). The 
posterior neuropore (PNP, highlighted by the red-dotted lines in C) is the last 
 
 
.1.2  Embryo harvesting and collection 
regnant females were killed by cervical dislocation. The uterus was removed and 
fer dia (DMEM; 
Figure 2.1 se d opment an or neurop
Key ev ng d pment o th. At embr
eura e initiates a  begin to e
region of the neural tube to close. At this same stage (E10.5) all other regions of 
the neural tube have closed (regions indicated by red arrowheads).  
2
P
trans red to a bijoux containing Dulbeco’s Modified Eagles Me
Invitrogen) with 10% fetal bovine serum (heat inactivated at 58˚C; Invitrogen). The 
uterus was then transported to the laboratory for dissection of the embryos under a 
stereo-microscope (Zeiss SV6 or SV11).  
 
The uterus was dissected in pre-warmed (37˚C) fresh media (Fig. 2.2 A). After counting 
the number of implantations, the decidua was removed from the uterus by tearing the 
uterine wall and releasing the decidua using forceps. The decidua was opened to allow 
removal of the conceptus contained within the trophoblast (Fig. 2.2 B). The trophoblast 
 60
tissue and Reichert’s membrane were then removed to expose the embryo within the 
yolk sac (Fig. 2.2 C-D). After removing the yolk sac, the chorion, was also removed to 
completely expose the embryo (Fig. 2.2 E). The number of somites was counted in each 
embryo and the PNP length was also measured in some embryos using an eyepiece 
graticule (Fig. 2.2 F). The PNP length of curly tail embryos was allocated to broad 
categories; small, intermediate and large (Table 2.1).  
 
After dissection, embryos were washed in diethyl pyrocarbonate (DEPC)-treated 
phosphate buffered saline (PBS; Appendix A, section A.1-A.2), or autoclaved PBS 
epending on the subsequent experiments:  
b) For immunohistochemistry whole embryos were fixed in 4% PFA as above. The 
following day embryos were washed in ice-cold PBS, dehydrated in an ice-cold 
 - 25%, 50%, and 70% and stored at 4˚C. In 
ative real-time reverse transcription polymerase 
chain reaction). Whole embryos or the cranial or caudal region (below the level 
of somite 14-15) were rinsed in PBS to remove excess media and transferred to 
1.5 ml clean eppendorfs. Excess PBS was removed and samples were 
immediately frozen on dry-ice straight before storage at -80˚C. 
d
a) For whole mount in situ hybridisation whole embryos were fixed in ice-cold 4% 
paraformaldehyde (PFA; Appendix A, section A.3) overnight at 4˚C. The 
following day they were washed twice in ice-cold DEPC-PBS, dehydrated on ice 
in a methanol (methanol:DEPC H2O) series, 25%, 50%, 75% and 100%, and 
stored at -20˚C.. 
ethanol series (absolute ethanol:H2O)
a few cases embryos stored in 100% methanol were needed for 
immunohistochemistry (IHC). In this case, they were washed twice in absolute 
ethanol, for 30 minutes each, at room-temperature and the appropriate protocol 
for IHC was then followed. 
c) For protein (two-dimensional protein gel electrophoresis or western blot), or 
mRNA extraction (for quantit
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Figure 2.2 Embryo dissection. (A) Each individual implantation (red arrows) 
was removed from the uterus. Decidual tissue was removed to expose the 
trophoblast (B), which was peeled off to expose the embryo within the yolk sac 
in 4% PFA as previously described, or in Bouin’s solution (Sigma) at room-temperature 
(C). (D-E) After removal of the yolk sac (ys) the amnion (seen in E) was also 
removed if this was still intact. (F) The number of somites was counted and the 
length of the PNP was measured (in the image forceps are used to hold the caudal 
region in place for measurement).    
 
At E11.5 – E18.5 embryos were dissected in ice-cold PBS. Embryos were either fixed 
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for one or two days depending on the stage. After fixation, embryos were thoroughly 
washed in cold PBS, and dehydrated in an ethanol series up to 70% ethanol before 
torage at 4˚C. Bouin’s fixative provides better preservation of tissue morphology than 
tion for genotyping. After separation of the yolk sac from the 
mbryo, it was rinsed in PBS and stored in an eppendorf on ice or at -20˚C prior to 
DNA extraction. 
 
egory 28-29ss PNP length (mm) 30-31ss PNP length (mm) 
s
PFA and was preferable for histology (e.g., haematoxylin and eosin staining).  
 
The yolk sac (ys) of all transgenic and some ct/ct or +ct/+ct (used as controls) embryos 
were kept for DNA extrac
e
PNP Cat
Closed [0] 0 0 
[1] 0.125  0.1-0.25 -0.25
SPNP 
[2] 0.3-0. 0.3-0.45 45 
Intermediate [3] 0.5-0.625 0.5-0.625 
[4] 0.7-0.8 0.675-0.8  L
   
PNP 
[5] 0.925-0.95 0.875-1.0
 
Table 2.1 Measurement of the posterior neuropore (PNP) length. PNP length 
f graticule to unis to mm: 
use tissue  
resh or frozen yolk sacs, ear clippings or tail clippings were digested with proteinase K 
0 mg/ml stock; Appendix A, section A.4). Proteinase K solution (12 µl for E7.5 – 
and 24 µl for E10.5 yolk sacs, 
was measured on a stereo microscope (conversion o
graticule units/100 x 2.5) and allocated to PNP categories, classified as small 
(SPNP), intermediate or large (LPNP).  
 
 
2.2 Genomic DNA extraction from embryo or adult mo
F
(1
E9.5 stage yolk sacs, embryos, or ear clip samples 
embryos, limbs of older embryos, or tail clip samples) was added to the sample and the 
digestion volume made up to a final volume of 500 µl with DNA extraction buffer 
(Appendix A, section A.5). Tubes were inverted to mix the contents and incubated 
overnight at 55˚C. The following day, the samples were vortexed. At this step they can 
be stored at -20˚C. Genomic DNA was precipitated by addition of 80 µl of 3M sodium 
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acetate and incubation on ice for 15 minutes. Samples were centrifuged at 4˚C, at 
13,000 rpm for 20 minutes to separate tissue debris from the aqueous layer which 
contains the DNA. The supernatant was transferred to a new tube and 1 ml of ice-cold 
ethanol was added and vortexed before centrifugation for another 20 minutes, at 13,000 
m at room-temperature. The supernatant was poured off and the pellet was washed in 
0% ethanol, and pelleted by centrifugation for 5 minutes at 13,000 rpm. The liquid was 
ellet was air-dried. The pellet was then 
x B). Components of the PCR reaction 
ixture are listed in Table 2.2. The amount of master mix prepared depended on the 
tal number of samples, with enough included for a negative control reaction (water 
stead of DNA sample as template).  
rp
7
carefully removed by pipetting and the p
resuspended in 50 µl of autoclaved Milli-Q H2O. DNA samples were stored at -20˚C 
until use. 
 
Some samples were genotyped after whole mount in situ hybridisation. In these cases 
DNA was extracted by washing embryos twice for 30 minutes in PBS, with shaking. All 
other steps were the same as described above, but using half the indicated volumes and 
the pellets were resuspended in a final volume of 10-20 µl of water (depending on the 
amount of initial tissue).  
 
 
2.3  Polymerase chain reaction (PCR) 
Most primers for PCR were designed with a length of twenty to thirty bases with 
melting temperatures ranging from 55˚C to 65˚C, and kept as 100 µM stock solutions at 
-20˚C (all primers, Sigma, are listed in Appendi
m
to
in
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 Volume (µl) Final concentration 
H2O 38.3  
10x Taq polymerase 1x 
buffer 
5.0 
25 mM dNTP 0.4 200 µM 
25 mM MgCl2 3.0 1.5 µM 
Forward primer (25 µM) 1.0 0.5 µM 
Reverse primer (25 µM) 1.0 0.5 µM 
Taq polymerase 5 units/µl 0.3  
   
DNA/cDNA template 1.0  
 
Table 2.2 PCR reaction mixture. The final volume was 50 µl and the mixture 
scaled down to 30 µl for some applications and adjusted as required for 
optimisation of the primers. The PCR reagents (taq polymerase, 10x buffer and 
magnesium chloride) used were from Bioline (Biotaq) and deoxynucleotides from 
Promega (dNTPs, Appendix A, section A.6). 
 
After com inb ing all reagents, the mix was vortexed and distributed to 0.2 ml or 0.5 ml 
ep s 
the  a 
sta e 
rea e 
Th al 
Cy
 
Th ll 
va s: 
denatur ; 
an d 
be higher temperature); followed 
). In theory, the  
pendorf tubes (depending on which Thermocycler was to be used). The template wa
n added to each tube, with exception of the control-tube (blank) which serves as
ndard of the PCR reaction to check for primer dimers or contamination of any of th
gents. The whole procedure was done on ice up to tubes were then transferred to th
ermocycler (PTC-200 Peltier Thermal Cycler, Bio-Rad; Techne TC-512, Therm
cler). 
e running conditions are listed on Table 2.3 and the annealing temperatures wi
ried according to the primers used (Appendix B). The PCR cycle include
ation of the DNA sample to separate the strands at high temperatures (≥ 94˚C)
 annealing step in which the primers bind to the DNA strands (temperature varie
tween 50-65˚C, with greater specificity conferred by 
by an extension step in which new DNA strands are generated (65-75˚C
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DNA-product doubles in concentration for each cycle (typically 30 cycles used). A final 
10 minute extension step was also included. 
 
Following the PCR reaction, products were analysed by agarose gel electrophoresis, 
with appropriate molecular-weight markers (Appendix A, section A.7). The gel 
concentration was varied depending on the product size and/or the similarity in size of 
products to be separated. 
 
Step Temperature (˚C) Duration 
(1) Heating lid/block 96 – 105 4 minutes 
(2) Denaturation 96  40 seconds 
(3) Annealing Variable 40 seconds 
(4) DNA extension 72 1 minute 
(5) Final extension 72 5 minutes 
 
Table 2.3 PCR cycling conditions. Running conditions were varied according to 
the primer pair used. Steps 2-4 were repeated for 30-35 cycles.  
 
 
2.4  Genotyping of transgenic embryos (ct/ctTgGrhl3) 
Embryos of the transgenic line were initially genotyped on the basis of the presence of 
the BAC (section 2.4.1). A complementary assay made use of the fact that the BAC 
carries the wild-type sequence at Grhl3 position -21350 where the C-21350T mutation 
is present in homozygous form in curly tail genomic DNA (Gustavsson et al., 2007); 
Fig. 2.3). For primer sequences see Appendix B, Table B.2.  
ing the intact 
rhl3 gene, used one primer, pTARBAC1, located in the BAC vector and another, 
27D13-R1, located close to the vector but in the genomic sequence 24 kb 3-prime of 
e Grhl3 gene (Fig. 2.3 A). For this PCR reaction a curly tail (no BAC) and a 
ansgenic (BAC) DNA sample were always used as negative and positive controls, 
 
 
2.4.1  Genotyping Grhl3 transgenic-BAC curly tail 
The PCR to genotype for the presence of BAC RP24-327D13, contain
G
3
th
tr
 66
r  PCR reactio conditions are summarised in 
Table 2.  run f a 230 bp 
b t the BA sgenic embryo) or lack of a band ct/ct samples 
(BAC ne B).  
 
2.4 notyping assay 
o confirm the BAC-PCR genotyping, most curly tail samples generated in crosses to 
e transgenic were also assayed for the C-21350T mutation. This assay consisted of a 
B) with r wild-type (+ct/+ct) DNA samples often used as controls. The 
run on a 2% agarose gel. The 
/T mutation in curly tail results in loss of one AciI restriction site (recognition site 
 
espectively. The n mixture and running 
4. Products were on 1% agarose gels to verify amplification o
and in he presence of C (tran
gative; Fig. 2.3 
 
.2  Curly tail ge
T
th
PCR (Table 2.4) reaction using primer pair Grhl3_UF10/UR10 (Table B.2, Appendix 
 transgenic and/o
resulting PCR product showed a 551 bp band on a 1% agarose gel for all genotypes. 
Following PCR amplification, the samples were digested with AciI restriction enzyme 
(10,000 U/ml, New England BioLabs) in a reaction containing 10 µl PCR product, 1.5 
µl NEB3 10x buffer, 1 µl AciI, and 2.5 µl H2O for a final volume of 15 µl. The products 
were digested overnight at 37˚C and a 10 µl aliquot was 
C
CCGC) and therefore results in two bands on the gel (115 bp and 436 bp) whereas three 
bands are generated for +ct/+ct samples (115 bp, 165 bp and 271 bp). Transgenics 
(ct/ctTgGrhl3) are heterozygous for the mutation, and give rise to four bands (115 bp, 165 
bp, 271 bp and 436 bp; Fig. 2.3 C-D).   
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Reagent (final 
concentration) 
Volume (µl) PCR conditions 
H2O 15.15 or 15.65
10x Taq polymerase buffer 3.0 
dNTP (2 mM) 1.5 
MgCl2 (50 mM) 0.7 
Forward primer (10 µM) 1.5 
Reverse primer (10 µM) 1.5 
Betaine 5.0 
DNA template 1.5 or 1.0 
Taq polymerase 5 units/µl 0.3 
5 minutes 96˚C heated lid 
30 seconds 96˚C denaturation 
30 seconds 54˚C annealing 
45 seconds 72˚C extension 
35 cycles 
5 minutes 72˚C final extension 
 
 
Table 2.4 PCR conditions for genotyping ct/ctTgGrhl3 embryos. Reaction 
conditions were used for both the BAC-specific and the Grhl3_UF10/UR10 PCR. 
Only 1.0 µl DNA template was used for the latter reaction and the volume of 
water was adjusted accordingly. Betaine (Sigma) was used as an enhancing agent 
for PCR amplification, to improve yield and specificity.  
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Figure 2.3 Schematic diagrams of the genotyping for the Grhl3 locus. (A) 
 illustrating the BAC region that is amplifDiagram ied including part of the BAC-
vector and part of the insert (region of the chromosome 4 including the whole 
Grhl3 gene). (B) Gel image showing a 230 bp band for samples which include the 
BAC (ct/ctTgGrhl3 transgenic embryos) compared to samples which do not (ct/ct 
embryos). (C) Diagram illustrating the 551 bp fragment encompassing the C-
21350T single nucleotide change present in ct/ct. The fragment includes two AciI 
restriction sites in the +ct/+ct sequence (wt, positions 165 and 436 bp), whereas the 
presence of a thymidine residue at position 165 results on loss of an AciI site in 
the ct/ct sequence. However, partial digestion sometimes occurs, resulting in 
incomplete digestion of the 551 bp fragment in samples from both strains, as seen 
on the 2% gel electrophoresis image (D, blue arrow).  
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2.5  Two-dimensional protein gel electrophoresis (2-DE) method 
The 2-DE method was first introduced by P. H. O’Farrel and J. Klose (1975). Since then 
the major technical advance in 2-DE has been the introduction of immobilised pH 
gradient (strips; (Bjellqvist et al., 1982), created by covalently incorporating a gradient 
f acidic and basic buffering groups into a polyacrylamide gel at the time it is cast. This 
reparation 
rotein homogenisation is a crucial step for optimal protein separation. Samples were 
onisable groups to solution. Detergent (CHAPS) ensures complete sample 
olubilisation by preventing interactions between hydrophobic protein domains, thus 
 
 
o
technique results in higher resolution, improves reproducibility, increases protein 
loading capacity and extends the pH ranges used in 2-DE.  Whole embryos or samples 
of isolated cranial or caudal regions were used for 2-DE. Caudal regions were cut at the 
level of somites 14-15 (Fig. 2.4 A), to include the hindgut and posterior neuropore 
(PNP). 
 
 
2.5.1  Sample p
P
removed from the -80˚C and kept on dry-ice. Lysis buffer (Appendix A, section A.8) 
was added straight to the frozen tissue and the sample homogenised by sonication (High 
Intensity Ultrasonic Processor, SONICS VIBRA CELL): at 40% amplitude and 5-10 
pulses for 2 seconds each, depending on sample size (Table 2.5; Fig. 2.4 B). At this 
stage is important not to overheat or cause foaming of the sample, which can cause 
protein degradation. The lysis buffer contains urea to solubilise and unfold proteins 
exposing the i
s
avoiding loss of protein due to aggregation and precipitation. The reducing agent 
dithiothreitol (DTT) is included, which breaks disulfide bonds and maintain all proteins 
in their reduced state. Finally, protease and phosphatase inhibitors were included to 
provide protection against proteolysis and phosphatases.  
 
Duplicate 1-2 µl aliquots of the homogenate were kept in 1.5 ml eppendorfs on ice for 
analysis of protein content by an adapted Bradford assay (Appendix A, section A.9) 
and returned to dry-ice or storage at -80˚C (if not used on the same day).  
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Stage Tissue Volume of lysis buffer 
Whole embryo 200 µl (or 300µl depending on embryo size) 
Cranial region 100 µl E10.5 
Caudal region 50 µl 
 
Table 2.5 Volumes of lysis buffer used for sonication of different amounts of 
tissue-sample.  
 
 
2.5.2  Isoelectric focussing: protein separation by charge using immobilised pH 
gradient strips 
D rrounding ent, proteins c itive, negative 
o m of a  charges of their am cid side chains, 
a rbox ini. In a pH t, under an elect , a protein will 
m radient wher  zero. This is the principle of 
t t ring isoele
Th : 
pH gth (pH 4-7, Bio-Rad; pH 4-7 and 
the Novex Mini-Cell system cell 
(Invitrogen). IPG strips are very easy to contaminate or  so when handling it 
w es nd use force  Narrow 
r  for n of proteins e experiments. 
Pr  
mi remove tissue debris. For whole embryos, 350 µg 
liquots of protein sample were initially used. In subsequent experiments the gel loading 
ding to IPG strip) or 2% pharmalyte (pH 3-
0, Amersham Biosciences), 1x protease inhibitor, and lysis buffer to a 350 µl final 
ependent on the pH of the su environm arry pos
r zero net charge, which is the su ll the ino a
nd amino- and ca yl-term  gradien ric field
ove to the position in the g e its net charge is
he use of pH gradien strips du ctric focusing.  
 
is project made use of immobilised pH gradient (IPG) strips of 18 cm (IPG strips
4-7, pH3-5.6, pH6-9; GE Healthcare) or 7 cm len
pH 6.1-7.1 Invitrogen). The latter were used in 
damage,
as necessary to rinse glov  in 70% IMS a ps for manipulation.
ange IPG strips were used  better separatio  in som
 
ior to use, samples were thawed and centrifuged for 2-5 minutes at 4˚C in a
crocentrifuge at 13,000 rpm to 
a
was reduced to 50 µg, as there was lower protein content in the caudal region and this 
loading was found to be sufficient to produce clearly stained gels. Samples were then 
diluted with 175 µl rehydration buffer (Appendix A, section A.10) containing 2% 
volume of IPG buffer (pH range correspon
1
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v .  7 cm strips the procedure was protein were diluted to a 
fin ol 25 µl  sample. 
 
or rehydration, samples were loaded onto a re-swelling tray (levelled on the bench). 
IP g 
rem d 
ba  contact with the sample and there 
ere no air bubbles. Each strip was covered with approximately 1.5 ml of Immobiline 
assive 
hydration of the strips. The number on strip, for each sample, was recorded.  
) was carried out the next morning, on a Multiphor (Multiphor 
uid was blotted out from rehydrated IPG strips and they were laid 
el side up on the strip holder on the Multiphor, with the acidic (+) end towards the 
ectrode strips (GE Healthcare) were cut for the anode and 
olume  For the the same, 10 µg 
al v ume of 1 loading
F
G strips were removed from -20˚C storage just previous to use, plastic backin
oved and placed onto tray’s slot, gel side down (Fig. 2.4 C-D). The strip was move
ck- and forwards to ensure the entire length was in
w
DryStrip cover fluid (GE Healthcare) to avoid drying. The lid was placed on the tray, 
taped in place, and the tray left overnight at room temperature to allow p
re
 
Isoelectric focusing (IEF
II Electrophoresis System with Immobiline DryStrip kit, GE Healthcare), with a cooling 
water system set to 20º C. A plastic strip holder container was placed onto the 
Multiphor platform with 10 ml cover fluid underneath to ensure contact between the 
cooling plate and gel holder. The cathode and anode electrodes were connected at either 
end. Excess cover fl
g
anode (+, red). IEF El
cathode, at the required length, depending on how many gels were to be run. The IEF 
electrode strips were soaked in water (MilliQ) and the excess was blotted off before 
placing the strips across each end of the IPG gels, overlapping the ends of the gel. The 
anode and cathode were inserted onto the Multiphor, with the central wire aligned with 
the IEF electrode strip, and pushed down so the electrode contacts the strip. Gels were 
then immersed in cover fluid and the lid placed on prior to connection to the power 
supply. In order to separate proteins by charge, a voltage of 3500 V was applied for a 
total of approximately 65 kVh. Focussing conditions are summarised in Tables 2.6 and 
2.7. If second dimension separation was not performed immediately, IEF gels were 
stored at -80˚C until required.   
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Step 1 (gradient)    Step 2 Step 3 Step 4 Step 5 
1 Vh                     6600 Vh 13.4 kVh 1 Vh 100 Vh 
200 V                  3500 V 3500 V 100 V 100 V 
1 mA                    1 mA 1 mA 1 mA  1mA 
5W 5W 5W 1W 1W 
 
Table 2.6 IEF conditions for 7 cm IPG strips (20 kVh). The first dimension is 
performed at very high voltages and low current, with active temperature control. 
After step 4 the run can be stopped. Step 5 was used to maintain a low voltage 
after the run until the apparatus could be disassembled. Volt-hour (Vh) is the 
ge and the hours elapsed at that same voltage.  product of the volta
 
Step 1 (gradient)    Step 2 Step 3 Step 4 Step 5 
1 Vh                     7000 Vh 58.0 kVh 6000 Vh 2000 Vh 
500 V                  3500 V 3500 V 100 V 200 V 
1 mA                    1 mA 1 mA 1 mA  1mA 
5W 5W 5W 1W 1W 
 
Table 2.7 IEF conditions for 18 cm IPG strips (65 kVh).  
 
 
2.5.3  Second dimension SDS-polyacrylamide gel electrophoresis: protein 
separation by molecular weight 
The second dimension separation (Fig. 2.4 E-F) was optimised for two different tank-
systems for maximal resolution and reproducibility. Both systems could accommodate 
18 cm IPG strips with a well at the side for molecular weight markers), and 1.5 mm 
thick gels were used in each case. The Hoefer DALT system enabled running of up to 
10-gels simultaneously in 23.5 x 19.2 cm cassettes (Anderson ISO DALT 
Electrophoresis System, HOEFER Scientific Instruments), whereas up to 12 gels could 
be run in the DALTtwelve system (GE Healthcare) in 25.5 × 19.6 cm cassettes. The 
running buffer conditions were adapted according for each tank (Appendix A, section 
A.11). A built-in heat exchanger and buffer circulation pump provided precise 
temperature control and a uniform thermal environment. The 10 gel tank generated 
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reliably produced reproducible gels. There was some run to run variation with the 12 gel 
tank and it was though that this partly resulted from lack of buffer circulation in the 
upper buffer chamber. However, the 12 gel tank had the advantage of larger gels which 
allows greater protein separation. 
 
Following IEF on 7cm gels the second dimension separation was performed using pre-
cast gels (NuPage 4-12% Bis-Tris gels, 1.5 mm 2D well; Invitrogen) on a Novex Mini 
Cell tank. The procedure was the same as for the large gels, but the buffer was MOPS 
based (Invitrogen). The SDS-PAGE gels were prepared in advance (at least two hours 
polymerisation were needed), usually the previous day and stored at 4˚C (Appendix A, 
section A.11). Prior to loading gels were allowed to reach room temperature. Buffer 
was added to the gel tank and allowed to circulate with cooling to 10°C for three hours 
prior to the run. 
 
IEF gels were equilibrated by incubation in plastic tubes (Fig. 2.4 E; Appendix A, 
section A.12) containing 10 ml equilibration buffer with 1% (w/v) dithiotreitol (DTT; 
GE Healthcare) for 15 minutes, with shaking (70 rpm), at room temperature, followed 
by incubation for 25 minutes in equilibration buffer containing 2.5% (w/v) 
iodoacetamide (GE Healthcare). DTT ensure proteins are in a reduced state while 
iodoacetamide alkylates any free DTT and sulphydryl groups and prevents their 
reoxidation.  
 
IEF gels were rinsed with running buffer and placed into the gel cassette with the plastic 
backing of the gel against the glass (Fig. 2.4 F). For orientation the acidic end of the 
IEF gel was always placed on the left-hand side, by the silicone hinge. With a ruler the 
plastic backing of the IEF gel was pushed down until it reached the surface of the SDS-
PAGE gel. Protein molecular weight markers (5 – 8 µl), soaked onto an IEF sample 
application piece (GE Healthcare), were placed a few cm from the IEF gel. Agarose 
ealing solution (Appendix A, section A.13) was used to cover the IEF gel and 
markers, ensuring that no air bubbles were trapped between the IEF gel and the SDS-
PAGE gel.  
 
s
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S
ce the agarose had set, gel cassettes were loaded in the tank. For the DALT tank the
l cassette was turned 90º (IEF gel stands vertically), dipped in buffer and slid betwee
rrier. Plastic spacers were used if not running 10 gels. The buffer level was adjuste
 that the buffer reached the level of the top of the cassette-spacers. For the 12 gel tan
 cassettes were slid directly into the tank and plastic spacers were inserted into any 
used slots. The lower buffer chamber was topped up with 1 x running buffer and the
 upper buffer chamber was fitted and filled with 2.5-3.0 x running buffer. These tw
ffers do not mix. Electrophoresis conditions are indicated in Tables 2.8 and 2.9. A
tial low power (1W/gel) step was included to facilitate protein transfer from the IE
l to the SDS-PAGE gel. 
tep 1 (gradient)      Step 2 Step 3 Step 4 
10 minutes                 1 h 50 min 2 h 25 h 
50 V                  50 V 125 V 125 V 
6 W (1W/gel)            6 W 18 W (3W/gel) 18 W  
12 mA (2 mA/gel) 12 mA 180 mA (30 mA/gel) 180 mA 
 
able 2.8 Electrophoresis conditions for SDS-PAGE using the 10-tank 
ystem. Running conditions for 6 gels, at 10˚C.   
    
T
s
  
Step 1            Step 2 Step 3 
0h50 minutes                     1h50 minutes Until front dye falls 
20 V constant                  50 V constant 125 V 
 
Table 2.9 Electrophoresis conditions for SDS-PAGE using the 12-tank 
system. Gels were run at 15˚C.  
 
For production of mini 2D gels the procedure was essentially the same as above except 
only half of the volume of buffer was necessary for equilibration of the IEF gels. At the 
end of equilibration, strips were washed in MOPS running buffer. The running 
co
 
 
nditions are summarised in Table 2.10. 
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Step Time Limits per gel 
1 20 min   50V   5 mA 1.0 W 
2 270 min 100V 20 mA 2.0 W 
 
Table 2.10 Electrophoresis conditions for the SDS-PAGE using 7 cm IEF 
ed to control the temperature because gels were run at low 
fter electrophoresis gels were fixed overnight, with agitation and stained next day with 
 water prior to addition of silver stain. Protein spots were then visualised by 
development with formaldehyde at basic pH and sodium carbonate. This reaction was 
stopped using EDTA once gel images had developed. PlusOne Silver stain kit 
(Amersham Biosciences, GE Healthcare) was used according to the manufacturer’s 
instructions with the exception of the volumes for the fixation step (300 ml per gel, 
instead of the 250 ml on the manual). In addition, when gels were run for the purpose of 
picking spots for mass spectrometry, glutaraldehyde was omitted from the sensitising 
step. 
 
 
gels. There was no ne
voltage and the run duration was relatively short. 
 
After electrophoresis, the glass plates were disassembled and the gels placed overnight 
in fixation solution, depending on which downstream stain was going to be used. 
 
 
2.5.4  2D-gel staining 
A
silver (Fig. 2.4 H) or fluorescent dyes (Sypro Ruby or Deep Purple) according to the 
manufacturers’ instructions. All solutions were made with MilliQ water. Glass trays 
were used for silver staining but metal trays with lids were used for Sypro Ruby or 
Deep Purple stains. 
 
 
2.5.4.1 Silver staining  
Silver staining involved fixation of gels to remove SDS and other buffer components. 
This was followed by cross linking of the proteins in the gel matrix with glutaraldehyde, 
and sensitisation with sodium thiosulfate in the presence of sodium acetate. Gels were 
washed with
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2.5.4.2 Sypro Ruby staining 
Sypro Ruby (Molecular Probes, Invitrogen) dye is a ready-to-use luminescent stain, 
which is compatible with mass spectrometry (Berggren et al., 2000). Gels were fixed in 
fixation solution (7.5% (v/v) acetic acid, 10% (v/v) methanol and water), using 300–500 
ml for large gels and 50–100 ml for mini-gels of Sypro Ruby solution, with gentle 
agitation, overnight. The next day the gels were destained (acetic acid/water) to remove 
background and washed in water for several times before scanning. Gels stained with 
this dye had to be carefully handled as they break easily.  
 
 
2.5.4.3 Deep Purple 
Deep Purple (Amersham Biosciences/GE Healthcare) stain contains a naturally 
occurring fluorophore, epicocconone compound, extracted from a fungal species 
(Epicoccum nigrum), which interacts noncovalently with SDS and proteins. It provides 
similar sensitivity to Sypro Ruby but has the advantage that it does not contain any 
heavy metals and is completely reversible. Staining was performed following the 
manufacturer’s instructions. Large gels were fixed overnight in 300 ml (50 ml for 
NuPage gels) 7.5% acetic acid and 10% ethanol (v/v). Gels were washed in 35 mM 
sodium hydrogen carbonate (NaHCO) for large gels or 200 mM sodium carbonate 
(Na2CO3) at pH11 for the mini gels, for 30 minutes. Wash solution was poured off and 
replaced by water before addition of deep purple (1:200), and incubated in the dark for 1 
hour (with agitation). Gels were then fixed in 7.5% (v/v) acetic acid, twice, for 15 
minutes, and thoroughly washed before imaging.  
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Figure 2.4 Diagrammatic representation of 2D protein electrophoresis 
method. (A) Samples comprised whole E10.5 embryos, or isolated cranial or 
caudal regions (separated at the level of the green dotted line) encompassing the 
posterior neuropore, PNP). (B) Tissue was homogenised by sonication. (C) 
Samples were loaded onto a rehydration tray for passive rehydration of strips. (D) 
First dimension isoelectric focusing (IEF) was performed on a flat-bed system. 
Before IEF proteins are randomly distributed across the IPG strip. After IEF 
t ns had reached their isoelectric point within the pH gradient or migrated to 
nds of the gels if pI lies outside the pH range of the gel. (E) The IPG strip was 
arated from the higher molecular weight to the lowest as indicated by the 
protein marker (kDa, kilo Daltons), and each spot corresponds to an individual 
ned gels 
e scanner protocol involved:  excitation with green laser (532 nm); emission at 560 
(LP) or 610 band-pass filter (BP). Gels were scanned at 100 
pro ei
e
equilibrated with the SDS buffer system for the second dimension. (F) Loading of 
the IPG strip onto the SDS-PAGE gel for second dimension electrophoresis to 
separate proteins by molecular weight (yellow arrow indicates direction of 
electrophoresis). (G) After electrophoresis, gels were fixed and stained. Image 
shows a typical silver stained gel using a pH range of 4.0-7.0 for IEF. Proteins 
were sep
protein species.   
 
 
2.5.4.4 Gel imaging  
Silver-stained gels were imaged using a GS-800 densitometer (Bio-Rad), and 
fluorescent-stained gels were imaged using a flat-bed laser based fluorescence imaging 
system, Typhoon 9400 scanner (Amersham Biosciences). For Sypro Ruby stai
th
nm with long-pass filter 
microns resolution. For Deep purple stain conditions were: excitation with green laser 
(532 nm); emission at 560 LP or 610 BP filter and 100 microns resolution. The 
photomultiplier tube voltage was adjusted for optimal signal intensity of spots. 
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Figure 2.5 Deep Purple and Sypro Ruby stained gels. A 2D-gel was divided in 
half before staining. (A) Image of a gel scanned using the Typhoon scan. The left 
half was stained with Deep Purple and the right half with Sypro Ruby. (B) The 
same gels were artificially coloured using ImageQuant TL V2005 software 
 stained gel to 
 Gel images were then separated into experimental groups (usually 
orresponding to mouse strain), for spot volume quantitation and comparison. Spots 
ge. 
 
(Amersham Biosciences).  (C) High magnification of a Sypro Ruby
show the difference between a protein spot (red arrow) and an artefactual speckle 
(red arrowhead). Black arrows indicate protein marker.  
 
 
2.5.5  2D-gel analysis 
After visualisation of the gel-spots and image acquiring, analysis of the resultant 2D 
array of spots was performed using Progenesis SameSpots software (Non Linear 
Dynamics). Analysis included semi-automatic gel alignment, inter-gel calibration and 
variance stabilisation.
c
found to be differentially abundant were reviewed manually and edited if necessary. 
Varying spots were ranked according to p-value (ANOVA) and/or fold chan
First the images were loaded into the software and automatically assessed for quality 
control and a reference gel was chosen for gel image alignment (Fig. 2.6 A-B). Ideally, 
a good reference image showed a clear and representative spot pattern, and a minimum 
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of distortion. All reference gels used in this study were from the curly tail strain unless 
otherwise stated. Before normalisation, spots were filtered by deleting speckles or spots 
in damaged areas (Fig 2.6 C). Typically of about 5200 spots initially defected, filtering 
left about 2200 spots to be compared (Fig. 2.6 C-D). All spots were reviewed and 
ma ually edited if needed. In cases where two spots were close together and detected as 
d. 
n
a single spot by the software they were manually split and re-analyse
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Figure 2.6 2D gel image analysis with SameSpots software. (A-B) After quality 
checking, images were aligned to a reference gel image. This was done by 
automatic application of vectors to each detected spot. Full image of a gel with 
etween the highest and the lowest 
spot volume. (F) Gel image with mapped spots of interest. 
applied vectors, and an enlarged view of one area (orange square). Spots in pink 
are from the reference image, while spots in green are from the image to be 
aligned (B). (C) Region of a gel after alignment. (D) 5219 spots were detected 
before filtering. At this step “false” spots were then deleted. (E) Spots were 
ranked after comparing spots volume between the groups. All spots were 
reviewed, but only spots that significantly differed (p<0.05) were taken into 
consideration. The fold change was calculated b
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During the spot review process, some spots that significantly differed between groups 
were excluded (Fig. 2.7). For example, some spots were present or absent in only one or 
two gels in the replicate group. Some spots were detected as being differently expressed 
but only as a result of an error during the alignment step with reference gel. False spots, 
such as streaking or speckles that had not been deleted in the filtering step were also 
excluded.   
 
          
 
Figure 2.7 les of hat cluded  sp eview. 
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2.5.6  Spot p  in stion for m rome lys
After analysis and comparison of the 2D gel images, spots of interest were excised from 
, or po c  low spot ce. C ak  not take 
excess gel from around the spot. Clean gloves were used to avoid contamination of 
ker t erred to a 1.5 ml eppendorf tubes for in-gel 
digestion of proteins for Liquid Chromatogra  M ectrometry (LC-
n a Q Quadru ight) Waters tio
el digestion 
Gel pieces were covered in 50 µl of 100 mM Ammonium bicarbonate (Ambic, Sigma) 
bu l 
pie . 
Sa eed vac (4-5 minutes). Gel-spots were rehydrated by 
ddition of 50 µl 10 mM DTT in 100 mM Ambic (made up fresh) and heating at 56oC 
r 30 minutes. After removal of the DTT solution, acetonitrile was re-added to further 
ehydrate the gel, excess solution was discarded and the gel piece dried in a speed vac. 
A uot of 55 t 0 m c (1 a
incubated at room t ure fo  (in the dark). Iodoacetam added 
after incubation of the protein with denaturan c nts, in order to 
c modify  resid form S-carboxym
disulfide bonds are no longer formed. After discarding the supernatant, the gel was 
b  with  Ambic buffer and then washed for a further 15 minutes. 
Excess liquid was again removed and the gel was dehydrated once again with 
a d d va
 
T  protein  pep l of 50 mM Ambic was added to 15 µl of 
t  A, section A.14) giving a final concentration of 13 ng/µl. Gel-spots 
were then rehydrated with 15-30 µl trypsin solution (enough to cover gel pieces) by 
inc trypsin was removed and 
a minimal volume of 50 mM Ambic (10-20 µl) was added to cover the gel pieces and 
keep them wet during enzyme cleavage. Tubes were incubated at 37oC for 1 hour and 
then overnight at room temperature.  
 
icking and -gel dige ass Spect try ana is 
each gel oled in the ase of very  abundan are was t en to
spots with atin. The cu  spot was transf
phy Tandem ass Sp
MS/MS) o
 
2.5.6.1 In-g
Tof ( pole Time-of-L  micro (  Corpora n).  
ffer, for 5 min, to remove stain and SDS. The supernatant was discarded and ge
ces dehydrated by addition of 50 µl acetonitrile (98%; Fisher Scientific), twice
mples were further dried in a sp
a
fo
d
 50 µl aliq  mM iodoace amide in 10 M Ambi 0 mg/ml) w s added, and 
emperat r 20 minutes ide is 
ts and redu ing age
ovalently cysteine ues (to ethyl cysteine), so that 
riefly washed 100 mM
cetonitrile and drie  in a spee c.  
o digest the -spots into tides, 100 µ
rypsin (Appendix
ubating at 4oC for 30-45 minutes. After this period, excess 
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2.5.6.2 Peptide extraction from the gel pieces (for QTOF analysis) 
The supernatant from the overnight in-gel digestion was transferred into a fresh 1.5 ml 
tube and left aside. To extract additional protein from each gel-spot, approximately 15 
µl of 50 mM Ambic was added to the gel piece and incubated for 15 minutes at 37oC. 
The resulting supernatant was pooled with the initial supernatant (above). The gel 
pieces were again dehydrated with acetonitrile and incubated for 15 minutes at 37oC 
until they were small white lumps. The supernatant was transferred and pooled as 
above. The steps with the 50 mM Ambic followed by acetonitrile were repeated once 
more and all the supernatants were pooled as above, completely dried in the speed vac 
and stored at -20 oC.  
 
The ‘in-gel digestion’ of all proteins identified in this study was either by Dr Kit-Yi 
Leung or with her assistance. Dr Leung also performed all the LC-MS/MS. 
 
Peptide sequences obtained by LC-MS/MS were submitted to MASCOT 
(http://www.matrixscience.com/search_form_select.html) search engine. The proteins 
were identified by selecting the following items: MS/MS Ion Search; SwissProt 
database; trypsin digestion; allowance of two missed cleavages; carboxymethyl and 
oxidation, variable modifications; micromass (.PKL file format). A score of 35 or above 
was considered sufficient for confident identification of a protein. Lower scores were 
t least one peptide with a score ≥35.   
2.5
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.7  2D-gel analysis of phosphatase digested protein-samples 
 test the hypothesis that lamin B1 protein spots were phosphorylated, a metho
amagata et al., 2002; Raggiaschi et al., 2006) was developed in which curly tail an
ld-type embryo-samples were treated by phosphatase, to remove phosphate group
m phosphorylated proteins. Whole embryo samples were prepared as describe
ove (section 2.5.1) but in a different lysis buffer (Appendix A, section A.8), usin
0-300 µg total protein (embryos pooled if necessary). 
.7.1 Dephosphorylation of proteins 
om the homogenised sample, 20 µl were mixed with 10 µl of 10% SDS, 945 µl o
O, 5 µl of 20 mM manganese chloride, 20 µl of λPPase buffer to a final volume of 1
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ml. This solution was then divided into two aliquots (500 µl each) to which 0.25 µl (100 
f λPPaseunits) o  (Lambda Protein Phosphatase, λPPase; New England BioLabs) were 
the same lysis buffer in which they were sonicated (20-25µl) and 
rotein assay was again performed. 2-DE was then carried out using 18 cm IPG strips as 
ylated proteins, but not to phosphatase-treated 
amples. 
re-cast 1 mm thick Bis-Tris gels (NuPage System, Invitrogen) with 10 wells were 
added to one of the aliquots the other was kept as control. Both samples (control and 
phosphatase treated) were incubated overnight at 30ºC, with rotation. After incubation, 
samples were purified using the 2-D Clean-Up kit (Amersham Biosciences). Pellets 
were re-suspended in 
p
described above. 
 
2.5.7.2 Validation of dephosphorylation of proteins 
To verify that proteins were digested by the phosphatase, one-dimensional protein gel 
electrophoresis was performed, the gel blotted onto a membrane and immunostained 
with an anti-phospho antibody (Table 2.11). The antibody should bind to control 
samples, which contain phosphor
s
 
 
2.6  Western blot 
 
2.6.1  One-dimensional protein gel electrophoresis 
Protein samples were prepared as described in section 2.5.1, but instead of the 2D-lysis 
buffer, Radio-Immunoprecipitation Assay (RIPA; Appendix A, section A.15.1) buffer 
was used. RIPA buffer is a harsh denaturing buffer due to the presence of SDS and 
sodium deoxycholate ionic detergents. 
 
Protein samples were stored at -80˚C and thawed on ice. For each lane, samples 
typically contained 1-5 µg protein (depending on the antibody), with 0.5 µl of β-
mercaptoethanol (Sigma) and the volume made up to 25 µl with neat Laemmli sample 
buffer (Bio-Rad). Samples were spun down in a 4˚C centrifuge and denatured on a 
100˚C hot block for 2 minutes, then kept on ice until the gel was loaded. 
 
P
used. Uniform 10% gels or 4-12% gradient gels were used depending on the size of the 
protein to be detected. Gels were washed with Milli-Q water. The comb was removed 
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and wells washed with 1x MOPS SDS running buffer (from 20x stock; Invitrogen). 
After placing gel-cassettes in the tank (XCell SureLock), the inner chamber was filled 
up with running buffer and checked for leakages. The rest of the running buffer was 
poured into the outer chamber. Samples were then loaded with one well containing 8 µl 
of protein marker (Precision Plus Protein Standards, Dual Color, Bio-Rad; Fig. 2.8). In 
general the running conditions were 20 minutes at 50 volts to allow samples to slowly 
enter the gel, followed by 2 or more hours at 100 volts. 
 
.6.2  Blotting 
Pr , 
Tr , 
Inv -
P, o 
the n 
tra  
bu . Care was taken to minimise touching the membrane and 
rceps were used. After electrophoresis was completed (dye front close to the bottom 
f the gel or fallen), gels were removed from the cassette and the procedure for transfer 
as:  
emi-dry blotter, followed by the equilibrated membrane, the gel 
and an additional  3 sheets of buffer-soaked filter paper added on top to complete the 
air 
  
2
otein transfer was optimised for two different systems: semi-dry blot (Bio-Rad
ans-Blot SD, Semi-Dry Transfer Cell) and wet blot (XCell II Blot Module
itrogen). Polyvinylidene fluoride membrane (PVDF, 0.45 µm pore size, Immobilon
Millipore) and filter paper (3MM, Chromatography paper, Whatmann) were cut t
 same dimensions as the gel. Membranes were first wetted in methanol, the
nsferred to clean Milli-Q water for 2 minutes and finally equilibrated in transfer
ffer for at least 15 minutes
fo
o
w
 
- Semi-dry: The gel was equilibrated in transfer buffer (Appendix A, section A.15.2) 
for at least 15 minutes. Filter paper was soaked in transfer buffer (3 sheets) and 
assembled on the s
‘sandwich’. A pipette was rolled over the gel-membrane sandwich to remove any 
bubbles (Fig. 2.8 B). The lid was connected and conditions were 25V for 25 minutes 
for one gel; and 25V for 45 minutes for 2 gels.   
 
- Wet: Filter paper soaked in transfer buffer was laid on top of the gel, which was turned 
over, the cassette discarded, followed by equilibrated membrane. Another buffer-
soaked filter paper was placed on the top of the membrane. A pipette was rolled over 
the gel-membrane sandwich to remove any air bubbles. Blotting pads were soaked in 
transfer buffer and aligned with the sandwich in the transfer cell (Fig. 2.8 C). The cell 
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was placed in the gel tank, locked in place and transfer buffer was added to cover the 
blotting pads. The outer buffer chamber was filled with milli-Q water to the same 
level of the blotting pads (~ 600 ml) to maintain constant temperature. Running 
conditions were constant 25V for 1 hour. 
 
 
2.6.3  Immunodetection 
After blotting, the transfer system was disassembled and the membrane was quickly 
 on 
e primary antibody (summarised in Tables 2.11 and 2.12). Secondary antibody was 
ts from two different samples. 
washed in 1x tris buffered saline (TBS; Appendix A, section A.15.3) to remove excess 
transfer buffer. Membranes were then incubated in blocking solution (Appendix A, 
section A.15.3), for 1 hour at room-temperature, with shaking (60 rpm). Primary 
antibody was added to 15 ml blocking solution and incubated with the membrane 
overnight at 4˚C with shaking. In some cases, membranes were blocked overnight at 
4˚C and the primary solution was added next day for 1 hour at room temperature. 
 
Primary antibody solution was poured off and the membranes washed 3 times for 5 
minutes with 1x TBST, shaking at room-temperature. TBST was replaced with 
appropriate secondary antibody in 15 ml blocking solution: with shaking, for 1 hour, at 
room-temperature. The concentrations of secondary antibody used were dependent
th
then discarded and the membrane washed five times for three minutes with 1x TBST at 
room temperature. While washing membrane, the chemiluminescent solution (2 ml per 
membrane; Amersham ECL Plus Western Blotting Detection Reagents, GE Healthcare) 
was prepared following manufacturer’s instructions. ECL provides a non-radioactive 
method for detection of antigens bound to horseradish peroxidase (HRP)-conjugated 
antibodies. The membrane was transferred to cling-film covered with ECL solution and 
left for 5 minutes at room temperature. The membrane was blotted to remove ECL, 
wrapped up with clean dry cling-film and placed in a cassette with Hi Speed X 
intensifying screen prior to exposure to X-ray film (Chemiluminescence BioMax Light 
film, Kodak) between 1 second and 5 minutes. Films were developed in an Autorad 
Developer. 
 
Optimal conditions for each antibody were determined using two different 
concentrations of antibody with different protein amoun
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Additional membranes were incubated without primary antibody to check for non-
specific binding of the secondary antibody.   
 
Protein Catalogue 
number 
Company Species Dilution Band Size 
(kDa) 
Β-Tubulin sc-9104 Santa Cruz 
Biotechnology 
Rabbit 
polyclonal 
1:1000 55 
Lamin B1  sc-30264 Santa Cruz Goat 1
(S-20) Biotechnology polyclonal 
:1000 67  
Gart  sc-83255 Santa Cruz Rabbit 
clonal 
1:1000 110 
(S-20) Biotechnology poly
VCP #2648 Cell Signalling 
Technology 
Rabbit 
polyclonal 
1:1000 89 
Fetuin-A  
(M-17) 
sc-9668 Santa Cruz 
Biotechnology 
Goat 
polyclonal 
1:1000 59 
Fetuin-B  sc-32535 Santa Cruz Goat 
(C-20) Biotechnology polyclonal 
1:5000 60 
Mat2a ab-26174 Abcam Chicken 
polyclonal  
1:4000 43  
Gapdh #MAB374 Millipore Mouse 1:10000
0 
38 
UBE2N * GTX1366
3 
Gene Tex, Inc Rabbit 
polyclonal 
1:1000 – 
1:2000 
17 
Phospho-
threonine 
antibody  
9381 Cell Signaling Rabbit 
polyclonal 
1:1000 Vary 
 
Table 2.11 Primary antibodies used in western blots. * This antibody gave no 
results or appeared to give non-specific binding. Band size indicates the 
predicted/expected band size.   
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Antibody Catalogue  Company Species Dilution Conjugated 
Anti-rabbit P0448 D
immunoglobulins 
AKO Goat 
polyclonal 
1:5000-
15000 
HRP 
Anti-goat 
immunoglobulins 
P0160 DAKO Rabbit 
polyclonal 
1:5000-
15000 
HRP 
Anti-mouse 
immunoglobulins 
P0260 DAKO Rabbit 
polyclonal 
1:150000 HRP 
Anti-chicken IgY ab-6877 Abcam Goat 
polyclonal 
1:10000 HRP 
Anti-sheep 
immunoglbulins 
61-8620 Invitrogen Rabbit  1:5000  
1:10000 
HRP 
 
Table 2.12 Secondary antibodies used in western blots.  
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Figure 2.8 Western blot for detection of protein expression. (A) Samples were 
loaded (blue arrows) onto precast gels, and electrophoresed for protein separation. 
A pre-stained protein marker (PM, red arrow) was used to estimate the size of the 
protein. Bromophenol blue contained in the sample loading buffer helped to 
follow progression of the run. Image of a silver-stained gel for total protein 
visualisation. (B-C) Proteins were electro-transferred from the gel to a membrane, 
using semi-dry (B) or wet (C) transfer. After transfer, membranes were blocked 
with a suitable blocking buffer and incubated with primary antibody. (D) After 
washes, membrane was incubated with horseradish peroxidase (HRP) secondary 
antibody conjugate in blocking solution. The HRP-antibody complex activates 
chemiluminescent solution for protein detection. (E) Image of the protein bands 
after X-ray exposure and development. Red arrows indicate direction of 
electrophoresis (A) and electrotransfer (B-C).     
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ag e 
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Af r 
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W  
mi s. 
M  minutes in TBST with shaking at room-
temperature. TBST was replaced by blocking solution and the protocol was followed as 
for immunoblotting (section 2.6.3). 
 
 
2.6.5  Analysis and statistics 
All X-ray films were scanned on a GS-800 Densitometer (Bio-Rad). Images were 
acquired and analysed with Quantity One software (Bio-Rad). The utility of β-tubulin 
and Gapdh for normalisation were evaluated by first testing whether the band volume 
increased linearly with total protein abundance. Different concentrations of the same 
protein sample were western blotted (as section 2.6.3) and X-ray films were exposed for 
1 second. Band analysis was performed using Quantity One software volume analysis 
tool which measures the total signal intensity of the pixels inside a defined boundary 
drawn on the image multiplied by the pixel area (Volume units = intensity units x mm2). 
A rectangle of equal size (for each blot) was drawn around each band. An additional 
rectangle was drawn in a background region of the image and used as the global 
background volume. The software calculates a single background intensity for the entire 
image, which is subtracted from all the volumes in the image. To assess linearity of the 
volume measurements with protein abundance, band volumes were measured for a 
series of samples and plotted on a bar graph (Fig. 2.9). 
 
In order to compare protein levels between samples the adjusted volumes (with 
background subtracted) of the protein of interest (Protein A) were normalised to the 
.4  Membrane stripping and re-probing for normalisation of total protei
content 
 verify equal loading of protein-samples and allow normalisation of protein conten
ainst a reference protein, membranes were stripped and re-probed with an antibod
ainst Gapdh or β tubulin (reference proteins assumed not to vary in abundanc
tween genotypes).  
ter exposure, dried-membranes were wetted in methanol and washed in Milli-Q wate
ice, for 6 minutes each). Water replaced with either stripping solution (Restor
estern Blot Striping Buffer, PIERCE), at 37˚C for 20 minutes, with shaking every 5
nutes or 0.2 M NaOH, at 37˚C for 10 minutes, with shaking every 2-3 minute
embranes were then washed twice for 6
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volum s of the reference protein (β-tubulin or Gapdh), to e give the ratio of Protein 
A/reference. For comparison between strains, one sample (usually a wild-type) was 
used as the calibrator with a nominal abundance of 1.0. The ratio of normalised volume 
for a sample/normalised volume for calibrator gave the final volume for each sample. 
For each western blot, a minimum of three samples per strain were used for comparison. 
The mean normalised volume for each strain were compared by One Way ANOVA 
using Sigma Stat software (Jandel Scientific). 
 
 
 
Figure 2.9 Sensitivity and linearity of detection for the antibodies used for 
protein normalisation. (A-B) Scans of Western blots loaded with different 
concentrations of total embryo protein and blotted with antibodies to β-tubulin (A) 
and Gapdh (B).  ( ) Plot of volumes of each band corresponding to the 
different concentrations detected by β-tubulin or Gapdh antibodies. The ideal 
s f lumetric analysis corr
C-D
band or vo espond to 2.5 µg of total protein, which gave 
sharp, unsaturated bands. 
 
 
 
 94
2.7
In n mRNA 
xpression (reverse transcription; qRT-PCR), and genomic DNA copy number 
enomic; qG-PCR). 
a) was added and tubes were vigorously shaken by hand for 
15 seconds and incubated at room-temperature for 3 minutes followed by centrifugation 
at 12,000x g for 15 minutes at 4˚C for phase separation. The upper aqueous layer, 
containing the RNA, was transferred to a clean eppendorf tube. To precipitate the RNA, 
200 µl of isopropyl alcohol were added and samples were incubated at 4˚C for 10 
minutes, followed by centrifugation at high speed at 4˚C. The supernatant was carefully 
removed, without disturbing the gel-like pellet. The pellet was washed with 75% 
ethanol (in DEPC-treated water) by vortexing and collected by centrifugation for 5 
minutes at 4˚C. Again the supernatant was removed and the pellet air dried for no 
longer then 10 minutes. The RNA pellet was then re-suspended in 20 µl of DEPC-
treated H2O and 0.7 µl of RNase inhibitor (Bioline) were added. At this stage the RNA 
was stored -80˚C or on dry ice prior to DNAse treatment. 
 
DNA contamination was removed from RNA samples by DNase treatment, using a 
DNA-free kit (Ambion). To the 20.7 µl of RNA, 0.5 µl of recombinant DNaseI 
(rDNAseI, 2 U/µl) and 2.5 µl of 10x DNaseI buffer were added and incubated at 37˚C 
for 30 minutes. The reaction was stopped by addition of 2.5 µl of DNase inactivation 
buffer, incubation at room-temperature for 2 minutes with occasional mixing. Samples 
were centrifuged at 10,000x g for 2 minutes at room-temperature or 4˚C, before 
transferring the supernatant to a new tube. The concentration of RNA was measured 
using a NanoDrop (ND-1000 Spectrophotometer) which gives concentration in ng/µl 
(absorbance 260 nm). Sample purity was assessed by consideration of the ratio of 
absorbance at 260 nm/280 nm, which is ideally 1.8 for DNA and 2.1 for RNA. A lower 
value may indicate the presence of contaminants and these samples were discarded. 
 
  Quantitative real-time polymerase chain reaction (qPCR) 
this project, fluorescence-based qPCR was used to quantify differences i
e
(g
 
2.7.1  RNA extraction and first-strand complementary DNA (cDNA) synthesis  
Total RNA was isolated from whole, cranial or caudal embryo samples frozen at -80˚C, 
using TRIzol Reagent (Gibco) Tissue was taken from dry ice and homogenised with 0.5 
ml of TRIzol by pipetting and incubated at room-temperature for 5 minutes. A 100 µl 
aliquot of chloroform (Sigm
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Typically 300 ng of RNA was used for reverse transcription to generate first strand 
5˚C for 10 minutes; 42˚C for 50 minutes for cDNA synthesis 
nd then 70˚C for 15 minutes to terminate the reaction. After cooling on ice and brief 
 was added, gently mixed and incubated at 37˚C for 20 
ll cDNA samples were tested to check that the first strand reaction had worked by 
PCR using 1 µl cDNA as template and a standard PCR reaction using previously tested 
p imers to the houseke  gene glyceraldehyde-3-phosphate 
d Appendix B, Tab ). Products were run on 2% agarose 
g r qRT-PCR were designed to give a product of 150–250 bp. 
P viously optimised to allow normalisation of qRT-PCR for a 
gene of interest to Gapdh abundance (Gustavsson et al., 2007).  
 
 
2.7
Qu r 
M at 
flu riments were performed on a 7500 
ast Real-Time PCR System (Applied Biosystems) which accommodates a 96-well 
using Primer3 software (http://frodo.wi.mit.edu/primer3/), and analysed by BLAST on 
cDNA, using SuperScript II Reverse Transcriptase (RT) kit (Invitrogen).  The reaction 
mixture contained RNA template, 1 µl dNTP mix (10 mM), 1 µl random hexamers (50 
ng/µl) and DEPC H2O to a final volume of 10 µl per sample. The mixture was denatured 
by incubation at 65˚C for 5 minutes, and then placed on ice for at least 2 minutes prior 
to addition of 9.3 µl reaction mix (containing 2.0 µl 10x RT buffer, 4 µl 25 mM MgCl2, 
2 µl 0.1 M DTT, 0.5 µl RNase OUT Recombinant (Ribonuclease Inhibitor), and 0.8 µl 
DEPC-treated H2O). The samples were gently mixed and briefly centrifuged. After 2 
minutes incubation at room-temperature, 0.7 µl of SuperScript II RT was added, gently 
mixed and incubated at 2
a
centrifugation, 1 µl of RNase H
minutes to remove RNA from the sample. First-strand cDNA samples were incubated 
on ice until use or at -20˚C if not used on the same day. 
 
A
rimers or pr eping
ehydrogenase (Gapdh; le B.7
els as most primers fo
rimers for Gapdh were pre
.2  Reverse transcription qPCR (RT-qPCR)  
antitative RT-PCR was performed using RealTime PCR Mesa Blue qPCR Maste
ix Plus for SYBR assay (EUROGENTEC), which utilises a SYBR green-like dye th
oresces bound to double stranded DNA. All expe
F
plate format (MicroAmp, Applied Biosystems).  
 
The experimental design included a minimum of three samples per experimental group, 
each of which was analysed in triplicates. All primers were (SIGMA Aldrich) designed 
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NCBI-BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to ensure that primers amplify 
unique products. 
 
 A master-mix was prepared on ice for each primer pair, which included: 12.5 µl Mesa 
lue mix, 1.5 µl of each primer (10 µM), and 8.5 µl H2O. A 1 µl aliquot of each cDNA 
tape; MicroAmp, Applied Biosystems), briefly vortexed and centrifuged, 
rior to loading of the plate onto the 7500 Fast Real Time-PCR System. 
o tion Plate assay; Standard 7500 
nning mode; detector - SYBR Green. The protocol involved a two-step standard 
and 95˚C for 5 minutes followed by 
e melting temperature. If not, there 
 likely to be contamination, mispriming or primer-dimer artifacts. The settings were as 
r PCR but the running conditions were: 95˚C for 15 seconds (step 1), 58-60˚C for 1 
nds.         
B
sample was loaded onto a well of a 96-well plate, followed by the 24 µl mix. Three 
wells were thus used for each primer-pair/sample combination. A negative control (mix 
with water instead of cDNA) was also included for each primer pair. The plate was 
sealed (sealing 
p
 
The s ftware was set up as follows: Relative Quantifica
ru
method involving: pre-run of 50˚C for 2 minutes 
40-46 cycles of denaturation at 95˚C for 15 seconds, annealing/extension at 56-60˚C 
(depending on primer) for 1 minute. 
 
At the end of the real-time PCR amplification a dissociation curve was generated using 
a programme in which the temperature is raised by a fraction of a degree and the change 
in fluorescence is measured. This relies on the fact that there is a rapid decrease in 
fluorescence when the two strands of cDNA are separated at the melting point. All PCR 
products for a given primer pair should have the sam
is
fo
minute (annealing temperature of primer pair), and 95˚C for 15 seco
 
The analysis of both Dissociation and Plate Analysis were performed by using the 7500 
Software version 2.1.1 (Applied Biosystems). The analysis consists of:  
- Dissociation: All the melting curves were checked. The rate of change of the 
relative fluorescence units with time on the Y-axis is plotted against the 
temperature on the X-axis, peaking at the melting temperature (Fig. 2.11). A 
primer-dimer artefact shows as a peak with lower melting temperature, and these 
wells were removed from the analysis.    
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-   Plate Analysis: A threshold level was set the baseline (background fluorescence 
signal emitted during the first cycles of the PCR reaction before amplifying the 
product itself) and within the linear part of the reaction (Fig. 2.10 A-B). The 
reference gene and a calibrator (in general a wild-type sample) were specified. If 
the Ct (point at which the fluorescence crosses the threshold) for a sample was 
higher than that of the negative control (later Ct value; Fig. 2.10 A-B) the 
affected wells were excluded from the analysis since this could mean the cDNA 
quality was bad or degraded. All the Ct values were then checked for 
consistency within the triplicates for each gene. Finally, the relative 
quantification (RQ), corresponding to cDNA expression, of all samples (within 
the experimental groups, e.g., curly tail versus wild-type, a minimum of three of 
each) were analysed using Sigma Stat software (ANOVA or t-test if comparing 
only two groups) and plotted (mean and standard error) with Sigma Plot 
software (Fig. 2.10 C-D).  
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Figure 2.10 Quantitative . (A-B)  plot 
nd ‘Linear’ views, respe  (software output). These plots show 
k arrow), Ct curve  arrow), and negative c l (green 
pdh reference gene. (B) The delta Rn value (Y axis), which is 
the Rn value of the reaction minus the Rn value of the baseline signal generated 
 number (X axis). Rn is the 
normalised reporter value = fluorescent signal (SYBR green)/the signal of the 
h 
groups after 
statistical analysis (Sigma Stat and Sigma Plot software). * Indicates significant 
real time RT-PCR analysis Amplification
in the ‘Log’ a ctively
the threshold (blac s (red ontro
arrow) for the Ga
by the instrument, is plotted against the cycle
passive reference dye for a given reaction. (C) Relative gene expression for eac
sample (Grhl3 gene, in this example). (D) Graphical representation of the 
expression of a given gene (e.g., Grhl3) within the biological 
difference to the other groups (p<0.05).  
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2.7.3 Quantitative PCR for genomic DNA quantification 
B, Table B.3). Each qG-PCR experiment included at least one ct/ct sample 
ormalisation sample, RQ 1.0), two single transgenic samples, for which the genotype 
rhl2 each in triplicate). Negative controls were 
repared separately with no DNA. A separate mix of primers was prepared containing 
primers for each reaction), and 3 µl was loaded 
ate Analysis), the Relative Quantification value 
 different genotypes: ct/ct, ct/ctTgGrhl3 (single transgenic) and 
tTgGrhl3/ctTgGrhl3 (double transgenic).  
A qG-PCR method was developed to genotype embryos generated from single 
transgenic intercrosses (ct/ctTgGrhl3 versus ct/ctTgGrhl3) litters, in order to distinguish 
between single and double transgenic embryos on the basis of Grhl3 genomic copy 
number. Primers were designed in the intronic region of Grhl3 and Grhl2, the latter to 
be used as a reference gene whose copy number is identical between samples 
(Appendix 
(n
was known (BAC positive embryos from crosses between ct/ct and ct/ctTgGrhl3 mice). 
These samples provided an index level for the copy number of Grhl3 gene in single 
transgenics, for comparison with the “unknown” BAC-positive samples which could be 
either single or double transgenics. 
 
A separate reaction mix was prepared for each sample containing 12.5 µl Mesa Blue 
(1x), DNA template, and H2O to a final volume of 22 µl: sufficient volume was 
prepared for 6 reactions (Grhl3 and G
p
1.5 µl each of the forward and reverse 
into each well, followed by 22 µl of reaction mix. The procedure was then the same as 
for qRT-PCR (as above).  
 
Following analysis (Dissociation and Pl
of each sample was plotted on a scatter plot using Sigma Plot software. Each plate was 
treated as a single experiment, i.e. plates were not combined. This analysis allowed the 
RQ values for individual embryo samples (which is determined by gene copy number) 
to be compared with the overall distribution of RQ values (Y-axis), which included the 
known: ct/ct and ct/ctTgGrhl3 samples. Thus, intervals of RQ values were defined which 
corresponded to the
c
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Figure 2.11 Genomic-qPCR analysis. Melting curve slopes for primer pairs used 
for amplification of Grhl2 (left) and Grhl3 (right) genes. Both show specific 
amplification characterised by sharp, single peaks for each sample, rather than 
diffuse or multiple peaks which would indicate non-specific amplification. 
 cDNA. Fifteen pairs of primers were 
esigned which flank the coding regions at genomic level (Appendix B, Table B.5), 
 
 
2.8  Sequencing of DNA and RNA (cDNA)  
In order to sequence the coding region of the lamin B1 gene (Lmnb1), primers were 
designed to amplify the genomic DNA and
d
and five pairs were designed to amplify overlapping regions to cover the cDNA 
(Appendix B, Table B.6).  
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2.8.1  Sample preparation and PCR amplification 
Genomic DNA was extracted from E10.5 ct/ct and +ct/+ct embryonic yolk sac samples 
(Section 2.2). To check the transcript sequence, RNA was extracted from whole E10.5 
embryos using TRIZOL, followed by DNase treatment, and first-strand cDNA synthesis 
(Section 2.7.1). Genomic DNA and cDNA samples were used as template for PCR 
mplification and an aliquot of the products were analysed on an agarose gel 
lectrophoresis. PCR products were then purified using QIAquick PCR Purification Kit 
manufacturer’s instructions but eluting the sample in a 
 Prism BigDye Terminator kit (Version 3.1; 
ycle Sequencing kit; Applied Biosystems). Reaction conditions are summarised in 
a
e
(QIAGEN) according to the 
lower volume (15 µl) of water. Purified PCR samples were re-run on agarose gels to 
check the product yield.  
 
2.8.2  Sequencing reaction  
Sequencing was carried out using ABI
C
Table 2.13. 
 
Reagents Volume (µl) 
PCR product    2.0 
5x Sequencing Buffer   2.0 
Primer    0.5 
BigDye Terminator mix   1.5 
Milli Q    4.0 
Final Volume  10.0 
 
f the 
primers used in the previous PCR amplification.  
ples were vortexed and stored at -20˚C for 30 
Table 2.13 Sequencing reaction with Big Dye Terminator. Initially, the water, 
buffer and the BigDye Terminator reagent were mixed together, vortexed, and 
added to the PCR product. A single primer was added corresponding to one o
 
Sequencing reactions were amplified on a Thermocycler using the following conditions: 
20 seconds at 95˚C denaturation, 15 seconds at 60˚C annealing, 1 minute at 50˚C 
extension for 24 cycles.   Samples were cleaned up by addition of 10 µl water, 2 µl 3 M 
NaAc and 50 µl absolute ethanol. Sam
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minutes to precipitate the DNA and then centrifuged at 13,000 rpm for a maximum of 
egaBACE 1000 (with 
ssistance from Dr Peter Gustavsson). Raw data (Ab1 files) were uploaded and the 
neration of an anti-sense probe for Lmnb1 
 in situ 
ybridisation it was necessary to produce an anti-sense cDNA probe. A 561 bp 
agment (Table B.6, Appendix B), corresponding to base pairs 726-1286 of the 
ns 3-5 and part of exon 6) was 
s section 2.8.1) and a 2 µl aliquot was re-run on a 1% agarose gel to 
etermine the concentration to be used for cloning.  
 
-TEasy (50 ng), 2 µl template 
CR product), 1 µl T4 DNA ligase (3 µg/µl) and 1 µl H2O. This reaction was incubated 
into 50 µl of DH5α competent cells 
nd incubated on ice for 20 minutes, followed by 50 seconds heat shock at 42˚C, and 
20 minutes. The supernatant was then removed and the pellet was washed with 70% 
ethanol, followed by 100% ethanol and then air dried and stored at -20˚C until use for 
sequencing. 
 
The sequencing products were separated and detected on a M
a
sequences assembled, aligned and analysed using Sequencher 4.7 software (Gene Codes 
Corporation).  
 
 
2.9  Ge
 
2.9.1  Preparation of PCR product for cloning 
In order to examine the expression of Lmnb1 mRNA and perform whole mount
h
fr
transcript sequence (encoded by part of exon 2, exo
amplified by PCR from a wild-type cDNA sample using the B1TrsF2/R2 primers. After 
confirmation of amplification by agarose gel electrophoresis, the PCR product was 
purified (a
d
 
2.9.2  Cloning of Lmnb1 fragment into pGEM-T Easy Vector 
The PCR product corresponding to Lmnb1 cDNA was cloned into the pGEM-T Easy 
Vector (Promega) which contains Sp6 and T7 promoters for RNA polymerase (Fig. 2.12 
A). For cloning, approximately 50 ng of template were used in a 10 µl ligation reaction 
containing 5 µl of 2x Rapid ligation buffer, 1 µl pGEM
(P
at room-temperature for 2 hours and 15 minutes.  
 
A 2 µl sample of ligation product was transformed 
a
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cooling on ice for at least 2 minutes. After addition of 950 µl of Luria Broth Base (LB-
Broth; Invitrogen), sample was incubated at 37˚C for 1 hour, shaking.  At the end of this 
period, samples were plated onto agar plates (LB-Agar; Invitrogen) containing 
ampicillin (50 µg/ml, 1:1000 of 50 mg/ml stock; Sigma), and spread with 5-bromo-4-
chloro-3-indolyl-β-D-galactopyranoside (X-gal, 100 µl of 20 mg/ml stock; Invitrogen) 
and isopropyl-thio-2-D-galactopyranoside (IPTG, 100 µl of 100 mM stock; Insight 
Biotechnology Ltd) for blue/white selection (Fig. 2.12 B).  
 
The following day, white colonies were harvested. Half of each colony was streaked 
onto a LB-agar plate, and the other half mixed into a PCR reaction mix to check for 
resence of the insert (by PCR using the primers that were used for cloning, see above). 
1 
sert was orientated in the same direction as the T7 promoter (Fig. 2.13 C).  
Promega) and transcribed with Sp6 RNA polymerase (Roche). For the 
p
For positive colonies a small sample was grown overnight in 10 ml LB-Broth 
containing 50 µg/ml ampicillin, at 37˚C with shaking. The following day cultures were 
centrifuged at 6,000x g for 15 minutes at 4˚C to obtain the bacterial pellet. Plasmid 
DNA was isolated using the QiaPrep Spin MiniPrep kit (Qiagen) according to the 
manufacturer’s instructions. The orientation of the insert was determined by PCR using 
a 1/50 dilution of plasmid DNA as template and using different combinations of cloning 
primers together with the T7 and Sp6 vector primers (Appendix B, Table B.9). Primer 
combinations were T7/B1TrsR2, B1TrsF2/T7, Sp6/B1TrsR2, B1TrsF2/Sp6 and 
B1TrsF2 /B1TrsR2. In addition, orientation of the insert was confirmed by restriction 
digest of 0.2 µl of plasmid DNA using EcoRI (Promega), which excises insert from the 
vector, HincII (Gibco, Invitrogen), which cut the insert at base-pair 436 and the vector 
at base-pair 88, and PstI (Promega), which cut the insert at base-pair 510 and the vector 
at base pair 92 (Appendix A, section A.16.1). These two tests showed that Lmnb
in
           
      
2.9.3 Production of anti-sense Lmnb1 probe 
In order to perform in vitro transcription, the circular plasmid was first linearised and 
linear DNA was purified with phenol-chloroform (Appendix A, section A.16.1). After 
purification, the linearised DNA fragment was resuspended to a concentration 300 ng/µl 
and used for transcription of digoxigenin-labelled probes (Appendix A, section 
A.16.2). For production anti-sense probe the Lmnb1 plasmid was linearised with NcoI 
endonuclease (
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sense-strand the plasmid was linearised with SpeI endonuclease (Invitrogen) and 
ibed with T7 polymerase (Rotranscr che).  
 
 
 
Figure 2.12 Cloning of Lmnb1 for production of mRNA probe. (A) A 561 bp 
Lmnb1 fragment was cloned into pGEM-T, which carries an ampicillin resistance 
cassette and T7 and Sp6 promoters. (B) Blue-white colony selection (IPTG/X-
Gal). IPTG induces expression from the lac promoter and its derivatives. Pink 
arrows indicate positive clones. (C) Direction of the Lmnb1 insert within the 
inai, Toronto), P. Ingham (ICRF, 
ilkinson (MIMR, Mill Hill). The probes used in this project are 
summarised on Table 2.14.  WMISH was performed on embryos at stages E7.5 to 
E1 a 
needle or fo
ml
 
vector. To generate a sense probe, the plasmid was linearised with SpeI enzyme 
and transcribed with T7 polymerase, and for the anti-sense probe, plasmid was 
linearised with NcoI and transcribed with Sp6 polymerase. Scale bar in B: 1 mm.  
 
 
2.10  Whole mount in situ hybridisation (WMISH) 
The protocol here described follows that typically used in our laboratory, and is 
modified from the protocols of R. Conlon (Mt. S
London) and D W
0.5. For analysis of whole E10.5 embryos a hole was made in the hindbrain using 
rceps to avoid trapping of the probe. Large buffer volumes (minimum of 4-5 
) were used with E10.5 embryos to ensure adequate washing 
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Gene Restriction Endonuclease Polymerase 
Lmnb1 - sense SpeI T7 
Lmnb1 – anti-sense NcoI Sp6 
Grhl3 – anti-sense SalI T7 
 
 
2.1
Al l 
rou
equent 
ashes in PBT (PBS with 0.1% Tween-20). Embryos were bleached in 6% hydrogen 
-
armed to 70˚C prior to use. When the embryos sank to the bottom of the tube, the mix 
Table 2.14 Probes used for whole mount ISH.  
0.1  Day-1: Tissue pre-treatment, pre-hybridisation and hybridisation steps 
l solutions used were DEPC-treated unless stated. Washes were carried out in 10 m
nd bottom tubes, for 10 minutes at room-temperature with shaking.  
 
Prior to use embryos were stored in 100% methanol at -20˚C.Embryos were rehydrated 
by a series of washes in cold 75%, 50%, and 25% methanol:PBT, and two subs
w
peroxide (10 ml in 50 ml PBT from the 30% stock; Sigma,) for 1 hour and washed three 
times in PBT. Embryos were then treated with 10 µg/ml proteinase K (10 µl in 10 ml of 
PBT, from a 10 mg/ml stock solution). Proteinase K permeabilises the tissue by 
partially digesting cellular proteins and treatment time therefore depended on embryo 
size: 1 minute for E8.5; 3-5 minutes for E9.5; 8-10 minutes for E10.5 (E7.5 embryos 
were not treated). The reaction was stopped by adding freshly made 2 mg/ml glycine 
(Fisher Scientific) in PBT. Next, embryos were washed twice in PBT before refixation 
in freshly prepared 0.2% glutaraldehyde (0.4 ml in 50 ml of 4% PFA, from 25% stock; 
Sigma) for 20 minutes, and two washes in PBT.    
 
Embryos were transferred to pre-hybridisation mix (Appendix A, section A.17.1), pre
w
was replaced by 2-5 ml of fresh pre-hybrdisation mix and incubated at 70˚C for 3-5 
hours. 
 
Embryos were transferred to DNase/RNase-free 2 ml tubes with 1 ml pre-hybridisation 
mix. A 10 µl aliquot of DIG-labelled probe was added, gently mixed and incubated at 
70˚C overnight. The single-stranded labelled probe hybridises to the target mRNA. 
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2.10.2  Day-2: Washes, pre-block and antibody binding 
Following hybridization, the embryos were washed at high stringency to remove 
nbound probe. Probe-mix was replaced by pre-warmed solution 1 (Appendix A, 
section A.17.2), and incubated at 70˚C for 15 minutes. Embryos were subsequently 
transferred to 10 ml Falcon tubes and washed twice in solution 1 for 30 minutes at 70˚C, 
followed by two washes for 30 minutes in solution 2 at 65˚C (Appendix A, section 
A.17.2).     
 
Prior to blocking embryos were washed three times for 10 minutes in TBST (Appendix 
A, section A.17.3), at room-temperature. Embryos were pre-blocked with 10% sheep 
serum (Sigma) in TBST for 90 minutes to block non-specific binding sites. At the end 
of this period the blocking solution was replaced by 2 ml of 1% Sheep serum in TBST 
containing 1:2,000 alkaline phosphatase-conjugated anti-digoxigenin antibody (AP-anti-
DIG; Roche), and incubated overnight at 4˚C, with shaking. The AP-conjugated anti-
DIG is an enzyme-conjugated antibody that binds to the DIG-labelled probe thereby 
allowing detection of the bound probe. 
 
2.10.3 Day-3: Post-antibody washes 
To remove unbound antibody embryos were washed three times in TBST for 5 minutes 
followed by six washes, for one hour at room-temperature and overnight at 4˚C. 
    
.10.4  Day-4: Development of signal 
Th f 
10 . Embryos were then incubated in a solution of NTMT containing 4.5 
l/ml nitroblue tetrazolium chloride (NBT, Roche) and 3.5 µl/ml 5-bromo-4-chloro-3-
dolyl-phosphate (BCIP, Roche) in the dark, at room-temperature, with gentle shaking. 
ates a 
 washing twice in 
BT for 10 minutes and then overnight. Sense probe was used for Lmnb1, and colour 
u
2
e TBST was replaced by NTMT (Appendix A, section A.17.4), for three washes o
 minutes each
µ
in
NBT/BCIP is a chromogenic substrate for alkaline phosphatase which gener
coloured precipitate. 
 
Embryos were monitored after 20 minutes and then every 1 hour until the colour had 
developed. When signal had developed, the reaction was stopped by
P
reaction was developed for the same period as for the anti-sense probe, but gave no 
signal. Embryos were stored at 4˚C, in PBT with a small amount of sodium azide 
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(BDH) to prevent fungal growth and photographed (Section 2.12).  Some photos were 
taken with the embryos oriented on agarose plates (made up in 1x PBS).  
 
 
2.11 Sectioning of embryos after whole mount in situ hybridisation (WMISH) 
To visualise the expression pattern in detail for internal tissues embryos were embedded 
and sectioned. Embryos at E7.5-E8.5 were embedded in wax and sectioned on a 
microtome. Embryos at E9.5-E10.5 were embedded in agarose or albumin-gelatin and 
sectioned on a vibrotome. 
 
2.11.1  Microtome sections 
After 2-4 hours or overnight fixation in 4% PFA, embryos were thoroughly washed in 
PBS and then dehydrated through an ethanol series. Each of these steps was for short 
periods, gradually increasing to 30 minutes in 100% ethanol. Embryos were then 
washed twice in HistoClear II (National Diagnostics) for 30 minutes each (15 minutes 
for E8.5 or smaller embryos), with the second wash at 60˚C. Finally embryos were 
transferred to paraffin wax (Thermo Scientific) at 60˚C and incubated with three 
changes of wax and then embedded, by allowing wax to cool. Wax blocks were left 
etting overnight. The next day, wax blocks were removed from the embedding dishes 
o SuperFrost 
lus slides (with a forceps and a paint-brush; VWR) where they were floated on water 
n some cases sections were counter-
tained with eosin (Raymond A Lamb) to enable visualisation of the tissue that does not 
s
by leaving at -20˚C for at least 15 minutes. Blocks were shaped into cubes and attached 
to wooden blocks using melting wax.  
 
Sections were cut on a microtome at 10-12 µm thickness and transferred t
P
on a 40˚C heated-plate. When sections had flattened out, with no remaining wrinkles, 
the water was removed, the slides transferred to metal racks and left overnight to dry, 
wrapped on tissue, on the 40˚C heated plate.  
 
Wax was removed by two 10 minutes washes in histoclear, and slides were mounted 
using DPX mountant for microscopy (BDH) and 1 mm cover-slips were applied 
(Menzel-Glasser, 24x60 mm; Agar Scientific). I
s
show gene expression. First, the wax was removed with Histoclear (2x 10 minutes each) 
and sections were then rehydrated in an ethanol series (75%, 50% and 25% for 1 minute 
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each) and washed in water for 2 minutes. Slides were then incubated in eosin solution 
(ready to use) for approximately 3 minutes and washed in water so that intensity of 
staining could be evaluated under a light microscope. Slides were quickly dehydrated in 
an ethanol series, washed twice in histoclear for 5 minutes and mounted in DPX 
ounting media. 
d 
en embedded in agarose:  1.5-2 % for E9.5 embryos and 2.5% for E10.5 embryos. 
garose was prepared in PBS, cooled for 15 minutes and then poured over the embryos 
tissue was sectioned within a few hours. 
ose, Sigma; aliquots kept at -20˚C). After PBS washes, the 
mbryo was transferred to embedding solution, and left overnight at 4˚C. The following 
bedded tissue (agarose or albumin) were shaped and attached to 
e specimen disc of the vibrotome (Leica VT 1000S, Leica Microsystems) with super 
m
 
 
2.11.2  Vibrotome sections  
Embryos stored in PBT were fixed in 4% PFA for 2-4 hours, washed twice in PBS an
th
A
(in plastic moulds), which were then oriented as the agarose set. Agarose embedded 
 
Alternatively embryos were embedded in a gelatine-albumin solution (45 g albumin 
from chicken egg white, Grade II, Sigma; 0.75 g gelatine from bovine skin made up in 
PBS, Sigma; 30 g sucr
e
day, embryos were embedded in 300 µl of gelatine-albumin to which 30 µl of 
glutaraldehyde was added and carefully oriented. The moulds were left to set for 30 
minutes to 1 hour (longer periods are not recommended since the block and the 
specimen get over-dried). Blocks were excised from the mould, immersed in PBS and 
left at 4˚C for at least 1 hour prior to use.   
 
Blocks containing em
th
glue. The vibrotome chamber filled with 1x PBS, and 50 µm sections were cut. 
  
 Agarose sections were transferred to PBS-filled wells of a 24 well plate, in sequence, 
and then mounted on SuperFrost slides with Mowiol mounting media  which contains 
2.5% 1,4-diazobicyclo-[2.2.2]-octane (DABCO; Sigma), cover-slipped and stored at 
4˚C. Albumin sections were directly transferred to slides and mounted in a 50% 
glycerol (BDH), 50% water solution.   
 110
2.12 Microscopy, image capture and analysis 
Photography of whole embryos was performed on a Leica MZFLIII microscope 
(LEICA) using a Leica DC500 camera. Images were captured by IrfanView or IM50 
ic  Image Analyser (version 1.20) software. In some cases photography was 
erformed using a Stemi SV11 microscope (Zeiss) with a Leica DFC490 camera, and 
im
 
Br  
wi ). 
Flu ), 
wi re 
for
ages were processed using Photoshop (Version 6.0) for cropping and adjustment of 
ed using Adobe Illustrator software.  
B.8), to allow cloning  
to the pEGFP-C1 vector (4.7 kb, Clontech) in frame with an EGFP cassette, which 
rotein (GFP; Fig. 2.13 A).  
 
Le a
p
ages imported into Adobe Photoshop (version 6.0) software.  
ight-field images of sections were captured using an Axiophot 2 microscope (Zeiss)
th a Leica DC500 camera, with import of images into Adobe Photoshop (Version 6
orescence images of sections were obtained using an Axiophot microscope (Zeiss
th a Leica DC500 camera, and images were imported using Leica FireCam softwa
 Mac.  
 
Im
brightness/contrast and figures were prepar
 
 
2.13  Preparation of Lamin B1 fusion constructs 
In order to perform functional analysis of lamin B1 protein variants, constructs were 
generated which encoded full-length (FL) and truncated versions fused to fluorescent 
proteins.   
 
2.13.1 Construct encoding full-length Lamin B1 fused to green fluorescent protein 
(GFP) 
Primers were designed to amplify the full-length Lmnb1 transcript 
(ENSMUST00000025486), with restriction sites for XhoI and KpnI included in the 
forward and reverse primers respectively (Appendix B, Table 
in
encodes green fluorescent p
 
The pEGFP-C1 vector was digested with XhoI (Promega) and KpnI (Promega) 
restriction enzymes using Buffer C (Promega) and purified by extraction with 
phenol/chloroform (Appendix A, section A.16.1).  
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First-strand cDNA synthesis was performed using RNA purified from embryos of the 
ct9E and ct strains and the reverse primer, B1TrsR4, located in the 3’UTR region of 
Lmnb1 (Appendix B, Table B.6). SuperScript First-Strand Synthesis for RT-PCR kit 
(Invitrogen) was used for first strand synthesis, according to manufacturer’s instructions 
sing the protocol for gene specific-primers. The cDNAs were then amplified by PCR 
sing AccuPrime Pfx Super Mix (Invitrogen) which provides high fidelity 
mplification, using the cloning primers which included XhoI and KpnI restriction sites. 
he PCR product was purified (PCR Purification kit, QIAGEN) digested with XhoI and 
pnI (using buffer C, Promega), overnight, at 37°C. Digested PCR products were 
urified by phenol extraction and ethanol precipitation.  
CR products were ligated into the pEGFP-C1 vector using in a 7 µl reaction which 
lso contained 1 µl linearised vector DNA, 1 µl T4 DNA Ligase (Promega), 1 µl T4 
igase buffer to a final volume of 10 µl. The volumes of PCR product and water were 
aried to give a molar ratio of vector DNA and insert DNA (PCR product) of 1:2.5 
ector:product). Ligation reactions were incubated over-night or for 48 hours, at 4°C. 
igated products were transformed into OneShot TOP10 Chemically Competent E. coli 
nvitrogen) and plated onto agar plates containing Kanamycin (50 µg/ml, 1:1000 of 50 
g/ml stock; Sigma), and incubated overnight at 37°C. The following day, 10 different 
clones of each strain were selected: half of each colony was used in a PCR reaction with 
anscript primers to Lmnb1 (B1TrsF2/R2 and B1TrsF3/R3; Table B.6, Appendix B) 
d half was streaked onto a new media plate to grow overnight. After establishing 
hether the selected clones had the respective insert, 5 of each of the streaked colonies 
ere grown overnight in 10 ml LB-Broth containing  10 µl of kanamycin (50 µg/ml). 
 
lasmid DNA was purified from cultures using the QIAprep Spin Miniprep kit 
IAGEN) following the manufacturers’ instructions, and plasmid DNA was eluted in 
 µl of water. Plasmids were digested with XhoI and/or KpnI in order to confirm 
erall size of the construct (vector with insert was 6515 bp), and the size of the insert 
(insert was 1815 bp and the empty vector was 4.7 kb; Fig. 2.13 B). Plasmids were then 
nt for sequencing (DNA Sequencing service at The Wolfson Institute for Biomedical 
Research, UCL) with primers B1 TrsR2, and B1TrsF4 (Appendix 
B, Table B.6). Sequence was analysed using Sequencher software (Gene Codes 
Corporation).  
u
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2.13.2 Cloning of constructs encoding truncated forms of lamin B1 fused to yellow 
fluorescent protein (YFP) 
Primers were designed in the transcript sequence in order to amplify a cDNA encoding 
the last 40 amino acids of the protein (C40, 123 bp including the stop codon, TGA). For 
cloning of this construct, Dr Ashraf Malha id which encoded the 
C40-human LMNB1 fused to YFP protein, tagged with a nuclear localisation signal 
(NLS), sub-cloned into pcDNA 3.1 vector. Plasmid DNA was prepared and the 
construct sequenced (as above) to check restriction sites. In order to clone the mouse 
Lmnb1 C40 sequence, the human LMNB1 sequence was excised by digestion with KpnI 
and XbaI (using buffer C, all reagents from Promega). After electrophoresis of the 
digest on a 1% agarose gel, the higher weight band (corresponding to the pcDNA 3.1 
vector, nuclear localisation signal and yellow fluorescent protein; total size of 6,136 bp) 
was  purified using a QIAquick Gel Extraction kit (Qiagen).   
 
The Lmnb1 C40 primers (Table B.8, Appendix B) were used for PCR amplification of 
cDNA from ct9E and ct strains,  and the products were digested with KpnI and XbaI  and 
purified as in section 2.13.1. The purified PCR products were ligated into the linearised 
vector (as above) and ligated products were transformed into OneShot TOP10 
competent cells and plated into agar plates containing ampicillin.  
 
id DNA was purified by mini-prep (as 
bove) and then digested with KpnI and/or XbaI to verify the insert and vector sizes 
). Plasmids for each strain were sent for sequencing with the forward 
 reverse primer (Table B.9, Appendix 
experiments. 
s kindly sent a plasm
Ten clones of each strain were selected and plasm
a
(Fig. 2.13 C-D
cloning primer (mC40_F2) and the pcDNA3.1
B). Sequence-verified clones were grown up in LB broth (with ampicillin) and plasmid 
DNA was prepared using the Hi Speed Plasmid Maxi kit (Qiagen) which provides 
sufficient DNA for cell transfections. Constructs were sent to Dr Ashraf Malhas 
(University of Oxford) for use in FLIP 
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Figure 2.13 Lamin B1 fusion constructs for functional analysis. (A) Diagram 
 th ding full-length Lamin b1 cloned in-frame with GFP coding 
o sequencing. Green 
arrow indicates empty vector (4.7 kb). (C) Diagram of the construct which 
cated forms in frame with yellow fluorescent 
ino acids of the protein including the polyglutamate tract 
and the C-terminus (CAAX) and a nuclear localisation signal sequence (NLS) for 
import. (D) Gel image e-digest of th resence 
 aster ow arrow ind ty vector with NLS 
 oaded perladder I to give an estimation of the 
zes (indicated by the red arrows).   
of e construct enco
sequence in the pEGFP-C1 vector which expresses green florescent protein 
(GFP). (B) Agarose gel image of double-digest of plasmids with cloning enzymes 
to confirm presence of the insert (1.8 kb, red asterisk) prior t
includes sequence encoding trun
protein (YFP), and sub-cloned into the pcDNA3.1 vector. This construct 
comprised the last 40 am
nuclear  of doubl e plasmids to verify p
of the insert (198 bp, red isk). Yell icates emp
and YFP. Gels were l with Hyp
product si
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2  localisation in Grh enic embryo rse PCR 
This experiment is summarised i  2.14. Inform tion about the enzymes used is 
 Appendix A, section A.16. The whole experiment is described in Chapter 5. 
 
Ge IAamp DNA Mini 
it (Qiagen) according to the manufacturer’s instructions but using half of the volumes 
ince embryo samples were very small. Genomic DNA (1 µg) was digested with RsaI 
, section A.16.1), overnight at 37°C. 
 was diluted in a final volume of 500 µl, also containing 50 µl 
gase buffer, 10 µl T4 DNA ligase (Promega). Reactions were allowed to proceed for 2 
ours at room-temperature. The DNA was then purified by precipitation with 50 µl 3 M 
m e volume with absolute ethanol, followed by 
endix B, Table B.4). PCR 
roducts were run on a 1% agarose gel and all obvious bands were excised from the gel 
d re-amplified by 
CR for subsequent sequencing with each of the inverse primers.  
.14  BAC l3-transg s by inve
n Figure a
in
nomic DNA was extracted from transgenic embryos using the Q
k
s
(Invitrogen) or HaeIII (Fermentas) (Appendix A
Enzymes were inactivated by incubation for 10 minutes at 65°C for RsaI and 20 
minutes at 80°C for HaeIII. For circularisation of DNA fragments a 25 µl aliquot of 
digested genomic DNA
li
h
sodiu  acetate and three times th
centrifugation at 13,000 rpm and the resulting pellet was resuspended in 8 µl of water.  
 
Following purification of the DNA after ligation, the DNA was digested with BamHI 
(Promega) for 2 hours at 37°C, to linearise the circular molecules. The enzyme was 
inactivated at 65°C for 15 minutes. The linearised product (2 µl) was then amplified by 
PCR with BAC inverse primers (PCR conditions as described in section 2.3, using a 
56˚C annealing temperature; primers sequence in App
p
and purified using QIAquick Gel Extraction kit (Qiagen) according to the 
manufacturer’s instructions. DNA was eluted in 15 µl of water, an
P
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Figure 2.14 Summary of inverse PCR experiment performed for BAC 
localisation. 
 
 
2.15 Production of primary mouse embryonic fibroblast cell lines (MEFs) 
Mouse fibroblasts (MEFs) were generated for in vitro studies from E13.5 fetuses (Fig. 
2.15 A) of each of the curly tail strains (ct, +ct, ct9E, ct8E, ct/ctTgGrhl3), and the C57BL/6 
inbred strain.  All materials used were sterilised by autoclaving and spraying with 70% 
ethanol. Fetuses with NTDs were not used for production of MEFs.  
 
Pregnant females were killed by cervical dislocation, and dipped in 70% ethanol prior to 
removal of the uterus. The uterus was rinsed in 70% ethanol and transferred to a fresh 
Petri dish containing 1x Dulbecco’s PBS (Gibco), in a laminar flow hood. Embryos 
were dissected from the uterus, the yolk sacs removed and the embryos transferred to a 
clean dish. All blood-filled internal organs (e.g., liver) were removed and the embryo 
 116
was washed with fresh PBS (removing as much blood as possible). In a new dish, using 
m ount of PBS, embryos were minced as finely as possible using a razor blade. 
The tissue homogenate was then transferred to a 50 ml falcon tube in a solution of 1x 
tr ted in PBS from a 10x stock solution, Gibco) and 
d ere occasionally inverted to mix the contents. 
C an 20 m .  
 
To the cell suspension were added 3 volumes of MEF medium (Appendix A, section 
A o settle to the bottom of e (appr ately 5 
m transferred to a new tube and centrifuged at 
low speed (5 minutes, 1000 rpm). The supernatant was discarded and the cell pellet was 
re-  
tis owing 
ay. The fibroblasts are the only cells that attach to the dish and plates were confluent 
enic line (ct/ctTgGthl3) only, embryos were treated individually, in 5 cm 
etri dishes for all tissue/cell suspension steps, kept in individual 15 ml falcon tubes and 
or the presence of the BAC.  
hen the MEFs were confluent (Fig. 2.15 B), they were passaged or frozen down. To 
d trypsinised (1x, 1.5 – 2 ml per 10 
ed for passaging. 
However, the cell pellet was re-suspended in cold freezing media (10% DMSO in FBS, 
Sigma) instead of MEF media, in a volume equivalent to one embryo per vial. Cell 
suspensions were transferred to cryo-vials (1 ml/vial; Nunc, Thermo Scientific), and 
inimal am
ypsin-EDTA (2 ml/embryo, dilu
igested at 37°C for 15 minutes. Tubes w
are was taken to limit the trypsinisation step to less th inutes
.18). Particulates were allowed t  the tub oxim
inutes) and the supernatant was carefully 
suspended in warm MEF medium and plated out at 1 embryo equivalent per 10 cm
sue culture dish (this is “passage No. 0”). The medium was changed on the foll
d
within 2 to a few days (depending on the strain).  
 
For the transg
P
plated individually in 10 cm Petri dishes. This procedure was taken because embryos of 
the transgenic strain needed to be genotyped f
 
W
passage the cells they were first washed in PBS, an
cm plate) for 5 minutes at 37°C. The trypsin was inactivated by addition of MEF 
medium. Cell clumps were then dissociated into single cells by pipetting up and down 
several times, and the cells were centrifuged at 1000 rpm for 5 minutes. The supernatant 
discarded and the cell pellet was re-suspended in fresh media (3 or 5 times the previous 
volume), plated out and cultured until confluent. 
 
To freeze the cells a similar procedure was performed to that describ
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cooled on ice before storing at -80°C. For long-term storage, cells were transferred to 
liquid nitrogen. 
 
Frozen MEFs were re-p d by quickly awing them in  37°C water
transferred to a Falcon tube with 20 ml rm fresh medi Cells were p eted by 
centrifugation (5 min at 1000 rpm), to rem ve the DMSO ntained in the freezing 
medium, and then re-suspended in fresh me  and plated out at the desired ratio.    
 
 
.15.1 Generation of chromosome spreads of fibroblast nuclei for Fluorescence in 
Th . 
C5 e 
(S rest the cells in metaphase. All centrifugation steps were at 1000 
m for 5 minutes each. 
s 
dded to each plate and left for a minimum of 1 hour at 37°C. To harvest the cells, 
lates were washed twice with Dulbecco’s PBS and incubated with trypsin (1x, 1.5-2 
om the plate. Fresh warm media was added 
7°C for 
5 minutes. A 2 ml aliquot of fixative (3:1 methanol/acetic acid) was added, and mixed 
being stored at -
0°C for at least 1 hour. After this period, cells were again re-suspended in fixative, 
drop-by-drop and centrifuged three further times. After the last centrifugation, cells 
were re-suspended in 100 – 200 µl fixative, dropped onto slides (previously kept 
overnight in 5% acetic acid in ethanol) and dried for 1 hour at 37°C. Slides were 
late th  a -bath and 
wa a. ell
o  co
dium
2
situ hybridisation (FISH) 
is technique was optimised from the method described by Kulnane et al (2002)
7Bl/6 and ct/ctTgGrhl3 MEFs were used at different passage numbers. Demecolcin
igma) was used to ar
rp
 
The culture media (MEF media) was removed and replaced with 10 ml of fresh media 2 
hours before starting the experiment. Demecolcine (1 µg/ml of the 200 µg/ml stock) wa
a
p
ml/plate), for 5 minutes to detach the cells fr
and cells were suspended by pipetting up and down several times, transferred to a falcon 
tube and centrifuged. 
 
Each cell pellet was re-suspended drop-by-drop in warm 0.56% KCL (hypotonic 
solution to eventually cause cell bursting) to a volume of 5 ml and incubated at 3
1
by inverting the tube before centrifugation. The cell pellet was re-suspended drop-by-
drop in fixative up to 5 ml, centrifuged and re-suspended again before 
2
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mounted in Vectashield mounting medium with DAPI (Vector Laboratories) and kept at 
4°C, protected from light (Fig. 2.15 C-D). 
     
 
Figure 2.15 Generation of mouse fibroblasts and metaphase spreads of cell 
nuclei. (A) E13.5 fetus for generation of primary cell lines. (B) Image of cultured 
cells. (C) Image of chromosomes in metaphase (red arrow, at higher 
magnification in D) and an interphase nuclei (orange arrow). Scale bars: A, 1 mm; 
B, 0.5 mm; C-D, 0.05 mm. Images were taken on: A, Leica MZFLIII microscope; 
ted in cold PBS and transferred to cold 100% 
thanol to fix the tissue. An incision was made in the abdominal region to allow better 
B, Time lapse microscope (Zeiss Axiovert 135); C-D Axiophot (Zeiss), under UV 
light for DAPI visualisation.  
 
 
2.16 Alcian blue staining of cartilage 
Fetuses collected at E15.5 were dissec
e
entrance of the fixative. After 48 hours the fetuses were washed in clean 100% ethanol 
for 1 hour with shaking and then incubated in acid staining solution (pH 2.8) composed 
of 14% Alcian Blue in 70% ethanol (1:10), Glacial Acetic Acid (1:5) and 70% ethanol 
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(Filtered). Fetuses were left incubating at room temperature until the temporal bone was 
visible (around five to ten days). Specimens were then incubated in 0.02% KOH to 
remove part of the epidermal tissue for three to five days until the staining was visible 
(solution was freshly made and changed twice a day). Stained samples were then 
“clarified” in a solution made with 1 part Benzyl alcohol, 2 parts Glycerol and 2 parts 
70% ethanol. Embryos were finally fixed in 50%:50% 70% ethanol/Glycerol. This 
experiment was performed with the help of Dr Valentina Massa. 
 
 
2.1
All sta
Embryo
differen plied: Chi-square (χ2) to establish the relationship between two or 
ree of the phenotypic categories according to the observed frequencies; or Z-test, 
wh  
of inte
neurop
 
 
 
7  Statistical analysis  
tistical analysis was performed using SigmaStat software (Jandel Scientific). 
s were scored for neural tube defects, tail flexion defects or no defects. Two 
t tests were ap
th
ich compares the difference in the proportions of individuals with the characteristic 
rest within two groups. For analysis of quantitative data (such as posterior 
ore lengths) experimental groups were compared by t-test or One Way ANOVA.  
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APPENDIX A – Solutions and buffers 
.1 Diethyl pyrocarbonate treated water 
DEPC was used to all solutions that needed to be ribo  such as for 
i ation of the target RNA. One ml DEPC (Sigma) 
was added to 1 L of milli-Q water and vigorously mixed. The following day the water 
w
 
 
A ered saline  
PBS tablets were dissolved in milli-Q water (100 tablets in 1 ) to give a 10x stock 
solution and stirred until the tablets were dissolved. If the PBS was needed for RNAse-
ee experiments, it was treated with 1 ml of DEPC (see above) and autoclaved the next 
da
 
rom the 10x stock, 100 ml were used to make up 1x DEPC-PBS working solution, and 
A ly, 10 PBS-tablets were added to already a r, stirred to 
m r other experiments which did not require RNase-free solutions. 
 
 
A ormaldehyde 
40 g of paraformaldehyde (PFA) was dissolved in 800 ml of DEPC-PBS and 1.5 ml of 
0.5
an opped up 
with extra DEPC-PBS to 1 litre. The solution was cooled on ice, aliquoted and stored in 
vacuum bags at -20˚C.   
 
 
 
 
 
 
A
nuclease (RNase) free,
n situ hybridisation, to prevent degrad
as autoclaved to break down DEPC. 
.2 Phosphate-buff
litre
fr
y.  
F
diluted in 900 ml of DEPC-H2O. 
 
lternative utoclaved milli-Q wate
ake up 1x PBS fo
.3 4% paraf
 M NaOH (made up in DEPC water) was added. The solution was incubated at 55˚C 
d mixed by inversion once in a while. When in solution, the volume was t
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A.4 Proteinase K   
Proteinase K powder (Roche), stored at 4˚C, was dissolved in DE  
mg in 250 ml to a final concentration of 10 mg/ml. The flask was inverted seve , 
and when mixed the solution was aliquoted and stored at -20˚C. 
 
A
All solu Table A.5.1
autoclaved m
 
Solution Volume Final concentration 
PC-treated water (250
ral times
.5 DNA Extraction Buffer  
tions listed in  were mixed and the volume completed with 
illi-Q water. 
1 12.0 ml 100 mM Tris-HCl (pH 8.5)a  M 
0.5 M EDTA (pH 8     5 mM .0) b   1.2 ml  
5 M NaClc   4.8 200 mM  ml 
10% SDSd   2     0.2% .4 ml 
H2O 99  .6 ml 
 
 
 this project different concentrations of agarose gels were needed for different 
raPure standard agarose 
(Inv ro
1 mM E
such as
Table A.5.1 DNA extraction buffer ingredients for a final volume of 120 ml. 
Each solution (a-d) was prepared individually and kept as stock.  
 
A.6 Deoxynucleotide (dNTP) mix for PCR 
 A 10 µM working-mix was made by combining equal volumes of the stock solutions of 
dATP, dTTP, dCTP, dGTP (100 mM each; Promega), and diluted 25 times. Aliquots 
were stored at -20˚C.  
 
 
A.7 Agarose gel electrophoresis 
In
purposes. Routine gels were typically 1% - 2% using Ult
it gen), 1g/100ml dissolved in 1x Tris-Acetate-EDTA (TAE, 40 mM Tris acetate; 
DTA). For genotyping purposes higher concentrations of agarose were required 
 3-5%. For example, for 5% gels, 4 g UltraPure Low Melting Point agarose 
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(LM ; 
1-2 µl e
 
Ora e
buffer (
 
NA molecular weight markers depended on the expected size of DNA bands and were 
re visualised 
nder ultraviolet trans-illumination (UVITEC) which results in the fluorescence of the 
ough a 0.45 µm 
circular filter (Whatmann Cellulose Nitrate Membrane Filters). The remaining reagents 
were added, the volume was completed to 50 ml with water and 1ml aliquots were 
stored at -80°C. 
P Invitrogen) was mixed with 1 g standard agarose and dissolved in 100 ml TAE. 
thidium bromide (10 mg/ml; Sigma) were added. 
ng  G was used as loading buffer: containing 50% glycerol (BDH) and 50% 1x TE 
10 mM Tris EDTA pH 8.0) with Orange G (Sigma) to colour. 
D
Hyperladder I, with bands ranging from 200-10,000 bp (BIOLINE) or Hyperladder V, 
with bands ranging from 25-500 bp (BIOLINE). The bands on the gel we
u
Ethidium Bromide dye (Fluka), which binds double stranded DNA by intercalation 
between the base pairs. The trans-illuminator was fitted with a camera (UVIDOC) for 
photography (High Density Paper; Mitsubishi Electric). 
 
 
A.8 Lysis buffer for protein homogenisation 
30 g urea was dissolved in 15-20 ml DNase, RNase free water (Sigma), by stirring with 
periods at 37°C. When the urea was in solution, 2 g amberlite (Amersham PlusOne 
Amberlite IRN-150) was added, stirred for 10 minutes and filtered thr
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Table A.8.1 Ingre lysis buff in
experiments. Final volume was adjusted to breviation: tabs, tablets. 
 
Prior to use of this buffer, a 2% volume (v/v)  range corresponding to 
IPG strip) or Pharmalyte (2% volume gives 0.8% final concentration, GE Healthcare) 
were added.  
 
F phatase treatm t, the bu
but no phosphatase inhibitors were added.  
 
 
A.9 Protein assay based on Bradford method 
Sam
au H2O. Standard solutions were made up (Table A.9.1). To the 10 µl 
f protein sample/standard, 25 µl of 0.1 N HCl:H2Oa (1:8) was added. Finally, 1 ml of 
orking reagent (diluted 1 + 4 with H2O; Bio-Rad Protein Assay, Bio-Rad) was added, 
. The optic density was 
 Final 
concentration 
dients of the er for prote  homogenisation in 2D 
 50 ml. Ab
of IPG buffer (pH
or phos ent experimen ffer used was the same as in Table A.8.1 
Reagent 
Urea (PlusOne, GE  Healthcare) 30.0 g 9.5M
CHAPS (PlusOne, 1g, GE Healthcare) 1.0 g 2% 
DTT (Dithiothreitol gent, USB Cleland’s Rea ) 0.5g 1% 
Protease inhibitors cocktail tablets, (Com
e) 
plete Mini, 5 tabs 1x 
Roch
Phosphatase inhibitor 1 (Sigma) 0.5 ml 1x 
Phosphatase inhibito igma)  r cocktail 2 (S 0.5 ml 1x 
ples (1 or 2 µl in duplicate) were kept on ice and diluted to a 10 µl volume with 
toclaved milli-Q 
o
w
mixed by inversion and left at room temperature for 10 min
measured at 595 (OD595) on a UV-Spectrophotometer (UV Mini 1240, SHIMADZU) 
and a standard curve plotted to allow protein quantitation in samples. 
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 BSA (µg/ml) µg in assay Vol. 1 mg/ml 
stock (µl) 
Vol. lysis 
buffer (µl) Vol H2O (µl) 
0 0 0 2 8 
1 1 1 2 7 
2 2 2 2 6 
4 2 4 
6 6 6 2 2 
8 2 0 
4 4 
8 8 
 
Table A.9.1 Protein assay. 1 mg/ml B t tein 
was used as standard p . Sta  and samples were 
in duplicates. The lysis buffer was the same as used for protein 
 
A  HCl 
F l (11.6 M, Sigma) were added to 495.7 ml H2O. 
F N HCl were added to 43  H2O to make up HCl:H2O (1:8). 
 
A.
Fo d 
wa (using 0.45 µm 
circular filter, as above). To the urea mixture, 60 mg DTT (0.2%), 600 mg CHAPS 
(2%), and a few grains of bromophenol blue (PlusOne GE Healthcare) were added. The 
volume was then completed with water and 1 ml aliquots were stored at -80°C. 
 
Before using this buffer, 1x Protease Inhibitor (10 µl aliquots stored at -20°C; 100x mix, 
Amersham Biosciences) were added, vortexed and centrifuged briefly. 
 
SA (Albumin s andard from BCA Pro
Assay kit, Pierce) rotein ndards
always prepared 
homogenisation.  
.9.a 0.1 N
or 500 ml, 4.3 ml concentrated HC
rom this, 62.5 ml 0.1 7.5 ml
 
10 Rehydration buffer for IPG strips 
r 30 ml final volume, 19.3 g of urea (8 M) were dissolved in 10-15 ml of purifie
ter. 0.5 g amberlite were added, stirred for 10 minutes and filtered 
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A.11 Acrylamide gels for second dimension: 12.5% gels 
Gel cassettes (for 1.5 mm thick gels) were cl
volume of gel-mix and therefore acrylamide (Acrylogel 2.6, 40% Solution; Electran, 
BDH) depended on which system was to be used. Table A.11.1 summarises the 
volumes of each ingredient of the gel-mix depending on the number of gels to be cast. 
 
nal 
Volume 
la Tris-
HCl
0% 
SDS 
%
PS
TEMED
(µl)
eaned with methanol and air dried. The 
No Fi
Gels 
Acry mide H2O 1 10  
A  
6 600 * 180 149.0 260.0 6 4.50 130.0
10 900 ** 270 223.5 390.0 9 6.75 195.0
1 * 330 273.2 476.7 11 8.25 238.32 1,100 *
 
Figure A.11.1 2D-gel mix volumes for a different number of gels. All volumes 
 ** 14 gel-caster, 
µm circular filter. Tris-HCl (1.5 M, pH 8.8; PlusOne, 
mersham Biosciences) and milli-Q H2O were added to complete the volume. This mix 
The cassettes were then assembled in the casting chamber using a plastic sheet between 
each cassette. Plastic sheets were added to level the casting cassette. Freshly prepared 
10% ammonium persulphate (NH4)2HO8 (APS, MW 228.20; PlusOne, Amersham 
Biosciences), and TEMED (N,N,N’,N’-tetramethylethylenediamine; PlusOne, 
Amersham Biosciences) were added to the mix. The gel mix was stirred and 
immediately poured into the gel caster. 
 
When using the 12/14-gel caster, it was necessary to make up 100 ml of displacing 
solution to fill up the balance chamber: 25 ml glycerol anhydrous (50% v/v; Fluka 
Biochemika), 25 ml 1.5 M Tris-HCl pH 8.8 (0.375 M), 25 ml milli-Q water and a 
are given in ml with exception of TEMED. * Six- and
respectively. 
 
To the acrylamide, amberlite (2 g) was added and stirred for 20 min. The acrylamide 
was filtered through a 0.45 
A
was de-gassed for 1 hour, with stirring. After this period, sodium dodecyl sulphate was 
added (SDS, Sigma), with stirring.   
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sprinkle of bromophenol blue. After pouring the gel mix, the funnel and feed tube were 
gel mix into 
e cassettes. The gels were immediately overlaid with water saturated butanol and left 
to set for a minimum of 2 hours. After polymerisat n, th was 
d he butanol was poured off and the top of the gels were rinsed with milli-Q 
water. The gel cassettes were wrapped between dam ues  the whole stack 
w n  u e same day. 
 
ng buffer for 10-DALT tank: for 1x buffer, 60.5 g Tris (PlusOne), 288.0 
e (Fisher Scientific) and 20.0 g SD d d straight to the tank and 
the volume was made up to 20 L with milli-Q water and left circulating for at 
• Running buffer for 12-DALT tank: 45.4 g Tris, 216.0 g glycine and 15.0 g 
 to a Duran bottle, made up to 1.5 L with water to give a 10x 
ke up 7.5 L of 1x buffer for the 
2-3 hours), 250 ml 1x buffer for washing 
ix, and 3x buffer for the upper chamber. 
mes of n-butanol (BDH) and milli-Q water were added to a Duran bottle, and 
ixed vigorously several times. The top layer was water-saturated n-butanol and the 
wer layer was n-butanol-saturated water.  
.12 Equilibration buffer for second dimension 
ffer. All ingredients were added to 400 
l of water and stirred for 2-3 hours. Once in solution, a few grains of bromophenol 
lue were added. The volume was topped up to 500 ml with milli-Q water and aliquots 
ere stored at -20°C. 
removed and the displacing solution was allowed to run in to displace the 
th
io e gel-casting cassette 
ismantled, t
p tiss , and then
as wrapped in cling-film and stored at 4°C over ight if not sed on th
• Runni
g glycin S were ad e
least 3 hours. 
 
SDS were added
buffer.  For the run itself: it was necessary to ma
lower chamber (left circulating for 
strips after equilibration and agarose m
          
 
A.11.a  Water Saturated n-butanol  
Equal volu
m
lo
 
 
A
Table A.12.1 summarises the recipe for this bu
m
b
w
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 Reagent Final concentration
Urea                                       180 g 6 M
Glycerol anhydrous                           150 g 30% (w/v)
S 0 gDS   1    2%  
1.5 M Tris pH 8.8 16.7 ml 0.05 M
B eromophenol Blu  few grains
Milli-Q H2O To 500 ml
 
Table A.12.1 Recipe for a 50 fe
 
 
A.13 Mix for the agarose sea
F
1 garos e adde  25 ml 1x running buffer, with a few grains of 
bromophenol blue and boiled pr n contains 25 
M Tris-HCl, 192 mM Glycine, 0.1% (w/v) SDS, Bromophenol Blue and 0.5% (w/v) 
ag
 
 
A.
25 in 
(25 r. 
W
0 ml stock solution of equilibration buf r. 
ling solution 
or 6 gels: 
25 mg of a e wer d to
ior to cooling before use. The final solutio
m
arose.  
14  Trypsin for in-gel digestion of protein spots 
0 µl of 0.1 % trifluoroacetic acid (TFA; Sigma-Aldrich) were added to bovine tryps
 µg/tube; Roche sequencing grade), and vortexed to dissolve the trypsin powde
hen in solution, 15 µl aliquots were stored at -20 oC.  
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A.15 Western blot buffers  
 
A m
 
ncen
.15.1 Radio-Im unoprecipitation Assay (RIPA) 
Reagent Final co tration 
1.5 ml Sodium Ch 50 mMloride (5 M stock) 1  
0.5 µl NP-40 (Fluka) 1% 
0.25 g Sodium deoxycholate (Sigma) 0.5% 
0.05 g SDS 0.1 % 
2.5 ml Tris-Cl (1 M, pH 7.4) 50 mM 
500 µl Phosphatase 1 1x 
500 µl Phosphatase 2 1x 
5 tablets protease inhibitors (Complete) 1x 
 
Table A.15.1 RIPA lysis buffer. All reagents were mixed and made up to a final 
l wit i-Q  at -80oC. 
 
A nd In og  
 
Reagent Final concentration 
volume of 50 m  mill  water. Aliquots were stored
.15.2 Bio-Rad a vitr en system transfer buffers 
5.82 g Tris-base 25 mM 
0.375 g SDS 25 mM 
2.939 g Glycine 1 mM 
20% methanol  0.05 mM 
 
Table A.15.2 Transfer buffer for semi-dry system. For the Tris-SDS transfer 
buffer all reagents were dissolved for 1 L final volume with milli-Q water.  
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nReagent Final concentratio
10.2 g Bicine (Fluka) M25 m
31.3 g Bis-Tris (free base) 25 mM
0.75 g EDTA (Sigma) 1 mM
0.025 g Chlorobutanol (Alpha Aesar) 0.05 mM 
 
Table A.15.3 Transfer buffer for wet system. er 
, ume 
ate
nol
To make up 20x NuPage transf
buffer, all regents were dissolved the pH adjusted to 7.2 and the vol
completed to 125 ml with milli-Q w r. 
  
1 Gel – 10% methanol  2 Gels – 20% metha
50 ml 20 x tran  mlsfer buffer 50
100 ml Methanol 200 ml
850 ml Milli-Q water 750 ml
1000 ml Total volume 1000 ml
 
Table A.15.4 NuPage buffer to transfer 1 or 2 gels. From the 20x stock buffer, 
1x buffers were made up with different methanol concentrations to transfer 1 or 2 
gels.    
15.3 Tris-buffered saline (TBS) and TBST for immunoblotting  
 
A.  
o the TBS buffer, 0.1% Tween-20 (Sigma) was added and thoroughly mixed. Blocking 
uffers were made with 5% non-fat dried milk (Marvel) or 5% Albumin from bovine 
erum (BSA; Sigma), depending on the antibody. 
.16 Restriction enzyme digests in general and transcription reactions 
.16.1 Enzyme digest: small/single, double and large scale 
- Small scale digest: 1 µl DNA template (0.2 – 0.5 µg), 2 µl 1x restriction enzyme 
buffer (1/10 of the 10x concentrate), 0.2 µl BSA (1/10; Promega enzymes), 0.5 
µl enzyme (5-10 Units), and the volume was made up to 20 µl with water. 
Digests were incubated for 2 hours at 37oC.  
T
b
s
 
 
A
 
A
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- Double dige and concentrations as above but 0.5 µl (5-10 
ea ated for um of 2 
7oC
e on enzym r, 20 – 50 
tric 00 µl. Di r 2 hours 
 
C  uncu  agaro For other 
a l con e fragme
 
L igests ith w d an equal 
v enol-c e. l; Sigma), 
m ntrifug eous pha ayer) was 
t a cle ding 1/10 volume of 3 M 
s e and cubating  oC for 30 
m  this  minutes at 13,000 rpm to 
p , the hed on of 500 
µ t  the pell ir dried at 
r ee water. 
st: same volumes 
Units) of ch restriction enzyme. Digests were incub  a minim
hours at 3 . 
- Large scal digest: 5 - 10 µg DNA with 1x restricti e buffe
Units res tion enzyme, to a final volume of 50 – 2 gested fo
at 37oC.  
ut DNA and t DNA (for comparison) were run on 1% se gels. 
pplications, ge centration would depend on the size of th nt.  
arge scale d  were purified by making up to 100 µl w ater an
olume of ph hloroform isoamyl alcohol mixture (24:24:1; i. , 100 µ
ixed and ce ed for 2 minutes (13,000 rpm). The aqu se (top l
ransferred to an tube and DNA was precipitated by ad
odium acetat  3 volumes of absolute ethanol and in at -80
inutes. After period, the tubes were centrifuged for 15
ellet the DNA  liquid phase was discarded and the pellet was by additi
l 70% ethanol. Af er 5 minutes centrifugation at 13,000 rpm et was a
oom-temperature and dissolved in 20 µl of RNase/DNase-fr  
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 tion  Enzyme buffer Experiment Restric  10x
enzyme 
AciI NEB3 
BioLab
n assa(New England Grhl3 C-21350T mutatio
s) 
y 
HindIII  E (Pro phism amega) Lmnb1 exon 1 polymor ssay 
EcoRI H (Pro  of inmega) Lmnb1 cloning (direction sert) 
PstI H (Pro rection of inmega) Lmnb1 cloning (di sert) 
HincII React 4  of in (Invitrogen) Lmnb1 cloning (direction sert) 
NcoI D (Pro (linearmega) Lmnb1 anti-sense probe ization) 
SpeI React 4  (linearizati (Invitrogen) Lmnb1 sense probe on) 
XhoI D (Pro cloning on 
construct 
mega) Full-length Lmnb1  fusi
K  pnI J (Promega) Full-length and C-40 Lmnb1 cloning
fusion construct  
XbaI D (Promega) C-40 Lmnb1 cloning fusion construct 
R 4-base cutter – for BAC localisation 
experiment 
saI React 1 (Invitrogen) 
HaeIII R (Fermentas) 4-base cutter – for BAC localisation 
experiment 
BamHI E (Promega) 6-base cutter – for ocalisation BAC l
experiment 
 
.16.1 ffers pplication 
(experiment).   
 
 
.16.2 Transcription of digoxygenin (DIG) labelled probes 
Typically, 1 µg of linear DNA was used for transcription in a reaction mix containing: 2 
µl DIG RNA Labelling Mix (10x concentrated; Roche), 2 µl transcription buffer (10x 
concentrate; Roche), 0.5 µl RNase inhibitor (Roche), 2 µl polymerase and RNase-free 
water to a final volume of 20 µl. This reaction was incubated for 2 hours at 37 oC. A 
sample of the product was then run on a 1% agarose gel. 
Table A  Restriction enzymes, respective bu and a
A
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 Transcripts were purified with DEPC-water BD CHROMA SPIN column BD 
B cco obe ready for 
u b
 
 
A itu hybridisation buffers  
A.
 
R
s (
iosciences) a rding to the manufacturer’s instructions giving 100 µl pr
se for in situ hy ridisation.  
.17 In s
 
17.1 Pre-hybridisation mix 
eagents Volume (ml) Final concentration 
Formamide (Sigma) 25.0 50% 
2 12.5 5x 0x SSC (pH 4.5)a
25 mg/ml RNA from baker’s yeast (S. 
cerevisae; Sigma) 
0.1 50 µg/ml 
10% SDS 5.0 1% 
Heparin (10 mg/ 50 µg/ml ml; FisherBiotech) 0.25 
H2O (DEPC-trea  ted) 7.15 
 
Table A.17.1 Pre-hybridisation mix. (a) 20x SSC, pH 4.5 was prepared by 
s in section A.5.d but with DEPC-treated water. 
dissolving 175.3 g of NaCl and 88.2 g sodium citrate (Sigma) in 800 ml DEPC-
H2O. The pH was adjusted to 4.5 before completion of the volume to 1 L. (b) 20x 
SDS was prepared a
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A.17.2 Post-hybridisation washing solutions 
 
V e Final 
concen
Reagent olume Final Reagent Volum
(ml) concentration (ml) tration 
Formamide 25.0 50% Formamide 25.0 50% 
20x SSC  
(pH 4.5) 
12.5 5x 20x SSC    5.0 
(pH 4.5) 
2x 
10% SDS   5.0 1% 10% SDS   5.0 1% 
H2O   7.5  H2O 15.0  
 
 P ext) and solution 2 
 
 
A fe  
T  ssium chloride (KCl74.55g; 
S  m  milli-Q  to a 
v xi  volu de up 
t ll
 
F o added to 890 ml of water with 
1 (t
 
Table A.17.2 ost-hybridisation solutions. Solution 1 (black t
(blue text). 
.17.3 Tris-Buf red Saline (TBST) for in situ hybridisation
o make up a 1 L of 10x TBS 80 g of 5 M NaCl, 2 g of pota
igma) and 250 l of 1 M Tris-HCl (pH 7.5) were mixed with  water
olume of appro mately 950 ml. The pH was adjusted to 7.0, and the me ma
o 1 litre with mi i-Q water. 
or the TBST w rking solution, 100 ml 10x TBS were 
0 ml Tween-20 o 1%), and 0.48 mg/ml levamisole (Sigma).  
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A.17.4 Sodium ch n (NTMT) buffe
F o 7.3). 
 
Final concentration 
loride/Tris/Magnesium chloride/Twee r  
or 50 ml final v lume the following reagents were added (Table A.1
Reagents  
5 M NaCl, 1 ml 100 mM 
Tris-HCl (of the 1 100 mM  M stock, pH 9.5) 5 ml 
Magnesium chlor M ide (MgCl2, of the 2 M stock) 1.25 ml 50 m
Tween-20 0.05 ml 0.1%  
Levamisole 0.024 g  
Milli-Q H2O  42.7 ml  
 
Table A.17.3 N
 
 
A EF Med
T DME
1 vine s
1 -Glut
1 enici
 
T i d warmed to 37°C before 
u
 
 
 
 
 
 
 
 
 
 
 
TMT buffer.  
.18  M ium 
o a 500 ml M (high glucose, Gibco) were added: 
0% fetal bo erum (FBS; Invitrogen); 
/100 (v/v) L amine (200 mM; Gibco); 
/100 (v/v) P llin-Streptomycin (Gibco). 
he media was m xed and stored at 4°C (stable for 10 days) an
se. 
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A  
 
 
d 
 
PPENDIX B – Primers 
Primer name 
Transcript 
region Primer sequence 
(bp) 
Size an
T˚
Mat2a_3UTRF 
Mat2a_3UTRR 
’ 
 
2403 - 5’- TGTATTCTGGGGTATGGCGT -3
2639 5’- CCAGCCAAGTCAGCTTTCTC -3’
237 bp 
60˚C 
Gart-T1_F3 *  
Gart-T1_R3 
2396-2603 5’- GGGTGATAGGCAGTGTCGTT -3’ 
GAG -3’ 5’- TCCCGGGTGCTATCTAT
208 bp 
60˚C 
Gart-T2_F2 * 
Gart-T2_R2 
937 - 1105 5’- CAAAGATGGCCCAAAAGTGT -
GGTTTT -3’ 
3’ 
5’- GGTTACGGCACTGT
169 bp 
60˚C 
Ube2n_F3 
Ube2n_R3 
2382 - 5’- GAAAGCCAGAGCTG
2622 3’ 
CTCCTA -
ACCTGT -3’ 
 
5’- CAACCTCCACCTCA
241 bp
60˚C 
 
Pri ising fro E 
gio ers and sizes of product-
e g ealing temperature used 
l ferent sets of . 
type-2 , 
0 rotein ad 3 
T00000120450); in-
z 9). 
Table B.1 mers for qRT-PCR of candidate genes ar m 2-D
analysis. Re n of the transcript amplified by the prim
fragments ar iven in base pairs (bp). T° indicates ann
for PCR amp ification. Asterisk (*) indicates two dif  primers
Transcript IDs: S-adenosylmethionine synthase isoform (Mat2a
ENSMUST00 00059472); Trifunctional purine biosynthetic p enosine-
(Gart, ENSMUST00000023684-1 and ENSMUS ubiquit
conjugating en yme E2N gene (Ube2n, ENSMUST0000009932
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 Size anPrimer name Primer sequence d T˚ 
pTARBAC-R   230 bp 
54˚C 327D13-R1 
5’-GTCGACATTTAGGTGACACTA-3’
5’-TCACGTGGTCATCATTAGGG-3’ 
Grhl3_UF10 
Grhl3_UR10 
5’-TTGTATTTTCTTGCTTGAAACG-3’ 
’ 
551 bp 
54˚C 5’- TCAGCGTAAGAAAGCTGTGG-3
 
 Prim . The first pair o s 
 to am pair (in green) w sed 
C -fragments are given in 
). or PCR amplification. 
 
 
nd 
Table B.2 ers for genotyping of transgenic mice f primer
were used plify a region of the BAC. The second ere u
to assay the -21350T polymorphism. Sizes of product
base pairs (bp  T° indicates annealing temperature used f
Primer name Intron Primer sequence 
region 
Size a
T˚ 
Grhl3_Int2-3_F 
Grhl3_Int2-3_R 
2-3 5’- tgcaggctgttagtgtctgg -3’ 
 5’- cacagccctgaaaatgacct -3’
188 bp 
60˚C 
Grhl2_Int1-2_F 
G
1-2 5’- tggcaactggtttgttgtgt -3’ 158 bp 
rhl2_Int1-2_R 5’- ccctgaatcggggtagaaat -3’ 60˚C 
 
 B.3 Primers for genomic genotyping of transgenic mice. Grhl3 intronic 
rimer-pairs used to amplify genomic DNA by qG-PCR for genotyping of single 
nd double transgenic embryos. Grhl2 was used as reference gene (ENSMUST 
0000022895). Sizes of product-fragments are given in base pairs (bp). T° 
dicates annealing temperature used for PCR amplification. 
 
 
 
 
 
 
 
 
Table
p
a
0
in
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Primer name Primer sequence 
pTARBAC-R invers
 inverse 
5’-TAGTGTCACCTAAATGTCGACe 
327D13-R1
-3’ 
5’-CCCTAATGATGACCACGTGA-3’ 
Chr18_F1 (18:3,005,256-3,005,276
0 5,11
Chr18_F23 (18:3,005,050-3,005,07
5 ,621
5,653-3,005,671
(18:3,005 ,776
18:3,005,906-3,005,925
(18:3,005 ,963
(15:74,916,886-74,9169
(15:74,9 7,7
 
T ’ 
3
-
T
) 5’-TATCTTTGGCCACGCAGTG
Chr18_F22 (18:3,0 5,098-3,00 9) 5’-ATAATGTAAGCAGCCCTGG
2) 5’-CTCTCTCTCTCTCTCTTTCT
Chr18_R1 (18:3,00
Chr18_R2 (18:3,00
,603-3,005 ) 5’-TGGCTGGCCTTCATGTGA-
) 5’-GTGCATGTCAGCTATCTTG
Chr18_R3 ,757-3,005 ) 5’-AACACAGAAGGGAGGTGG
Chr18_R4 ( ) 5’-AGAAACCACCATGCAGCTC
Chr18_R5 
Chr15_F15
,944-3,005 ) 5’-ATATACCTGCATGCCAGGA
06) 5’-TGGTTGTGGTGGCAGAGGG
Chr15_R15 17,756-74,91 76) 5’-CAATTGTGGATGGTAGTTC
GT-3’ 
CCG-3’
AA-3
’ 
3’ 
G-3’ 
T-3’ 
G-3’ 
A-3’ 
A-3’ 
 
.4 Primer nci s
nes in Table B.1 wer o C 
localisation in transgenic embryos. Primers designed against chromosomes 18 and 
˚
 
 
 
 
 
Table B s for seque ng for localisation of the BAC. Primer  inverse 
to the o e used to sequence genomic DNA f r BA
15 were designed in an attempt to genotype transgenic embryos. Forward primers 
are indicated in grey and reverse primers in green. These primers were used at 
58 C annealing temperature for 35 cycles. The genomic region within each 
chromosome where the primer was designed is given in brackets.  
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Primer name Primer sequence Size and T˚ 
LmnB1_F1ex1 
LmnB1_R1in1 
5 GGAAACAAAGT-3’ 
5’-CTGCGCACCTTATCGATGTA-3’ 
411 bp   
55˚C 
’-AGCCCGAGA
LmnB1_F1in2 
LmnB1_R1ex2 
5’-GGCCTGTGGTTTGTACCTTC-3’ 
5’-GGCACCCCTGTTCAGTTCTA-3’ 
568 bp 
55˚C  
Lmnb1_F1up 5’-CGCTCCCGTTTACTTTTGAA-3’ 551 bp 
Lmnb1_R1up 5’-GTACACGCACACTCGCAGAC-3’ 55˚C  
LmnB1_F2 
LmnB1_R2 
5’-CATGTGATGTGGGGAATGTC-3’ 
5’-ATGGTGGCTCACAACCATCT-3’ 
482 bp 
52˚C 
LmnB1_F3 
LmnB1_R3 
5’-AACGGCCCCAAAGTTAAAAT-3’ 
5’-GACCAGCCTAGGCAACAGAG-3’ 
352 bp 
60˚C 
LmnB1_F4* 
LmnB1_R4* 
5’-GACAGGCACAGAGGTTGGTC-3’ 
5’-ATGCATGCAGACAAAACACC-3’ 
396 bp 
60/55˚C 
LmnB1_F5 
LmnB1_R5 
5’-AGCGTGCTTTCCTGTTTCAT-3’ 
5’-TGTCTCATCTGGGACAAAAGA-3’ 
367 bp 
60˚C 
LmnB1_F6 
LmnB1_R6 
5’-AAGAGCTAGAGCTCCTTTAGGG-3’ 454 pb 
5’-AGAGCAGTCCTAAAATAATGGAGA-3’ 60˚C 
LmnB1_F7 
nB1_R7 
5’-ACATGGTGAGGGACCTCTTG-3’ 409 bp 
Lm 5’-GCATCCAGAAGACGGATAGC-3’ 60˚C 
Lm
LmnB1_R8 
nB GGGTCAT T
5’-GCCTCCCTCTTCTGGAGTGT-3’ 
p 
60˚C 
1_F8 5’-TCTG GGAT TGAT-3’ 301 b
LmnB1_F9 
LmnB
AGAGTC
TGGTGTGTC TTTT ’ 1_R9 5
5’-AAGCAGCTGGAC
’-TG
GT-3’ 
CTC-3CG
370 bp 
60˚C 
LmnB
LmnB
CGAAGGTCTA AACTGCTGCT-3’ 
5’-GAAACGGTAAAGGGCTACCA-3’ 
400 bp 
60˚C 
1_F10 5’-T
1_R10 
CT
LmnB
LmnB
GTGAGCT CTCATTT-3’ 
ACACGCAG TTTTCTT-3’ 
511 bp 
60˚C 
1_F11_p1 5’-AGGT
1_R11_p1 5’
GG
-GG TGG
LmnB
LmnB
CTCAAGTTT GGCATTT-3’ 
TAAAAGGGCC C-3’ 
621 bp  
55˚C 
1_F11_p2 5’-CC
1_R11_p2 5’-T
TT
AGTCACCT
 
Table B.5 Primers used for sequencing of Lmnb1 genomic DNA. All primers 
are flanking coding regions of the re ctive exons. Sizes of product-fragments 
are ). T° ind es annealing temperature used for PCR 
amp
 
 
 
 
 
 
 
 
spe
given in base pairs (bp icat
lification. 
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Prime
name 
ript 
Primer seq ce 
Size 
and T˚ 
r Transc
region (bp) 
uen
B1Trs
rs
5’-GGCCT GGTTTGTACCTTC-3’ 
5’-TCAGATCCTCC TCC
538 bp   F1  265 - 
B1T R1 802 
GT
AAGTC CT-3’ 55˚C 
B1TrsF2  
rs
726 - 5’-ACTAAACTCTAAGGATGC
5’-AGCAT CCTC TCCT 60˚C B1T R2  1286 
GGC-3’ 561 bp 
GT CAAT G-3’ 
B1Trs
B1Trs
5’-ACAAG AGA AGC
5’-TGCTT TGAGCAACC-3
 F3   1082 – 
R3 1934 
 GA GCTGG AG-3’ 
’ 
852 bp
60˚C CTC
B1Trs
rs
C CGCCTACAGGAAG-3’ 
5’-AGCTTGAGGAAGATCGAC
680 bp F4  1421 –  5’-AGAT
B1T R4  2081 
AG
CA-3’ 55˚C 
B1TrsF5  
Trs
1917 –  5’-GGTTGCTCAGAGAAGCA-3
5’-CACCC CTAGGGAGGCA
535 bp 
B1 R5  1451 
’ 
AT A-3’ 60˚C 
 
ab used for sequenc  of L sc  of primers: 
1, include regions of exons 1 and 2; 2, exons 2-6; 3, exons 4-10; 4, 6-11; and 5, 
10-11. Sizes of product-fragments are given in bp. T° indicates annealing 
p or PCR amplificatio
 
 
Prime er sequence 
T le B.6 Primers ing mnb1 tran ript. Pairs
tem erature used f n. 
r name Prim Size and T˚ 
RT_B
RT_B
AGGAATTGGAG CATGCT -3’ 
CTTGGAGAGAGCTT -3’ 
221 bp 
60˚C 
1_F2 5’- C
1_R2 5’- GAAGG
GA
G
Gapdh
Gapdh
CAAGA GTG  
- CATACCAGGAAATGAGCTTG-3’ 
_F 5’
-R 5’
- ATGACAT AG GTG-3’ 177 bp 
60˚C 
 
Tab sed for qRT- R of and Gapdh. Lmnb1 and 
Gap signed to cross ons 6  boundaries
 
le B.7 Primers u PC Lmnb1  
dh primers were de  ex -7 . 
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 Prime rimer sequence T˚ r name P
FL_L GAGTGTGGTTT TTCmn_F 5’-CTAGCTC GTACC GGTC-3’ 
FL_L CAT CTTG CAAGTT AC-3’ 
56˚C 
mn_R1  5’-CTGAGGTAC GT A C
mC40 C CAT GG_F2 5’-GCACCCGGTAC AC ACCCGA AG-3’ 
mC40
CA TTCACATAATGGCACAGCT-
3’  
60˚C 
_R 
5’-CTAGTCTAGA AG
 
ab mers for production o n
for and ouse C40 (mC40) constructs. Random 
qu e. Red sequence d tes X en in  blue 
indi sites. The random sequences will be excised upon 
restr
 
 
Primer name Primer sequence T˚ 
T le B.8 Lmnb1 pri f fusion-co structs. Primers were 
cloning of full-length (FL)  m
se ence is in purpl eno hoI, gre dicates KpnI and
cates XbaI restriction 
iction digest. 
Sp6 5’-TATTTAGGTGACACTATTAG-3’ ˚C 55 - 60
T7 5’-TAATACGACTCA TATAGGG-3’ C 55 - 60˚C 
R_pcD ACAG GAG 60˚C NA3.1 5’-TAGAAGGC TC G-3’ 
 
Table B.9 Vector primers. Sp6 and T7 prim
reverse prime
cD .  
 
 
 
 
 
 
 
 
 
ers were used when cloning with 
pGEM-TEasy vector and the R_pcDNA3.1 r was used with the 
p NA3.1 vector
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Primer name Primer sequence 
Size and 
T˚ 
D
D18Mit36_R 
CATGAATCCATCCA -3’ 
5’- TTCTTCCATGCTGTATACAAGGC -3’ 
147 bp   
58/60˚C 
18Mit36_L 5’- CTTGTATC
D18M
Mit44_R 
GTTGCAGAACGG  
5’- AACTGCCCATTACTTCAATAGAGG -3’ 58/60˚C 
it44_L 5’-AGGA
D18
AGAA -3’ 145 bp 
D18M
D18Mit50_R 
- TCCCTAAATCACTCTT CATT
5’-AACTCGGGGACTTTGACATG-3’ 
it50_L 5’ TC G -3’ 156 bp 
58˚C 
D18M
D18M
ACATGCCTGACCTCCC -3’ 
GAGCCAATTCCC AA-3’ 
 
58/60˚C 
it56_L 5’- TG
AC
251 bp
it56_R 5’-AAGA
D18M
8M
AAGGAACTTGATTAT TTCACA -3’ 
TCATCCACAGATAG CAA
184 bp it58_L 5’-G
D1 it58_R 5’-GA
TG
TC GC-3’ 58˚C 
D18M
D18M
CATAAAGTTAGGCTTCCA-3’ 
TACTTTTT GTAGC-3’ 
148 bp 
58/60˚C 
it81_L 5’-TCTCAT
it81_R 5’-GGTCAGCA GTT
D18M
D18M
CCTATGCCTACAGT CTGG-3’ 
CAAAACAAACAACACGCAC-3’ 
113 bp 
58˚C 
it103_L 5’-GG
it103_R 5’-C
AA
D18M
D18M
AATGTTGGCAGATTTTAAATG-3’ 
AGTAGATTTAGT TCTGGCACC-3’ 
94 pb 
58˚C 
it141_L 5’-CTAA
it141_R 5’-ATAC TC
D18M
D18M
TGGCTTCT G-3’ 
-GGCTTGCCATGACACATATG-3’ 
276 bp 
58˚C 
it158_L 5’-TCTGACAC GTG
it158_R 5’
D18M
D18M
ATCCTTC 3’ it172_L 5’-TGGGGTCCT
it172_R 5’-AGTGATACTTACTTTATCACACATGCG-3’ 
TGC- 106 bp 
58˚C 
D18M
D18M
’-CTGGCTCTGTGTGGGC 3’ 
’-TAATAAAAAGAAAAA ACACA-3 C 
it180_L 5 TT-
’ 
109 bp 
58/60˚it180_R 5 GAAAACC
D18Mit185_L 
D18Mit185_R 
5’-ACAATAAATGGTTGGGAATATAACG-3’ 
5’-CTGACTGACGGAAGTGCAAA-3’ 
79 bp 
58/60˚C 
D
D
18Mit194_L 
18Mit194_R 
5’- CCACCACATAAGGGAGGAAA -3’ 
5’- GTTTGTTGTTGTTCTATTTTCAAACA -3’ 
125 bp   
58/60˚C 
D
D18Mit209_R 
CAACCAAGATTAACTCTAGC -3’ 
5’- AGACCACCTTTGTAAATGTCTGTG -3’ 
125 bp 
58˚C 
18Mit209_L 5’- AAGTTGA
D18Mit237_L 
D18Mit237_R 
5’- CTGAACACTTATTATATAACCCCTGTG -3’ 
5’- ACAGTGTCCCTGAGGAGGC -3’ 
87 bp 
58/60˚C 
237746_L 5’-CATGGAACGCTTAAAGCACA-3’ ~ 300 bp 
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23774 TCTCAGATGTTC 3’6_R 5’-GGGC TTGC-  60˚C 
AV259382_L 
5
5’-GATTTTTACATGTTTCTTTTTGAGGA -3’ 
AAGCACATGAATGAGCAA
97 bp 
AV2 9382_R 5’-GAA -3’ 60˚C 
BB38
B38
GGTTTTGACAATGAGTTG-3’ 
-TGCACATTAGCTGGTC AA-3’ 
97 bp 
60˚C 
4708_L 5’-CG
B 4708_R 5’ AC
D18M
18M
-CTGGAAATAAAACCTG CA-3’ 
GAGT AGACC-3’ 
125 bp 
60˚C 
it25_L 5’ GG
D it25_R 5’-TTTAGCCTAACT TCC
RH12
H12
TTGGT GATAAGGC-3’ 
TTCAAGACATT TTAAAAAT-3’ 
203 pb 
60˚C 
6430_L 5’-CTAGAAAAATA TA
R 6430_R 5’-GTAGC CT
RH13 6_L 
3
5’-TTGAAATCAGGGAATGGTTCTG-3’ 
GTGGAACCTGTG
175-200 bp 081
60˚C RH1 0816_R 5’-CTAGCAGCT T-3’ 
RH13
RH136284_R 
TATTGCCTCCCAA A-3’ 
5’-CTTGAGATCTGCCTGCCTTC-3’ 
p 6284_L 5’-ATT ACC 175-200 b
60˚C 
Ttr_L 
Ttr_R 
CACAGATGAGAAG-3’ 
-3’ 
5’-CTCAC < 175 bp 
60˚C 5’-GGCTGAGTCTCTCAATTC
22471
224716_R 
GTGGACTTG A-3
5’-AGAAGCAGAAGGGCAAACAA-3’ 60˚C 
6_L 5’-TGGCCAT TAG ’ ~ 200 bp 
2
2
37730_L 
37730_R 
5’- CGCAAAGACTAAAAGAACCTGC -3’ 
5’- CATCAGAAGTCTGTGGAGCG -3’ 
200-250 bp  
60˚C 
D
D18Mit171_R 5’- AGGAAAGCAAGGGGAAGAAA-3’ 
110 bp 
60˚C 
18Mit171_L 5’- AATTAGAACAACCCTATTTATCCTGC -3’ 
D18Mit21_L 
D18Mit21_R 
5’-GCCCAGTCAAGGCATTTTAA-3’ 
5’-CCATCCAGGAACTCTTTGGA-3’ 
131 bp 
60˚C 
D18Mit66_L 
D18Mit66_R 
5’-AAACAAAACCAGAACAATAGAGCA -3’ 
5’-TAAGTTCCTCTCATTTTCTGACCC-3’ 
160 bp 
60˚C 
D18Mit82_L 
D18Mit82_R 
5’-AGTAGTTCTTGGAGGTCTGAAATAGG-3’ 
5’-CATGACACACATGCATTCACA-3’ 
135 bp 
60˚C 
D18Mit88_L 
D18Mit88_R 
5’-TCTTCTGGCCTCCACATACC-3’ 
5’-GCAATGCTGCTTTAATTGCA-3’ 
140 bp 
60˚C 
D18Mit146_L 
D18Mit146_R 
5’-ATGTCCCTCTGCTCTTTAGTTACC-3’ 
5’-GGACCACAGAGTCATTCCGT-3’ 
144 pb 
60˚C 
D18Mit167_L 
D18Mit167_R 
5’-AATGTAACCATGGAAACCAAGC-3’ 
5’-AGGTGTTCACACATTACTTCAACTT-3’ 
102 bp 
60˚C 
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D18Mit196_L 5’-GGGCT
D18Mit196_R 
ACATGATAACCTCTCTCA-3’ 
5’-AAATTCAGAACAGTACAGATGACCC-3’ 
117 bp 
60˚C 
D18Mit213_L 5’-ATGTTATCCTCTGGCTCCATATG-3’ 125 bp 
D18Mit213_R 5’-ATCCAGTTTCTTTTAAAATTATTTCCC-3’ 60˚C 
D18Mit215_L 
D18Mit215_R 
5’-TCACATTCTGCATTACTTTGTATAGA-3’ 
5’-TCACACTGTGTCATGCATGTG-3’ 
189 bp 
60˚C 
D18Mit219_L 
D18Mit219_R 
5’- TGTAAGACAATGTTTAACAATCATTCA-3’ 
5’- AAAAACATACATATTCATGCT
164 bp   
ACACAT -3’ 60˚C 
D18Mit221_L 5’- TCAGAGGACCCAGTGCTTTT -3’ 123 bp 
D18Mit221_R 5’- TCTTGTGTATGAATGCCTTTGC -3’  60˚C 
D18Mit231_L 5’- TCTCTGATCTGCACACACACC -3’ 119 bp 
D18Mit231_R 5’- GGCACTGCTTAAAAACTTAGAAGC-3’ 60˚C 
D18Mit3_L 
D18Mit3_R 
5’-TTCCCTATCCAGTTGTGTGC-3’ 
5’-AGCAGAGAATGCACCACCTC-3’ 
104 bp 
60˚C 
D18Mit8_L 5’-TTTGGAATCTGGCA
D18Mit8_R 
TGTTAC -3’ 
5’-GTCTGAAATGAAGTGCCTGC-3’ 
77 bp 
60˚C 
D
D AACCC-3’ 
100 bp 
60˚C 
18Mit47_L 5’-CTTCTTCTTCCCAACCAGACC-3’ 
18Mit47_R 5’-CTAGCACATTTTTATAAGC
D
D
CCCCCTACTTCC-3’ 141 bp 
60˚C 
18Mit84_L 5’-ATCACAAC
18Mit84_R 5’-TCACGTGTTCTGTCTCCAGTG-3’ 
D18Mit108_L 
D
5’-AGACAGAAGTGGGCTGGAGA-3’ 122 pb 
18Mit108_R 5’-CAGTGTTGATAATTGAATCAAGGC-3’ 60˚C 
D
D
 bp 
C 
18Mit118_L 5’-ACAGTGAGTTCCACTACAAGATGC-3’ 188
18Mit118_R 5’-TATGATGCGCTCTGCAGG-3’ 60˚
D
D
 bp 
C 
18Mit148_L 5’-GTGTTTATGGGGTAGAAGAACTGC-3’ 117
18Mit148_R 5’-TCTGTGGGCATCTGAACTCA-3’ 60˚
D
D
 bp 
C 
18Mit200_L 5’-TTTAATTGTGTGAATGTTTGAGCA-3’ 120
18Mit200_R 5’-AATTCCATGGGCATGTCACT-3’ 60˚
D
D
 bp 18Mit210_L 5’-TGGGCAGAAGTATAACTAAATCCA-3’ 119
18Mit210_R 5’-TTCAAACCGTATGCCTTTCC-3’ 60˚C 
D
D
18Mit227_L 5’- GCAAGCCCATCAGCATACTT-3’ 12
18Mit227_R 5’- TAGTGAACTCAAATGGGGGC -3’ 60˚C 
2 bp   
R bp H1 5196_L 5’- CTGGTGGAATCGTGAGC -3’ 279 2
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R C H125196_R 5’- ACACTGTGGCGGTAACAATC -3’ 60˚
2
2
bp 60951_L 5’- GATGAGCTTGGGTTCCGAGTAG -3’  < 200 
60951_R 5’- CCACGCAAGGACTCACAGAG-3’ 60˚C 
A
A
A763521_L 5’-TATGTAAGAACGCCAGCCAC-3’ 92
A763521_R 5’-GGATTAGGGCAGAATTTCCA-3’ 60˚C 
 bp 
A
A
-200 bp 
C 
W120568_L 5’-TGCTCTGACGTCCCTTTGTA -3’ 175
W120568_R 5’-TTGTCTAAAGGCAGCAGTGG-3’ 60˚
G
G
 bp 
C 
67025_L 5’-CTTTCCCTGCCATGACCTTA-3’ 469
67025_R 5’-CTACCGTTGAATTGGCAGGT-3’ 60˚
D
D
 bp 
C 
18Abb2e_L 5’-CAGGTGAAGGAAGGAACCAA-3’ 170
18Abb2e_R 5’-TTCCTAGACAGTGAGACAGG-3’ 65˚
D
D
00 bp 
C 
18Dev1_L 5’-CTGCTATTCCATTCAGTAGCTG-3’ ~ 3
18Dev1_R 5’-CACCCAAATAACTCAGTGAG-3’ 60˚
D
D
 bp 
˚C 
18Mit186_L 5’-AAGTGTTGGGCAAAGGCTAA-3’ 125
18Mit186_R 5’-CTTTAGTATAGTGTGCATGAGTGTGA-3’ 60
D18W 70e_L 5’-TGTGGTACAGTCAATGTGT-3’ 250-300 bp su
D18Wsu70e_R 5’-TCTGTGGGCATCTGAACTCA-3’ 60˚C 
 
Table B.10 Chromosome 18 microsatellite markers. 57 markers were used to 
c ll PCR products were run on 4-5% agarose 
 
 
 
compare the SWR and + /+ strains. Act
gels. 
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Primer name 
Transcript 
region (bp) 
Primer sequence 
Size and 
T˚ 
Matr3_F1  
Matr3_R1 
518 - 689 5’- TGTCTTCTCAACACCGTGGA -3’ 
5’- GGGCCTTCTTCAGTTCTCCT -3’ 
172 bp   
60˚C 
Isoc1_F Isoc1_R  418 - 646 5’-TGT GGACAGAGACTGTTGC-3’ 
5’- CACGTGCGTTTCTACTCCAA -3’ 
229 bp 
60˚C 
G
A730017C20Rik_F 
A730017C20Rik_R 
247 – 451 5’- CTGAGAGTCCTCCAGCATCC-3’ 
5’- TAC TATCCCCCAACCAAAA-3’ 
205 bp 
60˚C G
Tcof1_F1 
Tcof1_R1 
747 – 977 5’-GATCCTCCAGCAAGAACAGC-3’ 
5’- TCTGACATGGGGACCTTTTC -3’ 
231 bp 
60˚C 
Grpel2_F 
Grpel2_R 
482 – 706 5’-ACCAAGCATGGCCTAGAGAA-3’ 
5’- GGTTTGGTTCCAGTGACCTG -3’ 
225 bp 
60˚C 
Apcdd1_F 
Apcdd1_R 
983 - 1177 CCCACCACAG-3’ 
5’- TAT GGAGGGTGGTGTTCAT-3’ 
195 bp 
60˚C 
5’-AAGCAGTATC
G
Tubb6_F 
Tu
413 - 651 5’- TGAGCATTGCGACTGTCTTC -3’ 239 bp 
bb6_R 5’-TGTCGATGCAGTAGGTCTCG -3’ 60˚C 
 
Table B.11 Pr me 18. Gene: 
Matrin 3 (Matr3, ENSMUSG00000037236), Isochorismatase domain containing 
1 (Isoc1, ENSMUSG00000024601), RIKEN cDNA A730017C20 gene 
(A730017C20Rik, ENSMUSG00000050875), Treacher Collins Franceschetti 
syndrome 1, homolog (Tcof1, ENSMUSG00000024613), GrpE-like 2, 
mitochondrial (Grpel2, ENSMUSG00000024580), Adenomatosis polyposis coli 
down-regulated 1 (Apcdd1, ENSMUSG00000071847), Tubulin, beta 6 (Tubb6, 
ENSMUSG00000001473). 
 
 
 
 
 
 
 
imers for qRT-PCR of selected genes on chromoso
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APPENDIX C – Identified peptides for protein spots analysed by mass 
spectrometry 
. Peptides with a score lower than 5 
re also annotated for proteins which already had one or more scores of significance. 
 
 
Differentially abundant proteins on 2-DE, with a fold-change in abundance of 1.5 fold 
or greater were considered for analysis by mass spectrometry. Protein identity (ID) was 
obtained by matching of LC-MS/MS data on peptides using the MASCOT search 
engine. Peptides in bold represent those with a MASCOT score of 35 or greater which 
is considered significant for identification purposes
a
Abbreviations: Progenesis SameSpots number (PSS No); Mascot score; Accession 
number (No). 
 
PS
S 
No 
Matched peptides  Score Accession 
No 
Protein ID 
7 ASAPATPLSPTR 
LAVYIDKVR 
ALYETELADAR 
RALDDTAR 
FKAEHDQLLLNYAK 
AEHDQLLLNYAK 
ESDLSGAQIK 
DAALATALGDKK 
CQSLTEDLEFR  
KNMYEEEINETR 
LVEVDSGR 
LAQALHEMR 
47 
54 
59 
61 
39 
36 
46 
79 
68 
33 
44 
P14733 Lamin B1 
LYKEELEQTYHAK 
LSSEMNTSTVNSAR 
35 
47 
73 
IESLSSQLSNLQK  
NTSEQDQPMGGWEMIR 
KIGDTSVSYK 
NQNSWGTGEDVK 
NSQGEEVAQR 
AKLQIELGK 
75 
24 
54 
54 
40 
54 
8 KESDLSGAQIK 
LVEVDSGR 
LSSEMNTSTVNSAR 
KIGDTSVSYK 
IGDTSVSYK 
NSQGEEVAQR 
67 
40 
55 
49 
49 
41 
 P14733 Lamin B1 
20 SLETENSALQLQVTER 
ALYETELADAR 
IESLSSQLSNLQK 
68 
35 
77 
P14733 Lamin B1 
36 ALYETELADAR 68 P14733 Lamin B1 
RALDDTAR 
DAALATALGDKK 
LSSEMNTSTVNSAR 
32 
76 
29 
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LVEVDSGR 
LAQALHEMR 
LSSEMNTSTVNSAR 
39 
54 
45 
KIGDTSVSYK 
NSQGEEVAQR 
58 
63 
41 * LAQSPQVK 
ILSGPFVR 
 
29 
29 
 
Q64737 Trifunctional purine 
biosynthetic protein 
adenosine-3 * 
42 ALELEQER 
APDFVFYAPR 
40 
11 
P26041 Moesin 
47 LAQSPQVK  
AVQEIMQEK 
FGDPECQVILPLLK 
CFGPTAQAAQLE SSKK 
AFTNPEDACSFITSANFPALVVK 
31 
17 
67 
13 
15 
Q64737 Trifunctional purine 
biosynthetic protein 
adenosine-3  
52 
** 
ALGGEDVR 
 
28  P29699 ** Alpha-2-HS-
glycoprotein precursor 
** 
59 
 
EILFYDR 
GAEQLAEGGR 
TLLTQENPFFR 
DGQWFADWHEVPQGR 
34 
40 
36 
28 
Q1HFZ0 
 
tRNA (cytosine-5-)-
methyltransferase 
NSUN2 
60 SAECPGPAQK 
FMETATESLAK 
IISVTCSFFNSQAPTPR 
SEGSSCALESPGSVPVGICHGSLG
EPQGNQGK 
6 
15 
37 
 
11 
Q9QXC1  Fetuin-B 
61 QSPDEPLR 
FTEYETQVK  
TSDLIVLGLPWK 
FGGNPGGFGNQGGFGNSR 
35 
26 
34 
61 
Q921F2 
 
TAR DNA-binding 
protein 43 
63 EILFYDR 
GAEQLAEGGR 
FYALDPSFPR 
TLLTQENPFFR 
LFEHYYQELK 
DGQWFADWHEVPQGR 
LAQEGIYTLYPFINSR  
LSSPCIMVVNHDASSIPR 
42 
23 
31 
30 
28 
23 
14 
 methyltransferase 
NSUN2 
19 Q1HFZ0 tRNA (cytosine-5-)-
71 AIGVKPPR 
KGDIFLVR 
ESIESEIR 
DVDLEFLAK 
LAGESESNLR  
GILLYGPPGTGK 
LAGESESNLRK 
WALSQSNPSALR 
LDQLIYIPLPDEK 
IVSQLLTLMDGLKQR  
VRLGDVISIQPCPDVK 
NAPAIIFIDELDAIAPK 
QAAPCVLFFDELDSIAK 
QAAPCVLFFDELDSIAKAR 
LIVDEAINEDNSVVSLSQPK 
ELQELVQYPVEHPDKFLK 
ETVVEVPQVTWEDIGGLEDVK
R 
KAFEEAEKNAPAIIFIDELDAIAP
K 
48 
21 
27 
56 
73 
83 
59 
31 
142 
32 
98 
19 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
48 
65 
33 
24 
71 
39 
25 
72 
Q01853 
 
 
 
 
 
 
 
Transitional 
endoplasmatic 
reticulum ATPase  
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AFEEAEKN
KR 
APAIIFIDELDAIAP
MDELQLFR 
GGNIGDGGGAADR  
QAAPCVLFFDELDSIAK 
NAPAIIFIDELDAI
EVDIGIPDATGRLE
APKR 
ILQIHTK 
ETVVEVPQVTWEDIGGLEDVK
R  
LADDVDLEQVANETHGHVGA
DLAALCSEAALQAIR 
 
VSLAVLNPYIK 
LVRPPVQVYGIEGR 
 
59 
12 
 
Q9DB20 
 
ATP synthase subunit 
O 
25 
48 
39 
25 
 
42 
 
 
 
 
 
 
 
 
 
 
 
140   
72 HVGDLGNVTAGK 
DGVANVSIEDR   
VISLSGEHSIIGR  
AVCVLKGDGPVQGTIHFEQK  
22 
30 
86 
8 
P08228 Superoxide dismutase 
75 LSQETEALGR 
DLELLIQTATR  
Y
59 
34 
Q02819 Nucleobindin-1 
LQEVINVLETDGHFR 11 
76 AAIDYQK 
TGMILLAGEITSR 
TQVTVQYMQDR 
DLDLKKPIYQR 
FVIGGPQGDAGLTGR 
 
 
 
HLQLAIR 
VTIAQGGVLPNIQAVLL
 
PK 
VALTGLTVAEYFR 
SLQD 
IIAILGMDELSEEDKLTVSR  
22 
36 
87 
 
36 
45 
Q3THS6 
 
Q8CGP5 
 
 
Q3U774 
S-adenosylmethionine 
synthase isoform type-
ATP synthase subunit 
beta 
6 
22 
63 
 
 
 
16 
 
 
 
 
 
 
 
2  
 
 
 
Histone H2A  
 
81 GSPLVVISQGK 
IVLEDGTLHVTEGSGR 
27 
64 
O08553 
 
Dihydropyrimidinase-
related protein 2 
86 VAVSADPNVPNVIVTR 
LTLVCSTAPGPLELDLTGDLESF 
KK 
55 
13 
Q99PT1  Rho GDP-dissociation 
inhibitor-1 
88 DYDDMSPR  
NLPLPPPPPPR  
IDEPLEGSEDR  
IILDLISESPIK 
TDYNASVSVPDSSGPER  
ILSISADIETIGEILKK 
8 
20 
25 
22 
20 
36 
P61979 Heterogeneous nuclear 
ribonucleoprotein K 
96 LLAEPVPGIK  
TNEAQAIETAR 
21 
59 
P61089 
 
Ubiquitin-conjugating 
enzyme E2 
1, 9, 10, 23, 24, 30, 35, 37, 39, 46, 51, 54, 55, 56, 58, 62, 73, 74, 78, 79, 
82, 83, 85, 87, 91, 92, 93, 94 
No ID 
 
Table C.1 Proteins identified from 2-DE analysis of caudal regions at the 28-
29 somite stage. Spots 41* and 52** were also considered to be likely identities, 
other spots for the same proteins were identified with significance Mascot scores: 
47, Trifunctional purine biosynthetic protein adenosine-3, and 8, Fetuin-A (Alpha-
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2-HS-glycoprotein precursor; 30-31ss analysis). In addition, there are other 
Fetuin-A spots identified by random collection (Table C.4). Last row are the 
numbers of unidentified spots. 
 
PS
S  
No 
Matched peptides  Score Accession 
No 
Protein ID 
8 ALGGEDVR 
TPIVGQPSIPGGPVR 
52 
7 
P29699 
 
Alpha-2-HS-
glycoprotein 
precursor 
12 LVEVDSGR 
LAQALHEMR 
LSSEMNTSTVNSAR 
KIGDTSVSYK 
NSQGEEVAQR 
23 
33 
54 
55 
55 
P14733 Lamin B1 
 
20 ASAPATPLSPTR 
LAVYIDKVR 
SLETENSALQLQVTER 
SLETENSALQLQVTEREEVR 
ALYETELADAR 
ALYETELADARR 
RALDDTAR 
ESDLSGAQIK 
LREYEAALNSK 
DAALATALGDKK  
LVEVDSGR 
LSSEMNTSTVNSAR 
IESLSSQLSNLQK 
DQMQQQLSDYEQLLDVK 
IGDTSVSYK 
NSQGEEVAQR 
63 
54 
77 
26 
56 
31 
22 
59 
62 
60 
41 
56 
62 
56 
49 
62 
P14733 Lamin B1 
158 QQLQTTR 
YIAENGTDPINNQPLSEEQLIDIK 
ATVLTTER 
36 
8 
15 
Q99KP6 Pre-mRNA-
processing 
factor 19 
168 VLDLDLFR 
LLIDEAIQK 
LLIDEAIQK 
35 
36 
33 
P26638 Seryl-tRNA 
synthetase 
7, 15, 18, 19, 21, 27, 40, 46, 57, 65, 66, 67, 72, 74, 75, 76, 77, 85, 91, 97, 106, 
109, 110, 112, 116, 122, 126, 127, 129, 130, 133, 135, 137, 138, 140, 141, 143, 
147, 148, 149, 150, 151, 152, 153, 155, 156, 157, 160, 161, 164, 165, 166, 169 
No ID 
 
Table C.2 Identification of differentially abundant protein-spots from 2-DE 
analysis of caudal regions from 30-31 somite stage embryos. Last row are the 
numbers of unidentified spots. 
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Spo
t 
No 
Matched peptides  Score Accession 
No 
Protein ID 
S10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EQFLDGDAWTNR 
FYGDLEKDK 
DKGLQTSQDAR 
FYALSAK 
LFPSGLDQK 
KVHVIFNYK 
VHVIFNYK 
CKDDEFTHLYTLIVRPDNTYEVK 
IDNSQVESGSLEDDWDFLPPK 
IDNSQVESGSLEDDWDFLPPKK 
IKDPDAAKPEDWDER 
QIDNPDYK 
SGTIFDNFLITNDEAYAEEFGNETWGVT
K 
FYGDLEKDKGLQTSQDAR  
47 
23 
24 
32 
33 
24 
23 
40 
65 
36 
30 
30 
 
20 
88 
P14211 Calreticulin  
S11 
 
HTLNQIDSVK 
K.ALGGEDVR.V  
 
 
39 
28 
P29699 Alpha-2-HS 
glycoprotein 
(Fetuin-A) 
S60 R.SNVTAVHK.A 
R.NVTAIQGPGGK.W 
R.IAEFAFEYAR.N 
R.ENTEGEYSGIEHVIVDGVVQSIK.L 
K.IEAACFATIK.D  
23 
47 
61 
17 
23 
P47955 Isocitrate 
dehydrogenase 
[NAD] subunit 
alpha 
S79 AAVPSGASTGIYEALELR 
 
130 P17182 Alpha-enolase 
 
Table C.3 Identification of protein spots collected from 2-DE gels for 
reference. These spots were collected at random from different areas of silver- 
stained gels to confirm correlation of pH range and protein pI values.  
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AP
D.
Th d 
32 d 
32 d 
(bo d 
tex
 
PENDIX D 
 
 
1 Sequence assembly of the BAC 327D13 BAC vector insertion site (230 bp). 
e PCR product generated using the pTARBAC-R (in the BAC vector end) an
7D13-R1 (in the genomic DNA insert), was sequenced using the pTARBAC-R an
7D13-R1 primers. Primer sequences are underlined and the BamHI site highlighte
ld, six-base cutter). Sequence in black text corresponds to the BAC vector and re
t corresponds to genomic sequence (chromosome 4). 
GTCGACATTTAGGTGACACTATAGAAGGATCCAAGATGTCCTTGTTTTGAC
AATCACACAGAGATGATAGGCGATTACTAATGAGCCATCTCGAGGGGA
CTTTGCAGTCTGGTGTGTATCTGCTCTATGCAGCCTGCCTTAAGTTTGGA 
AGTCAAGTTTCCAGGGCTGATTGTGGATACTCTCTTGGTCATGCTGTTCT
TCCCCTGGAATAGCTGGA
ACC
GT
TC
AGAATGT CCCTAATGATGACCACGTGA 
 
 
 
 
D.2  BAC localisation – primer design  
 
>18 dna:chromosome:NCBIM37:18:3004060:3007000:1 
 
TATTATTTTTTT Region upstream of BAC insertion site 
*  Chr18:3,005,382: putative insertion site 
CTCTCTCTCTCT Forward primers 
TCACATGAAGGC Reverse primers 
 
 
1 CTGTCTGTCTGTCTGTCTTCTGTCTGTCTGTCTTTCTTTCTTTCTTCTGTCTTTCTTTCT 
TCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTCTGTCTGTCTT 
TCTATTTTTTTTTCGTTTTTTCTGAGATATGGTTTCCTAGCCCTGGCTGACTTGTAAGCC 
AGGGTGACCTTGAACACAGAAATCTGCCTGAGGTTAAAGGTGTGTTCCACAATTGCCCCA 
GCTCTACTCTAATTCTCTTTAAAAAAAATGTGTATGTATATATGTATATATAGAGGTAAT 
ATTAATCCGTTAATATCTTTTTTCCTAAAATTCATGTCTTTCTTTCTCTCTCTTTCTCTC 
TCTCTCTTTCTCTCTCTCTCTTTCTTTCTTTCTGTCTGTCTGTCTGTCTTTCTGTCTTTC 
TATTATTTTTTTCGTTTTTTTTCTGATATATGATTTCTCTAGCCCTAGCTGACTTGTAAG 
TCAGGGTGACCTTGAACGCAGAAATCTGCCTGAGGTTGAAGGTGTGTTCCACAATTGCCC 
CAGCTCTACTTTAATTCTCTTTTTAAAAATTGTGTGTATGTTTGTATGTATATATGTATA 
TATAGAAGTAATATTAATCCATTAATATCTGTTTCCTAAAATTCATGTCTTTCCTTCTCT 
CTCTCTCATTCTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTGTCTGTCTGTCTT 
TCTTTCTGTCTTTCTATTATTTTTTTCGTTTTTTCTGAGATATGGTTTCTCTAGCCCTAG 
CTGACTTGTAAGCCAGGGTGACCTTGAACGCAGAAATCTGCCTGAGGTTAAAGGTGTGTT 
CCACAATTGCCCCAGCTCTACTCTAATTCTCTTTTTAAAAATGTGTGTGTGTATATATGT 
ATATATGTATATATAGAAGTAATATTAATCCATTAATATCTGTTTCCTAAAATTCATGTC 
TCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTTTCTTAAATTTATTC F23bp 
TTTTCATACATAGTTTCATAATGTAAGCAGCCCTGGCCGTCTTGAAGACACTTTGTAGGC F22bp 
CTCAATCCTGTAAGAGCCTTCCTCTGCTTATCAAATGCTGCCATGAATGTTGTACCTCAC 
TATGACTGGCTGAGATTCTCACCTTTTCTTCCCCCCCCCTTTCTTTTTATGATTCTATCT F1 
TTGGCCACGCAGTGGTGGTGGTGGTGGCAGAGGGAGGTGGATCACTGTAACTTTGCAGCT 
AGCTTAGTCTTCAGTCTGATTTACTCGAAAGGAGTTCCAAGAAGACTGGTTATATTTTTC  
AT*TTATTATGCATTTTAATTAAAATTTAATTAAACCCAAAGAATTTAGACTGACCAATTC 
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AGAGTCT AGTA GTGA GTG
TGGTCGAGGCTGCTTTAGGGAACCTCCTCACCATTCTGCACTTGCAAACCGGGCCACTAG 
GCCATTTAAAAGCATAAGGAAAA GGAGAAAAC GGCTGTCT GA 
AACCTGGTGAAGGGAGAAACCAAAGTGACCTGAAACAATAGGTCACATGAAGGCCAGCCA R1 
CCATCTTGTTGTGCAGGTGGTCAGTTAGCAGACAAGATAGCTGACATGCACATGTTGTCT R2 
TTCATCTTGGTGAGGTCAATGTGCAACCGAGTGACAGGACAAGGAAGTAGACATGCAGAC 
AACAGACATGCAGGTGCACCACCTCCCTTCTGTGTTTGTATAAAACACACACAAAAATTT R3 
TCATTATTTACAGTAAGCCTTAAAAAGCACTCTGACAGCCTCGCATATATCTACATTCTA 
TGTGATTAGAATTTCCTTTTTTTGTTGTTTTTTA CTCAAG CTGCATGGTGG R4 ATTTATT AG
TTTCTC
CAAACAC
GAAAGAA
C CTGTTGCTCTCTCCTGGCATGCAGGTATATACACAGCAGATAAAG
ACATTGAAAAATAATTGTAATAAGAATGAAAGAAAGAAAGAAAGA
AGAAAGAAAGAAAGAAAGAAAGAAAGA AAAGAA AAAGAAAGGAA 
GGAAGGAAGGAAGGAAGAAACAAAGATCCTAACTTTGGCCCGGCTGTGTGGGTGGCAGAA 
GGAGGCAGGCAGGTAGGCAGAGAGGACCTCTCTGAGTTTGAGGTTACCAAAGCCTACAAA 
GGAAGTTCCAGGCAGGGATGCCAGGGCTACACCGAGAGAAACCCTATCTTGGGGAAAAAG 
AAAACAAAAGCAGAAAAAGTTCTGGCTTTTACTTTCAGACATATGATTCTTCTAGTACTA 
TTGACTATCTAATTTTGATCATGAAGGCACATTGGATTTTATGACAGTGTGTGTGTGTGT 
GTGTGTGTGTGTGTGTGTGTAATATTTCTACTGTGATTGTGGTAACTTGCACCCTAGTGG 
TTCTGTAATCT AT TCATTTA TTTTTATTTT
TT TTTTTGTTTG TT TTTTTG TGTTTGTTT
GACAGGGTTTCTCCATATAGCCCTGGCTGTCCTGGAACTCACTGTGCTGACCAT 
GACCATGATGGCCTTGAATTCAGAAATCCTCCCATCCCTGCCTCTCTAGGGCTGGGATTA 
AAGGCTTGAGCCACCACTCCCAGCTACTTTTTAATTTTTTAATTTTTTAATTTTATATAT 
TTAGTTTATTTTTGTTTTCTTCT TCTTTC CTCTCT CTCTCTCTC
TCTCTTTCTTTCTTTCTTTCTTTCTTCCTTTCTTTCAGTCTTTCTATTATTTTTTTCGTT 
GAGATATGGTTTCTCTAGCCCTAGCTGA GTCAGG TGAA  
T GAGGTTGAAG TCTGT TATTAA CTTG
 s 
 
 
D.3  Sequence ‘tag’ gener by seq  genom DNA of transgenic 
sample with R4 primer 
TAGGTT
ACATTT
CA R5 
AA 
AAGAAAG AG
GCTTATG
TTTTA
TTTTGA
TTTGAT
TTGGGT
TTTTTCTA
TTTGTTTGT
TCTTTT
TGTTTTG
TA
TT
A 
GT 
TTCTG TTTCTCT CT TC 
TTTTCT
CAGAAA
C 2941
 
CTTGTAA
TGGGAGC
ATGACCT
GACAGCC
AG
CTGCCT
letter
GTGTGT AT 
ated uencing ic a 
 
CTGTGGATGGT Tag 
TCTCACCAGCC BAC sequence 
GG
 
 
CC   HaeIII sites 
BAC - 
AG TGAGCAGTCGGGTGCTCTTACCCACTGAGCCATCTCACCAGCCCTTATTA
CATTTTAATTAAGATTTAATTACACCAAAAGAATTTAGACTGACCAATTCAG
AGTCTGCCGTTTAAAAGCATAAGGAAAAAGTAGGAGAAAACGTGAGGCTGT
CTGTGGATGGTCGAGGCTGCTTTAGGGAGCCTCCTCACCATTCTGCACTTGC
AAACCGGGCCACTAAAACCCGGTGAAGGGAGAAACCAAAGCGACCTGAAA
CAATAGGTCACATGAAGGCCAGCCACCTCCATCTTGTTGTGCGGGAGTTCA
GTTAGCAGACAAGATGGCTGCCATGCACATGTTGTCTTTCAGCTTGGTGAGG
TCAAAGTGCAACCGAGTGACAGAACAAGGAAGTAGACATGCAGACAACAG
ACATGCAGGCGAACCATCTGCCTTCTGTGTTTGGATAAAAGACACACAACA
ATTTTCATTACTTACACTAAGCCTTAAAAAGCACTCTGACAGCCTTGCATAT
ATCTACATTCTATGTGATTAGAATTTCCTTTTTTGTTGTTTTTTCATTTATTCT
CAAGAGCTGCATGGTGGTTTCT R4
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Chapter 3 
 
 
o-dimensional in gel electrophoresis analysis of a 
mouse model for neural tube defects 
 
 
 
 
 
Tw  prote
 155
3.1 Introduction 
 
As described in Chapter 1, curly tail is one of the most extensively characterised 
mouse models of NTDs, with resemblance to the multifactorial etiology and pathogenic 
features of human NTDs (Copp and Bernfield, 1994; Van Straaten and Copp, 2001). 
The penetrance of the ct mutation is strongly dependent on genetic background and 
influenced by environmental factors (Neumann et al., 1994; Van Straaten and Copp, 
2001).  Curly tail also provides a model in which NTDs are unresponsive to folate but 
preventable by inositol (Greene and Copp, 2005).  
 
Previous studies revealed that prevention of NTDs in curly tail embryos by inositol 
depends on downstream activity of protein kinase C (PKC), specifically the PKCβI and 
PKCγ isoforms, with a lesser requirement for PKCζ (Greene and Copp, 1997; Cogram 
et al., 2004). In order to build on these findings, one next step would be the 
identification of key target proteins that are phosphorylated by PKC in inositol treated 
embryos. As a precursor to such an approach it was decided to compare the proteome 
ofile of curly tail mouse embryos with wild-type embryos that do not develop NTDs. 
These studies were in l pro re  the 
curly tail proteome rmal would m  are present at 
reduced or excess abundance or are abnormally odified. These protein changes could 
b tly involved in d be indicative of downstream 
effects of Grhl3 (Figure 3.1).   
 
Differences between cellular states are reflected in changes in gene expression that 
typically manifest themselves at the level of both the message (mRNA) and the final 
protein products. While mRNA based approaches such as microarray allow many genes 
to be analysed in an experiment, it was decided to use a protein-based, ‘proteomic’, 
approach in this project. Analysis of proteins provides sensitivity to differences in both 
abundance and post-translational modification, the latter being particularly relevant if 
subsequent studies are to address the downstream phosphorylation events following 
inositol treatment of embryos. In addition, it can be the case that protein abundance can 
be altered without changes in mRNA level, due to changes in translational regulation. 
pr
tended to revea
. In this context abno
teins that a  abnormally represented in
ean that proteins
 m
e direc evelopment of spina bifida and 
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Since proteins are more likely to affect biological functions, studies at the protein level 
may therefore provide insight that mRNA based studies are not sensitive to. 
 
In one separation procedure, 2-DE technique is capable of simultaneously resolving 
thousands of proteins depending on the amount of sample, the apparent molecular 
weight, and the amount of each protein. The process requires stringently controlled 
steps of sample preparation, protein separation, image detection and analysis, followed 
by spot identification. Proteins are separated according to two independent properties in 
two discrete steps. The first-dimension step, isoelectric focusing (IEF), separates 
proteins according to their isoelectric point (pI). This is followed by the second-
dimension step, sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE), which separates proteins according to their molecular weight (MW). Gels are 
then stained and each spot on the resulting two-dimensional gel corresponds to a single 
protein species. The 2-DE method used in this project is based on the method developed 
by A. Görg and colleges (Gorg et al., 1985; Gorg et al., 1998), which utilises a first 
dimension separation method with precast immobilised pH gradient (IPG) with gel 
strips supported by a plastic film backing. The method is described in Chapter 2, 
section 2.5, and summarised in Figure 2.4. 
 
A proteomics approach has previously been used in mouse embryos to investigate the 
molecular events underlying the processes occurring at the stage of neural tube closure 
(Greene et al., 2002). The analysis revealed a number of developmentally regulated 
proteins whose abundance changes between E8.5 and E10.5 and which were identified 
by mass spectrometry (MS). This study encouraged the view that 2-DE and MS analysis 
could be applied to mouse embryonic samples for global analysis of the proteome at 
specific developmental stages. Therefore, in this study of a mouse model of spinal 
neural tube defects, a 2-DE approach was used to compare curly tail and wild-type 
embryos.  
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3.2  Results 
 
3.2.1 Two Dimensional Protein Gel Electrophoresis (2-DE) on neurulation stage 
mouse embryos 
The initial approach of this project was to identify candidate proteins which are 
abnormally represented in the curly tail proteome. A genetically matched wild-type 
(+ct/+ct) strain was previously generated by successive backcrossing (four generations) 
from an initial cross between ct/ct and SWR inbred strain. Grhl3 expression is reduced 
in curly tail (ct/ct) embryos compared to wild-type (+ct/+ct) embryos at the stage of PNP 
closure (Gustavsson et al., 2007). A Grhl3-transgenic curly tail line (ct/ctTgGrhl3) exhibits 
elevated expression levels of Grhl3 and hemizygous embryos do not develop spinal 
NTDs. 
 
Embryos of the ct/ct strain, +ct/+ct strain and the ct/ctTgGrhl3 line were collected at E10.5, 
during posterior neuropore (PNP) closure, and allocated to groups according to somite 
number, 26-27, 28-29 and 30-31 (Chapter 2, section 2.1). Initial experiments focussed 
on comparison of ct/ct and +ct/+ct samples, and ct/ctTgGrhl3 samples were included at a 
later stages of the project. 
 
The 2-DE method was first optimised for mouse embryos, using samples at the stage of 
PNP closure (26 – 31 somites; Chapter 2, section 2.5). The main elements that were 
varied were the amount of tissue used for sample preparation, the staining method, the 
pH range used for isoelectric focussing and the gel analysis software. In initial 
experiments, gels were generated using different amounts of tissue to determine the 
amount of protein that was the limiting factor in producing gels. Optimal sample 
quantity produces representation of spots across the gel, and without over-loading that, 
results in adjacent spots becoming indistinguishable (Fig. 3.2). Initially whole embryos 
were used for 2-DE. However, since the major interest was in the spinal defect, embryos 
were cut at the level of somites 14-15 to separate the caudal from the cranial region 
(Chapter 2, Fig. 2.4 A). Use of the caudal region provided the opportunity to identify 
differences in the neuroepithelium as well as the hindgut in which the proliferation 
defect is localised, and gave sufficient material to use one embryo per 2D gel.  
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Whole embryo 2-DE was performed using 18 cm IEF gels (350 µl total volume loaded). 
In order to increase resolution of proteins with similar isoelectric point (pI) values, a 
range of different pH gradients (4-7, 3-5 and 6-9) was tested to increase coverage of the 
whole ct/ct proteome (from very acidic proteins to more basic ones). In some cases pH 
3.0-5.6 gels were used to provide coverage of acidic proteins and to improve separation 
of spots of interest from the acidic end of pH 4-7 gels. Different stains were also tested, 
owing to their possible differences in labelling and linearity for quantification (Chapter 
2, section 2.5.4): silver, Sypro Ruby stain and Deep Purple stain. Table 3.1 summarises 
how many gels were run for samples from each strain at different somite stages. Figure 
3.1 shows examples of 2D gels using different pH ranges for first dimension separation 
and the different protein amounts used in this study.  
 159
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Figure 3.1 2D gels. (A-C) Typical 2D gels generated from whole embryo samples 
loaded on 18 cm gels for IEF in pH range 3.0-5.6 (A), 4.0-7.0 (B) or 5.0-6.0 (C), 
followed by SDS-PAGE on 12% gels and silver staining. These gels have a 
relatively high loading of 300 µg protein. (D) 2-DE using 200 µg of protein from 
the cranial region of an embryo at E10.5, with IEF on pH 4.0-7.0 gel. (E-F) 2-DE 
generated from isolated caudal regions using 50 µg protein loading with IEF on 
(E) pH 4.0-7.0 or (F) pH 6.0-9.0 gels. Gels with greater loading had more visible 
protein spots (B, approximately 5,000 spots) than gels loaded with the 50 µg 
proteins although on the latter still a large number of proteins (E, approximately 
2,000 spots) are readily detectable. Gels on pH 3.0-5.6 have a better separation of 
spots compared to pH 4.0-7.0 (red arrows within red box, A-B); and even better 
separation is achieved with pH 5.0-6.0 (orange arrow and orange bracket within 
orange box, B-C). +, indicates acidic side, and -, the basic side.  
 
Gel analysis was performed with the Progenesis SameSpots software (Chapter 2, 
section 2.5.6), which processes the gel images to match the image pattern across 
different gels and then to detect the spots and quantitate the spot volumes. Images were 
then separated into groups (ct/ct, +ct/+ct, ct/ctTgGrhl3) for comparison. Differences 
between mean spot volumes for the different experimental groups (genotypes) were 
ranked on the basis of the p value for the One Way ANOVA analysis and by maximum 
fold change, based on the normalised volume (total pixel intensity within the spot area) 
of the spot across all the groups being compared.  
 
Spots that showed statistically significant variation (p<0.05) and a fold change of 1.5 or 
greater were excised from gels. Manual in-gel digestion (Chapter 2, section 2.5.7) was 
performed and proteins were identified by electrospray-liquid chromatography tandem 
mass spectrometry (LC-ESI-MS/MS) on a QTof mass spectrometer (performed by Dr 
Kit-Yi Leung). 
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Tissue Somite stage (ss) Strain pH range No. gels Staining 
ct/ct 
3.0-5.6 
4.0-7.0 
5.0-6.0 
8†
5†
1†
Whole 
embryo 
26-31 
+ct/+ct
3.0-5.6 
4.0-7.0 
5.0-6.0 
4†
3†
1†
Silver 
Cranial 
region 
27-30 ct/ctTgGrhl3 4.0-7.0 5† Silver 
ct/ct 
4.0-7.0 
6.0-9.0 
17 + 6* 
2 
+ct/+ct
4.0-7.0 
6.0-9.0 
11 + 4* 
2 
Caudal 
region 
28-31 
ct/ctTgGrhl3 4.0-7.0 13 
Silver  
 
Sypro* 
Ruby 
 
 
Table 3.1 Summary of 2D gels generated for comparison between strains. The 
major focus of softw ial analysis between strains was whole 
embryos and isolated caudal-regions of embryos at somite stages 28-29 and 30-
31. † Some gels wer luded in the full analysis but were used to confirm 
patterns for spots of interest. * A total of 10 gels were stained with Sypro Ruby. 
 
 
 
 
 
 
 
 
 
 
are based different
e not inc
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3.2.2 2-DE analysis 
 
3.2.2.1 Analysis of whole embryos 
Initial analysis was perf d to compare the protein profile of ct/ct and +ct/+ct samples 
on 2-DE using pH ranges 3.0-5.6 and 4.0-7.0, and silver staining. The number of gels 
and spots that were found to `significantly differ in abundance between genotypes is 
shown in Table 3.2, while a representative gel, showing the position of varying spots is 
shown in Figure 3.2. Overall, relatively few spots were found to significantly differ in 
abundance between genotypes. This may reflect in part the relatively small number of 
gels included in the analysis of whole embryos. It was decided to focus on the isolated 
caudal region in subsequent experiments, in order to increase the likelihood of detecting 
differences specific to p ior neuropore closure. 
 
Strains pH No. gels 
 No. differentially 
abundant spots 
orme
oster
ct/ct 
+ct/+ct
3.0-5.6 4 
5 
19 
3.0-5.6 
ct/ct 
+ct/+ct
4.0-7.0 
4.0-7.0 
2 
2 
23 
 
Table 3.2 Analysis of whole embryo samples by 2-DE for comparison of ct/ct 
and +ct/+ct embryos. number of gels included in the analysis for each strain is 
indicated.  Spots were considered to be differentially abundant where p<0.05 and 
there was 1.5-fold or greater difference in mean spot volume. 
 
The 
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Figure 3.2 Analysis of ct/ct and +ct/+ct whole embryos by 2-DE. (A) Typical 
silver-stained curly tail 2D gels generated using pH gradient of (A) pH 3.0-5.6 or 
(B) pH 4.0-7.0. The position of spots that were differentially abundant between 
genotypes is indicated (with their unique spot number).  
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3.2.2.2 Analysis of the caudal region of ct/ct and +ct/+ct embryos by 2-DE with 
Sypro Ruby stain 
Following 2-DE analysis of whole embryo samples it was decided to focus on the 
isolated caudal region of embryos at the stage of PNP closure. This approach was 
expected to provide possible additional sensitivity to protein changes that only occur in 
this region, with the disadvantage that an individual caudal region only contains enough 
protein for production of a single gel. In the first study, staining of the gels was 
performed using Sypro Ruby stain, followed by laser scanning. This is a fluorescent 
stain which provides as least as much sensitivity as silver stain but has the advantage of 
enhanced dynamic range, such that in 16-bit scanned images it is possible to represent 
up to 65536 levels of intensity. Gels were generated for embryos at the 28-29 somite 
stage, when failure of PNP closure is first apparent in ct/ct embryos. The experimental 
groups are summarised in Table 3.3, and a typical Sypro Ruby stained gel is shown in 
Figure 3.3. Although fluorescent stains give a higher dynamic range than silver stained 
gels, and a number of variant spots were identified, this stain causes characteristic 
background speckling. In some cases speckles were recognised as spots by the analysis 
software such that there was an increased requirement for manual editing to eliminate 
these “spots” from the analysis.   
  
Strain 
pH range for 
isoelectric focussing 
Replicates
 Differentially abundant 
spots (P<0.05) 
ct/ct 
+ct/+ct
4.0-7.0 
4.0-7.0 
5 
5 
13 
 
Table 3.3 Experimental groups for 2-DE analysis of ct/ct and +ct/+ct embryos, 
using Sypro Ruby Protein Gel stain.  Each replicate is a separate gel generated 
from an individual sample. Spots were considered differentially abundant spots if 
the mean volume differed by 1.5 fold or greater (and p<0.05, ANOVA). 
 
 165
          
 
Figure 3.3 Typical appearance of 2D gel from a ct/ct caudal region (50 µg) 
sample following staining with Sypro Ruby Protein Gel Stain. The example 
shows the reference gel from comparison of +ct/+ct and ct/ct samples at the 28-29 
somite stage, using pH 4.0-7.0 for first dimension separation. Differentially 
expressed spots indicated by numbers.  
 
 
3.2.2.3 Analysis of the caudal region of ct/ct and +ct/+ct embryos at the 28-29 and 
30-31 somite stages by 2-DE with silver staining 
Two further experiments were designed in order to compare the proteome profile of 
isolated caudal regions at the 28-29 somite stage, while the PNP is gradually shortening 
in wild-type embryos, and at the 30-31 somite stage, when the PNP is undergoing final 
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closure or just closed in wild-type embryos but remains open in affected curly tail 
embryos. These are the stages at which diminished expression of Grhl3 and a reduced 
cellular proliferation rate are detected in ct/ct embryos (Gustavsson et al., 2007; Copp et 
al., 1988a).  The pH range chosen for isoelectric focussing was pH 4.0-7.0 based on 
preliminary studies that showed representation of spots across the gel and good 
separation of spots. In this case silver staining was used, which has a detection limit as 
low as 0.1 ng of protein per spot, but limited dynamic range compared with fluorescent 
stains. The advantage of silver staining was the ability to pick differentially abundant 
spots directly from gels for subsequent identification. The number of gels and variant 
spots is summarised in Table 3.4 and typical 2D gels for each stage are show in Figure 
3.4. 
 
Strain No. of somites Replicates
 No. spots significantly 
varying in abundance 
ct/ct 
+ct/+ct
ct/ctTgGrhl3
28-29 
28-29 
28-29 
3 
2 
2 
48 
ct/ct 
+ct/+ct
ct/ctTgGrhl3
30-31 
30-31 
30-31 
3 
2 
2 
58 
 
Table 3.4 2-DE analysis of the caudal region of ct/ct, +ct/+ct and transgenic 
embryos using silver staining. Spots were considered to significantly vary where 
p<0.05 (ANOVA) and mean volume differs by 1.5-fold or greater.   
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Figure 3.4 Silver stained gels following 2-DE of samples generated from 
caudal region of ct/ct embryos. Samples were from embryos at (A) the 28-29 
somite stage and (B) 30-31 somite stage. A pH 4.0-7.0 gradient was used for 
isoelectric focussing and gels were silver stained. Spots that differed in abundance 
between ct/ct, +ct/+ct and ct/ctTgGrhl3 gel are indicated by red outlines. Numbers 
indicate spot number allocated by the software. Outlined spots without numbers, 
are differentially abundant spots (p<0.05) with a fold change lower than 1.5. 
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Overall, a number of protein spots were found to differ in abundance between genotypes 
at both stages examined (Fig. 3.4 A-B). Among a total of approximately 1,315 spots 
analysed on 2D gels generated from embryos at the 28-29 somite stage, 114 
significantly differed in abundance between strains (p<0.05, One Way ANOVA). 
Following manual inspection (to confirm that detected spots were not gel artefacts), and 
application of a 1.5-fold change cut-off, 48 spots were considered to represent possible 
genuine differences of potential biological relevance. Overall, among these spots, 26 
were detected at greater abundance in wild-type than curly tail samples and 12 were at 
greater abundance in curly tail than wild-type samples while 8 spots were differentially 
abundant in Grhl3-transgenic embryos (details of numbers of spots which fit into 
different expression profiles are given in Table 3.5). 
 
At the 30-31 somite stage, 193 spots were found to significantly differ in abundance 
between strains (p<0.05, One Way ANOVA) out of approximately 1,675 spots detected 
on gels. Following manual inspection and application of the 1.5-fold change cut off, 58 
spots were considered to be of potential interest. Among these spots 16 were at greater 
abundance in wild-type than curly tail samples and 28 were at greater abundance in 
curly tail than wild-type samples while 12 spots were differentially abundant in Grhl3-
transgenic embryos (Table 3.5). 
 
Although a large number of gels were run for each genotype (Table 3.1), some gels 
were not considered ideal for the overall analysis (which uses the entire gel for ‘in-gel’ 
normalisation of values) owing to small areas of abnormal migration (Fig. 3.5). These 
gels were useful for visual inspection to evaluate spots that were indicated to vary 
between genotypes in the software-assisted analysis.  
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Profile No. differentially 
abundant spots 
28-29ss analysis 
No. differentially 
abundant spots 
30-31ss analysis 
1) +ct > ct > ctTgGrhl3     3 4 
2) +ct > ct ≡ ctTgGrhl3 16 5 
3) ct ≡ ctTgGrhl3 > +ct 7 8 
4) ct > +ct ≡ ctTgGrhl3 4 12 
5) +ct ≡ ctTgGrhl3 > ct 4 6 
6) ctTgGrhl3 > ct > +ct   3 6 
7) ctTgGrhl3 > +ct ≡ ct 5 5 
8) +ct > ctTgGrhl3 > ct 3 1 
9)  +ct ≡ ct > ctTgGrhl3 2 2 
10) ct > +ct > ctTgGrhl3 1 6 
11) ct > ctTgGrhl3 > +ct 0 2 
12) ctTgGrhl3 > +ct > ct 0 1 
Total no of spots 48 58 
 
Table 3.5. Differentially abundant spots on 2-DE among samples of curly tail 
(ct), wild-type (+ct) and transgenic (ctTgGrhl3) embryos at the 28-29 and 30-31 
somite stages. The total number (no.) of differentially abundant spots is indicated 
for each stage, as well as details of the relative abundance between strains. The 
Profile Number corresponds to that used in Figure 3.8.  
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Figure 3.5 Examples of 2D gels excluded from the caudal region analyses, of 
+ct/+ct, ct/ct, ct/ctTgGrhl3 strains, pH4.0-7.0. (A-C) Gels of the 28-29 somite stages 
analysis (red squares indicate bad areas). (D-F) Gels of the 30-31 somite stages 
analysis (orange squares indicate bad regions).    
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3.2.3 Peptides and spots/protein identification  
Spots of interest, that were differentially abundant on gels from different genotypes, 
were excised from a gel or pooled from different gels (in case of very small or weaker 
spots). Spots were subjected to in-gel digestion by trypsin and sent for identification by 
electrospray ionisation liquid chromatography tandem mass spectrometry (ESI-LC-
MS/MS). The MS/MS approach generates sequence data for fragmented peptides, and 
interrogation of protein databases allows protein identification (Chapter 2, section 
2.5.7.2). The matched peptides for each spot are shown in Appendix C. Some spots 
were not abundant on the 2D gels despite production of additional gels with increased 
protein content (400 µg protein loading for spot excision). Thus, some spots that were 
found to significantly vary on 2-DE by Progenesis SameSpots analysis were not 
identified. Among spots which exhibited statistically significant differences in 
abundance between groups (p<0.05 ANOVA; 1.5 fold-change), the identified proteins 
are listed in Table 3.6. Reference gels showing the location of identified protein spots 
are shown in Figures 3.6 and 3.7.  
 
PSS 
No 
Mean Spot 
Volume 
Fold 
Change 
No. 
MP Score Acc. No. Protein ID 
8 8,239,964 
3,192,257 
1,335,020 
6.2 2 52 
 
P29699 
 
Alpha-2-HS-glycoprotein 
precursor – Ahsg, Fetuin-
A, Fetua; countertrypin 
7    147,210 
   742,463 
   881,136 
6.0 20 1022 P14733 Lamin B1* 
8 1,048,049 
   292,823 
   181,853 
5.8 6 301 P14733 Lamin B1* 
12    942,028 
   197,702 
   349,901 
4.8 5 220 P14733 Lamin B1* 
20    440,175 
1,387,622 
1,858,381 
4.2 16 836 P14733 Lamin B1* 
20    283,280 
   100,262 
     72,549 
3.9 3 180 P14733 Lamin B1* 
36      75,628 
   209,056 
   219,517 
2.9 9 464 P14733 Lamin B1* 
41     182,216 
   110,613 
     68,344 
2.7 2 58 Q64737 
Trifunctional purine 
biosynthetic protein 
adenosine-3 
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42    297,065 
   144,495 
   112,763 
2.6 2 40 P26041 Moesin 
47    836,263 
   372,571 
   538,918 
2.2 5 143 Q64737 
Trifunctional purine 
biosynthetic protein 
adenosine-3  
52     503,573 
   775,073 
   365,906 
2.1 1 28  P29699 Alpha-2-HS-glycoprotein precursor 
60     535,295 
   814,396 
   438,187 
1.9 4 69 Q9QXC1 Fetuin-B 
61 1,639,971 
   882,975 
1,504,074 
1.9 4 156 Q921F2 TAR DNA-binding protein 43 
59 
 
 
 
63 
   400,067 
   214,428  
   237,702 
   
   798,581 
   438,128 
   534,891 
1.9 
 
 
 
1.8 
4 
 
 
 
8 
138 
 
 
 
210 
 
Q1HFZ0 
 
tRNA (cytosine-5-)-
methyltransferase 
NSUN2 
71 1,996,354 
1,152,346 
1,274,760 1.7 
26 
 
 
2 
1385 
 
 
59 
Q01853 
 
 
Q9DB20 
Transitional 
endoplasmatic reticulum 
ATPase  
 
ATP synthase subunit O 
72 1,268,203 
1,708,057 
2,148,528 
1.7 4  146 P08228 Superoxide dismutase 
75    448,305 
   524,152 
   734,653 
1.6 3 59 Q02819 Nucleobindin-1 
76 2,551,689 
1,565,114 
2,408,714 
1.6 
   5 
 
 
2 
 
2 
 149 
 
 
87 
 
81 
Q3THS6 
 
 
Q8CGP5 
 
Q3U774 
S-adenosylmethionine 
synthase isoform type-2 
 
Histone H2A  
 
ATP synthase subunit 
beta 
81 1,822,433 
1,143,352 
1,210,995 
1.6 2 64 
 
O08553 
 
Dihydropyrimidinase-
related protein 2 
86 1,818,534 
2,112,241 
2,747,851 
1.5 2 55 Q99PT1  Rho GDP-dissociation inhibitor-1 
88 2,628,033 
1,963,683 
1,747,780 
1.5 6 131 P61979 Heterogeneous nuclear ribonucleoprotein K 
96 1,674,772 1.5 2 59  Ubiquitin-conjugating 
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1,982,083 
2,436,848 
P61089 
 
enzyme E2 
158 1,061,683 
1,619,735 
1,571,230 
1.5 3 36 Q99KP6 Pre-mRNA-processing factor 19 
168 1,078,953 
1,311,369 
1,577,263 
1.5 3 104 P26638 Seryl-tRNA synthetase 
 
Table 3.6 Identity of protein spots that statistically differed in abundance in 
+ct/+ct, ct/ct and ct/ctTgGrhl3 samples. The Progenesis SameSpots software (PSS 
No) gives a unique identifier allowing localisation on the 2D gels. The mean 
normalised spot volume (MNSV; arbitrary units) is given for each group and is 
colour coded as +ct/+ct, ct/ct and ct/ctTgGrhl3. MP indicates the number of matched 
peptides that were identified for that spot and the identified protein. Score from 
Mascot analysis is also indicated with scores of ≥35 considered sufficient for 
confident identification. The protein database accesstion number (Acc. No.) and 
protein names (ID) are also indicated. Proteins are listed in order of the magnitude 
of the fold-change in abundance between the highest and the lowest mean 
volumes. * A difference in lamin B1 spots between ct/ct and +ct/+ct was evident 
on every gel analysed. Text colour indicates whether the spot difference was 
observed in the analysis of caudal regions at the 28-29 somite stage (black) or the 
30-31 somite stage (blue).  
 
In some cases a protein spot was found to correspond to more than one protein identity. 
For example, PSS71 included transitional endoplasmatic reticulum ATPase, and ATP 
synthase subunit O.  This probably results from co-migration on 2-DE owing to very 
similar molecular weight and pI of the proteins. In these cases it is possible that use of 
narrow range pH strips for isoelectric focussing would allow separation of the spots to 
allow determination of which one differs in abundance between groups. In addition, 
some proteins were identified from more than one spot. For example, PSS 59 and 63 
both correspond to tRNA (cytosine-5-)-methyltransferase NSUN2, and are likely to 
correspond to different isoforms or post-translationally modified variants.  
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Figure 3.6 Representative 2D gels of embryo caudal regions showing the 
location of identified proteins at the 28-29 (A) and 30-31 (B) somite stages. 
Isoelectric focussing was performed on a pH4-7 gradient (acidic side on left of gel 
image). Numbered spots (PSS No., Progenesis Spot Number) are indicated. 
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Figure 3.7 Location of additional proteins identified by mass spectrometry on 
pH 3.0-5.6 (A) and pH 4.0- 7.0 (B) 2D gels. Gels were generated from whole 
embryo samples at E10.5.  
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3.2.4 Protein profiles  
The proteins which were identified by mass spectrometry can be broadly divided into 
profiles according to their differences in relative abundance between experimental 
groups. A graphical representation of each possible profile is shown in Figure 3.8 and 
Table 3.7 lists the proteins that correspond to each profile. The graph bars correspond 
to the colour codes used in Table 3.6.  
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Figure 3.8 Profiles of protein abundance for identified spots that are 
differentially represented between experimental groups. Graphical 
representation of the relative expression observed in the three strains. * Spots that 
are significantly more abundant (Profiles 1, 2, 4, 6, 7) or less abundant (Profiles 3, 
5) than in the other two strains. ** Spots that are significantly more abundant than 
in the strain with lowest abundance (Profiles 1, 6). Note that, profiles 5 and 7 
represent proteins whose abundance is positively correlated with the expression 
level of grainyhead like-3, whereas profile 4 represents proteins whose abundance 
is negatively correlated with the expression level of grainyhead like-3. Profiles 1, 
2, 3 and 6 could represent proteins whose abundance is influenced by the small 
differences in genetic background between ct (and ctTgGrhl3) on the one hand and 
+ct strain on the other. 
PSS 
No 
Protein – Gene Symbol Function 
1) +ct/+ct > ct/ct > ct/ctTgGrhl3
8 Fetuin-A  Development-associated regulation of calcium metabolism and osteogenesis 
 
2) +ct/+ct > ct/ct  ≡ ct/ctTgGrhl3 
8, 12, 
20 
Lamin B1 – Lmnb1 Nuclear envelope protein – control of cell 
cycle and nuclear shape 
41, 47 Trifunctional purine 
biosynthetic protein 
adenosine-3 - Gart 
Purine metabolism 
42 Moesin - Msn Belongs to the ERM (ezrin/radixin/moesin) 
protein family. Regulates epithelial 
organisation by linking membrane-associated 
proteins to the actin-cytoskeleton 
59, 63 tRNA (cytosine-5-)- 
methyltransferase NSUN2 
– Nsun2 
Control of cell cycle 
71 Transitional endoplasmic 
reticulum ATPase – Vcp or 
p97 
Role in nuclear envelope assembly and 
proliferation 
71 ATP synthase subunit O – 
Atp5o 
ATP synthase involved in oxidative 
phosphorylation 
81 Dihydropyrimidinase-
related protein 2 – Dpysl2 
Necessary for signaling by class 3 
semaphorins and subsequent remodelling of 
the cytoskeleton.  Substrate of Rho kinase in 
the brain 
88 Heterogeneous nuclear 
ribonucleoprotein K - 
Hnrpk 
RNA/DNA-binding protein – gene expression 
and signal transduction 
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3) ct/ct ≡ ct/ctTgGrhl3 > +ct/+ct
7, 20, 
36 
Lamin B1 – Lmnb1 Nuclear envelope protein – control of cell 
cycle and nuclear shape 
158 Pre-mRNA-processing 
factor 19 –Prpf19 
Acts as a structural component of the nuclear 
framework 
168 Seryl-tRNA synthase - 
Sars 
Catalyses the attachment of serine to tRNA 
 
4) ct/ct > +ct/+ct  ≡ ct/ctTgGrhl3 
52 Fetuin-A  Development-associated regulation of 
calcium metabolism and osteogenesis 
60 Fetuin-B  Like fetuin-A, mRNA level is down-regulated 
in recovery phase of acute inflammatory 
response 
 
5) +ct/+ct ≡ ct/ctTgGrhl3 > ct/ct 
61 TAR DNA-binding protein 
43 – Tardbp or Tdp-43 
DNA and RNA-binding protein - regulates 
transcription and splicing 
76 S-adenosylmethionine 
synthase isoform type-2 – 
Mat2a 
Role in the methylation cycle – synthesis of 
S-adenosylmethionine from methionine and 
ATP 
76 Histone H2A – Hist1h2af Transcription regulation, DNA repair, DNA 
replication and chromosomal stability 
76 ATP synthase subunit beta 
– Atp5b 
ATP synthase 
 
6) ct/ctTgGrhl3 > ct/ct > +ct/+ct
72 Superoxide dismutase – 
Sod1 
Antioxidant enzyme defence mechanism to 
minimise cellular damage by reactive oxygen 
species (ROS) 
86 Rho-GDP-dissociation 
inhibitor-1 – Gdi1, Arhgdia
Regulates the GDP/GTP exchange reaction of 
the Rho dissociation proteins  
   
7) ct/ctTgGrhl3 > +ct/+ct ≡ ct/ct 
75 Nucleobindin-1 – Calnuc, 
NucB1 
Major calcium-binding protein of the Golgi.  
96 Ubiquitin-conjugating 
enzyme E2 – Ube2n 
Mediates transcriptional activation of target 
genes. Controls progress of cell cycle and 
differentiation  
   
 
Table 3.7 Protein profiles. Identified proteins were allocated into broad profiles 
(see Fig. 3.8) according to the mean spot volume of each strain seen in Table 3.6. 
For example, spot 41 (Gart protein), is in the profile +ct > ct ≡ ctTgGrhl3 as there 
was no statistically significant difference between the mean spot volume in ct/ct 
and ct/ctTgGrhl3 strains, whereas both statistically differ from the wild-type strain.   
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3.2.5  Evaluation of differentially abundant proteins from 2-DE analysis 
After evaluation of all the proteins which exhibited differential abundance, certain 
proteins were chosen for further validation (Table 3.8). Proteins were selected on the 
basis of several considerations including the magnitude of the fold change, whether the 
spot was found to vary in different analyses (e.g. using different gel conditions or 
embryonic stages), information from a microarray-based expression analysis recently 
performed in the laboratory (in a parallel project; N. Greene personal communication) 
and possible functional relationship to NTDs or the known cellular defect in curly tail 
embryos. In order to attempt to validate the findings of 2D gel analysis these proteins 
were analysed further by Western blot and/or real-time quantitative polymerase chain 
reaction (RT-qPCR). 
 
One approach to evaluate findings of 2-DE analysis is Western blotting to investigate 
the total abundance of a protein of interest. A protein whose abundance differs between 
strains on a 2-DE spot may also differ on Western blot, thereby validating the 2-DE 
result. However, this may not be an informative approach in every case since an 
individual isoform or post-translational variant of a protein may differ in abundance, 
apparent on a 2D gel, while the overall abundance (i.e., all isoforms pooled) is 
unaltered. 
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Protein  
Gene, 
chr 
pI 
MW 
(kDa)
Comments 
Lamin B1 
Lmnb1, 
18 
4.92, 
5.11 
  66.7 
Strains differ by presence or 
complete absence of spots, 
detectable in all analyses 
Trifunctional purine 
biosynthetic protein 
adenosine-3 
Gart, 16 6.25 107.3 
Involved in folate one-carbon 
metabolism; two different spots 
vary; differential expression in 
microarray 
Transitional 
endoplasmic 
reticulum ATPase  
Vcp, 4 5.14   89.3 
Involved in nuclear envelope 
assembly and cell proliferation 
S-
adenosylmethionine 
synthase isoform 
type-2  
Mat2a, 6 6.02   43.7 
Involved in folate one-carbon; 
altered methylation cycle 
detected in ct/ct embryos; 
differential expression  in 
microarray 
Alpha-2-HS-
glycoprotein 
precursor 
Fetuin-A, 
16 
5.26   38.4 
High fold change; two different 
spots differ on 2D gels  
Fetuin-B 
Fetuin-B, 
16 
5.59   52.6 Paralogue of Fetuin-A 
Ubiquitin-
conjugating enzyme 
E2 
Ube2n,10 6.13   17.1 
Ubiquitin related enzymes 
implicated in NTDs 
 
Table 3.8 Proteins selected for further validation from 2-DE data. Gene 
symbol and mouse chromosome, isoelectric point (pI) and molecular weight 
(MW) are given, as well as information that indicates the reason for further 
analysis. 
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3.2.5.1 Proteomic analysis of Lamin B1 in curly tail embryos  
2D gels generated from ct/ct and +ct/+ct embryos, at the 26-27, 28-29 and 30-31 somite 
stages (ss), allowed picking and identification of proteins that were differently 
expressed between the two strains (Table 3.1). A row of spots, each of which was 
identified as lamin B1 showed an interesting difference in migration on ct/ct and +ct/+ct 
gels (Fig. 3.9 A-B). Three spots present on +ct/+ct gels were not detected on ct/ct gels 
whereas three spots detected on ct/ct gels were not present on +ct/+ct gels. Examination 
of the gel patterns showed that these differences are due to a shift of the lamin B1 spots 
to a more  basic position on ct/ct  gels compared to the lamin B1 spots on the +ct/+ct 
gels (Fig. 3.9 B). This same difference in pattern of lamin B1 spots was detected using 
samples of whole embryos, cranial or caudal regions alone, large or small PNP. 
Immunoblots of 2D gels were carried out using an antibody raised against a peptide 
mapping at the C-terminus of the lamin B1 protein. This allowed further confirmation 
that the gel spots correspond to lamin B1 (Fig. 3.10 A), thereby complementing the 
mass spectrometry analysis.  
 
Samples of the caudal region of ct/ct, +ct/+ct and ct/ctTgGrhl3 strains, at somite stages 28-
29 and 30-31 were used for this analysis (Chapter 2, section 2.6). Commercial 
antibodies (Chapter 2, Table 2.11) were acquired to validate lamin B1 and the other 
seven proteins in Table 3.8. Blots were scanned and target protein expression was 
normalised to β-tubulin and/or Gapdh, by adjusted volumetric measurement (with 
background subtraction), in order to compare the samples (Chapter 2, section 2.6.5). 
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Figure 3.9 Difference in lamin B1 protein migration on 2D gels of +ct/+ct and 
ct/ct samples. (A) Silver stained 2D gels, with isoelectric focussing on pH 3.0 to 
5.6, generated from +ct/+ct and ct/ct embryo samples. Coloured rectangles indicate 
the region encompassing lamin B1 protein spots. (B) Higher magnification of the 
lamin B1 region in +ct/+ct and ct/ct gels (indicated by the green and pink 
rectangles on gels in A), respectively, with a merged and pseudo-coloured image 
below. The spots on the ct/ct gel (indicated by the pink arrows) migrate differently 
from the spots on the +ct/+ct gel (indicated by green arrows). The merged image 
most clearly shows this difference.  
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Lamin B1 spots on 2D gels generated from ct/ct and +ct/+ct samples appeared at similar 
intensity, and western blots of 2D gels suggested that additional lamin B1 spots were 
not present elsewhere on the gels (Fig. 3.10 A). Western blotting analysis on 1D gels 
was also performed to examine the hypothesis that there may be a difference in total 
abundance of lamin B1 between ct/ct, +ct/+ct and ct/ctTgGrhl3 samples. Lamin B1 was 
detected on immunoblots as a band at 67 kDa as expected (Fig. 3.10 B). Overall there 
were no differences between the +ct and ct strains in the total abundance of lamin B1, 
normalised to β-tubulin (Table 3.9).  
 
 
Figure 3.10 Western blots of lamin B1 on 2D and 1D gels. (A) Blotting of 2D 
gels with an antibody to lamin B1 confirmed the identity of the spots identified as 
lamin B1 by mass spectrometry. The number of detectable isoforms varies 
between experiments with three to five spots present on different blots (no 
consistent difference between the number of isoforms detected for each strain was 
apparent). (B) Western blots at the 28-29 (B.1-2) somite stages were used to 
compare lamin B1 abundance in +ct/+ct and ct/ct samples generated from isolated 
caudal regions. The lamin B1 antibody recognises a 67 kDa band. Blots were 
stripped and re-probed with an antibody to ß-tubulin for normalisation (55 kDa 
band in B.2). In each experiment, ratios were calibrated relative to a wild-type 
sample (◊, value 1.0).   
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Protein 
Stage and 
Spot number 
Fold 
change 
Profile 
28-29SS: S8, 
S20, 30-31SS: 
S12 
5.8, 3.9, 
4.8 +
ct > ct ≡ 
ctTgGrhl32D-gel  
28-29SS: S7, 
S36, 30-31SS: 
S20 
6.0, 2.9, 
4.2 ct ≡ ct
TgGrhl3 > 
+ct
N Volume Comments 
+ct 8 2.24 ± 0.92 
Lamin B1 
Western 
blots ct 8 2.23 ± 0.37 
1.1 fold 
+ct ≡ ct 
(No difference) 
    
Table 3.9 Western blot results for lamin B1 protein.  Lamin B1 spots, in 
contrast to other differential abundant proteins on 2-DE, migrated differently in 
ct/ct (and ct/ctTgGrhl3) and +ct/+ct 2D-gels. The spots fit into two different profiles 
for both stages (28-29 and 30-31 somite stage). Western blot analysis comparing 
the two strains at the 28-29 somite stage did not show any difference in the 
expression of lamin B1. Volume indicates the band volume normalised to the 
volume of the corresponding β-tubulin band for that sample (arbitrary units) and is 
given as the mean and standard error. Fold change is between the highest and the 
lowest values.   
 
 
3.2.5.2 Proteomic analysis of Gart in curly tail embryos  
The 2-DE analysis revealed two spots that varied between curly tail and wild-type 
samples and were identified as trifunctional purine biosynthetic protein adenosine-3 
(Gart): S47 (approximately 65 kDa; Fig. 3.11 A) and S41 (approximately 110 kDa). In 
ct/ct and +ct/+ct samples, the antibody against Gart recognised three different band sizes: 
at around 45 kDa, 65 kDa and 110 kDa (the latter is the expected size according to the 
manufacturer; Fig. 3.11 B.1). The 65 kDa band detected on Western blot showed a 
similar greater abundance in wild-type than in curly tail samples, as detected for the 65 
kDa spot on 2D gels (Table 3.10). However, with the sample size used this apparent 
difference was not statistically significant. No difference in intensity of the 110 kDa 
band was observed in comparison of the two strains.   
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Quantitative Real Time RT-PCR (qRT-PCR) was also performed (as described in 
Chapter 2, section 2.7) using two different sets of primers designed against the Gart 
transcripts (Appendix B, Table B.1). The mRNA expression level appeared very 
similar in the ct and ctTgGrhl3 strains while expression was slightly lower in the +ct strain 
but not to a significant degree (Table 3.10). Therefore, differences in Gart protein 
profile appear unlikely to be a direct consequence of transcriptional misregulation. 
 
 
 
Figure 3.11 Evaluation of Gart protein abundance by Western blot. (A) High 
magnification of the region on a 28-29 somite stage 2D-gel image where Gart 
spots are localised: S41 (~110 kDa, red arrow), and S47 (~65 kDa, blue arrow). 
(B) Western blots for Gart on protein samples from 28-29 somite stage ct/ct and 
+ct/+ct embryos. This antibody recognises three major bands (65, 95 and 110 kDa; 
B.1). To measure the volume of the bands for the 110 kDa size-band, the blot had 
to be exposed for a longer period (B.3). Samples were normalised to Gapdh 
protein (38 kDa; B.2, B.4). In each experiment, ratios were calibrated relative to a 
wild-type sample (◊, value 1.0).   
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Protein 
Spot  Fold 
change 
Profile 
S41 2.7 +ct > ct ≡ ctTgGrhl32D-gel 
S47 2.2 +ct > ct ≡ ctTgGrhl3
N Volume Comment 
110 kDa ≡ S41 
+ct 4 0.44 ± 0.19 
ct 7 0.36 ± 0.13 
1.2 fold 
+ct > ct (Not significant) 
65 kDa ≡ S47 
+ct 4 0.83± 0.18 
Western 
blot  
 
ct 7 0.42 ± 0.11 
2.0 fold 
+ct > ct (Not significant) 
Gart - Primer set 1 
+ct 3 1.01 ± 0.08 
ct 3 1.48 ± 0.28 
ctTgGrhl3 3 1.40 ± 0.17 
1.5 fold 
ct ≡ ctTgGrhl3 > +ct
(Not significant) 
Gart – Primer set 2 
+ct 3 1.05 ± 0.13 
ct 3 1.46 ± 0.20 
Gart 
qRT-
PCR 
ctTgGrhl3 3 1.52 ± 0.12 
1.4 fold 
ct ≡ ctTgGrhl3 > +ct
(Not significant) 
 
Table 3.10 Gart protein validation. Gart spots, S41 and S47 (110 and 65 kDa, 
respectively), were both found to be more abundant in +ct than ct on 2D-gels. 
Western blot analysis of Gart in +ct and ct samples shows a similar profile to 2-
DE. Although the strain differences were not statistically significant (t-test), the 
western blot analysis appears to support the 2-DE data. The relative expression of 
Gart mRNA, as determined by qRT-PCR, was very similar in ct and ctTgGrhl3 
strains but lower in the +ct strain although these differences were not statistically 
significant (One Way ANOVA). Both pairs of primers gave similar results. 
Volume indicates the volume of the band on the western blot normalised to the 
volume of the corresponding Gapdh band for that sample (arbitrary units) and 
Gart relative expression in the RT-qPCR is given as the mean and standard error. 
Fold change is between the highest and the lowest values.   
 
 
3.2.5.3 Proteomic analysis of Vcp in curly tail embryos  
Transitional endoplasmic reticulum ATPase or Valosin-containing protein (Vcp), was 
found to be more abundant in +ct than ct samples on 2D gels. This protein migrates at 
approximately 89 kDa, and the same size was recognised by the antibody in Western 
blots (Fig. 3.12 A-B). Vcp total protein expression revealed no difference in abundance 
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between the three strains (1.3 fold difference between +ct and ct), unlike the 2-DE 
analysis which showed a 1.7 fold change for spot S71 (+ct > ct ≡ ctTgGrhl3; Table 3.11).   
 
 
 
Figure 3.12 Validation of Vcp protein by Western blot. (A) High magnification 
of the region where the Vcp spot localises on 2D-gels: S71 (red arrow). (B) 
Western blot of Vcp in protein samples from ct/ct, +ct/+ct and ct/ctTgGrhl3 embryos 
at the 28-29 somite stage. Protein abundance was normalised to Gapdh protein 
using the same blot (38 kDa; B.2). In each experiment, ratios were calibrated 
relative to a wild-type sample (◊, value 1.0). 
 
Protein 
Spot   Profile 2D-gel 71 1.7 fold +ct > ct ≡ ctTgGrhl3
 
N Volume Comment 
+ct 3 1.74±0.62 
ct 3 1.33±0.23 
Vcp Western 
blot 
ctTg 3 1.35±0.54 
1.3 fold 
+ct > ct ≡ ctTgGrhl3
(Not significant) 
 
Table 3.11 Western blot results for Vcp protein.  Total Vcp protein expression 
did not significantly differ between strains on western blot (One Way ANOVA) 
although it was noted that there was a slightly higher apparent abundance in +ct 
than in ct samples (the same profile as was observed on 2-DE). Normalised band 
volumes (determined using Gapdh bands as Table 3.10) are given as the mean 
and standard error (arbitrary units). Fold change refers to the difference between 
the highest and the lowest mean values.  
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3.2.5.4 Proteomic analysis of Fetuin-A in curly tail embryos  
In separate 2-DE analyses, two spots corresponding to Fetuin-A (Fetu-A) were found to 
differ in abundance; spot S52 which migrates at approximately 60 kDa, and differs at 
the 28-29 somite stage, and S8, which migrates at approximately 65 kDa (different at 
the 30-31 somite stage; Fig. 3.13 A-B). Both spots were found to be at lower abundance 
in ctTgGrhl3 samples than the other strains. In samples at the 28-29 somite stage, the 
antibody recognises two bands at around 45 kDa and the expected 59 kDa, 
corresponding to spot S52 (Fig. 3.13 C.1). The latter band was more abundant in ct than 
in ctTgGrhl3 samples as found for 2-DE spot S52, further suggesting that there is a 
difference in protein level between the strains. However, there was major variation 
between individual samples within experimental groups such that this result should be 
treated with caution (Table 3.12). A band corresponding to the same molecular weight 
as spot S8 was not detected by western blot (Fig. 3.13 C.3).   
 
It was previously found there are other isoforms of Fetuin-A present on 2-DE (Fig. 3.7). 
Therefore, it is unclear whether western blot analysis will be of use to validate any 
differences in one or a few Fetuin A spots. Narrow range 2D-gels could be run in order 
to better separate these spots and allow investigation of whether there is a different 
representation of Fetuin-A isoforms in the different strains.  
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Figure 3.13 Analysis of Fetuin-A protein by 2-DE and Western blot. (A-B) 
High magnification of regions of 2D gel that contain spots identified as Fetuin-A 
on 2D-gels: S52 (28-29 ss, 59 kDa; A), and S8 (30-31 ss, 65 kDa; B). (C) Western 
blot of Fetuin-A in samples from ct/ct, +ct/+ct and ct/ctTgGrhl3 embryos at the 28-29 
somite stage (C.1).  The antibody recognises two bands, at ~ 45 kDa and the 
expected 59 kDa. In embryos at the 30-31 somite stage (C.3), the antibody 
recognises a main band ~ 45 kDa with the higher molecular weight band only 
faintly apparent. Therefore, the altered abundance of spot 8 on 2-DE could not be 
validated. The blots were stripped and re-probed with the antibody to Gapdh for 
normalisation (C.2, C.4). Normalised band volumes (determined as described in 
Table 3.9) were calibrated relative to a wild-type sample (◊, value 1.0). 
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Protein 
Spot  Fold Profile 2D-gel 52 2.1  ct > +ct ≡ ctTgGrhl3
 
N Volume Comment 
+ct 3 0.30±0.35 * 
ct 3 5.95±4.13 
Fetuin-A Wester
n blot 
ctTgGrhl3 3 2.86±2.26 
2.1 fold 
ct  > ctTgGrhl3
(Not significant) 
 
Table 3.12 Western blot results for Fetuin-A protein.  A band corresponding to 
the same molecular weight as Spot 52 (59 kDa), identified as Fetuin-A protein, 
showed a difference between the ct and ctTgGrhl3 strains with the same magnitude 
of difference as observed on the 2-DE analysis. However, there was considerable 
inter-sample variation (with correspondingly high standard errors) and the 
difference was not significant (One Way ANOVA). Normalised band volumes 
(determined using Gapdh bands as described in Table 3.9) are given as the mean 
and standard error (arbitrary units). The indicated fold change is that between the 
ct and ctTgGrhl3 samples.  * In some cases +ct samples on the 
Western blot gave a barely detectable band with the Fetuin-A antibody and the 
quantitative data were not considered reliable.   
 
 
3.2.5.5 Proteomic analysis of Fetuin-B in curly tail embryos  
A paralogue of Fetuin-A, Fetuin-B (S60), was also identified as differentially abundant 
on 2D gels (Spot S60). Fetuin-B was detected at 28-29 somite stage as S60 which 
migrated at approximately 55 kDa (Fig. 3.14 A). This spot was found to be at lower 
abundance in ctTgGrhl3 samples than in the other strains. In samples from embryos at the 
28-29 somite stage, the antibody recognises a band at around 55 kDa (Fig. 3.14 B.1). A 
first analysis showed the opposite result than predicted i.e., the Fetuin B band was 
apparently more abundant in ctTgGrhl3 than in the ct and +ct strains (1.5 fold difference; 
Table 3.13). However, as observed for Fetuin-A, there was a major variation between 
individual samples within experimental groups (i.e., more abundant in ct sample 2 or 
less abundant in ct sample 3 and +ct sample 7; Fig. 3.14 B.1).  To further investigate 
this result, another Western blot was performed to compare +ct and ct individuals only 
(Fig. 3.14 B.3). A similarly variable result was obtained, e.g., curly tail samples 7 and 
8, and wild-type sample 9 contained higher levels of this protein than the other samples 
mean volume for 
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of the same strains (Fig. 3.14 B.3). In this experiment, +ct seems to express more 
Fetuin-B at the total protein level, compared to ct (1.9 fold; Table 3.13). Overall, 
western blot analysis of the fetuin proteins (A and B) did not provide evidence that there 
is a consistent difference in abundance of these proteins in the strains examined. 
 
 
 
Figure 3.14 Evaluation of Fetuin-B protein by 2-DE and Western blot. (A) 
High magnification of the region of that contains spot S60, identified as Fetuin-B, 
on 2D gel generated from a 28-29 somite stage embryo. (B) Western blots of 
Fetuin-B in samples from 28-29 somite stage ct/ct, +ct/+ct and ct/ctTgGrhl3 embryos, 
with two different experiments shown (B.1, B.3).  The antibody recognises a band 
at approximately 55 kDa. Similar to Fetuin-A, Fetuin-B is shows variable 
abundance (e.g. higher in samples 2 and 9 in B.1; and 7-9 in B.3) in individual 
samples independently of strain, rather than a general up- or down-regulation 
within a strain. The blots were stripped followed by re-probing with an antibody 
to Gapdh for normalisation (B.2, B.4). Normalised band volume ratios were 
calibrated relative to a wild-type sample (◊, value 1.0). 
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Protein 
Spot Fold 
change 
Profile 
2D-gel 
60 1.9 fold ct > +ct ≡ ctTgGrhl3
WB - B.1-B.2 
N Volume Comment 
+ct 3 0.49 ± 0.28 
ct 4 0.85 ± 0.35 
ctTg 2 1.24 ± 0.56 
1.5 fold - ctTgGrhl3  > ct 
2.5 fold - ctTgGrhl3  > +ct
(Not significant) 
WB - B.3-B.4 
+ct 3 31.38 ± 16.6
Fetuin B 
Western 
blot 
ct 6 11.96 ± 6.80
2.6 fold 
+ct >ct (not significant) 
 
Table 3.13 Western blot analysis of Fetuin-B protein. Two different 
experiments were performed for this 55 kDa protein as shown in Figure 3.14 
(B.1-B.2, B3-B4). It should be noted that there was considerable variability in 
fetuin-B level between samples such that no differences between strains were 
statistically significant (One Way ANOVA). In contrast to observations on the 
2D-gels, the total protein expression was apparently lower in ct/ct compared to 
ct/ctTgGrhl3 (ctTg), and still lower in +ct (2.5 fold). As some ct/ct and +ct samples 
had undetectable levels of Fetuin-B, a second experiment was performed using 
only samples of these two strains. In this case, Fetuin-B seemed to be present at 
higher level in +ct than in ct samples (2.6 fold difference, although not statistically 
significant). Volume refers to band volume normalised to the Gapdh band (as in 
Table 3.10). Values are given as the mean and standard error. Fold change 
indicates the difference between the highest and the lowest volume values.   
 
 
3.2.5.6 Proteomic analysis of Mat2a in curly tail embryos  
A spot migrating at approximately 43 kDa (S76; Fig. 3.15 A) and corresponding to S-
adenosylmethionine synthase isoform type-2 (Mat2a) protein was detected in the 2D 
analysis as being more abundant in the wild-type strain. On Western blots the antibody 
to Mat2a recognised a band of the expected size (43 kDa; Fig. 3.15 B.1) and this was 
present at 1.9 fold higher abundance in +ct compared to ct samples, apparently 
validating the 2-DE findings (Table 3.14). However, this difference was not statistically 
significant, probably owing to the small sample size and variability between samples, 
and the statistical test did not have sufficient power. Therefore, additional western blots 
would be necessary to establish whether the total Mat2a abundance truly differs 
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between strains.  Surprisingly, Mat2a protein expression was apparently down-regulated 
in ctTgGrhl3 (2.8 fold lower level than in +ct). To further investigate the difference 
between the +ct and ct strains, the Mat2a antibody was used for western blot of 7 cm 2D 
gels, using a narrow pH range (6.1-7.0) for isoelectic focussing to better separate the 
protein spots (Fig. 3.15 C-D). Mat2a blots for both, ct and +ct, show the antibody 
recognises more than one protein spot. These could represent either isoforms (e.g. with 
different post-translational modifications) or lack of specificity of the antibody. 
Consequently, there may be a difference between data obtained by Western blot, which 
detects total levels of protein expression, and 2-DE where one Mat2a spot was 
differently abundant 
 
As another approach, qRT-PCR was performed using cDNA extracted from the caudal 
region of ct/ct, +ct/+ct and ct/ctTgGrhl3 embryos. A set of primers was designed to amplify 
part of the 3’UTR of Mat2a (Appendix B, Table B.1) and qRT-PCR was performed as 
described in Chapter 2, section 2.7. This did not show any significant difference in 
Mat2a expression between strains (Table 3.14). However, there was a trend towards 
lower expression in ct then in +ct samples, as observed on 2-DE. Given the relatively 
small fold-change detected in 2-DE analysis it may be necessary to analyse a much 
larger number of samples by qRT-PCR to test whether there is really a difference in 
expression at the mRNA level. 
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Figure 3.15 Evaluation of Mat2a protein abundance by Western blot and 2D-
blots. (A-B) High magnification of the region of a 2D gel, generated from a 28-29 
somite stage embryo, that includes the differentially abundant spot (S76) 
identified as Mat2a. (B) Western blot of Mat2a in samples from 28-29 somite 
stage ct/ct, +ct/+ct and ct/ctTgGrhl3 embryos. The antibody recognises a band at 
approximately 43 kDa. (C) Silver stained 7 cm-2D gel with first dimension 
separation on pH 6.1-7.1. The red arrow indicates molecular weight of Mat2a (43 
kDa). (D) Four different 7 cm 2D gels generated from +ct/+ct and ct/ct embryo 
samples and western blotted with the antibody to Mat2a. The black arrowhead 
indicates a parallel 1D lane on the gel which provides an indication of total 
protein loading. In all blots, the antibody detects two or more spots which may 
represent multiple isoforms of Mat2a.  
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Protein 
Spot  Profile 
76 1.6 fold +ct ≡ ctTgGrhl3 > ct  2D-gel 
N Volume Comment 
+ct 3 1.98 ± 0.82 
ct 4 1.02 ± 0.12 Western blot ctTg 2 0.72 ± 0.69 
2.8 fold  
+ct > ctTgGrhl3   
(Not significant) 
N  Relative 
expression 
Comment 
+ct 2 1.14 ± 0.14 
ct 6 0.80 ± 0.10 
Mat2a 
 
RT-qPCR 
ctTg 3 0.77 ± 0.03 
1.4-1.5 fold  
+ct > ct ≡ ctTgGrhl3  
(Not significant) 
 
Table 3.14 Western blot and qRT-PCR results for Mat2a. Mat2a was found to 
be down-regulated in the 2D gels from ct samples compared with the other strains. 
On Western blots total Mat2a protein level apparently differed between strains but 
these differences were not statistically significant (One Way ANOVA). 
Normalised band volumes (determined using ß-tubulin bands as Fig 3.15) are 
given as the mean and standard error (arbitrary units). Fold change refers to the 
difference between the highest and the lowest mean values. In addition, qRT-PCR 
was performed to investigate the possibility of a difference in Mat2a mRNA 
between strains level: the mean values are very similar in ct and ctTgGrhl3 samples 
and overall lower than in the +ct strain but these differences are not statistically 
significant. Volume refers to the normalised band volume (arbitrary units) and 
both band volumes and relative expression levels in qRT-PCR are given as mean 
and standard error. Fold change describes the difference between the highest and 
the lowest values. These differences were not significant (One Way ANOVA). 
 
 
3.2.5.7 Proteomic analysis of Ube2n in curly tail embryos  
The Ubiquitin-conjugating enzyme E2 (Ube2n), is a low molecular weight protein 
migrating at approximately 17 kDa on 2D gels. This protein was present at higher 
abundance on ctTgGrhl3 gels than gels for the other strains at the 28-29 somite stage. 
Unfortunately, after testing a commercially available antibody against Ube2n protein 
under different conditions, a specific band of the expected differential expression was 
not detected. Therefore, primers were designed for RT-qPCR amplification of a region 
of the Ube2n coding sequence. Ube2n mRNA expression analysis showed marginal up-
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regulation in the ct strain compared to the other two strains, including ctTgGrhl3 (Table 
3.15). Hence, RT-qPCR did not reproduce the finding on 2D-gels. 
 
Protein 
Spot  Profile 2D-gel 96 1.5 fold ctTgGrhl3 > +ct  ≡ ct  
 
N Relative 
expression 
Comment 
+ct 3 0.84±0.19 
ct 3 1.13±0.11 
Ube2n 
RT-qPCR 
ctTg 3 0.69±0.09 
1.6 fold  
ct  > ctTgGrhl3   
(Not significant) 
 
Table 3.15 Quantitative real time RT-PCR analysis of Ube2n. In contrast to 
findings on 2-DE, Ube2n mRNA levels were not higher in ctTgGrhl3 samples than 
the other strains. In fact there was a trend towards higher expression in ct than in 
ctTgGrhl3 samples, although this was not a statistically significant difference (One 
Way ANOVA). Relative expression is given as mean and standard error and the 
fold change refers to the difference between the highest and the lowest values.   
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3.3  Discussion 
 
In order to perform proteomic analysis of curly tail embryos it was first necessary to 
optimise the 2-DE protocol for embryo samples using large format 10-gel and 12-gel 
tanks. Previous experiments on neurulation-stage mouse embryos had made use of gel 
equipment in another laboratory (Greene et al., 2002), and initial experiments suggested 
that modification of running conditions was necessary. Key considerations for 
production of high quality 2D gels were found to be avoidance of heating or bubbling of 
samples during the homogenisation step, concentration of CHAPS in lysis and 
rehydration buffers, and selection of second dimension electrophoresis conditions to 
allow maintenance of the buffer at 10°C. Finally, the silver staining conditions were 
changed to increase the incubation time for each step. These conditions resulted in 2D 
gels with approximately 4,000 well resolved proteins. In combination with use of 
software that provides semi-automatic gel alignment and for inter-gel calibration, the 2-
DE analysis of curly tail embryos was sufficiently robust and sensitive to detect changes 
in abundance of spots and subtle shifts in migration. 
 
Most 2D gels analysed in this study were silver-stained, which although time 
consuming, is a sensitive method, and suitable for manual picking of spots for 
proteolytic digestion and mass spectrometry analysis of the resulting peptides. 
Fluorescent stains such as SYPRO Ruby protein gel stain gave a very similar protein 
spot pattern to that observed with silver stain. Thus, SYPRO gave the same sensitivity 
as silver, but has the advantage of increased dynamic range for quantification of spot 
volume. The drawback with SYPRO Ruby stain was the creation of background 
speckles which were frequently detected as spots by the analysis software. An 
alternative approach could be the use of Deep Purple fluorescent stain, which is reported 
to have a dynamic range equivalent to SYPRO Ruby, similar sensitivity to silver 
staining, and does not give background speckles (Tannu et al., 2006). Alternativelly, a 
more accurate quantification would involve the use of 2D Fluorescence Difference Gel 
Electrophoresis (DIGE), in which protein samples are pre-labeled with different 
fluorophors, and a combined sample labelled with a third fluorophor for use as internal 
standard. The samples are then mixed prior to co-separation on the same gel, with 
visualisation by scanning with the gel still in the gel cassette. The co-separation and 
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absence of a separate staining step improves reproducibility, while the internal standard 
increases the accuracy of quantification. In addition, use of fluorophors offers the same 
advantages of sensitivity and dynamic range as fluorescent stains. In the latter stages of 
the project, DIGE was used to analyse samples from curly tail embryos treated in vivo 
with inositol compared with untreated curly tail. These preliminary experiments (not 
reported) suggest that DIGE will be a useful approach for detection of subtle changes in 
protein abundance or post-translational modification. 
 
2-DE analysis at the 28-29 somite stage revealed more spots that show greater 
abundance in wild-type than curly tail samples than vice-versa. In contrast, at the 30-31 
somite stage a greater number of spots showed higher abundance in ct gels than in the 
+ct and ctTgGrhl3 gel strains. The reason for this difference is not known but it could be 
speculated that as PNP closure is nearly complete or complete in wild-type and 
transgenic embryos at the 30-31 somite stage, there may be associated changes in 
protein expression. A temporal analysis of closure within either of these strains might 
address this question. At both stages the abundance of a number of spots correlated with 
genetic background rather than predicted Grhl3 expression level, for example,  +ct > ct 
≡ ctTgGrhl3 (Profile 2) or ct ≡ ctTgGrhl3 > +ct. Alternatively, some of these spots may differ 
in expression due to a downstream effect of the reduced Grhl3 expression in curly tail 
embryos that is not rescued in the transgenic, perhaps due to differences in the exact 
timing or level of Grhl3 expression from the BAC compared to the endogenous locus. 
 
Proteins were chosen for validation based on the possible relationship between their 
biological function and the cellular defect in curly tail and/or NTDs, parallel data from a 
microarray study and the magnitude of change in protein abundance. A difference in 
abundance of an individual 2D gel spot between samples could result from a 
corresponding alteration in the total abundance of that protein. Alternatively, a 
difference in the charge or mass of that protein, for example owing to post-translational 
modification, could alter protein migration with the result that a spot at a particular 
location shows differential abundance. Western blotting, using commercially available 
antibodies, was therefore used to evaluate total protein levels. In some cases, for 
example trifunctional purine biosynthetic protein adenosine-3 (Gart), a similar 
difference in protein abundance was observed between samples by 2-DE and Western 
blot. However, in other cases, such as lamin B1, major differences in abundance of 
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specific protein spots was not reflected in a difference in overall protein abundance. 
Inspection of 2D gels showed that this was due to a shift in migration of lamin B1 spots. 
In a few cases RT-qPCR was performed to test whether there was a correlation between 
the observed change in protein abundance and expression at the mRNA level. Such a 
change would be predicted if expression of the candidate protein was downstream of 
transcriptional regulation by Grhl3.  
 
The proteomic analysis of curly tail and wild-type embryos by 2-DE in the present 
study revealed a differential abundance of proteins which can be broadly divided into 
functional groups: cell cycle, metabolic pathways, DNA repair, ubiquitination, 
cytoskeleton. In the current study one protein, lamin B1, has been investigated further in 
detail (Chapter 4). Other proteins are potentially of biological interest in the context of 
the development of NTDs in curly tail embryos, although not all 2-DE changes have yet 
been validated by Western blot.  
 
The transitional endoplasmic reticulum ATPase (Vcp, or p97, or CDC48) and lamin B1 
have been implicated in cell cycle function. They are both present in greater abundance 
in wild-type than curly tail samples (+ct > ct ≡ ctTgGrhl3). Other lamin B1 spots were 
found at greater abundance in curly tail than wild-type (ct ≡ ctTgGrhl3 > +ct), and these 
reciprocal differences were later found to result from differential migration of lamin B1 
spots rather than differences in total protein abundance. Vcp/p97 plays several roles, it 
is involved in cell cycle progression through mitosis and is necessary for the formation 
of a closed nuclear envelope and subsequent expansion of the nuclear envelope (Hetzer 
et al., 2001). Vcp/p97 deficiency resulted in early embryonic lethality in null mutants 
showing that Vcp/p97 is an essential protein in early mouse development (Muller et al., 
2007). On 2-DE analysis, Vcp was found to be down-regulated in curly tail embryos 
compared with wild-type. That is an interesting finding since the cellular defect in curly 
tail embryos is a cell-type specific proliferation defect. Western blot analysis also 
suggested that there is a difference between strains, although the magnitude of this 
change was smaller than that observed on 2-DE.  
 
In the case of lamin B1, comparison of strains showed a difference in protein migration 
in curly tail and wild-type samples, rather than in total protein abundance. Lamin B1 
belongs to the family of intermediate-type filament proteins, which are key structural 
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components of the nuclear lamina, a complex polymer underlying the inner nuclear 
membrane of the nuclear envelope (Stuurman et al., 1998). The nuclear envelope is 
thought to be important for nuclear stability, cell cycle regulation, chromatin 
organisation, DNA replication, cell differentiation, apoptosis and regulation of gene 
expression (Schirmer et al., 2001; Goldman et al., 2002; Hutchison, 2002b; Malhas et 
al., 2007; Malhas et al., 2009). Vertebrate lamins have been classified into A/C and B 
types based on primary sequences and biochemical properties, and four lamins (A, B1, 
B2, and C) are commonly found in mammalian somatic cells (Stuurman et al., 1998). 
Lamins are associated with the inner nuclear membrane (INM) of the interphase cell 
and just before mitosis starts, the nuclear envelope and nuclear lamina disassemble for 
chromosomal segregation. During this period, Lamin B1 remains attached to 
endoplasmic reticulum vesicles, while A-type lamins are dispersed as soluble proteins 
and later incorporated into the nuclear lamina during post-mitotic nuclear assembly 
(Hutchison et al., 1994).   
 
Lamin B1 was the only protein for which a significant difference in abundance of 
protein spots corresponded to the presence or complete absence of a particular spot, and 
for which a likely shift in migration was apparent by comparison of gel patterns. The 
altered migration of lamin B1 in ct/ct samples represented the loss of a negative charge, 
since the spots shift to a more basic position on the gels compared to the +ct/+ct lamin 
B1 (Fig. 3.9 B). Western blotting showed there was no significant difference in the total 
levels of the lamin B1 protein between the two strains. So what could be the cause of 
altered migration of the ct/ct lamin B1 protein and could this shift play a role in the 
pathogenesis of neural tube defects (NTDs) in ct/ct embryos? These questions will be 
investigated in Chapter 4. 
 
Proteins involved in folate one-carbon metabolism and associated metabolic pathways 
(Fig. 3.16) are potentially of relevance to the study of the curly tail phenotype. NTDs in 
curly tail are not preventable by folic acid, or other related molecules (Van Straaten and 
Copp, 2001). On the other hand, dietary folate deficiency increases the frequency of 
cranial NTDs in both ct/ct and +ct/+ct embryos (Burren et al., 2010), suggesting an 
interaction with the genetic background. Notably, the response of the methylation cycle 
(as shown by ratio of abundance of s-adenosylmethionine to s-adenosylhomocysteine) 
to folate-deficient conditions is atypical in curly tail embryos, showing an increase 
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rather than a decrease as observed in wild-type embryos (de Castro et al., 2010). 
Inhibition of the methylation cycle has previously been shown to cause cranial NTDs in 
non-mutant embryos (Dunlevy et al., 2006a). Thus, while diminished methylation cycle 
activity appears unlikely to be the cause of cranial NTDs in folate-deficient conditions, 
it is possible that there is an as yet undefined imbalance in folate one-carbon 
metabolism in curly tail embryos (de Castro et al., 2010).  
 
Folate one-carbon metabolism plays several important cellular roles as it is required for 
nucleotide biosynthesis and provision of methyl units for methylation reactions as well 
as being interconnected with other metabolic pathways (Fig. 3.16). Proteins involved 
with both nucleotide synthesis and methylation reactions were found to be differentially 
abundant in the proteomic analysis in the current study. 
 
For example, the trifunctional purine biosynthetic protein adenosine-3 (Gart) catalyses 
the synthesis of formylglycinamide ribonucleotide in the purine synthetic pathway, with 
donation of a one-carbon unit from 10-formyl-tetrahydrofolate (Deacon et al., 1985). 
Purine nucleotides function as precursors for RNA and DNA synthesis, coenzymes, and 
as substrates for mitochondrial ATP synthases, Atp5b and Atp5o. The diminished 
abundance of Gart in curly tail samples (+ct > ct ≡ ctTgGrhl3) raises the possibility that 
purine synthesis may be impaired, which could contribute to reduced cellular 
proliferation and/or sensitivity to folate deficiency.  
 
The folate cycle supplies methyl units to the methylation cycle from 5-
methyltetrahydrofolate. This is important for ensuring an adequate supply of S-
adenosylmethionine which acts as a methyl donor in a wide range of methyltransferase-
mediated reactions which result in methylation of DNA, RNA, lipids, hormones and 
proteins (Scott and Weir, 1994). Two proteins found to differ in abundance in the 
proteomic analysis of curly tail embryos function in the methylation cycle or 
methylation reactions. S-adenosylmethionine synthase isoform type-2 (Mat2a) catalyses 
the formation of S-adenosylmethionine from methionine and ATP. In this study Mat2a 
protein was present at lower level in curly tail than wild-type embryos (+ct ≡ ctTgGrhl3 > 
ct) this correlated with a difference in mRNA expression level.  
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NSun2 (tRNA (cytosine-5-)- methyltransferase; Misu) is a methyltransferase  acting on 
RNA and possibly DNA (Sakita-Suto et al., 2007), and its activity thus depends on 
supply of S-adenosylmethionine from the methylation cycle as methyl donor. A role for 
NSun2 in cell cycle progression has been suggested by studies showing that it acts 
downstream of c-Myc to regulate epidermal cell proliferation (Frye and Watt, 2006). 
This function appears to be mediated through stabilisation of the mitotic spindle 
(Hussain et al., 2009). Interestingly, NSun2 was another protein (like Vcp and lamin 
B1) that was differentially represented in the proteomic analysis and may be implicated 
in the proliferation defect observed in curly tail embryos (+ct > ct ≡ ctTgGrhl3). 
  
 
Figure 3.16 Diagrammatic summary of folate one-carbon metabolism. The 
main function of the folate cycle (in black) is to accept one-carbon units from 
donor molecules and pass them on via various biosynthetic reactions. 10-formyl-
tetrahydrofolate donates C-2 and C-8 to the purine ring during purine 
biosynthesis, in reactions catalysed by Gart (in brown box). Folate is essential for 
the DNA biosynthesis cycle (cell replication; cycle in purple). The folate cycle is 
the methyl donor to the methylation cycle (cycle in blue). Methyl groups are 
donated from 5-methyltetrahydrofolate to remethylate homocysteine back to 
methionine in a reaction catalysed by methionine synthase. Methionine is 
converted to s-adenosylmethionine by the action of Mat2a (in blue box), which is 
the methyl donor for the various cellular methylation reactions (catalysed by 
methyltransferases such as NSun2). Abbreviation: MTHFR, 5, 10 -
methylenetetrahydrofolate reductase.  
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Several varying proteins in the proteomic analysis have possible involvement in the 
response to cellular/oxidative stress including nucleobindin-1 (Nucb1), superoxide 
dismutase (Sod1), fetuin-A (alpha-2-HS-glycoprotein), and fetuin-B. Cellular stress 
conditions such as altered redox status, increased protein synthesis, expression of 
misfolded proteins, and perturbation of calcium homeostasis can induce an endoplasmic 
reticulum (ER) specific stress response (Teixeira et al., 2006). There are three signal 
transduction pathways involved: the inositol-requiring enzyme 1 (IRE1), activating 
transcription factor 6 (ATF6), and double-stranded RNA-activated protein kinase-like 
ER kinase (PERK). Nucleobindin-1 is the major calcium-binding protein of the Golgi 
and a repressor of the S1P (site-1 protease)-mediated ATF6 activation. Nucb1 is an ER 
stress-inducible gene with the promoter region having functional cis-elements for 
transcriptional activation of ATF6. Knock-down of NUCB1 by siRNA accelerates 
ATF6 cleavage during ER stress (Tsukumo et al., 2007).  
 
Superoxide dismutase (Sod1) gene is expressed throughout mouse embryogenesis, 
including the neural folds and neural tube at E7.5-10.5 (Yon et al., 2008). Its main 
function is to destroy toxic free radicals which are normally produced within cells and 
have been implicated in diabetes-induced teratogenesis, which includes increasing risk 
of NTDs (Loeken, 2005). Correlating with oxidative stress, Sod1 activity was found to 
be elevated in embryos exposed to diabetic conditions (Dheen et al., 2009). Both Nucb1 
and Sod1 are up-regulated in the transgenic strain (in relation to the wild-type strain, 
ct/ctTgGrhl3 > ct/ct > +ct/+ct, and ctTgGrhl3 > +ct ≡ ct), perhaps suggesting that elevated 
Grhl3 expression is associated with oxidative stress, a possibility which needs to be 
further investigated. 
 
At the 28-29 somite stage, both fetuins A and B, were found to be up-regulated in curly 
tail embryos compared to the wild-type and transgenic strains (ct > +ct ≡ ctTgGrhl3). 
However, western blotting analysis showed considerable variation in abundance 
between individual embryos, even within strains, suggesting that the 2-DE differences 
may not represent a generalised differential expression. Fetuin-A is an abundant serum 
protein which acts as an inhibitor of spontaneous calcium phosphate precipitation, by 
forming soluble colloidal calciprotein particles that contain fetuin, calcium, and 
phosphate (Heiss et al., 2003). Other functions attributed to this protein include 
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inhibition of insulin receptor tyrosine kinase activity, and protease inhibitory activity in 
the recovery phase of acute inflammatory response (Olivier et al., 2000).  
 
Most of the proteins identified to be differentially expressed in curly tail and wild-type 
strains by 2-DE analysis could be potential targets of protein kinase C (PKC) or be 
involved in the inositol phospholipid pathway. Since the normalising effect of inositol 
treatment on neural tube closure in curly tail embryos is mediated through activation of 
PKC (Greene and Copp, 1997), it is an interesting possibility that one or more of the 
key PKC targets could be proteins whose expression is misregulated in curly tail. For 
example, lamin B1 is both a substrate of PKC isoforms and a PKC-binding protein 
(Martelli et al., 2000; Tabellini et al., 2002), while moesin, an actin binding protein, is 
phosphorylated by PKC-θ in the actin-binding domain (Pietromonaco et al., 1998). 
Another differentially expressed protein, Vcp, binds phospholipids (preferably 
phosphatidylinositol mono-biphosphates) through its N-terminal domain (Waugh et al., 
2003) and protein function could be affected by alterations in inositol phospholipid 
levels.  
 
Overall, 106 spot-differences were detected in the 2D-gel analysis of the caudal region 
of curly tail embryos compared to background matched wild-type and Grhl3-transgenic 
curly tail strains (48 differences at the 28-29 somite stage and 58 at the 30-31 somite 
stage). Given that an average of 2000 total spots were detected on these gels, it does not 
appear that there are massive differences between the proteome of curly tail and wild-
type caudal regions. This is perhaps to be expected since curly tail carries a 
hypomorphic, as opposed to completely null, allele of Grhl3 which confers diminished 
Grhl3 expression. In addition, the embryos were analysed at or immediately after the 
stage when defective neural tube closure becomes apparent, thereby minimising the 
possible detection of secondary changes owing to the presence of spina bifida. Finally 
the closely matched genetic background of the strains should minimise non-specific 
changes. Among the 106 differentially abundant protein spots, the fold-change in 
abundances were not dramatic (maximum two-fold), with the exception of the lamin B1 
protein, perhaps suggesting that a combination of subtle changes in a few proteins might 
contribute to the neurulation defect. However, it is important to consider that spots 
identified on 2-DE represent the most abundant proteins in the sample and it is possible 
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that some of the undetected proteins change more significantly in abundance than the 
detectable ones.   
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Chapter 4 
 
 
Studies of lamin B1 protein variants and their effect on 
development of neural tube defects 
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4.1 Introduction 
 
Investigation of the possible causes of NTDs in curly tail embryos by two-dimensional 
gel protein electrophoresis revealed altered migration of lamin B1 protein in curly tail 
samples compared to wild-type samples (Chapter 3). In the studies described in this 
chapter, the variation in lamin B1 was further analysed and its possible involvement in 
the pathogenesis of NTDs was investigated.     
 
Lamin B1 is a 67 kDa protein, comprising a central rod domain separated by flexible 
linker regions with globular head and tail domains (Fig. 4.1 A). The tail-domain 
harbours a nuclear-localisation signal sequence necessary for nuclear import and a 
CAAX-box motif (C, cysteine; A, any aliphatic amino acid; and X, any other residue), 
which is processed in a series of post-translational modifications (PTMs; Fig. 4.1 B). 
First, the cysteine is subject to farnesylation, which is important for the peripheral 
localization and membrane association of the lamins. This process is followed by 
endoproteolysis, which removes the three C-terminal amino acids, and subsequent 
carboxymethylation increases the hydrophobicity of the carboxyl terminus and may 
stabilize the membrane association. Both endoproteolysis and carboxymethylation are 
dependent on farnesylation of the cysteine residue and are membrane-associated 
processing events (Dai et al., 1998; Otto et al., 1999). Consequently, lamin B1 remains 
stably associated with the lamina and with the inner nuclear membrane (Stuurman et al., 
1998; Maske et al., 2003). Deficiency in endoproteolysis or in methylation processing 
results in loss of integrity and deformity of the nuclear lamina (Maske et al., 2003). 
Furthermore, deficiencies of CAAX processing enzymes result in severe phenotypic 
changes in mouse models. For example, Rce1 (endoprotease)-deficient mice died during 
gestation or soon after birth (Kim et al., 1999). A more severe phenotype was observed 
in isoprenylcysteine carboxyl methyltransferase (Icmt) deficient mice and knockout 
embryos died by mid-gestation (Bergo et al., 2001).  
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Figure 4.1 Schematic diagrams showing the structure and processing of the 
lamin B1 protein. (A) Lamin B1 has three domains. The head and tail domains 
mediate polymer assembly whereas the central rod, comprising four coiled-coil 
domains (C1A, C1B, C2A, C2B) separated by flexible linker regions (L1, L12, 
L2), mediates lamin dimerization. Phosphorylation sites (P) flank each end of the 
α-helical rod domain. Specific conserved serine (or threonine) residues are 
phosphorylated during mitosis, associated with disassembly of the nuclear lamina 
meshwork concomitant with NE breakdown. Importantly, the tail domain 
harbours a nuclear localisation signal (NLS) sequence necessary for nuclear 
import, and a CAAX box that is post-translationally modified. (B) The processing 
of lamin B1 protein to the mature form involves a series of posttranslational 
modifications of the CAAX motif. First, a farnesyl moiety is attached to the thiol 
group of the cysteine (C) by the protein farnesyltransferase (PFT). Next, the 
terminal three amino acids (AAX) are removed by the endoprotease Rce1. Finally, 
the carboxylate anion of the carboxyl-terminal farnesylcysteine is methylated by 
the isoprenylcysteine carboxyl methyltransferase (Icmt).  
 
Lamins localised within the NE can interact with chromatin, nuclear pore proteins, and 
integral proteins of the inner and outer nuclear membranes (Fig. 4.2; (Glass and Gerace, 
1990). The nuclear envelope derives its structural integrity from higher order lamin-
lamin interactions mediated by the coiled-coil domains (McKeon et al., 1986; Heins and 
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Aebi, 1994). In addition, lamins and their associated proteins are proposed to have roles 
in large-scale chromatin organisation, the spacing of nuclear pore complexes (NPCs), 
the positioning of the nucleus in cells and the reassembly of the nucleus after mitosis 
(Gerace and Foisner, 1994; Gruenbaum et al., 2005).  
 
         
Figure 4.2 Schematic diagram of the nuclear envelope (NE). The NE consists 
of the inner (INM) and outer (ONM) nuclear membranes, nuclear pore complexes 
(NPC) and the nuclear lamina. The ONM is continuous with the smooth and 
rough endoplasmic reticulum (SER and RER). NPCs mediate trafficking of 
macromolecules between the cytoplasm and the nucleus. The nuclear lamina 
(NL), which is adjacent to the INM, is a fibrillar meshwork providing an 
attachment site at the nuclear envelope for interphase chromatin. The lamina 
consists of polypeptides called lamins (A, B1, B2, and C), members of the 
intermediate filament protein superfamily. Lamins interact not only with 
chromatin, nuclear pore proteins or NPCs directly, but also with integral 
membrane proteins (e.g., lamin B receptor, LBR; lamina associated polypeptide-
2β, Lap-2β).  
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Essential nuclear functions also depend on lamins, notably DNA replication and RNA-
polymerase-II-dependent gene expression (Moir et al., 1994). Interestingly, Malhas et al 
(2007) found that the stable association of the nuclear lamina with chromatin is 
important for regulation of gene expression. Their study showed that either absence of 
full-length lamin B1 or lack of the C-terminal processing affects gene expression and 
some of the dysregulated genes were clustered on certain chromosomes. Hence, loss of 
interaction with the nuclear lamina is thought to affect chromosome position within the 
nucleus, and therefore gene expression. Subsequently, interaction of lamins with 
chromatin and transcription factors has been shown to play a direct role in 
transcriptional regulation (Malhas et al., 2009). For example, sequestration of the 
octamer transcription factor 1 (Oct-1), at the nuclear periphery by lamin B1 might be a 
mechanism by which the nuclear envelope can regulate gene expression and contribute 
to the cellular response to stress, development, and ageing.  
 
Dozens of disease-causing mutations in Lamin A (LMNA) have been catalogued (Capell 
and Collins, 2006; Worman and Bonne, 2007; Worman et al., 2009). In contrast only 
two diseases have been described as possible laminopathies of the B type lamins. Until 
recently it had been presumed that mutations in B-type lamins would result in 
embryonic lethality, because these lamins are primary components of the nuclear lamina 
in undifferentiated cells. Knockdown of either lamin B1 or lamin B2 with small 
interfering RNAs (siRNAs) in cultured cells inhibited cell growth and promoted 
apoptosis, suggesting that both genes are essential for viability, whereas reduced 
expression of the A-type lamins had no appreciable effect on cell growth (Harborth et 
al., 2001). However, rare novel mutations in LMNB2 have been identified in patients 
with Barraquer-Simons syndrome, an acquired partial lipodystrophy (Hegele et al., 
2006), and duplications in LMNB1 have been found to cause the adult-onset 
demyelinating condition known as autosomal dominant leukodystrophy (ADLD, 
(Padiath et al., 2006; Meijer et al., 2008).  
 
There are no reports of a possible involvement of lamins in neural tube closure. Mouse 
models of laminopathies, which model different human mutations in lamin A, resulted 
in progeria, muscular dystrophy and dilated cardiomyopathy (Stewart et al., 2007). In 
vitro, a deletion in the rod domain of lamin B1 resulted in nuclei becoming lobulated, 
associated with a patchwork accumulation of lamins, together with clustering of nuclear 
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pore complexes and other NE proteins (Schirmer et al., 2001). In vivo, mice that are 
homozygous for a gene-trap allele of Lmnb1 survived embryonic development but died 
at birth with defects in the lungs and bone (craniofacial dysmorphology and a variety of 
skeletal abnormalities). In addition, fibroblasts from mutant embryos had grossly 
misshapen nuclei with frequent blebs, reduced replication rates, impaired 
differentiation, and premature senescence (Vergnes et al., 2004). However, the gene-
trap allele may produce a truncated protein and a complete null allele for lamin B1, with 
no protein product at all, has not yet been generated and this could plausibly reveal 
further mutant phenotypes.  
 
Although lamins have not been implicated in NTDs, loss of another NE component, 
Nup50, has been found to cause NTDs. Nup 50 is a nuclear pore protein involved in 
export of proteins and is expressed in the developing neural tube. Mice carrying a 
homozygous deletion in Nup50 develop exencephaly with 100% penetrance 
(Smitherman et al., 2000).  
 
In spite of the fact that a role for lamin B1 in neural tube closure has not been 
demonstrated to date, this protein has a number of functions which could be 
hypothesised to influence NTD risk. For example, it is possible that an alteration in 
lamin B1 function could affect the cell cycle, which is known to be dysregulated in ct/ct 
embryos. In addition, an effect on transcriptional regulation could potentially alter 
xpression of genes which are required for neural tube closure such as Grhl3 targets or 
other, perhaps unrelated, genes. Therefore I decided to investigate in detail the basis of 
the 2D gel change in lamin B1 migration and its possible functional consequences in 
curly tail embryos undergoing neural tube closure. 
e
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4.2  Results 
 
4.2.1  Sequence analysis of genomic DNA and mRNA encoding lamin B1 in ct/ct 
and +ct/+ct strains  
The lamin B1 spots in ct/ct and +ct/+ct 2D gels were differently charged, migrating to a 
more basic position in ct/ct gels than the equivalent spots in +ct/+ct gels. This migration 
difference could be due to a difference in post-translational modification (PTM), such as 
phosphorylation, or a difference in amino acid sequence, either of which could cause a 
change in the isoelectric point (pI) of the protein. For instance, lamin B1 spots of curly 
tail 2D gels could be less phosphorylated (more basic) than the lamin B1 spots of the 
wild-type gels, which were more negatively charged (more acidic). To address this 
possibility, aliquots of individual ct/ct and +ct/+ct embryo protein samples were digested 
with lambda protein phosphatase to remove phosphate groups. Another aliquot of each 
sample, was left untreated, to be used as a control. After incubation and protein 
purification, the phosphatase-treated and untreated aliquots were run on separate 2D-
gels. If there was a phosphorylation difference in lamin B1 spots between ct/ct and 
+ct/+ct samples it would be expected that spots in +ct/+ct would become more basic after 
phosphatase treatment, and migrate like the spots on ct/ct gels. However, phosphatase 
treatment did not cause changes in the pattern of the lamin B1 spots either in ct/ct or 
+ct/+ct gels (Chapter 2, section 2.5.7; Fig. 4.3).  
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Figure 4.3 Phosphatase treatment suggests that lamin B1 protein spots are 
not phosphorylated. (A) Comparison of control and phosphatase-treated (PP) 
samples does not any alteration in the migration of lamin B1 spots in either (i) 
wild-type (green arrows) or (ii) curly tail (pink arrows) 2D-gels. Other spots 
shifted to more basic positions in the PP-treated gels compared with control gels 
generated from wild-type (blue arrow in iii) and curly tail (yellow and orange 
arrows in iv). These spots are predicted to correspond to phosphorylated proteins 
that are dephosphorylated by phosphatise treatment. (B) Validation of 
phosphatase activity by western blot using an anti-phospho-threonine antibody. 
Bands were detected in control (C) samples but not in phosphatase treated (P) 
samples. ß-tubulin (β-t) immunoblot was to show total protein sample loading.   
 
In order to test whether a sequence change is present, primers were designed to amplify 
the genomic DNA and cDNA of the lamin B1 gene (Lmnb1, Ensemble NM 010721.1, 
ENSMUSG00000024590). The Lmnb1 gene is located on mouse chromosome 18 and 
comprises 11 exons and 10 introns, covering 65.6 kilo bases (kb), encoding a 2.8 kb 
transcript (Fig. 4.4 A), and a protein of 588 residues (Maeno et al., 1995). The 
presumptive promoter region has high GC content suggestive of a typical housekeeping 
gene. Fifteen pairs of primers were designed to flank the coding regions at the genomic 
level, and five primer pairs were designed to amplify overlapping regions covering the 
cDNA (Appendix B, Tables B.5 and B.6). Genomic DNA was extracted for 
sequencing from E10.5 ct/ct and +ct/+ct embryonic yolk-sac samples, using a standard 
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protocol (Chapter 2, section 2.2). To check the transcript sequence, mRNA was 
extracted from whole E10.5 embryos and used for synthesis of cDNA (Chapter 2, 
section 2.7.1). Genomic DNA and cDNA samples were amplified by PCR, and the 
products were purified and sequenced (Chapter 2, section 2.8).  
 
Comparison of the LmnB1 sequences of ct/ct and +ct/+ct revealed two differences in the 
coding sequence of genomic DNA (summarised in Fig. 4.4 B), which were confirmed 
by sequencing the cDNA. In exon 1 a single base pair change, C612T, was detected that 
does not change the encoded amino acid, leucine 104, located in the coiled-coil domain 
of the protein. In exon 10 of curly tail Lmnb1 there was a three base-pair deletion of one 
of a sequence of nine GAG repeats (nucleotides 1957 to 1983) which encodes a 
sequence of glutamic acid residues (Glu, E, position 553-561) in the wild-type 
sequence. Henceforth, the GAG variant will be denoted GAG 1957-1983∆  because it is not 
possible to identify which of the nine residues is deleted. The lamin B1 protein forms 
will be denoted 9E lamin B1 (wild-type protein) and 8E lamin B1 (curly tail protein), to 
describe the number of Glu residues. These Glu residues make up an acidic region of 
the tail domain of the protein, which could be involved in chromatin binding 
(http://www.uniprot.org/uniprot/P14733). The loss of a Glu was hypothesised to explain 
the migration change of the lamin B1 spots in ct/ct 2D gels, since Glu is a negatively 
charged residue. 
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Figure 4.4 Diagram of Lmnb1 gene and sequencing results. The Lmnb1 gene 
comprises eleven exons and ten introns. Sequencing of Lmnb1 revealed two 
sequence changes in ct/ct compared with +ct/+ct. In exon 1, a single cytosine to 
thymine nucleotide change (C612T, black arrow), does not change an amino acid. 
In exon 10, one of the nine GAG repeats (purple traced square) in +ct/+ct is absent 
in ct/ct (red traced square).   
 
 
4.2.2 Quantitative analysis and expression pattern of Lmnb1 mRNA in +ct/+ct and 
ct/ct embryos  
It is possible that differences in Lmnb1 sequence would result in alteration of 
transcription or translation in ct/ct and +ct/+ct embryos. Analysis of total abundance of 
lamin B1 protein by western blot did not show any difference between +ct/+ct and ct/ct 
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samples (Chapter 3, section 3.2.5.1). To check whether the sequence changes had any 
effect on levels of mRNA, reverse transcription quantitative real-time polymerase chain 
reaction (RT-qPCR) was performed. 
 
RNA was extracted from the caudal region of E10.5 +ct/+ct and ct/ct embryos and 
reverse transcribed for the generation of cDNA.  A primer pair was designed to amplify 
a region of Lmnb1 coding sequence (position 1267-1487 of Lmnb1-transcript; 
Appendix B; Table B.7), and tested in RT-qPCR (Chapter 2, section 2.7.2). 
Expression levels of Lmnb1 were normalised to Gapdh (reference gene), and one +ct/+ct 
sample was selected as a calibrator with an expression level of 1.0. No significant 
difference in Lmnb1 mRNA abundance was observed between strains (mean relative 
expression levels were 0.74 ± 0.07 and 0.89 ± 0.08 in +ct/+ct and ct/ct samples 
respectively).  
 
The lamin B1 protein is reported to be present in almost all cell types (Stuurman et al., 
1998). However, the spatial expression pattern of Lmnb1 has not been investigated in 
ct/ct embryos. In order to examine the expression of Lmnb1 mRNA, a 561 bp fragment 
(Appendix B, Table B.6) was cloned into pGEM-T Easy Vector for production of an 
anti-sense cDNA probe (Chapter 2, section 2.9). Using this probe, the expression 
pattern of Lmnb1 was investigated by whole mount in situ hybridisation (WMISH; 
Chapter 2, section 2.10) in +ct/+ct and ct/ct embryos (Fig. 4.5 A-F).  
 
Initially, embryos were analysed at the stage of posterior neuropore closure (E10.5), 
revealing an mRNA expression pattern that was almost ubiquitous. However, no signal 
was observed in the heart or the surface ectoderm (Fig. 4.5 A-B, D-E). There were no 
apparent differences between +ct/+ct (Fig. 4.5 A, D) and ct/ct (Fig. 4.5 B, E) embryos. 
The control sense probe gave no signal as expected (Fig. 4.5 C, F). The expression 
pattern in neurulation-stage embryos may be worthy of further investigation, and is 
supported by a limited number of studies of lamin B1 protein in human tissue (Broers et 
al., 1997; Ausma et al., 1996). These studies showed that Lamin B1 was not 
ubiquitously expressed but was negative in the muscle and connective tissue and 
reduced or absent in the skin.  
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Figure 4.5 Lmnb1 mRNA expression pattern. (A-B) Whole mount in situ 
hybridisation of +ct/+ct and ct/ct embryos at E10.5. The expression was almost 
ubiquitous but appeared negative in the surface ectoderm (SE) and in the heart (H, 
seen at higher magnification in D-E). Overall, there were no apparent differences 
between +ct/+ct (A, D) and ct/ct (B, E) embryos. (C, F) The control probe (sense) 
was negative as expected. Scale bars represent 1 mm in A-C and 0.5 mm in D-F. 
 
To investigate this Lmnb1 expression pattern a little further, I performed WMISH on 
embryos at earlier embryonic stages as well as on embryos with NTDs (exencephaly) to 
check whether the pattern was altered (Fig. 4.6 A-M). At all studied stages, Lmnb1 had 
a very similar pattern, being expressed in almost all cell types with the exception of the 
heart and the surface ectoderm. This pattern was not different in embryos with forebrain 
or midbrain exencephaly (Fig. 4.6 I, K-M). 
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Figure 4.6 Lmnb1 mRNA expression pattern at E7.5-10.5. (A-D) Whole 
mount in situ hybridisation for Lmnb1 on +ct/+ct and ct/ct E7.5 embryo. Dorsal 
view of an embryo, characterised by the neural groove (NG, A). Lmnb1 
expression is widespread in the neural plate (NP) but diminished in intensity 
caudally. Expression is not observed in extra-embryonic tissues such as the 
allantois (All) in either strain.  (D-J) Lmnb1 expression in ct/ct embryos between 
E8.5 and E9.5. Similar to expression observed at E10.5, Lmnb1 is present in the 
cranial region and throughout the trunk, but is negative in the surface ectoderm 
(SE, red arrows) at all levels of the head folds (HF; forebrain, Fb; midbrain, Mb; 
hindbrain, Hb) and in the heart (H, red arrowheads). The same expression pattern 
was observed in embryos with forebrain (I) or midbrain (K-M) exencephaly 
(yellow arrows indicating level of defect). Other abbreviations: PNP, posterior 
neuropore level. Scale bars represent 1 mm H, K-M, and 0.5 mm A-G, I-J. 
 
Analysis of sections through +ct/+ct and ct/ct embryos confirmed that Lmnb1 is not 
expressed in the heart (Fig. 4.7 B1, C3, E2, F2) or surface ectoderm (Fig. 4.7). 
Analysis of sections also confirmed the expression sites of Lmnb1 in the cranial 
region (Fig. 4.7 C1-C2, E1-E2, F1-F2), in neuronal tissues, neural folds of the spinal 
region, notochord and the gut (Fig. 4.7 B1-B4, C3-C4, E2-E4, F3).  
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Figure 4.7 Lmnb1 WMISH sections. (A, D) E9.5 and E10.5 embryos show the 
level of sections cut for E.9.0-9.5 (B1-B4; C1-C4) and E10.5 (E1-E4) curly tail 
embryos, and E10.5 wild-type embryos (F1-F3). Lmnb1 is expressed throughout 
the cranial region, neuroepithelium, head mesenchyme (Hm), and optic vesicles 
(OpV), even in embryos with open fore- and hindbrain (Fb, Hb; E1). Expression 
is also detected throughout the spinal cord (SC), including open neural folds 
(NFs) at lower spinal levels (B2-B4, C4, E3-E4, F3), to the level of the tail bud. 
At all levels the expression is absent in the surface ectoderm (SE), and it is also 
negative in the heart (H). Other abbreviations: BA, branchial arch; Da, dorsal 
aorta; Fg, foregut; Hg, hindgut. Scale bars: A, E1-E2, F1-F2, 0.5 mm; B, 1.0 mm; 
B1-B4, C1-C4, E3-E4, F3, 0.1 mm.  
 
 
4.2.3 Dynamics of the lamin B1 variants within the nuclear envelope 
Identification of the 8E variant form of lamin B1, lacking one glutamic acid in the
polyglutamate tract (Fig. 4.4), in the curly tail strain raised the question of whether 
lamin B1 function may be altered in curly tail and whether this could contribute to 
development of NTDs. Loss of an amino acid could potentially affect lamin B1 protein 
conformation. For example, an alteration in the secondary structure of the protein 
(which is more conserved than the primary structure), might cause the 8E and 9E 
variants to fold differently. Using PSIPRED Protein Structure Prediction Server 
(http://bioinf.cs.ucl.ac.uk/psipred/psiform.html
 
) bioinformatics tool, the predicted 
secondary structures of the two variants were analysed from their amino acid sequence. 
The region of the tail domain containing the glutamic acid repeat is predicted to consist 
of a helix region in both variants, suggesting that there is not a major effect of the 8E 
variant on protein conformation. The lamin B1 tail domain is also necessary for normal 
processing of the protein into its mature form (Maske et al., 2003). Therefore, an in 
vitro approach was taken to test if the variation in number of glutamic acid residues 
could have an effect on stability of the nuclear envelope  
 
Expression constructs of green fluorescent protein fused with full-length Lmnb1 (GFP-
Lmnb1-FL) encoding the 8 and 9 glutamic acid variants were generated (Chapter 2, 
section 2.13.1). In order to investigate the dynamics of the nuclear lamina, these 
constructs were analysed using fluorescence loss in photobleaching (FLIP), in 
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collaboration with Dr Ashraf Malhas (Oxford University). This method, like 
fluorescence recovery after photobleaching (FRAP),  can be used to measure the ability 
of a molecule to move around over time due to the capacity of fluorescent dyes which 
emit light of one wavelength (e.g., green) after they have absorbed light of another 
wavelength (e.g., blue). Nevertheless, if a high intensity blue light is delivered to the 
dye, it “photobleachs”, i.e. the dye is unable to fluoresce (Lippincott-Schwartz et al., 
2001). In the FRAP method a small area of a cell is rapidly bleached using a high-
intensity laser pulse. The movement of unbleached molecules from the neighbouring 
areas is then recorded by time-lapse microscopy as the recovery of fluorescence in the 
bleached area. FLIP is based on the same principle, the difference is that while the area 
in the cell is repeatedly bleached, a different area is monitored. The loss of fluorescence 
in areas that are distant from the bleached one correspond to movement of molecules 
into the bleached area. FLIP largely eliminates the concern that the recovery properties 
are due to damage at the bleach spot, as all measurements are made in areas that are 
never bleached.  
 
FRAP and FLIP can be used to investigate the stability and dynamics of the nuclear 
lamina.  Within the lamina of interphase cells, lamins are relatively stable and that is 
revealed by their long recovery time during FRAP experiments. In this project FLIP 
was used to investigate the mobility of the 9E and 8E lamin B1 variants in the nuclear 
envelope in wild-type (+ct) mouse fibroblast (MEFs, Chapter 2, section 2.15) 
following transfection with the full-length GFP-Lmnb1 constructs. The two constructs 
did not show a difference in FLIP because the full-length protein has very stable 
interactions at the nuclear envelope.  
 
Owing to the stability of the full-length lamin B1 protein in FLIP experiments truncated 
forms are commonly used to assess variant proteins and these provide more sensitivity 
in the assay. Expression constructs were generated for truncated forms of the two 
proteins, composed of forty amino acids upstream of the C-terminus (thirty nine for the 
8E-lamin B1 variant), which includes the polyglutamic tract (thirty amino acids 
upstream). The cloning strategy used a plasmid containing a yellow fluorescent protein 
(YFP)-human LMNB1 fusion construct (kindly provided by Dr Ashraf Malhas and used 
in Maske et al, 2003). The human LMNB1-C40 sequence was excised by restriction 
digestion. A PCR-generated fragment was then inserted containing the mouse coding 
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sequence encoding the 9E and 8E variants (Chapter 2, section 2.13.2) in frame with a 
nuclear localisation signal (NLS), necessary for nuclear import of lamins, fused to YFP. 
FLIP experiments were performed, by Dr Malhas, on wild-type MEFs transfected with 
the NLS-YFP-C40 constructs (9E and 8E variants). After photobleaching the YFP-8E 
protein showed a significantly greater loss of fluorescence intensity within the first 100 
seconds than the YFP-9E protein (Fig. 4.8). This data shows that the 9E variant is less 
dynamic, indicative of a more stable interaction with the nuclear envelope than the 8E 
variant. Thus, the 8E lamin B1 variant present in the curly tail strain may confer altered 
stability and function of the nuclear envelope.  
 
 
Figure 4.8 FLIP analysis of YFP-lamin B1 fusion proteins. FLIP was 
performed on wild-type MEFs expressing NLS-YFP-C40. Plot shows 
measurements of fluorescence loss after photobleaching (mean values ± SE) of 
the 9E and 8E NLS-YFP-C40 constructs. These results indicate that the 9E 
protein has more stable associations with the nuclear lamina than the 8E fragment, 
as shown by its slower loss of fluorescence.  
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 4.2.4 Sequence analysis of Lmnb1 in multiple species and mouse strains  
Alignment of the mouse lamin B1 protein with lamin B1 of other species and the mouse 
lamins B2 and A using the Constraint-based Multiple Alignment Tool (COBALT), 
showed that the number of glutamic acid residues at the 8E/9E position varies between 
species (Fig. 4.9). Lamin B2 contains a 7E repeat while lamin A, has a combination of 
glutamic and aspartic acids (2E/4D).   
  
N Amino acid sequence 
  1 A Q R S T V F K T T I - - - P E E E E - E E E E E P I G V - A V E E E
  2 A Q R S T V F K T T I - - - P - E E E - E E E E E A A G V - V V E E E
  3 A Q R S T V F K T T I - - - P E E E E - E E E E E P I G V - P L E E E
  4 A Q R S T V F K T T I - - - P - E E E - E E E E E A A G V - V V E E E
  5 A Q R S T V F K T T I - - - P - E E E - E E E E E A A G V - V V E E E
  6 A Q R S T V F K T T I - - - P - E E E - E E E E E A A E V - A V E E E
                                    
  7 A Q R S T V F K T T I - - - P - E E E - E E E E E A P E V - V V E E E
  8 A Q R S T V F K T T V - - - N - E G E - E E E E E G E E - - E I L E D
  9 A Q R T T V Y T T T I - - - P - E E E L E E E M L E E - I T K E S H Y
10 A Q R T T V Y T T N I - - - P - E E E L E E E E E I F E E - T A K E S
11 A V R S T V F K T A V - - - E - D E D - D D E E E E K E A E V I E E R
12 A V R S T A F N T T V - - - E - - E - - E E E E E D A D V I E E R F F
                                    
13 A V K A A K H S S V Q G R E N G E E E - - E E E E A E F G - - - E E D
14 A M R K L V R S L T M V - - - - - E D - N E D D D E D G E - - - - E L
                                     
 
 
 
 
 
 
 
1. NP
2. NP
3. NP
4. XP
540
5. XP
(aa
6. NP
7. XP
8. NP
9. NP
10. NP
11. NP
12. BA
13. NP
14. NP_034851 Lamin B1 [Mus musculus]  - Mouse (amino acid 541-575) 
_005564lamin B1 [Homo sapiens]  - Human (amino acid 540-574) 
_446357lamin B1 [Rattus norvegicus] -  Rat (amino acid 540-574) 
_001158129PREDICTED: lamin B1 isoform 2 [Pan troglodytes]  - Chimpanzee (aa 
-574) 
_0010972340PREDICTED: lamin B1 isoform 1 [Macaca mulatta]   - Rhesus monkey 
 540-574) 
_001096765lamin B1 [Bos taurus]              - Cattle (aa 540-574) 
_531892PREDICTED: similar to Lamin B1 [Canis familiaris]       - Dog (aa 473-507) 
_990617lamin B1 [Gallus gallus]    - Chick (aa 539-573) 
_989198lamin B1 [Xenopus (Silurana) tropicalis] (aa 540-574)    
_001080053lamin B1 [Xenopus laevis] (aa 540-574) 
_694504lamin B1 [Danio rerio]  - Zebrafish (aa 541-575) 
B32979lamin B1 [Carassius auratus]       - Goldfish (aa 275-308) 
_034852Lamin-B2     - Mouse (aa 549-583)       
001002011Lamin-A/C          - Mouse (aa 539-573)  225
Figure 4.9 Alignment of lamin B1 protein sequence at the region 
encompassing the glutamic acid repeat. The number of E residues (yellow 
shaded) varies between species. Mice and rats have a 9E repeat (1, 3); while 
humans, chimpanzee, rhesus, cattle, dog, and Xenopus have an 8E repeat (2, 4, 5, 
6, 7, 10). The sequence is less similar in other species (11, 12). Mouse lamin B2 
contains a 7E repeat (13), while lamin A (14) contains a combination of aspartic 
acid (D) and glutamic acid residues. Shaded in grey are amino acids conserved 
between species. Amino acid (aa) number from the start of the sequence to the 
end, indicated in brackets.    
 
Searches for annotated mouse single nucleotide polymorphisms (SNPs) in the online 
databases at http:\\www.ensembl.org/index.html, showed that the C216T single 
nucleotide change (exon 1) and the GAG variant (exon 10) had not yet been described. 
Therefore, I tested whether these sequence changes were present in other mouse strains. 
In later searches, I exported the full Lmnb1 transcript sequence from the Ensembl 
website and performed a BLAST search against the NCBI-SNP Mouse Data Base 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi), which revealed that C216T had been annotated 
as a SNP.  
 
In order to test if the Lmnb1 sequence changes identified in the ct strain were present in 
other mouse strains, methods were developed for genotyping. Exon 1 of Lmnb1 was 
assessed for loss or creation of restriction sites using the online Webcutter 2.0 software 
(http://rna.lundberg.ru.se/cutter2/). The C612T base pair change results in the creation 
of a HindIII restriction site in the ct/ct sequence (Fig. 4.10 A). Therefore, amplification 
of a PCR product using primer pair F1in2/R1ex2 (Appendix B, Table B.5), followed 
by digestion of the PCR product with HindIII enzyme resulted in different fragment r 
ct/ct and +ct/+ct (Fig. 4.10 A; Table 4.1). 
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Strain HindIII site Fragment size (bp) 
+ct/+ct Absent 568  
ct/ct Present 225 and 343  
Heterozygous Present in one allele only 568, 225 and 343  
 
Table 4.1 Restriction enzyme site difference between the wild-type sequence 
and the C612T nucleotide change at position 348 of Lmnb1 exon 1. 
 
For the GAG1957-1983∆ variants, two pairs of primers (Table 4.2) were designed to 
amplify regions of exon 10, encompassing the nine GAG repeat (Fig. 4.10 B). In order 
to visualise the three base pair difference between ct/ct and +ct/+ct samples, PCR 
products were run on 5% agarose gels. Both primer pairs produced products whose size 
difference between strains could be readily visualised. 
 
 
Primer 
No 
Sequence 
Size of fragment  
(bp) – 9E; 8E 
1 - Forward  
1 – Reverse   
5’ – AGACCACCATACCCGAGGA - 3’ 
5’ – AAACGCTCCTCCTCCACAG – 3’ 
       73; 70 
2 – Forward 
2 - Reverse 
5’ – GACCACCATACCCGAGGAG – 3’ 
5’ – TCCACAGCCACTCCGATG – 3’ 
58; 55 
 
Table 4.2 Exon 10 Lmnb1 primers for genotyping the GAG1957-1983∆ deletion. 
The fragment size differentiates the wild-type (9E) and variant (8E) alleles. 
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Figure 4.10 Diagrams of assays to genotype Lmnb1 sequence changes. (A) The 
C612T single nucleotide in exon 1 (bold) change creates a HindIII site in ct/ct 
such that a PCR product encompassing  this site can be digested by HindIII in 
ct/ct but not in +ct/+ct. The digested products were run on 1% agarose gels, where 
+ct/+ct sample generate the undigested band (568 bp), ct/ct have two bands (225 
and 343 bp) and heterozygous samples (ct/+ct) have the three band sizes. (B) 
Schematic diagram of the PCR products amplified by primers designed 
specifically against exon 10 (111 bp length), amplified by PCR and run on 5% 
gels. For example, for primer 1, ct/ct samples generated a 70 base pair (bp) band, 
+ct/+ct a 73 bp band and heterozygotes both bands. Green arrow in A indicates 
HindIII recognition site (a/agctt).  
 
Having optimised these two assays as a means to genotype ct/ct and +ct/+ct strains for 
Lmnb1 polymorphisms, other NTD and inbred strains were genotyped for the same 
sequence changes (Table 4.3). This analysis showed that splotch (Sp2H), another mouse 
model for NTDs, and the inbred strains CBA/Ca and 101 shared the same Lmnb1 
variants as ct/ct. Therefore, Lmnb1 sequence changes in ct/ct and Sp2H appear to be 
polymorphisms characteristic of the CBA inbred strain (one of the background strains of 
ct/ct and Sp2H). Moreover, in the strains analysed these sequence differences always 
occurred together. The exon 1 and exon 10 polymorphisms have not been separated by 
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recombination, despite many generations of mouse breeding and thus appear to be in 
linkage disequilibrium.  
 
Strains Background/Inbred 
strain 
Exon 1: C612T  Exon10: 
9GAG/8GAG 
Curly tail Curly tail C612T 8GAG  
Congenic 
(+ct/+ct) 
93.7% Curly tail wt 9GAG  
ct/ctTgGrhl3  100% Curly tail C612T 8GAG  
    
C3H/HeJ Inbred # wt 9GAG  
C57BL  Inbred wt 9GAG 
DBA/2J Inbred # wt 9GAG  
SWR/J Inbred # wt 9GAG  
SWR Inbred  wt 9GAG  
CAST/EiJ Inbred #  wt 9GAG  
CBA/Ca Inbred C612T 8GAG  
CBA/J Inbred # C612T 8GAG  
101 Inbred   C612T 8GAG  
    
ct2J/J C57BL/6J # wt 9GAG  
Crsh BALB/c + C57BL wt 9GAG  
Crc CBA/Ca + Circle tail wt 9GAG  
Kumba C57BL wt 9GAG  
Loop tail LPT/Le  wt 9GAG  
MTHFR KO BALBc wt 9GAG  
Splotch CBA + C3H C612T 8GAG  
Twist  C57BL wt 9GAG  
 
Table 4.3 Lmnb1 sequence variations genotyped in inbred and other NTD 
mouse strains. Genomic DNA was extracted from in-house mouse strains or 
purchased from The Jackson Laboratory (indicated by #). Each strain was tested 
for the presence or the absence of the single nucleotide change in exon 1 (C612T 
or wt, wild-type) and whether exon 10 contained an 8 or 9 GAG repeat, using the 
genotype assays previously described.  
 
More recently the Sanger Institute (Mouse Genomes Project, ) provided sequence data 
for 17 mouse strains and this provided more extensive information on SNPs and 
INDELs (insertions and deletions), showing that both sequence changes were present in 
various mouse strains. The C/T is annotated as a synonymous coding SNP (18: 
56868078), for the A/J, AKR/J and CBA/J strains. The GAG variant is annotated as 
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non-synonymous coding SNP (Deletion, 18: 56909394), with the 8E variant present in 
the A/J, AKR/J, CBA/J, PWK/PhJ and WSB/EiJ strains. 
 
4.2.5 Investigation of Lmnb1 as a potential modifier gene for NTDs in curly tail 
Evidence from functional analysis of lamin B1 showed that the 8E variant could have 
an effect on the stability of the nuclear envelope. The analysis of different mouse strains 
suggested that this polymorphism is rare and insufficient to cause NTDs alone. For 
example, mice from the CBA/Ca inbred strain do not normally develop NTDs. 
However, the CBA/Ca genetic background may include risk factors, since both curly 
tail and splotch develop NTDs whose penetrance varies with genetic background. 
Studies have suggested the presence of modifiers for NTDs in the ct genetic background 
(Neumann et al., 1994; Letts et al., 1995). Therefore, I hypothesised that lamin B1 could 
act as a modifier gene, such that the frequency of NTDs caused by the ct mutation may 
be affected by the presence of the 8E or 9E variant. To test this hypothesis ct sub-strains 
carrying different combinations of the Lmnb1 polymorphisms and the Grhl3 mutation 
were generated in a two step breeding program (Fig. 4.12). At each step of this scheme, 
mice were selected on the basis of the Lmnb1 polymorphisms (genotyping described on 
section 4.2.4) and for the presence of the Grhl3 mutation (Chapter 2, section 2.4.2) 
and two polymorphic markers located on chromosome 4 on the opposite side of the 
gene to the mutation, D4Bwg1551e and D4Mit204 (Fig. 4.11). 
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Figure 4.11 Schematic diagram of the genotyping using chromosome 4 
polymorphic markers. (A) The D4Bwg1551e (black box) and D4Mit204 (green 
box) microsatellites were used to distinguish between ct/ct, +ct/+ct and 
heterozygous (ct/+ct) samples. The diagram illustrates the position of the 
microsatellites in relation to the Grhl3 gene on chromosome 4 and the expected 
product sizes upon PCR amplification. (B-C) Amplified samples were 
electrophoresed on 5% agarose gels.  
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Initially, ct/ct mice were crossed to +ct/+ct mice to generate double-heterozygous 
offspring (Fig. 4.12 A). These mice were backcrossed to ct/ct mice (Fig. 4.12 B) to 
decrease genetic variability and from this backcross, double-heterozygotes were 
intercrossed (Fig. 4.12 C) to generate all the possible genetic combinations of the 
Lmnb1 polymorphism on a ct background (Fig. 4.12 D). Henceforth the annotation for 
each curly tail strain will be as summarised on Table 4.4. Two strains were of particular 
interest for investigation of the possible effect of Lmnb1 variants in determining risk of 
NTDs: ct9E (L9E/9E;Gct/ct) and ct8E (L8E/8E;Gct/ct).  
 
Strain Annotation Genotype Abbreviation 
Curly tail ct Lmnb18E/8E;Grhl3ct/ct L8E/8E;Gct/ct
Curly tail – 8E ct8E Lmnb18E/8E;Grhl3ct/ct L8E/8E;Gct/ct
Curly tail – 9E ct9E Lmnb19E/9E;Grhl3ct/ct L9E/9E;Gct/ct
Wild-type – 8E +ct;8E Lmnb18E/8E;Grhl3+/+ L8E/8E;G+/+
Wild-type  +ct Lmnb19E/9E;Grhl3+/+ L9E/9E;G+/+
 
Table 4.4 Annotation for curly tail strains after the generation of the ct-
substrains. 
 
Wild-type (+ct/+ct) embryos and mice develop normally, without tail flexion defects or 
NTDs. Following generation of wild-type mice carrying the 8E lamin B1 variant 
(L8E/8E;G+/+; Fig. 4.12), these mice were twice backcrossed to ct/ct to increase the ct-
background and to generate a colony of wild-type ct-strain carrying the 8E Lmnb1 
variant (L8E/8E;G+/+), for comparison with the +ct/+ct (L9E/9E;G+/+) strain 
 
The microsatellite markers D4Bwg1551e and D4Mit204 were informative, 
distinguishing ct/ct from +ct/+ct and heterozygotes (ct/+ct). This complemented the 
genotyping of the putative Grhl3 mutation which lies upstream of the gene (summarised 
on Chapter 2, section 2.4.2; Fig. 2.3 C-D). Therefore, if both the C-21350T mutation 
and the D4Bwg1551e and/or D4Mit204 markers typed as ct/ct we could be confident 
that the Grhl3 locus carries the ct mutation, and that a recombination event at the Grhl3 
locus had not arisen. The latter microsatellite was used for validation of the genotype 
obtained with D4Bwg1551e for the +ct;8E strain, since recombination at the Grhl3 locus 
 232
occurred in some offspring, which were eliminated prior to establishment of  a colony 
of +ct;8E mice.  
 
 
 
Figure 4.12 Schematic diagram of breeding programme to generate Lmnb1 
and Grhl3 sub-strains of ct/ct. (A) Wild-type and curly tail males and females 
were crossed to generate double heterozygous offspring. (B) Double 
heterozygotes from initial crosses were backcrossed to ct/ct. (C-D) Intercrosses 
generated mice which were used to establish sub-strains for comparison. (D) The 
key strains of interest were ct8E (same genotype as ct/ct at Grhl3 and Lmnb1), and 
ct9E which both carry the Grhl3 mutation, but differ in Lmnb1 sequence. A third 
strain, +ct;8E, is wild-type for Grhl3 but carries the 8E Lmnb1 variant. The 
predicted frequency of each genotype is indicated. 
 
Once mice of specific genotypes for Grhl3 and Lmnb1 had been generated, they were 
intercrossed to generate closed homozygous colonies. Mice and embryos of the 
Grhl3/Lmnb1 sub-strains were analysed according to their phenotype: straight tail (ST) 
indicative of normal spinal development, tail defects (TD, such as kinked or bent tail, 
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BT, or curled tail, CT), and cranial (exencephaly, Ex) and/or caudal NTDs (spina bifida, 
SB; Fig. 4.13). Embryos were analysed at E11.5-E15.5, stages at which it is possible to 
clearly visualise spina bifida. The phenotypic appearance of tail flexion defects and/or 
NTDs was the same as in homozygous ct/ct embryos of the original strain. Thus, ct 
embryos carrying the 9E Lmnb1 variant (Fig. 4.13) or the 8E Lmnb1 variant exhibited 
straight, bent or curled tails or spina bifida accompanied by a curled tail. As in the 
original ct strain, spina bifida was always accompanied by a tail defect. 
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Figure 4.13 Phenotypes of curly tail ct9E sub-strain. (A-C, D-F) Images of ct9E 
embryos at E11.5 (A-C, G, I) and E13.5 (D-F, H, J) respectively, portraying the 
typical phenotypes observed in the ct9E sub-strain. Typical examples of embryos 
displaying different categories of tail phenotypes: ST, straight tail; BT, bent tail; 
and CT, curled tail. (G-J) Embryos with NTDs, comprising spina bifida (SB) 
together with CT (I and J, higher magnifications of defects in embryos G and H). 
These phenotypes were observed at all developmental stages studied (E11.5 – 
E15.5) and do not differ from the phenotypes observed in ct/ct. Scale bars: 1 mm. 
 
 
4.2.6 Frequency of NTDs in curly tail sub-strains expressing different Lmnb1 
variants 
To investigate if the differing Lmnb1 variants could influence the penetrance of the 
curly tail mutation, the frequency of defects was compared in the ct9E (ct9E/9E;Gct/ct) and 
ct8E (ct8E/8E;Gct/ct) sub-strains, the latter strain being equivalent genotype to the original 
ct strain. Embryos between E11.5 and E15.5 were then analysed for the presence of 
NTDs. The data for cranial and caudal defects are presented separately because 
exencephaly can occur in isolation or in combination with spina bifida and a curled tail 
or with tail defects alone and can be observed from E9.5.  
 
A total of 224 ct9E, 101 ct8E, 113 +ct, 105 +ct;8E and 113 ct embryos were collected for 
comparison (Table 4.5; Fig. 4.14). The frequency of SB in the ct8E strain was similar to 
that in ct. This suggests that the out-cross to +ct has not resulted in loss of genetic 
modifiers that significantly affect frequency of NTDs. Only 5.8% of the ct9E embryos 
developed SB compared to 15.8% of the ct8E embryos. Thus, the frequency of SB was 
significantly lower in ct/ct embryos carrying the 9E Lmnb1 variant compared with the 
8E variant, equivalent to a 63% reduction in frequency. In contrast, the frequency of tail 
flexion defects did not differ between the two strains. 
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Strain ct9E ct8E +ct +ct;8E ct 
Genotype L9E/9E;Gct/ct L8E/8E;Gct/ct L9E/9E;G+/+ L8E/8E;G+/+ L8E/8E;Gct/ct
Embryos (n) 224 101 113 105 113 
SB + CT 13   (5.8%)* 16 (15.8%) 0 0 16 (14.2%) 
CT 121 (54.0%) 52 (51.5%) 0** 6 (5.4%)† 49 (43.4%) 
No 
defects/ST 
90 (40.2 %) 33 (32.7%) 113 (100 %) 98 (0.9%) 48 (42.5%) 
 
Table 4.5 Frequency of tail flexion defects and spinal NTDs in curly tail sub-
strains. Total number of embryos (n) collected for each strain (ct9E, ct8E, +ct, 
+ct;8E and ct) is indicated. Embryos were scored for spinal NTDs (SB) and tail 
flexion defects (CT) compared to no defects (straight tail, ST). Curly tail embryos 
affected with spina bifida always have a curled tail (SB+CT). The frequency of 
SB is significantly lower in the ct9E than in the ct8E and ct strains (* p<0.02, χ2). 
Spina bifida and tail flexion defects were never observed among +ct embryos (** 
+ct versus +ct;8E; p=0.03, Z-test)  but tail flexion defects did occasionally occur 
among +ct;8E embryos although at significantly lower frequency than among ct 
mutant embryos († p≤0.001, χ2). 
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Figure 4.14 Frequency of tail flexion defects and spinal NTDs in curly tail 
sub-strains. Phenotypes were analysed at E11.5-E15.5. The frequency of spina 
bifida frequency is significantly lower in the ct9E strain compared with ct8E and ct 
(* p=0.02, χ2).   
 
All +ct embryos developed apparently normally. Most +ct;8E embryos developed 
normally, however, tail flexion defects were observed in a few cases. Nevertheless, the 
rate of tail defects was significantly lower than in ct (Table 4.5). Thus, in spite of the 
wild-type Grhl3 allele, it appears that the presence of the 8E lamin B1 variant can affect 
the penetrance of tail defects in mice with a ct genetic background since +ct embryos 
were never observed to develop tail defects.     
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4.2.6.1 Analysis of posterior neuropore length within the ct sub-strains 
 
An enlarged posterior neuropore (PNP) at the stage of spinal neurulation indicates delay 
or failure of closure, suggestive of the likelihood that a curly tail embryo will develop 
spina bifida and/or tail defect (Copp, 1985a). Since SB occurs at lower rate in the ct9E 
strain, it was predicted that this would be reflected by a lower mean PNP length. 
However, it was unknown at what specific developmental stage PNP closure would 
begin to differ in ct and the sub-strains. Therefore, the PNP length was measured for a 
series of embryos at different somite stages to better understand at what stage (s) the 
PNP is enlarged and/or fails to close.  
 
Examples of the different lengths of PNPs observed in these embryos are shown in 
Figure 4.15. Data for individual embryos were plotted (Fig. 4.16) and mean PNP 
lengths calculated for each stage (Table 4.6). Mean PNP lengths in embryos of both 
wild-type strains (+ct; +ct;8E) were significantly smaller than in the ct strains at all the 
stages examined (Table 4.6). This is particularly evident at the 30-31 somite stage 
where there is a major decline in PNP length in wild-types but not in the curly tail 
strains. The PNP length in +ct;8E was larger than in +ct, particularly at the 26-27 somite 
stage, but this did not reach statistical significance (Fig. 4.16). The PNP lengths in the ct 
and ct8E strains did not significantly differ. However, from somite stages 28-29 onwards 
the mean PNP length of embryos of the ct9E strain was smaller than in the curly tail 
strains carrying the 8E lamin B1 variant (ct and ct8E), and this difference was significant 
Table 4.6).  
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Figure 4.15 Typical appearance of different posterior neuropore (PNP) sizes 
during neural tube closure in ct sub-strains. Images of the PNP of embryos at 
E10.5, at the 28-29 (A-C) and 30-31 (D-F) somites stage (ss). A small PNP 
(SPNP; A, D), is characteristic of embryos in which the neural tube is closing 
normally. A medium (B, E) or large PNP (LPNP; C, F) is characteristic of 
embryos in which PNP closure is more likely to fail (C, F) or be delayed (B, E), 
leading to spina bifida and/or tail defects. PNPs are delineated by red-dotted lines 
and/or arrows for better visualisation (A-F). PNP length in µm: A = 375, B = 625, 
C = 800, D = 200, E = 500, F = 1050. Scale bar: 0.5 mm. 
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Strain Somite stages 
 26-27 28-29 30-31 
 n PNP (µm) n PNP (µm) n PNP (µm) 
+ct 10 307.5 ± 29.4 * 28 257.1 ± 21.6*, ** 37   68.9 ± 18.9*, **,
+ct;8E 16 385.9 ± 23.1* 15 286.7 ± 25.0*, ** 14   75.0 ± 21.6*, **
ct9E 5 490.0 ± 90.3 31 434.7 ± 28.8**, ‡ 30 324.2 ± 55.1**, ‡
ct8E 7 482.1 ± 59.7 26 478.8 ± 41.4 ** 20 427.5 ± 50.3**
ct 12 581.3 ± 45.3* 64 540.2 ± 23.6*, ‡ 66 453.8 ± 32.5*, ‡
 
Table 4.6 Mean PNP length of embryos of ct and the ct-substrains. Values are 
given as mean PNP length (µm) ± standard error. The somite stage intervals 
analysed correspond to the stage at which the PNP is closing. ANOVA (Holm-
Sidak Method, p≤0.001): * at all stages, ct have larger PNPs than +ct and +ct;8E 
strains; ** from somite 28 to 31, both ct9E and ct8E strains also have larger PNPs 
than +ct and +ct;8E; ‡ at somite stages 28-31, the mean PNP length of ct embryos is 
significantly larger than in the ct9E strain. 
 
Consideration of PNP lengths in individual embryos (Fig. 4.16) shows that in the wild-
type strains (+ct and +ct;8E) the PNP rapidly diminishes in length from the 28 somite 
stage onwards and closes in the majority of embryos at 30-31ss (25 out of 37). While 
the mean PNP length in the ct strains is larger than in the wild-type strains at the 26-27 
somite stage the variation between embryos appears broadly similar. However, from the 
28 somite stage onwards a considerably larger range of values is observed, particularly 
within the ct and ct8E strains. Thus, at the 30 and 31 somite stages, ct and ct8E embryos 
show a range of PNP lengths, from closed to as much as 1 mm long. This reflects the 
range of phenotypes observed in these strains.  Overall, the mean PNP length observed 
in ct9E embryos is lower than in the other ct strains from the 29 somite stage onwards. 
The distribution of PNP lengths also appears shifted to smaller values with few embryos 
showing very large PNP lengths, an observation which correlates with the lower 
frequency of spina bifida in the ct9E strain compared with the ct and ct8E strains. 
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Figure 4.16 Plot of posterior neuropore length against somite stage for ct sub-
strains. The data for individual embryos is shown, with the mean PNP length 
(and standard error) indicated for each strain at each stage. Number of embryos at 
the 26, 27, 28, 29, 30 and 31 somites stages are: for +ct 3, 7, 14, 14, 19, 18; for 
+ct;8E 7, 9, 6, 9, 9, 5; for ct9E 2, 3, 13, 18, 16, 14; for ct8E 1, 6, 11, 15, 12, 8; for 
ct/ct 6, 6, 32, 32, 39, 27.  
 
 
4.2.7  Frequency of cranial NTDs in curly tail sub-strains  
Exencephaly was observed amongst embryos of all the ct sub-strains. Since I was 
testing the hypothesis that Lmnb1 variants can modify the frequency of NTDs in ct, it 
was of interest to investigate whether there is also an effect on the cranial defects. For 
that reason the frequency of exencephaly was compared among embryos collected at 
E10.5 of the ct9E, ct8E and +ct;8E  strains (Fig. 4.17).  
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Figure 4.17 Appearance of exencephaly in curly tail sub-strains. (A-C) Side 
views of ct9E embryos at E11.5-E12.5; (D-F, G-I) ct8E and +ct;8E embryos at 
E10.5. The different types of exencephaly observed among embryos of the ct sub-
strains reflect the range of phenotypes among ct/ct embryos. The neural folds may 
remain open in the hindbrain (B), mid- and hindbrain (C, F, H-I) or fore- and 
midbrain (D-E) compared to normal neural tube closure (A, G). Panel I, is a back 
view of embryo in H. Red arrows indicate level and length of defect. Scale bars: 1 
mm.  
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The ct9E, ct8E and +ct;8E strains exhibit a mix of types of exencephaly at different levels 
of the developing brain as summarised in Figure 4.17. Data collected for embryos of 
the ct sub-strains at E10.5-E15.5, showed that exencephaly occurred to some extent in 
each strain (Fig. 4.18). Exencephaly occurred at significantly lower frequency in ct9E 
embryos (3%) compared with ct8E (8.3%), representing a 63% reduction in exencephaly, 
similar to that observed for spina bifida. There is a small difference in the frequency of 
exencephaly between ct8E (8.2%) and ct (6.4%) which was not statistically significant.  
 
Surprisingly, 2.6% of the +ct;8E embryos also developed exencephaly suggesting that the 
presence of the 8E lamin B1 variant is sufficient to confer susceptibility to NTDs even 
in the absence of the Grhl3 mutation (Fig. 4.18). Thus, in the context of the curly tail 
genetic background, the presence of either the Grhl3 mutation or the 8E lamin B1 
variant can cause cranial NTDs at approximately 3% frequency (ct9E and +ct;8E) while 
the presence of both together increases the frequency to around 6.5-8% (ct, and ct8E) 
and if neither the mutation nor the 8E variant are present then cranial NTDs do not 
occur (+ct). 
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Figure 4.18 Frequency of exencephaly among embryos of the ct sub-strains. 
There is a significant variation in the frequency of exencephaly between the five 
strains (p ≤ 0.001, χ2). The frequency of exencephaly was significantly lower in 
+ct, which does not develop exencephaly, compared with the other strains (* 
Versus ct and ct8E, p ≤ 0.001; versus ct9E, p = 0.02, Z-test), but not with +ct;8E. The 
frequency of exencephaly was significantly lower in ct9E compared with ct8E 
embryos (** p=0.01, Z-test). Exencephaly occurs at low frequency among +ct;8E 
embryos (2.6%) suggesting a possible effect of the 8E lamin B1 variant on cranial 
neural tube closure  since  exencephaly was not observed in the +ct strain. The 
frequency of exencephaly was significantly lower in +ct;8E than in ct8E († p=0.049, 
Z-test). Number (n): underneath strain names are embryos with exencephaly; on 
the grey bar, n = embryos without exencephaly.  
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4.2.8 2D gels of ct9E embryos 
The analysis of Lmnb1 polymorphisms in various mouse strains (inbred and NTD 
mouse models), showed that like curly tail, the splotch (Sp2H) mouse strain also carries 
the 8 GAG repeat variant. In addition, the availability of a sub-strain of curly tail 
carrying wild-type Lmnb1 (i.e., ct9E) provided an opportunity to test if it is indeed the 
GAG deletion that causes the lamin B1 migration shift on 2D gels of ct/ct embryos 
(Chapter 3, section 3.2.6.1). Therefore, 2D gels were generated for ct/ct, +ct/+ct, 
ct/ctTgGrhl3, ct9E/ct9E and Sp2H/+ embryo samples and analysed using Progenesis 
SameSpots software to allow comparison of the migration of lamin B1 spots.  
 
Lamin B1 spots on gels generated from ct/ctTgGrhl3 and Sp2H/+ embryos show the same 
pattern as on gels for ct/ct embryos (Fig. 4.19).  Conversely, lamin B1 spots on gels for 
ct9E/ct9E embryos show the same migration pattern as +ct/+ct samples. These analyses 
indicate that the migration pattern of lamin B1 corresponds to the presence of the 8E or 
9E variant and provide further evidence that it is indeed the glutamic acid deletion 
which causes the shift of lamin B1 spots on the 2D gels of ct/ct embryos compared with 
+ct/+ct. 
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Figure 4.19 2D protein gel analysis of different lamin B1 variants. (A) 2D gels 
for curly tail (ct/ct) and heterozygous splotch (Sp2H/+) embryos were generated 
for comparison of the spot pattern of lamin B1. Higher magnification of the area 
of lamin B1 spots (red boxes). Splotch embryos show the same lamin B1 pattern 
as ct/ct (blue arrow, and blue circle at higher magnification). (B-D) 2D gels were 
aligned against a ct/ct and a +ct/+ct reference gel generated from embryo samples. 
(B) Enlarged region of ct/ct and +ct/+ct gels in which the blue arrow indicates the 
most abundant lamin B1 spot (red boxes), shown circled in blue on panels C-D. 
(C) The lamin B1 spot aligns on ct/ct and ct/ctTgGrhl3 gels but not with spots on 
gels for +ct/+ct or ct9E/ct9E samples, which carry the 9E lamin B1 variant. (D) The 
lamin B1 spot (circled) aligns on +ct/+ct or ct9E/ct9E but not with ct/ct and 
ct/ctTgGrhl3 gels.  
 
 
4.2.9 Lamin B1 protein localisation in the nuclei of mouse embryonic 
fibroblasts 
It was therefore hypothesised that the mechanism by which lamin B1 variants influence 
risk of NTDs may relate to the apparent effect on stability of the nuclear envelope as 
shown by FLIP (Section 4.2.3). In order to further investigate the structure of the 
nucleus in the different mouse strains, mouse embryonic fibroblasts (MEFs) were 
generated from E13.5 embryos of various ct strains as well as the inbred strain 
C57BL/6.  
 
These cells were stained by Dr Ashraf Malhas (Oxford University) with an anti-lamin 
B1 antibody to investigate its localisation by immunofluorescence (Fig. 4.20). The key 
finding was that ct nuclei showed a high degree of irregularity in terms of nuclear shape. 
Lamin B1 staining (green) on a proportion ct fibroblasts was discontinuous and even 
missing in certain cases (Fig. 4.20 G-I) reminiscent of cells with nuclear envelope 
abnormalities, such as from progeria models (Scaffidi and Misteli, 2005; Young et al., 
2005). Staining for lamin A (Fig. 4.20, red) showed a similar distribution to lamin B1, 
indicating that the nuclear lamina as a whole is disrupted as opposed to solely an 
abnormality of lamin B1. This was perhaps to be expected since the nuclear lamina is a 
continuous meshwork so it is likely that disruption of one type of lamin will also affect 
the distribution of others.   
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Figure 4.20 Lamin protein expression in mouse embryonic fibroblasts 
(MEFs). MEFs were stained with antibodies to lamins B1 (green) and A (red) and 
the nucleus was visualised by staining with DAPI (blue). Typical irregularities of 
lamin organisation are indicated by yellow arrows, and include lobulations (H-L), 
and herniations (N-O).  
 248
To provide a quantitative measure of the morphological observations, the contour ratio 
(CR = 4п x area/perimeter) of DAPI-stained nuclei (minimum 500 nuclei per strain) 
was analysed using MetaMorph software (by Dr Malhas, Oxford University). A lower 
CR indicates a more dysmorphic nucleus and a score of less than 0.7 is considered 
abnormal (Scaffidi and Misteli, 2005). These analyses showed statistically significant 
(p<0.001, One Way ANOVA) differences between strains. A greater proportion of ct 
strain MEFs have dysmorphic nuclei than all the other strains (Fig. 4.21 A), and the 
mean CR is correspondingly lower than for all the strains (Fig. 4.21 B). These 
abnormalities are in association with the 8E lamin B1 variant and low Grhl3 expression 
(summarised in Table 4.7). 
 
In contrast to ct MEFs, nuclear envelope abnormalities were rarely observed among 
C57BL/6 cells, which were characterised by the lowest percentage of cells with CR 
<0.7 (Fig. 4.20 A-C), and the highest mean CR (Fig. 4.21 B). The ct9E showed partial 
rescue of the phenotype compared with ct (Fig. 4.20 J-L), with similar proportion of 
abnormal nuclei and mean CR value to the +ct strain (Fig. 4.21 A-B). These results 
suggested that the lamin B1 variant plays a key role in determining nuclear envelope 
morphology. In addition these findings imply that in the presence of the wild-type form 
of lamin B1 (9E variant) low Grhl3 expression does not have a major effect on nuclear 
structure (although still causing NTDs at a lower rate). Interestingly, the Grhl3-over-
expressing transgenic line (ctTgGrhl3; Fig. 4.20 M-O), exhibited more cells with 
abnormal nuclei than ct9E and +ct, in association with the presence of the 8E lamin B1 
variant. However, nuclei were less abnormal than in the ct strain (Fig. 4.21), which has 
identical genetic background, perhaps suggesting a normalising effect of increased 
Grhl3 expression on nuclear envelope integrity. Overall, these data suggest that the 
combination of 8E lamin B1 variant and diminished Grhl3 expression has the most 
deleterious effect on nuclear morphology, which correlates with the highest risk of 
NTDs in embryos. 
 
The finding of more frequent nuclear envelope abnormalities in each of the ct strains, 
including +ct, than in C57BL/6 suggests that in addition to the lamin B1 variant there 
might be another underlying factor, characteristic of the ct genetic background, which 
compromises nuclear structure. Indeed, there is evidence that the genetic background 
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present in both +ct and ct strains includes factors that give susceptibility to folate-
deficiency induced NTDs (Burren et al., 2010).  
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Figure 4.21 Contour ratio of nuclei in MEFs derived from mouse strains 
carrying 9E or 8E lamin B1 variants. (A) Analysis of the percentage of cells 
with contour ratio lower than 0.7 shows that the ct strain has significantly higher 
frequency of dysmorphic nuclei than all other strains (44.78%), whereas 
significantly fewer C57BL/6 (17.79%) nuclei are dysmorphic compared with all 
other strains (p ≤ 0.001, χ2). Frequency was calculated by dividing the number of 
cells with ratio <0.7 (“n=”, underneath strain names) by the total number of cells 
(inset). (B) Mean contour ratio (CR) and standard error on MEFs. C57BL/6 (*) 
have higher mean CR than all other strains whereas ct (**) have lower mean CR 
value than all other strains. Wild-type (+ct, ***) and ct9E (***) have higher mean 
CR than ctTgGrhl3 MEFs. One Way ANOVA and Pairwise Multiple Comparison 
Procedures (Holm-Sidak method), p ≤ 0.001. 
 
Strain Lamin B1 Grhl3 Background 
Nuclear 
morphology
C57BL/6 9E Normal C57BL ‘Normal’ 
+ct 9E Normal SWR/ct Mildly dysmorphic 
ct 8E Low  ct Highly dysmorphic 
ct9E 9E Low  SWR/ct Mildly dysmorphic 
ctTgGrhl3 8E High ct Dysmorphic 
 
Table 4.7 Summary of nuclear morphology in relation to Lamin B1 variants, 
Grhl3 expression and genetic background for strains for which mouse 
embryonic fibroblasts were generated. 
 
 
4.2.10  Analysis of Lmnb1 region on chromosome 18 in the ct strain 
Sequencing of the Lmnb1 gene revealed differences between the ct and the +ct strains. 
The Lmnb1 gene is on a different chromosome to Grhl3 and would therefore be 
expected to be the same sequence in the congenic +ct strain as in the ct strain owing to 
backcrosses to ct during the production of this strain (as explained in Chapter 2; 
section 2.1.1). However, it is possible that small areas of DNA from the SWR strain, 
from which the wild-type Grhl3 allele was introduced, persist in the +ct background at 
 251
locations other than the Grhl3 locus, which would explain how sequence differences in 
Lmnb1 could be present. Hence, polymorphic markers on chromosome 18 upstream and 
downstream of the Lmnb1 gene (Fig. 4.22 A; Appendix B, Table B.10) were typed to 
investigate how much of the SWR inbred strain persists in the +ct strain. Fifty seven 
microsatellite markers were tested of which fifteen markers were informative, in that the 
microsatellite size differed between SWR and ct (Fig. 4.22 B).  Eight of those differed 
between SWR and the +ct strains, showing that the ct sequence is present in +ct (Fig. 
4.22 B). Thus, seven markers were informative and differed between +ct and ct, 
D18Mit200, 84, 194, 237, 36, 185 and 141. These markers lie within a region from 
mega base (Mb) 32.47 to 73.8 (between markers D18Mit88 and D18Dev1, respectively) 
including Lmnb1 (at 56.59 Mb). This region of approximately 41 Mb encompasses the 
region on chromosome 18 that could differ between +ct and ct. 
 
 
Figure 4.22 Schematic of chromosome 18 markers used to evaluate the 
contribution of SWR and ct/ct DNA in the +ct/+ct strain. (A) The map positions 
of chromosome 18 microsatellites are shown in relation to Lmnb1 gene (not to 
scale). The beige straight line demarks chromosome 18, with names of markers 
above the line (D18Mit… unless indicated), and the position on chromosome 18 
in mega bases (Mb) underneath. (B) Of the fifty seven markers used, fifteen were 
informative, i.e., differed between SWR and the ct/ct strain. Eight markers differed 
between SWR and +ct/+ct but were indistinguishable in +ct/+ct and ct/ct: 
D18Mit146, 21, 88, Dev1, AW120568, D18Mit8, D18Mit210, and D18Mit213 
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(shown within circles). Seven markers differed between +ct/+ct and ct/ct: 
D18Mit200, 84, 194, 237, 36, 185 and 141 (shown by the coloured squares). The 
first and the last chromosome 18 markers were not used in this analysis.  
 
Further to this analysis (Fig. 4.22), I also used the same informative chromosome 18 
markers to genotype ct sub-strains (Fig. 4.23). These analyses revealed that strains 
carrying the 8E lamin B1 variant like ct (+8E;ct and ct8E) type for the same markers 
across this region, whereas the ct9E strain shares the same ‘SWR’ regions as +ct. 
 
 
 
Figure 4.23 Schematic of the region of chromosome 18 encompassing Lmnb1 
in the ct-sub-strains. A 41 Mb region of chromosome 18 is shared by ct, +8E;ct 
and ct8E. Conversely, this same region in +ct and ct9E types as SWR. 
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One possible implication of the fact that a region of SWR genomic DNA on 
chromosome 18 is retained in the ct9E strain is that modifier genes other than lamin B1 
could also lay within this region. As a step towards addressing this issue the list of 
genes within the 41 Mb chromosome 18 region was used to interrogate data obtained 
from a microarray  analysis of the caudal region of 28-29 somite stage ct/ct and +ct/+ct 
embryos (Dr N. Greene, Personal Communication). It was reasoned that if genes from 
this region differ in expression between ct and +ct strains, this could be due to the fact 
they are downstream targets of Grhl3, or that this is a consequence of the local genomic 
sequence. In the latter case these genes would also be candidates to differ in expression 
between the ct8E and ct9E strains and potentially contribute to variation in the frequency 
of NTDs. 
 
A list of genes within the 41 Mb of the chromosome 18 Lmnb1-region was downloaded 
from UCSC Genome Bioinformatics site (http://genome.ucsc.edu) and compared to a 
list of genes that differ in expression between curly tail and wild-type by 1.5-fold or 
greater (p<0.05). Nine genes were common between the two lists (Table 4.8).  
 
Gene Symbol Gene name Curly tail 
Array 
fold 
change 
p-value
Matr3 Matrin 3 Down regulated 2.3 0.01
Rnf14 Ring finger protein 14 Up regulated 1.8 2.34E-05
Isoc1 Isochorismatase domain containing 1 
Down 
regulated 3.5 0.02
A730017C20Rik RIKEN cDNA A730017C20 gene 
Down 
regulated 5.9 
4.04E-05
Tcof1 
Treacher Collins 
Franceschetti syndrome 1, 
homolog 
Down 
regulated 1.7 0.007
Grpel2 GrpE-like 2, mitochondrial 
Down 
regulated 1.9 0.006
Apcdd1 Adenomatosis polyposis coli down-regulated 1 Up regulated 1.5 0.04
Tubb6 Tubulin, beta 6 Up regulated 1.5 0.005
4930503L19Rik Putative uncharacterized protein
Down 
regulated 1.7 0.04
 
Table 4.8 Genes from the chromosome 18-Lmnb1 region that differ in 
expression between curly tail and wild-type. Microarray analysis was performed 
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using Affymetrix MOE430v2 arrays with data processing using GeneSpring 
(Version 11). Fold change indicates expression in wild-type relative to curly tail 
samples (for down-regulated genes) or vice-versa (for up-regulated genes). 
 
Primers were designed for seven of these genes in order to investigate levels of 
expression by qRT-PCR using ct9E and ct8E cDNA as template (Appendix B, Table 
B.11). For each gene, the level of expression was normalised to a ct9E sample. For the 
majority of these genes no statistically significant differences in expression were 
detected between ct9E and ct8E, suggesting that the expression difference between ct and 
+ct may be a consequence of difference in Grhl3 expression (and may be worthy of 
further investigation in this context). However, there was a small but statistically 
significant down-regulation in ct8E of the unannotated RIKEN EST, A730017C20 
(Table 4.9), which is predicted to encode a transmembrane protein. Given the small 
fold-change in expression level the biological significance of this finding is unclear.  
   
Gene Symbol Gene name Ct8E Fold change p-value
Matr3 Matrin 3 Down regulated 1.1 
Not 
significant
Isoc1 Isochorismatase domain containing 1 Up regulated 1.1 
Not 
significant
A730017C20Rik RIKEN cDNA A730017C20 gene 
Down 
regulated 1.2* 
0.02
Tcof1 
Treacher Collins 
Franceschetti syndrome 1, 
homolog 
Down 
regulated 1.6 
Not 
significant
Grpel2 GrpE-like 2, mitochondrial 
Down 
regulated 1.1 
Not 
significant
Apcdd1 Adenomatosis polyposis coli down-regulated 1 Up regulated 1.3 
Not 
significant
Tubb6 Tubulin, beta 6 Up regulated 1.2 Not significant
 
Table 4.9 Comparison of expression of seven genes from the chromosome 18 
Lmnb1 region in ct9E and ct8E strains by qRT-PCR. Three individual embryo 
samples were used for each strain. None of the differences were significant with 
the exception of A730017C20 (* p<0.02, t-test). Fold change indicates expression 
in ct9E relative to ct8E samples (for down-regulated genes) or vice-versa (for up-
regulated genes). 
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4.3 Discussion  
 
Lamin B1 represented a good candidate to play a role in influencing the risk of NTDs in 
curly tail embryos for several reasons. A defect in this protein could have an effect on 
its function in cell cycle progression and maintenance of nuclear shape and thereby 
contribute to the proliferation defect in curly tail embryos (Section 4.1). In addition, 
alteration of lamin B1 protein structure could affect its binding to chromatin or 
transcription factors, thereby affecting regulation of gene expression.  
 
It was interesting to find that the migration change of lamin B1 protein on 2D gels of 
ct/ct embryos resulted from a genetic variation in the coding sequence of Lmnb1, 
resulting in the loss of a glutamic acid (E) in a region of nine repeats (polyglutamic acid 
tract) in the tail domain of the protein. The crystal structure of the mouse protein lamin 
B1 has not yet been described, but the crystal structure of human lamin-B1 was recently 
published (Protein Data Bank Japan, http://www.pdbj.org/pdb_nc/pdb3hn9.ent). 
However, the published structure does not extend beyond amino acid 548, whereas the 
E repeats are located at amino acids 552-559. It was therefore not possible to verify 
what type of 3D structure the eight glutamic acids would be present in, or to predict 
how the variation in number of Glu residues (as observed in different mouse strains) 
could affect tertiary structure. Having said that, polyglutamic acid tracts are known to 
become increasingly alpha-helical when interacting with phospholipid membranes. A 
tract length difference of one residue could therefore be important. It could induce local 
curvature owing to the almost hundred-degree rotational shift in the orientation of the 
distal portion of the protein sequence (Mori et al., 1977; Subramanian et al., 2000; 
Agresti et al., 2008). In lamin B1, the polyglutamic acid tract is situated in the tail 
domain of the protein, which is short and contains another strong membrane interactor 
(the farnesylcysteine) with a specific orientation. In consequence, a difference in tract 
length of a single residue (E deletion) could be hypothesized to lead to a dramatic loss 
of a stable membrane association. Functional testing of the lamin B1 variants by FLIP 
confirmed that the 8E variant could compromise stability of the nuclear lamina. The 
generation of ct sub-strains carrying combinations of the Lmnb1 polymorphisms and the 
Grhl3 mutation, strongly suggested that Lmnb1 could act as a modifier gene which 
affects the risk of NTDs in curly tail (summarised in Table 4.10). 
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Strain  Lmnb1
  
Grhl3 Phenotype 
ct  8E Mutation   Spina bifida, tail defects 
ct9E  9E Mutation Less frequent spina bifida, tail defects 
+ct;8E 8E Wild-type Infrequent  tail defects 
+ct 9E Wild-type No defects 
 
Table 4.10 Phenotype of ct-substrains in relation to Lmnb1 polymorphism 
and the Grhl3 mutation. 
  
Analysis of the frequency of NTDs observed in ct9E and ct8E embryos suggested that 
Lmnb1 might be a major modifier, with an effect on the frequency of spina bifida as 
well as exencephaly. Although exencephaly occurs at much lower frequency than spina 
bifida, Lmnb1 variation affected the penetrance of both defects to the same extent with a 
63% reduction in frequency in ct9E. Thus, although both the ct9E and ct8E strains carry 
the ct mutation which results in diminished Grhl3 expression, a ‘wild-type’ Lmnb1 (9E) 
lessens the effect on neural tube closure. Even so, embryos carrying the Grhl3 mutation 
can develop spina bifida even when wild-type Lmnb1 (ct9E-strain) is present. 
Conversely, reinstatement of Grhl3 expression rescues spina bifida and tail defects 
independently of Lmnb1, since Grhl3 transgenic (ctTgGrhl3) embryos show the same 
lamin B1 2D gel pattern as ct (8E), but do not develop spinal NTDs (Gustavsson et al., 
2007). On the other hand, embryos that are wild-type for Grhl3 but which carry the 
Lmnb1 polymorphism (+ct;8E) can develop occasional tail flexion defects. It is therefore 
apparent that Grhl3 is the major curly tail gene, but the penetrance of resulting NTDs is 
influenced by lamin B1 function. In summary, this study suggests that Lmnb1 is a major 
modifier gene influencing the risk of NTDs in curly tail embryos.  
 
Lamin B1 is known to play a role in the size and shape of the nuclear lamina during the 
cell cycle (Hutchison, 2002a). Lamin B1 plays a direct role in the reassembly of nuclear 
components after mitosis. In addition, differently from other lamins, this protein is 
stably associated with membrane vesicles even during mitosis (Hutchison et al., 1994). 
The in vitro studies described here are supportive of the hypothesis that disturbance of 
lamin B1 function can affect the nuclear lamina in general. I hypothesise that this could 
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lead to disturbances of the cell cycle and contribute to the proliferation defect which has 
been detected in the hindgut and notochord in ct/ct embryos (Copp et al., 1988a; Copp 
et al., 1988b). Studies on exencephaly in curly tail are suggestive of a temporary 
reduction in cell proliferation rate at the cranial level at the time of neural tube closure 
(Seller and Perkins, 1986). Fibroblasts generated from the Lmnb1 gene-trap mouse 
mutant, a mutation which results in lack of a portion of the rod domain, the nuclear 
localisation signal and the CAAX motif, display striking nuclear dysmorphology and 
reduced proliferation (Vergnes et al., 2004). The mutant embryos (Lmnb1∆/∆) are 
smaller and have abnormal curvature of the spine compared to their littermates, as well 
as abnormalities at the cranial level. It could be hypothesised that there would be an 
increase in the frequency of NTDs in double homozygous ct/ct;Lmnb1∆/∆ compared to 
ct/ct. 
 
Lamin B1 mutant MEFs (Lmnb1-/-; Vergnes et al., 2004), which lack full-length lamin 
B1, have a higher proliferation rate than wild-type Lmnb1 fibroblasts. It is not clear how 
this increased proliferation relates to the in vivo phenotype in which there appears to be 
diminished cell proliferation, with smaller pups that die perinatally. Unlike the Lmnb1 
mutant the levels of expression of Lmnb1/lamin B1 do not appear to be deficient in 
curly tail embryos. Nevertheless, in the future, it would be interesting to investigate cell 
cycle progression and the proliferation rate in the MEFs of the curly tail strains. An 
initial approach could involve culture of curly tail 9E and 8E MEFs, with counting of 
total cell number immediately after plating and then at twenty four hour intervals. Such 
an approach may reveal differences in proliferation rate or defects such as premature 
senescence. In another experiment, curly tail 9E and 8E MEFs could be treated with 
EdU (5-ethynyl-2’-deosyuridine) which allows detection of cells that are in S-phase. 
Quantification of stained cells may reveal differences in the proportion of cells in S-
phase, indicative of differential proliferation rate. 
 
Another possible mechanism by which the 8E lamin B1 variant could modify the curly 
tail phenotype might involve abnormal interaction between the lamin B1 8E variant and 
nuclear envelope binding partners. Weaker association between lamin B1 and chromatin 
and/or transcription factors could affect regulation of gene expression (Malhas et al., 
2007; Malhas et al., 2009), and thereby contribute to disease pathogenesis. It is not 
known whether Grhl3 interacts with lamin B1/Lmnb1 or if they share interacting 
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partners. To date, the functional role and downstream mediators of Grhl3 in neural tube 
closure are still undetermined. At present it is difficult therefore to predict: (i) whether 
Lmnb1 mutations would alter expression of genes that are also Grhl3 targets, or (ii) 
whether Lmnb1 and Grhl3 mutations would result in independent transcriptional effects 
that summate to enhance the cellular defects in curly tail embryos (Fig. 4.24). 
  
                                       
 
Figure 4.24 Summary. Diagram summarising possible mechanisms by which the 
8E lamin B1 variant could modify risk of NTDs in curly tail mice. The Grhl3 
mutation is assumed to affect expression of downstream target genes, ultimately 
leading to reduced cell proliferation and NTDs. The lamin B1 8E variant could 
directly affect cell cycle regulation (a) owing to abnormal stability of the nuclear 
envelope. The lamin B1 8E variant could also result in defects of the nuclear 
envelope associa  with chromatin or directly with transc tion factors, 
leading to altered gene regulation (b) and enhancement of the ct phenotype. 
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Chapter 5 
 
 
Over-expression of Grainyhead-like-3 in mouse embryos  
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5.1  Introduction 
 
Spinal NTDs occur in Grhl3 null embryos, generated by gene targeting, and curly tail 
embryos, which carry a hypomorphic allele of Grhl3 (Ting et al., 2003a; Gustavsson et 
al., 2007).  Over-expression of Grhl3 in curly tail Grhl3-transgenic mice (ctTgGrhl3) 
prevents the development of spinal NTDs. These studies show that sufficient levels of 
Grhl3 are essential for neural tube closure in the mouse. 
 
In Drosophila, loss of GRH function causes late embryonic lethality, embryos have 
flimsy cuticles, grainy and discontinuous head skeletons and patchy tracheal tubes 
(Bray and Kafatos, 1991a). Moreover, a mutant lacking the GRH activation domain 
acted as a dominant-negative inhibitor of GRH activation in cultured cells, by forming 
inactive heterodimers with the full-length protein (Attardi et al., 1993). However, gain 
of function experiments, involving over-expression of GRH in the embryo or larva also 
suggest that excessive GRH is harmful during multiple stages of the Drosophila life 
cycle, resulting in 46% mortality, compared with 0% mortality in the wild-type control 
strain. In addition, over-expression of the dominant-negative protein (transgenic 
N∆447) also had severe consequences, causing 83% mortality (as measured by 
unhatched embryos; Attardi et al, 1993). Transgenic embryos over-expressing full-
length GRH that failed to hatch presented several defects including abnormal cuticle, 
and remained curved with failure to elongate during the dorsal closure stage of 
development (dorsal hole). The latter is a phenotype characterised by failure of contact 
and fusion of the epidermis at the dorsal midline. Interestingly, N∆447 embryos did not 
develop these defects even though there was a high rate of mortality. Attardi et al (1993) 
concluded that over-expression of either the wild-type or dominant negative protein 
disturbed development by different mechanisms, resulting in the differences in the 
phenotypes of the two strains.  
 
These observations raise the question of whether excessive expression of Grhl3 might 
also have a deleterious effect in the mouse. In the literature, in the context of 
neurulation, the low-density lipoprotein receptor-related protein 6 (Lrp6, a coreceptor 
for Wnt ligands) is one example in which opposing changes in the gene function both 
cause NTDs during neural tube closure (Harris and Juriloff, 2007). Lrp6 null mutant 
 261
embryos, with no protein function, exhibit exencephaly and/or spina bifida (Pinson et 
al., 2000). A hypomorphic mutation of Lrp6, ringelschwanz (rs), which retains partial 
protein function, results in spina bifida only (in approximately 70% of the homozygotes; 
(Kokubu et al., 2004). Conversely, crooked tail (Cd) mutant embryos, which carry a 
gain-of-function mutation in Lrp6 develop only exencephaly (at 20-30% frequency; 
(Carter et al., 2005). 
 
The ctTgGrhl3 BAC transgenic mouse provides an opportunity to test the hypothesis that 
over-expression of Grhl3 may have deleterious effects on embryonic development. To 
date, only embryos carrying a single copy of the BAC have been generated. Therefore, 
by intercrossing ‘single’ transgenic mice, with the BAC present at a single locus, it 
should be possible to generate embryos carrying double the dosage of the BAC. It was 
previously shown that ctTgGrhl3 embryos express higher levels of Grhl3 mRNA, by 
approximately 2-6 fold, than in curly tail embryos, at all stages examined (Gustavsson 
et al., 2007). Embryos with double the dosage of the BAC (ctTgGrhl3/ctTgGrhl3) would 
carry the BAC in homozygosity, and therefore be predicted to show double the level of 
Grhl3 expression from the BAC compared to ctTgGrhl3 embryos, in addition to expression 
from the endogenous Grhl3 locus.    
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5.2  Results 
 
5.2.1  Intercrosses between curly tail-transgenic mice to generate embryos that 
over-express Grhl3 
To generate transgenic Grhl3-expressing mice, curly tail (ct/ct) mice were crossed to 
BAC positive (ct/ctTgGrhl3) mice. In these crosses the BAC is present in hemizygous state 
(one insertion site; Figure 5.1 A), and embryos were always normal with respect to 
spinal neural tube development (as reported by Gustavsson et al, 2007). In order to 
vestigate the effect of over-expression of Grhl3, male and female ct/ctTgGrhl3 mice 
were intercrossed (Fig. 5.1 B).     
 
Embryos were collected at stages between E10.5 and E18.5 and genotyped for the 
presence or absence of the BAC containing the intact Grhl3 gene (Chapter 2, section 
2.4.1). All samples were also genotyped for the C-21350T polymorphism in which 
transgenic embryos are expected to show both ct/ct and wild-type (from the BAC) 
genotypes, whereas non-transgenic samples only exhibit the ct/ct (T) allele (Chapter 2, 
section 2.4.2). The number of embryos collected at different stages of development is 
summarised in Table 5.1. At all stages the frequency of BAC-negative (ct/ct) and BAC-
positive (ct/ctTgGrhl3 and ctTgGrhl3/ctTgGrhl3) embryos did not significantly differ from the 
predicted Mendelian ratio, 1:3. Therefore, it appears unlikely that over-expression of 
Grhl3 results in embryonic lethality (Table 5.1).  
 
 
in
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Figure 5.1 Schematic of the genetic crosses to generate Grhl3-homozygous 
transgenic embryos. (A) Diagram of genetic crosses between ct/ct and ct/ctTgGrhl3 
mice to generate Grhl3-single transgenic mice. In these crosses the BAC is 
present in hemizygous state, and the expected proportion of F1 offspring is 50% 
ct/ct and 50% transgenic (1:1). (B) Diagram of genetic intercrosses between 
ct/ctTgGrhl3 mice to generate homozygous transgenics, the expected proportion of 
F1 offspring is: 25% ct/ct, 50% ‘single’ transgenic and 25% ‘double’ transgenic. 
Overall, it is expected that 75% of these mice carry the BAC (1:3, BAC-negative: 
BAC-positive).  
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Developmental 
Stage 
No. 
Embryos 
No. Bac-ve 
embryos  
Frequency 
No. Bac+ve 
embryos 
Frequency 
E10.5 316 81 25.6% 235 74.4% 
E11.5 –E13.5   49  13 26.5%   36 73.5% 
E14.5 – E16.5        109 30 27.5%   79 72.5% 
E17.5 – E18.5   80       15 18.8%   65 81.3% 
Total  554     139 25.3% 415 74.7% 
Expected 
frequency 
  25%  75% 
 
Table 5.1 Frequency of BAC negative and positive embryos collected from 
Grhl3-transgenic curly tail intercrosses. All embryos were collected between 
embryonic days 10.5 and 18.5, and scored for the presence or absence of the 
BAC.  
 
 
5.2.2  Investigation of gross development abnormalities in embryos of the Grhl3-
transgenic curly tail mice  
Embryos generated by the intercross of Grhl3-transgenic mice were investigated for 
gross developmental abnormalities. The different phenotypes observed among embryos 
of the transgenic intercrosses are shown in Figure 5.2.  Surprisingly, both exencephaly 
(Fig. 5.2 A-B, I) and spina bifida (Fig. 5.2 D, F, H-L) were observed among BAC-
positive embryos. Spina bifida has not previously been observed among ‘single’ 
transgenic embryos, and it was therefore hypothesised that BAC-positive embryos 
which developed spina bifida corresponded to ctTgGrhl3/ctTgGrhl3. Spina bifida was 
accompanied by a straight, bent or curled tail. The spina bifida defect was itself variable 
in size with some embryos having larger defects (Fig. 5.2 K) compared to littermates 
also with spina bifida (Fig. 5.2 J).  Predicted ctTgGrhl3/ctTgGrhl3 E10.5 embryos had 
enlarged PNPs (5.2 A-B). Embryos were scored according to the type of NTD (spinal 
and cranial) and presence of tail flexion defects. The penetrance of these defects was 
compared between BAC-negative (ct/ct) and BAC-positive embryos (Table 5.2).  
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Figure 5.2 Phenotypes of embryos derived from transgenic intercrosses. (A-
B) Predicted ctTgGrhl3/ctTgGrhl3 transgenic embryos at E10.5 exhibit forebrain-
midbrain exencephaly (Ex, failure of closures 2 and 3) and an enlarged PNP. Both 
defects are characterised by open neural folds. (C) E11.5 ct/ctTgGrhl3 embryo 
(known genotype) with normal spine. (D) Predicted ctTgGrhl3/ctTgGrhl3 embryo at 
E11.5 exhibiting spina bifida. (E) E12.5 ct/ct embryo with SB and a curled tail 
(CT; G) compared to (F) a predicted ctTgGrhl3/ctTgGrhl3 litter-mate with SB and a 
straight tail (ST; H). (I) Predicted ctTgGrhl3/ctTgGrhl3 embryo at E13.5 showing Ex, 
SB and a ST. At this stage, the nervous tissue of the brain bulges out and this will 
degenerate at later stages. (J-K) Predicted ctTgGrhl3/ctTgGrhl3 embryos at E13.5 
showing differences in length of SB and with (J) straight and (K) bent tails. (L) 
E15.5 ctTgGrhl3/ctTgGrhl3 embryo exhibiting curled tail. Scale bar: 1 mm. Embryos 
shown in the figure are of known genotype.  
 
Phenotype 
Genotype Total No. Normal 
Exen Tail 
defect 
alone  
Total SB  SB + 
BT/CT 
SB + 
ST 
BAC negative: 
ct/ct 
  58  29 ‡
(50.0%
) 
  4 * 23  2   
(3.4%) 
2 
(100.0%) 
0 
(6.9%) (39.7%) 
BAC positive: 
ct/ctTgGrhl3 or 
ctTgGrhl3/ctTgGrhl3
180 109 
(60.6%)
13 †   
(7.2%) 
11 
(6.1%) 
47 † 
(26.1%) 
23 
(48.9%) 
24 
(51.1%)
 
Table 5.2 Neural tube defects in embryos derived from Grhl3-transgenic 
curly tail intercrosses. E11.5 – E18.5 embryos were assessed for NTDs (spinal 
and cranial) and tail flexion defects (tail defect alone) or no defects (Normal). 
Exencephaly (Exen) can occur in isolation with straight tail (ST), or in 
combination with spina bifida (SB) and/or tail defects (bent, BT, or curled tail, 
CT). * Includes three embryos with exencephaly and tail defects. † Figures 
include three embryos with exencephaly and spina bifida accompanied by tail 
defects. Sub-types of spina bifida are indicated in blue and it should be noted that, 
in general, spina bifida in curly tail embryos is almost always accompanied by a 
curled tail. By comparison, among BAC positive embryos around half of the spina 
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bifida cases are accompanied by a straight tail. χ2 test comparing the proportion of 
SB, tail defects and no defects shows a significant difference between the 
proportions in each category in ct/ct compared with BAC-positive embryos (p ≤ 
0.001). 
                      
A proportion of both curly tail and of BAC-positive embryos developed NTDs. BAC-
positive embryos have a significantly higher percentage of spina bifida than ct/ct 
embryos (p<0.001, Z-test). On the other hand, the rate of isolated tail defects is the 
inverse: more frequent in ct/ct embryos than BAC-positive embryos. This finding 
suggests that excessive Grhl3 expression predisposes to spina bifida but not tail defects. 
The frequency of spina bifida in ct/ct embryos within these litters is lower (3.4%) than 
usually observed among ct/ct (14-15%), but this may reflect the relatively small sample 
size (n = 58). Indeed, these differences are not significant by Z-test or χ2 (spina bifida 
versus no spina bifida) when comparing ct/ct from double transgenic crosses (Table 
5.2) to ct/ct from ct litters collected during a similar period (n = 113, 16 with spina 
bifida). In contrast, the frequencies of exencephaly and tail defects among ct/ct embryos 
from transgenic intercrosses are very close to those normally observed in ct/ct litters. 
Interestingly, both, ct/ct and BAC-positive embryos within these litters had similar rates 
of exencephaly (not significantly different).    
 
It was hypothesised that transgenic embryos that developed spina bifida (26.1%) 
corresponded to those which carry double the copy number of the BAC 
(ctTgGrhl3/ctTgGrhl3). These were predicted to comprise 25% of the total number of 
embryos (one third of the BAC-positive). Thus, 60 of the 180 BAC-positive embryos 
are predicted to be ctTgGrhl3/ctTgGrhl3, of which 47 developed spinal NTDs, i.e. 75% of the 
predicted ctTgGrhl3/ctTgGrhl3 developed spina bifida (Table 5.2). Overall, these data 
suggest that the risk of spina bifida is higher in the predicted ctTgGrhl3/ctTgGrhl3 than in 
ct/ct littermates and that over- or under-expression of Grhl3 can cause spinal NTDs 
 
Interestingly, a proportion of the predicted ctTgGrhl3/ctTgGrhl3 embryos developed spina 
bifida with a straight tail (Fig. 5.2 D, F, H-J; Table 5.2), unlike the typical spina bifida 
with curly tail observed in ct/ct embryos. This phenotypic difference could be 
suggestive of possible variation in the mechanism underlying failure of neural tube 
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closure and development of spina bifida resulting from insufficient (ct/ct) or excessive 
(predicted ctTgGrhl3/ctTgGrhl3) Grhl3 expression levels.  
 
 
5.2.3  Investigation of Grhl3 expression level in relation to posterior neuropore size   
To further investigate the possibility that over-expression of Grhl3 in ctTgGrhl3/ctTgGrhl3 
embryos can result in NTDs, it was important to determine the relationship between 
Grhl3 expression levels and PNP closure. 
 
Using the same primers, Grhl3_F6/R6, as previously (Gustavsson et al., 2007); 
Appendix B, Table B.2), expression levels in the caudal region of stage-matched 
embryos undergoing PNP closure, were compared by quantitative RT-PCR. Expression 
of Grhl3 was diminished in ct/ct embryos compared with transgenics, as previously 
observed (Fig. 5.3 A; Gustavsson et al, 2007). Transgenic embryos could be broadly 
divided into two groups on the basis of Grhl3 expression level. One group exhibited 
expression levels approximately 2.7 fold higher than in ct/ct. These embryos were 
predicted to correspond to ‘single’ transgenic embryos as this degree of elevation of 
expression corresponds to that in known ct/ctTgGrhl3 embryos from ct/ct versus ct/ctTgGrhl3 
crosses. In the latter case, data from two RT-qPCR experiments showed a mean fold 
change for Grhl3 of 2.9 ± 0.70 for ct/ctTgGrhl3 compared with ct/ct. A second group of 
samples showed expression elevation of up to 7.0 fold higher than ct/ct, and were 
predicted to correspond to ctTgGrhl3/ctTgGrhl3 embryos.  
 
To investigate if there was a correlation between the expression levels of Grhl3 and the 
length of the PNP, the mean PNP length of 26-31 somite stage embryos of different 
predicted genotypes were plotted (Fig. 5.3 B). A PNP larger than 500 µm at the 28-29 
somite stage , is considered an indication of likelihood of developing spina bifida or a 
tail flexion defect (Copp, 1985). Comparison of mean Grhl3 expression (Fig. 5.3 A) and 
mean PNP length (Fig. 5.3 B) for the same group of embryos showed that the embryos 
with the highest expression of Grhl3 corresponded to the embryos with largest PNP (7.3 
fold compared to ct/ct). The PNP in ct/ct embryos was larger than in ct/ctTgGrhl3 but 
Grhl3 expression was diminished (2.7 fold), albeit not significantly with this sample 
size. The predicted ‘single’ transgenics had small PNP sizes and higher Grhl3 
expression indicating rescue of the phenotype as shown previously (Gustavsson et al., 
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2007). The small PNP size (200 µm) in ct/ctTgGrhl3 embryos reflects the fact that 
embryos of this genotype do not develop spina bifida.  
 
These results indicate that the size of the PNP varies with expression level of Grhl3 
(Fig. 5.3). Overall, there seems to be a requirement for tight regulation of Grhl3 
expression, with insufficient or excessive expression both causing spinal NTDs. Wild-
type and ‘single’ transgenic (ct/ctTgGhl3) express Grhl3 at a level that is compatible with 
normal spinal neurulation.  
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Figure 5.3 Grhl3 mRNA expression versus posterior neuropore length. (A) 
Grhl3 expression in ct-Grhl3 expressing embryos (ct/ct, ct/ctTgGrhl3 and 
ctTgGrhl3/ctTgGrhl3) at the time of PNP closure (mean values ± SEM). Grhl3 
expression in predicted ctTgGrhl3/ctTgGrhl3 embryos is significantly higher than 
expression in ct/ct (7-fold increase) and single transgenic (2.7-fold increase) 
embryos (* p = 0.0001, One Way ANOVA and Pairwise Multiple Comparison – 
Holm-Sidak Method). Grhl3 expression is 2.7-fold elevated in single transgenics 
compared with ct/ct. A ct/ct sample was used as calibrator on the RT-qPCR 
analysis. Dotted line indicates expected wild-type level of expression. (B) The 
PNP lengths of the same group of embryos were plotted as mean ± SEM. In this 
experiment, predicted ctTgGrhl3/ctTgGrhl3 transgenic embryos (n = 3) had 
significantly larger PNPs than single transgenics (n = 3) but not ct/ct (n = 4) 
embryos (* p = 0.011, One Way ANOVA and Holm-Sidak Method).  
 271
5.2.4 Genotyping of predicted ‘double’ transgenic embryos by quantitative real-
time PCR of genomic DNA 
In transgenic intercrosses (ct/ctTgGrhl3 versus ct/ctTgGrhl3) embryos were genotyped for the 
presence or the absence of the BAC, and it was predicted that BAC-positive embryos 
with very large posterior neuropores (vLPNP) or spina bifida correspond to double 
transgenics. However, it was not possible to know for certain which of the embryos that 
carry the BAC are ‘single’ or ‘double’ trangenics. Moreover, it was not known whether 
all ‘double’ transgenic embryos develop such obvious phenotypes and whether defects 
are observable at earlier stages, such as E8.5 or E9.5. Therefore, it was necessary to 
develop a method to genotype embryos of the transgenic intercrosses without using 
qRT-PCR on embryo samples as this precludes use of the embryos for other analysis.  
 
Primers for real-time quantitative genomic PCR (qG-PCR) were designed to amplify an 
intronic region of the Grhl3 gene, as well as for the Grhl2 gene, to be used as an 
internal control (Appendix B, Table B.3). Genomic DNA was extracted from the yolk-
sac (E8.5 – E10.5) or from a limb (E11.5 – E18.5) and a 100 ng sample was used as 
template for qG-PCR based on the SYBR green method. Additional ‘single’ transgenics 
from ct/ct versus ct/ctTgGrhl3 crosses were used as controls since their genotype is known 
and expression levels were normalised to a ct/ct sample (Chapter 2, section 2.7.3). 
 
Embryos with phenotype of predicted ‘double’ transgenics, i.e. spina bifida and/or tail 
defects (at E11.5 or later), or enlarged PNP (at E10.5) showed the highest Grhl3 values 
compared to single transgenic-controls as well as to predicted ‘single’ transgenics 
(BAC-positive but no defects and/or small PNPs; Fig. 5.4). This method made possible 
the genotyping of transgenic embryos according to the abundance of Grhl3 genomic 
DNA. With values normalised to a mean value of 1.0 for ct/ct samples (equivalent to the 
two copies of the endogenous gene), ct/ctTgGrhl3 samples had a mean value of 2.3 and 
ctTgGrhl3/ctTgGrhl3 samples a mean value of 3.9 (Fig. 5.4). Therefore, it is possible to 
predict the genotype of embryos from transgenic intercrosses by qG-PCR.  
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Figure 5.4 Predicted genotyping of ct-Grhl3-transgenic embryos. Symbols 
represent individual embryo samples (X axis) plotted against Grhl3 genomic 
DNA level (Y axis). Known ct/ct (green circles) and single transgenics (pink 
triangles) fit within broadly consistent Grhl3 levels. The genotype of double 
transgenic embryos (red diamonds) from transgenic intercrosses can be predicted 
on the basis of Grhl3 qG-PCR with these embryos showing the highest values, 
whilst single transgenic embryos from the same crosses (pink diamonds) have 
comparable levels of Grhl3 to known embryos of the same genotype (pink 
triangles).  
 
 
5.2.5   Analysis of posterior neuropore length in double transgenic embryos 
Following the observation of spina bifida among both ct/ct and Grhl3-transgenic curly 
tail embryos at E11.5 – E18.5, this phenotype was analysed at E10.5. It is known that 
the size of the PNP gives an indication of the likelihood of ensuing spina bifida. 
Enlargement of the PNP (LPNP) is associated with progression of spina bifida, whereas 
a small PNP (SPNP) predicts an unaffected embryo (Copp, 1985b). Consequently, the 
PNP was measured in a series of embryos (Chapter 2, section 2.1.2) and classified as 
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SPNP or LPNP. The typical appearance of large and small PNPs is shown in Figure 
5.5.  
 
Embryo images show the degree of severity of PNP enlargement in ctTgGrhl3/ctTgGrhl3 
embryos. PNP lengths were measured at three somite stage intervals: 26-27, 28-29, 30-
31 (Table 5.3). The mean PNP size of double transgenics is significantly larger than in 
all other strains.  In contrast, single transgenic embryos have smaller PNPs throughout 
the period of closure. The PNP length of individual embryos and the mean value at each 
stage were plotted to allow visualisation of the pattern of closure through the 26-31 
somite developmental period (Fig. 5.6). These data show a range of PNP sizes with 
progression of closure to completion in most wild-type (+ct/+ct) and single transgenic 
(ct/ctTgGrhl3) embryos and failure of closure in most ct/ct, and double (ctTgGrhl3/ctTgGrhl3) 
transgenic embryos.  
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Figure 5.5 Differing appearance of posterior neuropore in E10.5 Grhl3 
transgenic embryos at the stage of PNP closure. (A-B) In some embryos, the 
PNP was closed (PNP=0), as is observed in wild-type embryos at this stage. (C-F) 
Embryos at the 27 and 29 somite stages with small PNPs, 125 µm (C, D) and 500 
µm (E, F). (G-H) Enlarged PNP (875 µm) typical of affected curly tail embryos. 
(I-L) Two embryos with high levels of Grhl3 showing very large PNPs, 1,550 µm 
(I, J) and 2,000 µm (K, L), larger than usually observed in ct/ct embryos. B, D, F, 
H, J and L, are enlargements of the indicated area in A, C, E, G, I, and K, 
respectively. Scale bars: A, C, E, G, I, and K, 1.0 mm; B, D, F, H, J, and L, 0.5 
mm.  
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Closure of the PNP (length of 0 µm) occurs at the 30-31 somite stage in the majority of 
embryos expressing normal (wild-type, blue circles; Fig. 5.6) or moderately elevated 
(ct/ctTgGrhl3, pink squares; Fig. 5.6) levels of Grhl3. From the 27 somite stage, the PNP 
length of ct/ct embryos, which were previously found to express reduced levels of 
Grhl3, is higher than in wild-type and single transgenic embryos (green diamonds; Fig. 
5.6, Table 5.3). The PNP is severely enlarged at all stages in double transgenic 
embryos, which express high levels of Grhl3 (purple triangles, and mean value higher 
than for the other three strains, Fig. 5.6; Table 5.3). Thus, PNP lengths are larger in 
double transgenics than even in ct/ct embryos (Table 5.3; Fig 5.6).  
 
Since, PNP lengths are already enlarged in double transgenic embryos with 26 somites, 
it appears likely that PNP closure becomes abnormal in these embryos prior to this 
stage. For this reason, litters were collected at E9.5 and the PNP length was measured in 
a series of embryos at the 20-25 somite stages (Table 5.4; Fig. 5.7). Although the 
number of embryos is not large, it is apparent that the defect in PNP closure starts at the 
20-21 somite stage (or even earlier) in double transgenic embryos.  
 
Number of somites 
26-27 28-29 30-31 Strain 
n PNP (µm) n PNP (µm) n PNP (µm) 
Wild-type 10 307.5 ± 29.4 28 257.1 ± 21.6 37 68.9 ± 18.9 
Single 
transgenic 10 332.5 ± 30.3 31 332.3 ± 23.0 43 73.8 ± 16.3 
Curly tail 14 ‡569.6 ± 41.5 78 ‡536.9 ± 22.9 87 ‡410.1 ± 29.2 
Double 
transgenic 8  
†1,150.0 ± 80.9 21  †1,236.9 ± 79.6 20  †1,408.8 ± 81.6 
 
Table 5.3 Posterior neuropore (PNP) length of wild-type, curly tail, single and 
double transgenic embryos at E10.5. Mean and standard error values are given 
for the posterior neuropore length (PNP) within the 26-27, 28-29, and 30-31 
somite stages. Double transgenics have significantly enlarged PNPs compared to 
all other strains at all stages examined (One Way ANOVA, and Holm-Sidak 
Method, p ≤ 0.001†). Likewise, curly tail embryos have significantly larger PNP 
lengths than wild-type and single transgenic embryos but smaller PNPs than 
double transgenics (‡). There was no difference between the PNP length of single 
transgenics and wild-type embryos. Abbreviations: n, number of embryos of each 
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strain. Wild-type (+ct) embryos are from the partially congenic wild-type (curly 
tail) strain. 
               
 
 
Figure 5.6 Variation in length of posterior neuropore with stage among 
embryos that differ in Grhl3 expression level. The data for individual embryos 
is shown, with the mean PNP length (± SEM) indicated for each strain at each 
stage. Number of embryos at the 26, 27, 28, 29, 30 and 31 somites stages are: for 
+ct/+ct 3, 7, 14, 14, 19, 18; for ct/ctTgGrhl3 5, 5, 19, 12, 22, 21; for ct/ct, 6, 8, 39, 39, 
54, 33; for ctTgGrhl3/ctTgGrhl3, 4, 4, 12, 9, 10, 10.  
 
Number of Somites 
20-21 22-23 24-25 Strain 
n PNP (µm) n PNP (µm) n PNP (µm) 
Curly tail 3 516.7 ± 16.7 1 375.0 ± 0.0 4 562.5 ± 47.3 
Single 
transgenic 5 520.0 ± 12.2 6 475.0 ± 25.8 5 550.0 ± 30.6 
Double 
transgenic 2 750.0 ± 0.0* 1 1,000.0 ± 0.0 4 887.5 ± 83.2* 
 
Table 5.4 Posterior neuropore lengths of single transgenic embryos between 
somite stages 20 and 25. At 20-21 and 24-25 somite stages, double transgenics 
have significantly larger PNPs than single transgenic and curly tail embryos (* p 
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≤ 0.001 and p = 0.002, respectively; ANOVA – Holm-Sidak method). There was 
no significant difference in PNP length between single transgenics and curly tails. 
It was not possible to do statistical analysis at somite stage 22-23, owing to the 
small sample size (n). 
 
         
 
Figure 5.7 Posterior neuropore length of curly tail and Grhl3 transgenic 
embryos at somite stage 20-25.  The length of the PNP (between red arrows) 
does not apparently differ between curly tail and single trangenics but is greatly 
enlarged in double transgenics. PNP lengths: (A) 550 µm; (B) 500 µm; (C) 1125 
µm. Scale bars: A-B, 0.5 mm; C, 1.0 mm. 
 
Having established that the BAC-positive embryos which exhibit spinal NTDs 
correspond to the double transgenics, I next investigated whether Grhl3 expression level 
also influences cranial neural tube closure. The presence of cranial NTDs (exencephaly) 
among embryos collected at E10.5 or later was compared between genotypes (Table 
5.5). It is apparent that exencephaly occurs in both ct/ct and BAC-positive embryos, 
including known single transgenics, suggesting that reinstatement of Grhl3 expression 
by the BAC is not sufficient to rescue these defects. The similar frequency of 
exencephaly between groups suggests that cranial neural tube closure is not exacerbated 
in a comparable manner to spinal closure in double transgenics. 
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Phenotype No of Embryos Curly tail 
ct/ct  
BAC 
negative  
Transgenic  
ct/ctTgGrhl3, ctTgGrhl3/ctTgGrhl3 
BAC positive 
E10.5 316   81 235 
Exencephaly  18    6 (7.4%)   12 (5.1%) 
Combined data 
E10.5 – E18.5 554 139 415 
Exencephaly  34   10   (7.2%)   25 (6.0%) 
 
Table 5.5 Cranial NTDs among embryos collected at E10.5-18.5. No 
significant differences were observed between groups. 
 
Of the 25 BAC-positive embryos with exencephaly (Table 5.5), 22 were genotyped by 
qG-PCR, while the other 3 were undetermined (poor DNA quality). Among these 
embryos, 14 genotyped as single transgenics and 8 as double transgenics (including 3 
embryos that showed both spina bifida and exencephaly). As an approximation, if one-
third of the 415 transgenic embryos are double transgenics, 5.8% developed 
exencephaly (8 out of 137) compared to 5.1% of the single transgenics (14 out of 277). 
These data suggest that there is not exacerbation or rescue of exencephaly in double 
transgenics. 
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5.2.6   Examination of spina bifida in ct/ct and ctTgGrhl3/ctTgGrhl3  
In the analysis of phenotypes and PNP sizes, some differences were noticed between 
spina bifida in ct/ct and transgenic embryos. In the double transgenics, not only do 
embryos develop spina bifida accompanied by a straight tail, as opposed to the 
association with curled tails in ct/ct, but the extent of the open defect also appears larger 
than in ct/ct embryos at least as indicated by PNP size (Fig. 5.5). To investigate the 
extent of the defect further, skeletal preparations were prepared from E15.5 embryos 
generated in the transgenic intercrosses (Fig. 5.8). 
 
Curly tail and double transgenic embryos had the same number of ribs and vertebrae 
(Fig. 5.8 A-G). Comparisons were made between a ct/ct and double transgenic 
littermate, with curled tail (CT) and straight tail (ST) respectively (Fig. 5.8). Both 
fetuses exhibit lumbosacral spina bifida. In the ct/ct fetus the spina bifida lesion starts 
between lumbar vertebrae III and IV (Fig 5.8 L) and in the double transgenic between 
vertebrae II and III (Fig. 5.8 M). Variation in the extent of the defect likely reflects the 
size of the PNP and the axial level from which the neuropore remains open.  
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Figure 5.8 Alcian blue staining of E15.5 embryos from transgenic 
intercrosses. (A-G) Skeletal structure of ct/ct (A, C and F), ct/ctTgGrhl3 (B, E) and 
ctTgGrhl3/ctTgGrhl3 (D, G) BAC-positive embryos. All studied embryos had 13 pairs 
of ribs (R) and equal numbers of vertebrae (v): 7 cervical (I-VII, Cv), 13 thoracic 
(I-XIII, Tv), 6 lumbar (I-VI, Lv), and 5 sacral (I-V, Sv). At the level of the iliac 
bone (double-headed arrows), it is noticeable that the level of spina bifida in ct/ct 
(H) differs from the double transgenic (I). To investigate this further, the internal 
organs of the embryos with spina bifida (F, G) were removed up to the diaphragm 
(J, L) and the lumbar and sacral vertebrae were counted (boxed areas at higher 
magnifications in K, M). In ct/ct the spina bifida starts between the LvIII and IV, 
and in the double-transgenic between Lv II and III. H and I are higher 
magnifications of F and G, respectively. Scale bar: 1 mm. Interpretation of 
skeletal structure was based on: (Menegola et al., 2001). 
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5.2.7   Localisation of the Grhl3-expressing BAC 
In transgenic experiments, BAC transgenes usually insert randomly into the genome. 
his raises the possibility that, in the present study insertion of the Grhl3 BAC could 
have disrupted another gene, and that the observed phenotype in double transgenic 
embryos could result from homozygous disruption of such a gene. For this reason, a 
strategy was designed to localise the BAC by inverse PCR in order to isolate genomic 
DNA adjacent to the BAC (Fig. 5. 9).  
 
All transgenic embryos were genotyped for the presence of the BAC (Chapter 2, 
section 2.4.1) using primers 237D13-R1 (D13) and pTARBAC, within the genomic 
DNA insert (the region of chromosome 4 containing the Grhl3 gene) and the BAC ends 
(vector). These primers allow PCR amplification of a 230 bp region which was 
sequenced, to confirm the position of the primers and presence of a six-base cutter 
restriction enzyme, BamHI (Appendix D, section D.1). Adjacent to the BAC end 
sequence lies the ‘unknown genomic region’ where the BAC is inserted (Fig. 5. 9 A). In 
principle, obtaining the sequence of this adjacent region and interrogation of the mouse 
genomic sequence should allow identification of the insertion site. Two enzymes within 
the BAC region were chosen to allow two independent experiments, to increase the 
chance of cutting the ‘unknown genomic region’ close to the BAC (Fig. 5.9 B). The 
four-base cutter restriction enzymes, RsaI and HaeIII that were not present within the 
230 bp sequenced region, nor within the primer sequences, were selected for digestion 
of ctTgGrhl3 genomic DNA.  
 
After digestion with RsaI or HaeIII (Chapter 2, section 2.14; Appendix A.16), the 
reaction products were ligated to circularise the DNA fragments. A dilute reaction 
mixture was prepared to favour unimolecular ligation (440 µl of water, 50 µl ligase 
buffer and 10 µl T4 ligase). Following ligation, the DNA products were purified by 
ethanol precipitation and digested with BamHI, to linearise the fragments (Fig. 5.9 C).  
Finally, primers with the inverse sequence to D13 and pTARBAC were used 
(Appendix B, Table B.4) for PCR amplification of the intervening region of unknown 
genomic DNA (Fig. 5.9 C). The fragments were then sequenced (DNA Sequencing 
Service, The Wolfson Institute for Biomedical Research, UCL) using both inverse 
primers, i.e., for identification of the ‘unknown region’.   
 
T
 282
 
 
Figure 5.9 Diagram summarising the inverse PCR strategy used to localise 
the BAC. (A) The BAC insert (blue box) contains the intact Grhl3 gene (yellow 
arrow indicates direction of transcription). The insert-BAC end junction 
encompasses a 230 bp region between genotyping primers 237D13-R1 (D13, 
blue) and pTARBAC (green), which was sequenced. This end junction is adjacent 
to an ‘unknown region’ of genomic DNA. (B) Sequencing of the 230 bp region 
revealed a 6-base cutter site, BamHI. Transgenic DNA was digested with the 4–
base cutter restriction enzymes: RsaI and HaeIII. An RsaI site is known to lie 
upstream of the D13 primer site within the BAC but not between the D13 and 
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pTARBAC primer sites. It was predicted that an RsaI site would lie in the 
‘unknown’ genomic region, close enough to generate a fragment that could be 
circularised. Hence, the digested samples were ligated to circularise the DNA 
fragments. (C) BamHI linearization should then result in a molecule whereby the 
‘unknown region’ would be flanked by an RsaI site, and the sites for the D13 and 
pTARBAC primers. Inverse primers to D13 (D13 inverse) and pTARBAC 
(pTARBAC inverse) were therefore designed to amplify and sequence the 
‘unknown region’.  
 
After sequencing, sequences were used to interrogate the mouse genome sequence using 
the BLAST feature of the ENSEMBL database 
(http://www.ensembl.org/Multi/blastview), followed by alignment of the hits. None of 
the sequencing hits from HaeIII fragments were informative since all corresponded to 
chromosome 4 (Chr 4:135,077,174 – 135,077,383 Mb). It appears likely that there is a 
HaeIII site close to the pTARBAC site, so that all sequencing reads went immediately 
into the BAC insert and this was confirmed on sequencing across the insertion site (see 
below). On the other hand, sequencing of fragments generated with RsaI produced 
matches to both BAC sequence (corresponding to chromosome 4) and novel sequence, 
adjacent to the BAC insertion site. Alignment of these sequences with genomic 
sequence, using BLAST revealed several possible chromosomal locations as 
summarised in Table 5.6. 
 
Overall, the sequence fragments generated by inverse PCR did not allow definitive 
localisation of the BAC as none of them had a 100% match to a specific chromosomal 
localisation. This is presumably because the curly tail genomic sequence differs from 
the reference sequence in the database (C57BL/6). Moreover, the BAC appears to be 
inserted in a low complexity repeat region, such that several possible chromosomal 
locations were indicated. The sequencing alignment of the hits generated from the RsaI 
fragments suggested that chromosome 18, position 3,005,382, is the most likely site for 
the BAC position. The two primers generated sequence fragments that aligned to a 
contiguous region of chromosome 18 (Fig. 5.10), whereas this was not the case for 
possible locations on chromosomes 14 and 15. The only other regions for which both 
primers generated sequence fragments in close proximity were on chromosome 16. 
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However, the sequence identity and region of homology were lower for the possible 
insertion sites on chromosome 16 than for chromosome 18.  
 
Primer Chr 
Alignment with genomic sequence 
(Mb) 
% Identity bp
pTARBAC 
inverse 
14 
15 
18 
16 
16 
9,119,164 – 9,119,375 
74,916,993 – 74,917,205 
3,005,382 – 3,005,593 
3,115,855 – 3,116,065 
3,350,523 – 3,350,733 
96.73 
96.71 
95.33 
94.37 
93.93 
214
213
214
213
214
D13 
inverse 
4 
18 
16 
16 
2 
19 
135,077,172 – 135,077,354 
3,005,889 – 3,006,013 
3,115,432 – 3,115,556 
3,351,034 - 3,351,158 
181,667,047 – 181,667,158 
61,341,681 - 61,341,786 
98.36 
94.40 
91.20 
91.20 
89.29 
88.99 
183
125
125
125
112
109
 
Table 5.6 Chromosomal locations which align with sequence fragments 
generated by inverse PCR following RsaI digestion. Chromosome number 
(Chr.), the region of the alignment, percentage of identification (% identity) and 
length of homologous region (base pairs, bp) are indicated. 
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Figure 5.10 Diagram to possible localisation of Grhl3-containing BAC on 
chromosome 18, as indicated by inverse PCR using RsaI. (A) Schematic of 
predicted ligation product following RsaI digestion. The position of primers used 
for inverse PCR (pTARBAC-inverse and D13-inverse) are indicated. The same 
primers were used for sequencing of the inverse PCR product and the sequence 
fragments which align to chromosome 18 are indicated by black bars. (B) 
Diagram of putative BAC insertion site on chromosome 18. The position of 
primers used to further investigate the insertion site are indicated. 
 
Despite the ambiguity of localisation based on sequencing data, one can deduce that in 
each possible location the potential insertion site of the BAC was at least 200 kb from 
the nearest gene. The closest gene to the putative insertion site on chromosome 18 (18: 
3,005,382) is 260.8 kb away (Fig. 5.11), while the possible insertion sites on 
chromosome 16 lie 476.6 kb and 241.7 kb from the nearest gene. However, one of the 
possible insertion sites on chromosome 16 lies only 3.0 kb from a predicted non-coding 
mRNA (Fig. 5.11). 
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Figure 5.11 Possible chromosomal locations of the Grhl3-BAC as indicated by 
inverse PCR using RsaI digestion. (A) Putative insertion site on chromosome 18 
where the closest known gene, Crem, is 260 kb from the BAC. (B-C) Putative 
insertion sites on chromosome 16 where the closest known gene, Olfr1, is 476.3 
kb (B) or 241.7 kb (C) from the BAC. A predicted non-coding mRNA 
(AC191865.2) is located 133.6 kb from one possible insertion site (B) and 100.8 
kb from the other site (C). Another predicted non-coding mRNA (AC191865.1) 
lies 237.8 kb (B) and 3.0 kb (C) from the possible insertion sites, respectively.  
Chromosome diagrams adapted from ENSEMBL. 
 
In order to further investigate the potential sites for localisation of the BAC, primers 
were designed (Appendix D, section D.2; F1, F22, F23 and R1-R5; Fig. 5.10 B, 
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Appendix B, Table B.4), which could be used in pairs to amplify the wild-type 
genomic sequence. In addition, the reverse primers (R1-5) were also used in 
combination with the pTARBAC-inverse primer (Figure 5.10 B). If the BAC is 
localised in the predicted region on chromosome 18 it was predicted that the reverse 
primers (Chr18_R1-R5) with pTARBAC-inverse primer should amplify genomic DNA 
of double and single transgenics, but not curly tail or wild-type samples, and this is 
indeed what was observed (Fig. 5.12 A-C). 
 
 
Figure 5.12 Genotyping using primers flanking the BAC region. (A-C) The 
pTARBAC-inverse primer used in combination with all reverse primers amplified 
the expected size products. DNA of single and double transgenic embryos 
amplified with R1-R5, whereas wild-type and curly tail samples did not amplify, 
as expected (*). Lanes: (1) +ct/+ct; (2) ct/ct; (3) ct/ctTgGrhl3; (4) ctTgGrhl3/ctTgGrhl3; (5) 
ct/ctTgGrhl3; (6) negative control. 
 
Sequencing of the product amplified using pTARBAC-inverse with Chr18-R4, made it 
possible to sequence across the insertion site of the BAC and therefore to generate a 
‘tag’ which corresponds to the chromosomal localisation (Appendix D, section D.3). 
Interrogation of the genomic database with this ‘tag’ sequence produced homology with 
several chromosomal locations (Table 5.7), all of which contained the HaeIII site. 
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Stats score Chr Location (Mb) % ID bp 
422 
374 
342 
332 
249 
139 
18 
15 
16 
16 
14 
19 
3,005,382 – 3,005,924 
74,916,993 – 74,917,205 
3,115,521 – 3,116,065 
3,350,523 – 3,351,069 
9,119,164 – 9,119,444 
61,299,655 – 61,299,967 
94.32 
94.24 
90.55 
90.04 
97.15 
85.76 
546 
486 
550 
552 
281 
323 
 
Table 5.7 Chromosomal locations which align with sequence fragments 
generated by BLAST analysis of the sequence tag at the BAC insertion site. 
Chromosome number (Chr.), region of the alignment, percentage of identification 
(% ID) and length of homologous region (base pairs, bp).  
 
Using CLUSTALW (http://align.genome.jp/), the genomic sequences corresponding to 
the sequence tag at the insertion site, plus 500 base pairs upstream and 500 base pairs 
downstream of it were aligned with chromosomes 18, 16 and 15 to search for regions 
that differ between these three chromosomes. This alignment allowed the design of a 
pair of primers that were unique to chromosome 15. The forward primer was designed 
87 bp upstream of the putative insertion site and the reverse primer 241 bp downstream 
(Chr15_F15/R15; Appendix B, Table B.4). None of BAC-positive samples generated a 
PCR product using a combination of pTARBAC-inverse with the Chr15_R15 primer, 
suggesting that the BAC was not located on chromosome 15. The chromosome 15 
primers did work in PCR since the F15/R15 primer pair amplified the expected 890 bp 
product (in all genotypes including ctTgGrhl3/ctTgGrhl3), while Chr_F15 generated a PCR 
product in combination with the non-chromosome specific primers R1-5, but with 
differing product size to that amplified using the chromosome 18-specific forward 
primer (see above, Fig. 5.12). 
 
Ideally it would have been possible to design a chromosome specific forward primer 
upstream of the putative BAC insertion sites on chromosomes 16 and 18. In 
combination with the R1-R5 reverse primers, the primer corresponding to the insertion 
site would be expected to amplify a PCR product from wild-type, curly tail and ‘single’ 
transgenics but not from double transgenic genomic DNA. However, although several 
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primer combinations were tested (Appendix B, Table B.4), design of chromosome-
specific forward primers was not possible owing to the low complexity repeat region in 
which the BAC is inserted.  
 
 
.2.8  Grhl3 expression pattern in double transgenic embryos 
The expression pattern of Grhl3 has previously been characterised in ct/ct and single 
BAC-transgenic embryos (Gustavsson et al., 2007). In order to investigate whether 
Grhl3 is expressed in ectopic locations in ctTgGrhl3/ctTgGrhl3 embryos, as well as at 
increased levels, whole mount in situ hybridisation (Chapter 2, section 2.10) was 
performed on embryos of each genotype at different stages of development during 
neural tube closure (Figures 5.13 – 17). 
 
At embryonic days 8.0 to 8.5, Grhl3 expression has been reported in the surface 
ectoderm adjacent to the tips of the neural folds (Fig. 5.14 A-B, and N. Greene, 
Personal Communication; (Ting et al., 2003a). In wild-type and curly tail embryos, 
whole mount in situ hybridisation for Grhl3 requires a relatively long period of signal 
development, of up to one week. In the current study, the development of signal was 
stopped at the point when intense expression was observed among a subset of the 
embryos, which were presumed to correspond to transgenics (later confirmed by 
genotyping). Therefore, at E8.0 Grhl3 expression was not detectable in ct/ct embryos 
(Fig. 5.13 A-C). Signal is observed along the lateral edges of the open neural folds in 
the caudal half of ct/ctTgGrhl3 embryos (Fig. 5.13 D-E), which corresponds to the surface 
ectoderm expression previously reported in wild-type embryos (Ting et al., 2003a) and 
using a Grhl3-Cre knock-in allele in combination with a conditional lacZ reporter 
(Camerer et al., 2010a). A more intense signal in a similar location was observed in 
ctTgGrhl3/ctTgGrhl3 (Fig. 5.13 G-M) embryos. At E8.5, Grhl3 expression was also observed 
in the anterior forebrain and at the lateral edges of the PNP in ctTgGrhl3/ctTgGrhl3 embryos 
(Fig. 5.13 N, O).  
5
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Figure 5.13 Grhl3 mRNA expression in curly tail and Grhl3 transgenic 
embryos determined by whole mount in situ hybridisation. (A-L) Grhl3 
expression at E8.0 in ct/ct (A-C), ct/ctTgGrhl3 (D-F), and ctTgGrhl3/ctTgGrhl3 (G-L) 
embryos. At this stage, no signal is detectable in ct/ct embryos (see text) while 
expression was evident in a line (red arrowheads in D-E) at the lateral edges of 
the neural folds (NF) in ct/ctTgGrhl3 embryos with a stronger signal in 
ctTgGrhl3/ctTgGrhl3 embryos (G-L). (M-O) Grhl3 expression at E8.5 in a 
ctTgGrhl3/ctTgGrhl3 embryo can be detected in the anterior forebrain (FB; M, O). 
Signal is also evident in the dorsal surface of the embryo (as seen from the side in 
M) and a ventral view (N) shows that this signal corresponds to the midline, 
thought to be the dorsal surface of the closed neural tube, (green arrowhead in M 
and O) and flanking the open neural folds in the posterior region (red arrowhead 
in N). Yellow arrowhead in N indicates expression in the primitive streak. Panels 
A, B, D, E, G, J, K, and M, side views; Panels C, F, H, and O, front views; 
Panels I and L, dorsal view; Panel O, ventral view. Scale bar: 0.1 mm. 
 
To investigate the level of Grhl3 expression further, E8.0 embryos were embedded in 
wax, sectioned and counter-stained with eosin (Chapter 2, section 2.11.1; Fig. 5.14). 
Grhl3 is strongly expressed along the body axis of ctTgGrhl3/ctTgGrhl3 embryos, in the 
surface ectoderm and neuroepithelium at the tips of the open neural folds (Fig. 5.14 
A.1-A.4). Weaker expression in a similar pattern was observed in ct/ctTgGrhl3 (Fig. 5.14 
B1-B4) but not detected in ct/ct (Fig. 5.14 C.1-C.4). Expression of Grhl3 has not 
previously been reported in the dorsal neuroepithelium, suggesting that there may be 
ectopic expression of Grhl3 at the tips of the neural folds in ctTgGrhl3/ctTgGrhl3 embryos at 
E8.0-8.5. 
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Figure 5.14 Sections of embryos at E8.0 following whole mount in situ 
hybridisation for Grhl3. Transverse sections through ctTgGrhl3/ctTgGrhl3 (A.1-A.4) 
ct/ctTgGrhl3 (B.1-B.4), and ct/ct (C.1-C.4) embryos at E8.0. The axial level of the 
sections is indicated in the whole mount images (A-C) and sites of Grhl3 
expression are indicated by black arrows. Grhl3 is strongly expressed in the 
surface ectoderm (SE) and neuroepithelium at the tips of the neural folds (NF) of 
ctTgGrhl3/ctTgGrhl3. Expression in the surface ectoderm (and possibly the neural 
folds) was detected in ct/ctTgGrhl3 transgenic embryos but was not in ct/ct embryos. 
Scale bars: 0.05 mm. 
 
At E8.5 – E9.5 expression of Grhl3 was less intense in ct/ct embryos than in ct/ctTgGrhl3 
and ctTgGrhl3/ctTgGrhl3 embryos where strong expression was observed (Fig. 5.15). In the 
three strains, Grhl3 is expressed in the posterior neuropore (Fig. 5.15 A-F) as well as in 
the ventral forebrain (Fig. 5.15 A, C, D). At these stages, the sites and intensity of 
expression of Grhl3 in ct/ctTgGrhl3 and ctTgGrhl3/ctTgGrhl3 embryos seemed to be similar. 
Interestingly, expression was observed in a caudal region which may correspond to the 
primitive streak (or possibly the hindgut pocket), and also at later stages in the tail bud 
(Fig. 5.15, F, L; 5.16). Expression of Grhl3 in the anterior forebrain was also observed 
throughout E9.5-E10.0 among embryos of all genotypes (e.g. ct/ctTgGrhl3 embryos in Fig. 
5.16). This expression was also observed in embryos that developed exencephaly (Fig. 
5.16 B). Strong expression was also observed at the level of the posterior neuropore of 
the closing neural folds of a ct/ctTgGrhl3 embryo (Fig. 5.16 A-C). In the caudal region of 
embryos later at E10.5, the most intense expression of Grhl3 was observed in the 
hindgut and the expression in dorsal tissues and the tail bud is absent or very weak (Fig. 
5.17).  
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Figure 5.15 Grhl3 expression pattern amongst embryos at E8.5-E9.5 stages of 
development. (A-B) E8.5 curly tail embryo showing expression in the ventral 
forebrain (FB), the posterior region of the extending trunk (red arrow, A), surface 
ectoderm of the closing neural folds (NF) at the cranial level, posterior region and 
primitive streak or gut pocket (red arrow, B). (C) Lateral and dorsal views of a 
ctTgGrhl3/ctTgGrhl3 embryo at E8.5 (at slightly later stage than A-B), showing 
expression in the posterior region caudally from the forming somites (red 
bracket), and in the ventral forebrain (FB). Yellow arrow in C indicates most 
caudal somite. (D) E8.5 ct/ctTgGrhl3 embryo with similar expression pattern to ct/ct, 
but with more intense staining which extends more rostrally staining in the 
posterior region, as in the ctTgGrhl3/ctTgGrhl3 embryo (red bracket). (E) A ct/ct 
embryo at early E9.5 shows expression in the anterior forebrain (FB) and 
posterior neuropore region (red bracket), as well as weakly in the tail bud. A 
comparable pattern is observed in a similarly staged ct/ctTgGrhl3 embryo (F), but 
staining is more intense. (G-L) Sections through the caudal region of the embryo 
in F.  (G) Grhl3 is not expressed in the upper spine where the neural tube (NT) is 
closed. (H-L) Expression is observed in the open neural folds (NF, H), and 
notochord (N, J) with increased intensity in more caudal sections. The primitive 
streak (PS), remnant with the tail bud, is strongly positive (K, L). Panels: A, C, D, 
F, side views; B, D, E, back views. Scale bars: A-F, 1.0 mm; G-L, 0.1 mm. 
 
To further examine the pattern of expression of Grhl3 in the caudal region of Grhl3 
transgenics at E10-E10.5, transverse sections were cut through this region (Fig. 5.16 D-
F; Chapter 2, section 2.11.2). Analysis of the sections confirmed that Grhl3 expression 
in the caudal region was localised to the tail bud and neural folds. Weak expression in 
the hindgut endoderm was also apparent on sections at the level of the closed neural 
tube (Fig. 5.16 D). 
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Figure 5.16 Expression of Grhl3 in ct/ctTgGrhl3 embryos at E10.0-E10.5. At 
E10.0 (A-B) and early E10.5 (C) expression was detected in the ventral forebrain 
(FB), and in the neural folds of the closing posterior neuropore as well as the tail 
bud (yellow arrowhead). Grhl3 expression is observed in embryos with 
exencephaly (Exenc, B), in a comparable pattern to embryos in which the cranial 
neural tube closed normally (A, C). (D-F) Sections of the caudal region of the 
embryo in panel C (at the levels indicated by the red lines). Expression is apparent 
in the neural tube (NT) and hindgut (Hg) at the level of the closed neural tube (D), 
in the open neural folds at the level of the posterior neuropore (E) and in the tail 
bud (F). Panels: A - C, side views. Scale bars: A-C, 1.0 mm; D-F, 0.1 mm. 
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The aim of the experiments described above was to characterise the Grhl3 expression 
pattern in BAC-transgenic embryos. Colour development for in situ hybridisation was 
allowed to proceed for the same period of time for embryos of all genotypes, to avoid 
over-development of signal in transgenic embryos but to allow comparison with 
comparably-developed ct/ct embryos. Longer periods of signal development reveal the 
pattern of expression of Grhl3 in ct/ct that was previously reported (Ting et al., 2003a; 
Gustavsson et al., 2008; Gustavsson et al., 2007). Analysis of embryos at intervals 
through the signal development process confirmed the elevated expression of Grhl3 in 
transgenic embryos. For example, E10.5 embryos that were photographed after: 8 hours 
and 16 hours of development (Fig. 5.17 A-F), emphasised the much more intense 
expression of Grhl3 in ct/ctTgGrhl3 and ctTgGrhl3/ctTgGrhl3 embryos (Fig. 5.17 B-C), than in 
ct/ct embryos (Fig. 5.17 A, D). Sections through the caudal region of the “16-hour” 
embryos revealed expression of Grhl3 in the hindgut of ct/ct (Fig. 5.17 G), but much 
more intense expression in the hindgut of transgenic embryos (Fig. 5.17 H-I). These 
sections also show the persistence of Grhl3 expression in the neural folds of transgenic 
embryos but absence from ct/ct. 
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Figure 5.17 Grhl3 expression at E10.5 at intervals of signal development. (A-
F) Grhl3 expression in the caudal region of E10.5 ct/ct (A, D), ct/ctTgGrhl3 (B, E) 
and ctTgGrhl3/ctTgGrhl3 (C, F) embryos. (G-I) Transverse sections at the axial level 
indicated by the dotted lines in D-F. After 8 hours of signal development (A-C), 
Grhl3 is faintly detectable in the hindgut of ct/ct embryos (arrow in A), while 
expression is already clearly evident in transgenic embryos (B-C). After 16 hours 
signal development expression is detected in the hindgut of ct/ct (arrow in D, G), 
as well as Grhl3 transgenic embryos with stronger expression in ctTgGrhl3/ctTgGrhl3 
(F, I) than in ct/ctTgGrhl3 (E, H) embryos. Grhl3 is expressed in the ventral neural 
folds (NF) of Grhl3 BAC-transgenics but not in curly tail embryos. Red 
arrowheads indicate the extent of the PNP. Scale bars: 0.5 mm in A-F, 0.1 mm in 
G-I.     
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5.3 Discussion 
 
The initial aim of this chapter was to investigate the possible effect of over-expression 
of Grhl3 on neural tube closure, using the Grhl3-trangenic curly tail mice. These 
experiments show that over-expression of Grhl3 can result in NTDs. Hence both, 
insufficient or excessive expression of Grhl3 can prevent spinal neural tube closure. 
Interestingly, the defects in some of the embryos that over-express Grhl3 differed 
markedly from those typically observed in ct/ct embryos. First, the double transgenic 
embryos have larger posterior neuropores than in ct/ct and this phenotype is apparent 
from an earlier developmental stage. Second, in approximately 50% of cases spina 
bifida was accompanied by a straight tail rather than curled tail. These factors suggest 
that there may be a different mechanism underlying the NTDs in these two strains.  
 
Localisation of the BAC in Grhl3 transgenic embryos by inverse PCR showed that it is 
present in a low complexity repeat region. While this made it difficult to determine 
precisely which chromosome carries the BAC, it is apparent that the BAC does not 
disrupt another gene. It also appears unlikely that regulatory regions distant from 
another gene are affected. However, one possible BAC-insertion site on chromosome 16 
lies only 3 kb from a predicted non-coding mRNA, and the possible effect of this should 
be further investigated. Overall, it appears likely that NTDs in double transgenics result 
from over-expression of Grhl3 rather than homozygous disruption of another locus. In 
support of this hypothesis, NTDs have recently been observed in Grhl3 single 
transgenic embryos (+/+TgGrhl3) on a BALB/c genetic background, where the ct 
mutation is absent (N. Greene, Personal Communication). Nevertheless, precise 
localisation of the BAC would potentially allow a genotyping method to be developed 
that would avoid the need for qG-PCR.  Another way of confirming the localisation of 
the BAC would be by fluorescence in situ hybridisation (FISH). For this reason, mouse 
primary fibroblast cell lines were generated from single transgenic embryos and wild-
type control strains for analysis of metaphase chromosomes (Chapter 2, sections 2.15, 
and 2.15.1). FISH will be performed in the near future, in collaboration with Dr. P. 
Gustavsson. 
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Use of quantitative real-time genomic PCR (qG-PCR) to evaluate the genomic copy 
number of Grhl3 enabled the differentiation of transgenic embryo samples into single 
and double transgenics to be used in subsequent experiments.  The gene copy number 
can be inferred through the level of Grhl3 DNA using a ct/ct sample to normalise with a 
value of 1.0, equivalent to two Grhl3 alleles and no BAC. Single transgenic embryos 
had a mean relative quantity of 2.5, which is predicted to correspond to the 2 
endogenous alleles and 3 “copies” of the BAC in hemizygosity. The predicted double 
transgenic embryos had a qG-PCR mean value of around 4.0, which corresponds to the 
two endogenous Grhl3 alleles and an estimated 6 “copies” of the BAC. Assuming that 
the chromosomal location of the BAC does not result in a higher apparent qG-PCR 
result, these data suggest that the BAC was inserted as a triplicate repeat.  
 
The high levels of Grhl3 expression in the double transgenic embryos and the fact they 
develop spina bifida, instigated an investigation of the expression pattern of Grhl3 
throughout stages of neural tube closure. Attardi et al (1993) demonstrated that the 
correct regulation of GRH is essential for proper development and viability in 
Drosophila, although it was unclear whether the defects induced by over-expressing 
full-length GRH resulted from abnormally high levels of GRH in cells in which it is 
normally present, expression of GRH in cells which it is not usually found, or both. 
 
In the current study it is possible that spina bifida resulting from over-expression of 
Grhl3 is due to excessive levels at the normal sites of expression. Alternatively, it is 
possible that expression also occurs at ectopic or temporally inappropriate sites. For 
example, Grhl3 expression in the neural folds is normally seen at E9.0, but it was found 
to persist in the ventral neural tube to E10.5 in Ghrl3-transgenic curly tail embryos 
(Gustavsson et al., 2007). 
  
In curly tail embryos, Grhl3 expression has been reported in the surface ectoderm 
adjacent to the neural folds and the most anterior neural folds in the forebrain at E8.5 
(Ting et al., 2003a; Gustavsson et al., 2007), although expression was barely detectable 
at E8.0 in this study. Between E9.0-E9.5, ct/ct embryos express Grhl3 in the tail bud, 
the open neural folds of the PNP and the ventral forebrain (Gustavsson et al., 2007). 
The expression in the open neural folds is no longer detected at later stages (E10.0-10.5) 
but expression is evident in the hindgut (Gustavsson et al., 2007). In this project, Grhl3 
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expression in ctTgGrhl3 embryos was clearly detectable in the surface ectoderm 
immediately lateral to the neural plate at E8.0-8.5. At later stages the expression pattern 
reproduced that observed in ct/ct, except that the signal was more intense and the 
expression in the ventral neural tube persisted until E10.5, the same stage at which 
Grhl3 is expressed in the hindgut (Fig. 5.13-5.17, and (Gustavsson et al., 2007). 
 
Expression of Grhl3 in ctTgGrhl3/ctTgGrhl3 embryos was very similar to that observed in 
ct/ctTgGrhl3 embryos but the signal was more intense. Interestingly, transverse sections 
through the neural folds of ctTgGrhl3/ctTgGrhl3 at E8.0, revealed expression of Grhl3 not 
only in the surface ectoderm, as expected (Ting et al., 2003a; Camerer et al., 2010b), but 
also in the tips of the neural folds. Thus, there appears to be ectopic expression of Grhl3 
in the dorsal neuroepithelium of ctTgGrhl3/ctTgGrhl3 embryos at E8.0-8.5, as well as 
abnormally persistent expression of Grhl3 in the ventral neuroepithelium at E10.0-10.5. 
 
Expression of Grhl3 in the tail bud has not been previously investigated and it is 
therefore not known whether altered expression in the tail bud relates to the 
development of tail flexion defects in ct/ct embryos. In addition, the biological function 
of Grhl3 expression in the posterior primitive streak has not yet been addressed. It has 
been shown that genes expressed in regions of the streak continue their expression in 
subpopulations of the tail bud (Gont et al., 1993; Wilson and Beddington, 1996). 
Sagittal sections of the posterior region of whole mount in situ hybridisation E8.5 
embryos could reveal the exact Grhl3 expression sites compared to fate maps of the 
primitive streak already existent in the literature, such as the one published by Wilson 
and Beddington (1996). The use of lineage trace markers could also be applied to 
embryos in culture followed by in situ hybridisation to see if cells of the primitive streak 
co-express with sites of Grhl3.  
 
In contrast to the rescue of spinal NTDs, transgenic embryos develop exencephaly with 
the same frequency as ct/ct embryos and there was no significant difference in the 
incidence of exencephaly between single and double transgenics. These data suggest 
that over-expression of Grhl3 does not exacerbate cranial neural tube closure. On the 
other hand, a role for insufficient expression of Grhl3 in the causation of exencephaly in 
ct/ct embryos cannot be ruled out as a low incidence of exencephaly has been reported 
in Grhl3 null embryos (Ting et al., 2003a; Yu et al., 2006e). However, it also appears 
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likely that the curly tail genetic background predisposes to exencephaly as folate 
deficiency can induce exencephaly in +ct/+ct embryos, but not in other wild-type strains 
(Burren et al., 2010). It will be necessary to analyse the expression level of Grhl3 in the 
cranial region at E8.5-9.0, to further investigate the correlation with failure of cranial 
neural tube closure. 
 
As described in Chapter 1, the cellular mechanism resulting in spina bifida and/or tail 
defects in curly tail embryos is a reduced proliferation rate in the hindgut and 
notochord, while normal proliferation occurs in the neural folds (Copp et al., 1988a; 
Copp, 1985a). In ct/ctTgGrhl3 embryos, enhanced Grhl3 expression correlates with an 
increased proliferation rate in the hindgut and consequent normalisation of neural tube 
closure (Gustavsson et al., 2007). It has not yet been investigated whether Grhl3 
expression in the neural folds, detectable at E9.5, is necessary for neural tube closure in 
the spinal region. However, expression is not detected in the spinal neural folds in ct/ct 
or wild-type embryos at E10.5, while it is present in ct/ctTgGrhl3 embryos that develop 
normally. Whether this expression has any functional effect has yet to be determined. 
For example, it would be of interest to examine expression of dorso-ventrally restricted 
genes, such as the floor plate marker sonic hedgehog (Shh), to test whether the 
persistent expression of Grhl3 in the ventral neural folds perturbs overall patterning.  
 
The cellular basis of NTDs in ctTgGrhl3/ctTgGrhl3 embryos and indeed in Grhl3 null 
embryos remains to be determined. The phenotype and earlier onset of PNP delay in 
double transgenic embryos suggest that the mechanism underlying NTDs could differ 
from ct/ct embryos, and it could be speculated that the over-expression of Grhl3 in the 
neural folds plays a role. Excess Grhl3 could potentially misregulate target genes in the 
neural folds, perhaps leading to an effect on proliferation. Given that Grhl3 up-
regulation in the hindgut stimulates proliferation, it is possible that there could be a 
similar effect in the neural folds. At E9.5-10.5, this expression is in the ventral neural 
folds and it could be hypothesised that a proliferation imbalance between the dorsal and 
ventral neural folds would hinder closure. Indeed, a similar mechanism has been 
suggested to underlie exencephaly in the Phactr4 mutant mouse (Kim et al., 2007). 
Alternatively, a mechanism related to faulty fusion of the neural folds might be 
implicated. For example, the ectopic expression of Grhl3 in the tips of the neural folds 
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in ctTgGrhl3/ctTgGrhl3 embryos, as well as in the overlying surface ectoderm, might exert a 
cellular effect that compromises the fusion process.  
 
Would other defects, unrelated to NTDs, be expected in the ctTgGrhl3/ctTgGrhl3 embryos? 
Grhl3 null embryos show defective skin barrier formation in addition to NTDs. In 
epidermal wound healing, Grainy head-like transcription factors (dGrh, Grhl3 in 
mammals) drive expression of proteins that participate in cross-linking of barrier 
components (Mace et al., 2005; Ting et al., 2005; Yu et al., 2006d). In a microarray 
analysis of skin at E18.8 (Yu et al., 2006c) there was a decrease in the expression of a 
large number of tight junction molecules, including claudin and occludin which may 
contribute to the barrier defect of the null-Grhl3 mice. In addition, Grhl3 mutant mice 
also have defective epithelial barrier formation in the bladder, resulting from failure of 
apical membrane specialization (Yu et al., 2009). Grhl3 knockout mice have an open-
eye phenotype at birth, thought to result from loss of the downstream effects of this 
gene in actin polymerisation and filopodia formation, required for migration and 
differentiation of epithelial cells at the leading edge during eyelid closure (Yu et al., 
2006b; Yu et al., 2008). Whether there is an overall epidermal barrier and/or terminal 
differentiation effects in the same tissues in the curly tail transgenic embryos over-
expressing Grhl3, in addition to failure of neural tube closure, has yet to be determined.  
 
Key questions remain to be answered in relation to the development of spinal NTDs 
caused by over- or under-expression of Grhl3. What genes are direct targets of Grhl3 
during neural tube closure (activated or suppressed by Grhl3) and which of these are 
misregulated in association with development of NTDs? These questions have been 
addressed in two different ways, by 2D gel analysis (Chapter 3) and in a microarray 
comparing samples of the caudal region of the curly tail, wild-type, single and double 
transgenic strains (N. Greene, personal communication). In future, 2D gels will be 
generated using samples of double transgenic embryos in order to determine whether 
there are specific proteome changes in comparison to the three other strains. It is 
hypothesised that one or more of the Grhl3 target genes are essential for the timing of 
the development of certain tissues in the mouse embryo (characterised by the dynamic 
spatio-temporal Grhl3 expression). Faulty regulation of these target genes in ct/ct or 
double transgenic embryos is suggested to contribute to the NTD phenotype. Also, it is 
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possible that over-expression of Grhl3 affects novel targets, or disrupts function of 
binding partners (Kudryavtseva et al., 2003; Yu et al., 2006a). 
 
In conclusion, this chapter has identified a deleterious effect of over-expression of 
Grhl3 that is analogous to the loss-of-function effect (neural tube closure failure) but is 
distinct in precise timing and phenotype. Further comparative analysis of this 
over/under expression phenomenon should significantly advance our understanding of 
the role of Grhl3 in mouse neurulation.  
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Chapter 6 
 
 
General Discussion 
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6.1 Identification of a polymorphism in lamin B1 that modifies risk of NTDs 
In this project, investigation of possible abnormalities in the curly tail proteome by two-
dimensional protein electrophoresis revealed several proteins whose differential 
abundance may be influenced by Grhl3 expression level. However, the most striking 
difference between wild-type and curly tail was in migration of lamin B1 protein spots, 
which led to the identification of a polymorphism in lamin B1. Proteomic studies often 
focus on identification of proteins whose abundance differs under different conditions 
or in particular disease states. In contrast, few studies have used 2-DE and mass 
spectrometry to define the genetically encoded variations in proteins in related mouse 
strains. This information can be revealed, as in this study, by altered migration of 
proteins on 2-DE. In one study using large-scale 2D gels a comparison of the distantly 
related mouse strains, Mus musculus C57BL/6 and Mus spretus, found consistent 
differences in 1,000 of 9,000 detected proteins. Among these differences around one-
third corresponded to variation in protein migration some of which were attributed to 
amino acid variation (Klose et al., 2002). In other cases genetic mapping of the protein 
phenotype implied that migration differences were secondary to polymorphism in other 
proteins. Another recent 2-DE based study of inbred mouse strains that differ in 
susceptibility to experimental autoimmune encephalomyelitis found missense variants 
in around 5% of proteins analysed (Mikkat et al., 2010). In the strains used in the 
current study it is anticipated the far fewer proteins will show sequence variation as the 
wild-type (+ct) and curly tail strains are predicted to share more than 93.8% genetic 
background. Thus, while polymorphisms will be evident at the level of genomic or 
mRNA sequence, proteomic approaches may be useful to identify protein variants, 
particularly in strains for which full genomic sequence is not available. 
 
The variation in length of glutamate repeat in lamin B1 (8 or 9 residues) appears to have 
a functional effect on the stability of lamin B1 within the nuclear envelope and to 
influence morphology of the nucleus. Notably, the lamin B1 variants influenced the 
penetrance of NTDs in the curly tail mouse, suggesting that lamin B1 is a modifier gene 
for NTDs, at least in this model. A survey of 150 mouse mutants known in the literature 
showed that only 20% exhibit risk of either exencephaly and spina bifida or both, 
whereas 70% only develop exencephaly (Harris and Juriloff, 2007). Reduced expression 
of Grhl3 can cause both spina bifida and exencephaly, and it is now apparent that 
Lmnb1 can modify the risk of both conditions. 
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It is not yet know whether the 8E lamin B1 variant exacerbates a deleterious 
consequence of the diminished Grhl3 expression in curly tail or increases the 
susceptibility to NTDs through an independent mechanism. The finding that nuclear 
morphology is partially normalised in ct/ctTgGrhl3 cells, which over-express Grhl3 but 
carry the 8E lamin B1 allele, perhaps argues that both lamin B1 and Grhl3 can 
functionally affect nuclear structure and this is the basis of the genetic interaction. On 
the other hand, mild tail flexion defects and occasional exencephaly have been observed 
in wild-type embryos carrying the 8E lamin B1 variant (+ct;8E), which suggests that on a 
permissive genetic background for NTDs the lamin B1 variant can cause NTDs even in 
the absence of a Grhl3 mutation. This finding raises the possibility that lamin B1 
polymorphisms could influence susceptibility to NTDs in other models. 
 
Interestingly, the Lmnb1 glutamic acid variant is present in the genetic background of 
splotch (Sp2H) mutant mice in our laboratory. Splotch (Sp2H) carry a mutation in the 
transcription factor Pax3 (paired box gene 3), and homozygous embryos develop 
exencephaly (around 60% frequency) and almost fully penetrant spina bifida (Greene et 
al., 2009a). The primary cellular defect leading to NTDs in these embryos is in the 
neuroepithelium and neural crest cell migration is also defective (Greene et al., 2009a). 
As in curly tail, the frequency of NTDs in splotch mutants is also influenced by genetic 
background and environmental factors (Greene et al., 2009a). Homozygotes for another 
mutant allele of Pax3, the Pax3-Cre knock-in (Engleka et al., 2005), also display spina 
bifida in most cases but the frequency of exencephaly is only around 25% in our 
laboratory (N Greene, Personal Communication). Since both the Sp2H and Pax3-Cre 
knock-in alleles are thought to be functionally null alleles, it is intriguing to speculate 
that the differences in frequency of exencephaly relates in part to an effect of the lamin 
B1 polymorphism. In future, it would be interesting to generate a splotch line carrying 
the lamin B1 9E variant, to test whether there is a decline in the penetrance of cranial 
NTDs. 
 
 
6.2 Lamin B1 as a candidate gene to affect risk of human NTDs  
Curly tail is probably the best characterised mouse model of spina bifida and similar to 
human NTDs, the risk is attributed to multifactorial inheritance and environmental 
factors (Van Straaten and Copp, 2001). The identification of lamin B1 as a modifier 
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gene raises the possibility that lamin B1 polymorphisms could influence risk of NTDs 
in humans. The glutamate repeat contains 8 residues in humans, perhaps casting doubt 
as to whether this repeat is likely to be deleterious for neural tube closure in humans. To 
follow up this study, it would be interesting to sequence human LMNB1 in a cohort of 
spina bifida and exencephaly patients. 
 
Duplications in LMNB1 (over-expression) have been associated with the demyelinating 
disease adult-onset autosomal dominant leukodystrophy (ADLD; (Padiath et al., 2006; 
Meijer et al., 2008). In spite of the fact that ADLD has a phenotype similar to chronic 
progressive multiple sclerosis (MS), no duplications/deletions or point mutations were 
identified in a study of MS patients (Brussino et al., 2009). More recently, an Italian 
family with ADLD but without mutations in LMNB1 has been reported, suggesting that 
ADLD is clinically and genetically heterogeneous (Brussino et al., 2010).  
 
 
6.3  Possible relationship between lamin B1 and the effect of inositol status on 
risk of NTDs 
Depletion of inositol in media used for whole embryo culture causes NTDs (Cockroft et 
al., 1992). Interestingly, embryos of the CBA and curly tail strains showed similar high 
incidence of cranial defects compared to the inbred PO (Pathology Oxford) strain. It 
was suggested that the greater sensitivity of the ct and CBA strains, compared to PO, 
was due to background genetic differences between the strains since ct and CBA share a 
similar background. In the current project it was shown that this shared genetic 
background includes the 8E lamin B1 variant, which affected susceptibility to cranial as 
well as spinal NTDs, and may therefore be implicated in predisposition to inositol 
deficiency-induced NTDs. 
 
Spinal NTDs in curly tail embryos can be prevented by inositol supplementation at the 
time of posterior neuropore closure (Greene and Copp, 1997). This effect is exerted 
through protein kinase C (PKC), downstream of the inositol phospholipid cycle, which 
acts to phosphorylate as yet unknown target proteins and stimulates proliferation in the 
hindgut (Greene and Copp, 1997; Cogram et al., 2004). Interestingly, human lamin B1 
protein is phosphorylated by protein kinase C-βII at serines 395 and 405 in the 
carboxyl-terminal domain, immediately adjacent to the central α-helical rod-domain 
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(Hocevar et al., 1993; Goss et al., 1994). In addition, in the mouse lamin B1 has been 
found to be a PKC-binding protein, where amino acids 200-217 of the calcium-
dependent lipid binding (CaLB) domain of PKC-α seem to be essential for binding of 
lamin B1 at the carboxyl-terminus of the protein (Martelli et al., 2000; Tabellini et al., 
2002). Another study have shown that the inositide-specific phospholipase Cβ1 
(PLCβ1) also co-localises and physically interacts with lamin B1, and may play a role in 
G2/M progression of the cell cycle (Fiume et al., 2009).   
 
As lamin B1 is a potential target for PKC it would be of interest to determine whether 
the tail domain of lamin B1 can interact with PKCßI and/or γ, the isoforms required for 
prevention of NTDs in curly tail (Cogram et al., 2004). To test for a functional role of 
lamin B1 phosphorylation in the protective mechanism of inositol it would be necessary 
to investigate the possibility of differential phosphorylation in inositol-treated and 
untreated samples. These two experiments might provide a clue to a possible correlation 
between inositol status and lamin B1 function in the rescue of spina bifida in curly tail.  
 
 
6.4 Grainyhead-like-3 and the pathogenesis of NTDs 
In parallel with studies on the curly tail mouse, in which Grhl3 is expressed at 
diminished levels, this project also investigated the effects of over-expressing Grhl3 by 
making use of the ctTgGrhl3 strain. The presence of severe spinal NTDs in ‘double’ 
transgenic embryos, demonstrated that both over-expression, as well as insufficient 
expression of Grhl3 can cause NTDs. Together these data suggest that regulation of 
Grhl3 expression is crucial for neural tube closure (summarised in Figure 6.1). 
 
Key questions remain to be answered related to the role of Grhl3 and the mechanism of 
neural tube closure. Primary neurulation of the spinal cord involves elevation of the 
neural plate, apposition of the neural folds and their subsequent fusion. Neural fold 
elevation involves cell shape changes, cell rearrangements and cell division within the 
neuroepithelium. In addition, forces extrinsic to the neuroepithelium can affect closure, 
as is the case in curly tail embryos where reduced proliferation in the hindgut leads 
indirectly to impaired closure (Greene and Copp, 2004). As Grhl3 is a transcription 
factor the deleterious effect of altered expression levels is presumed to result from miss-
regulation of target genes. A key step in understanding development of NTDs in curly 
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tail and Grhl3-transgenic embryos will be identification of the key downstream genes. 
The possible range of genes that could be involved is illustrated by the large number 
and diversity of mouse models for NTDs (Harris and Juriloff, 2007; Harris and Juriloff, 
2010). The genes implicated include transcription factors, signalling proteins, 
cytoskeletal proteins, cell membrane proteins, nuclear receptors and tumor repressors. 
 
The causative defect in curly tail embryos is localised in the hindgut, resulting in 
increased axial curvature which is apparent from about the 25 somite stage and more 
evident at somite stages 27-29 (Brook et al., 1991). The proliferation defect correlates 
with the expression of Grhl3 in the hindgut at this stage. In contrast, measurements of 
the posterior neuropore in ctTgGrhl3/ctTgGrhl3 embryos suggest that the defects arise earlier 
in development than in ct/ct, at a stage when Grhl3 is expressed in the surface ectoderm 
and neuroepithelium.  The stage at which defects arise in Grhl3-/- embryos has not been 
accurately determined (Ting et al., 2003a; Rifat et al., 2010), but recent studies in our 
laboratory suggest that closure fails from as early as the 15 somite stage (Dr N Greene, 
Personal Communication). 
 
In embryos with moderately up-regulated expression of Grhl3 (ct/ctTgGrhl3), expression 
was first detected in the surface ectoderm adjacent to the tips of the dorsal neural folds. 
This correlates with expression reported in wild-type embryos (N Greene, Personal 
Communication) and in embryos carrying a Grhl3-Cre knock-in allele with a lacZ 
reporter (Camerer et al., 2010b). Expression of Grhl3 in ctTgGrhl3/ctTgGrhl3 embryos is 
observed in appropriate sites but at higher intensity, but it is also detected in the dorsal 
neural folds at E8.5. Therefore, it is possible that the cellular defect which causes spinal 
NTDs in these embryos could be localised in the surface ectoderm, neural folds or both. 
Expression of Grhl3 also persists in the ventral neural folds of ctTgGrhl3/ctTgGrhl3 at E10.5, 
a later stage than observed in wild-type embryos. However, as spinal neural tube closure 
is already abnormal prior to this stage the ectopic expression in the ventral neural folds 
appears less likely to be the cause of NTDs.  
 
In order to test further the tissue localisation of the causative defect in Grhl3 over-
expressing embryos it may be possible to make use of intercrosses between Grhl3 over-
expressing and conditional mutant mice. An initial experiment would be to test whether 
knock-out of endogenous Grhl3 is sufficient to rescue the Grhl3 over-expression 
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phenotype, and vice versa. If double homozygotes do not show NTDs it would suggest 
that the Grhl3 expression level has been brought within a range that is compatible with 
neural tube closure. In this case it may then be possible to make use of conditional 
Grhl3 mutant mice (Yu et al., 2006), together with mice expressing Cre recombinase in 
the neuroepithlium which would allow deletion of Grhl3 selectively in this tissue. A 
breeding scheme would be performed to generate embryos in which endogenous Grhl3 
is deleted specifically in the neural folds but Grhl3 is over-expressed from the BAC in 
homozygosity. If these embryos complete neural tube closure it would suggest that 
NTDs associated with Grhl3 over-expression result from a defect in the 
neuroepithelium, that is rescued by reduction of Grhl3 expression in this tissue (through 
deletion of the endogenous gene). 
 
Ybot-Gonzalez et al. (2002) showed that DLHP formation requires signals from the 
surface ectoderm, and it could be hypothesised that Grhl3 expression in the surface 
ectoderm is required for this signalling. It has been reported that dorsolateral hinge 
points (DLHP), which are normally formed in the neural folds from E9.5 (Ybot-
Gonzalez et al., 2007a), are absent in the neural folds of Grhl3 P-/-P embryos (Rifat et al., 
2010). However, this phenotype was shown in sections at E10.5 and distant from the 
site where closure fails so it is possible that the reported lack of DLHPs is a secondary 
consequence of a very large open PNP. To investigate the possible contribution of 
abnormal DLHP formation in Grhl3 P-/-P spinal NTDs, it will be necessary to analyse 
transverse sections through the caudal region of embryos from somite stage 14-15. The 
presence or absence of DLHP in ct PTgGrhl3P/ctPTgGrhl3 P embryos has not yet been assessed. 
 
It is thought that the initial contact of the neural folds during closure may occur at the 
junction of neural folds and surface ectoderm. It is therefore possible that the loss or 
over-expression of Grhl3 may have a cell autonomous effect leading to failure of the 
fusion process. Alternatively, over-expression of Grhl3 in an ectopic location in the 
dorsal neural folds at E8.5 may alter cellular properties required for closure. As Grhl3 is 
required for correct proliferation in the hindgut, it could be speculated that high levels 
of Grhl3 could result in excessively high proliferation rates in the neural folds that 
compromise closure. Overall, differences in the stage at which defects arise and the 
possible affected tissues will need to be considered in analysing gene expression 
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abnormalities that may be causally related to NTDs in the Grhl3 related models (Table 
6.1). 
 
Strain 
Predicted site of cellular 
defect 
Possible mechanism 
ct/ct Hindgut Proliferation 
ctPTgGrhl3 P/ctPTgGrhl3 P 
Surface ectoderm? 
Neural folds? 
Grhl3 P-/-P 
Surface ectoderm? 
Neural folds (?) 
Proliferation? 
Fusion? 
Signalling – DLHP? 
 
Table 6.1 Possible mechanisms underlying development of NTDs in Grhl3 
related mouse models. In ct/ct the spinal NTDs are due to a proliferation defect 
in the hindgut. The molecular and cellular defects leading to NTDs in Grhl3 null 
or over-expressing mice remain to be determined. Abbreviation: DLHP, 
dorsolateral hinge points. 
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Figure 6.1 The relationship between Grhl3 expression and development of 
NTDs.  (A) Grhl3 domains (blue) of expression during the events of neural tube 
closure in the ct/ctPTgGrhl3P strain. (1) From E7.5 Grhl3 is expressed dorsally in the 
surface ectoderm, at the tips of the neural folds (NF) after initial site of neural 
tube closure (Closure 1). (2) At the spinal level, E9.0-9.5, Grhl3 is expressed in 
the ventral neural folds including the floor plate (FP). During this period, 
dorsolateral hinge points (DLHP) are formed, which facilitate apposition of the 
tips of the folds. (3) At E10.5, neural tube closure culminates with adhesion and 
fusion of the folds at the level of the posterior neuropore, when Grhl3 is expressed 
in the hindgut endoderm and still expressed in the ventral neural folds (although 
this expression is not detected in wild-type or ct/ct embryos. (B) The 
ctPTgGrhl3 P/ctPTgGrhl3 P embryos exhibit the same domains of Grhl3 expression as in 
ct/ctPTgGrhl3 P, but expression levels are elevated. In addition, expression is observed 
in the dorsal neural folds at E8.5. Spinal closure fails in these embryos from E9.5. 
(C) Curly tail embryos express low levels of Grhl3. At E10.0 a cellular defect in 
the hindgut (Hgut) and notochord (N) leads to ventral curvature, this mechanically 
apposes dorsal closure of the neural folds, resulting in spina bifida. Closure 1 
occurs normally in the ctPTgGrhl3P/ctPTgGrhl3 P and in ct/ct embryos. Abbreviations: Mes, 
mesoderm; MHP, median hinge point; SE, surface ectoderm. 
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6.5 GRHL3 as a candidate gene for NTDs in humans 
The human orthologue of Grhl3 is localised on human chromosome 1p36, a region 
often somatically deleted in Merckel cell carcinoma (Leonard et al., 2000), basal cell 
carcinomas (Jin et al., 2001), and melanoma (Zhang et al., 1999). Whether GRHL3 itself 
is involved in these conditions is yet to be determined. 
 
As loss of Grhl3 function causes NTDs in mice it is speculated that GRHL3 represents a 
candidate gene for NTDs in humans, but to date no putative GRHL3 mutations have 
been reported. However, studies in the mouse have shown that regulation of Grhl3 
expression level is critically important for neural tube closure, even when the coding 
sequence is intact. This raises the possibility that regulatory mutations, which affect 
expression levels of GRHL3, could also increase risk of NTDs in the human population. 
It would also be of interest to screen NTD cases for variation in GRHL3 gene copy 
number that could affect the expression level during development. 
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